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ABSTRACT 
Biases in medical research are becoming acknowledged as a serious and increasing problem for 
medicine all over the world. They compromise the evaluation of the real effects of drugs, and 
jeopardise the possibility of evidence-based decisions and knowledge in medical practice. The 
current measures adopted to attempt to reduce them, although important and necessary, seem to 
have had only a limited effect. The fundamental aim of this study is to be a piece of exploratory 
research on the possible factors involved in medical education that can be related to the existence 
of bias in medical research. 
The randomised controlled trial, the main research method in much of medical research, is 
analysed concerning its strengths and weaknesses as a scientific instrument and the most common 
biases that may occur in this research method are evaluated. Questionnaires and interviews with 
students and teachers of five medical schools in Parana State (Brazil) were used to appraise 
aspects of a potential connection between medical education and the aforementioned problems in 
medical research. Qualitative and quantitative analyses of the data obtained were performed. 
The level of awareness about bias in research, in these schools, was evaluated as insufficient and 
fragmentary. Some critical obstacles, related to the transmission of knowledge about bias to the 
students, were identified. There is evidence that, at least in the schools involved in this research, 
the problem of bias is considered as a minor issue, when compared with other structural and 
educational problems. Possible solutions to the problem of low level of awareness about bias in 
research were collected by the research instruments employed, and are discussed in regard to their 
potential efficacy and feasibility. 
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Chapter 1 
An overview of bias in medical research 
1.1 Introduction 
As a physician and a teacher, when I first had contact with the theoretical concepts of 
'evidence-based medicine' and 'evidence-based medical education' about ten years ago 
they seemed rather relevant for improving medical practice. Although I had some 
reservations about the use of the term 'evidence-based medicine', because I believed that 
modem medicine was already based on current medical evidence, the forecast of being 
able to use straightforwardly the results of trials, systematic reviews and meta-analyses in 
clinical practice was quite appealing. 
A posteriori evaluation of the problems of modem medical research and its 
methodological framework showed me that it would be extremely difficult to rely on 
existing 'evidence' due to the high number of biased studies. My initial reasoning about 
the problem was that the biased 'evidence' was jeopardising the progress of modem 
medical education. However, there was also evidence that many medical researchers were 
not being prepared for correctly using the new methods of medical research (Altman, 
1994), and that many physicians were not equipped to critically appraise the results of 
such research (Kenny, 1997): 
The initial education of most physicians practising today was didactic and fact-
oriented. Ironically, this fact orientation is inimical to the scientific enterprise 
and to the skills of inquiry essential to science. Such education does not help 
students develop skills for assessing and judging new knowledge or managing 
uncertainty. An element in physicians' difficulties in incorporating new 
information is clearly rooted in their initial education. (Kenny, 1997, p.35) 
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From such a perspective, contrary to my initial belief about the problem, current medical 
education could be one of the causes of the incidence of bias in medical research. Based 
on this assumption, the present study was structured focusing on one main objective: to 
evaluate and discuss the relationship between current medical education and the incidence 
of bias in medical research and the potential deleterious influences they might have over 
each other. 
This chapter aims to introduce the concept of bias, and more specifically bias in medical 
research, as an initial step to the appreciation of the problems it represents to medical 
education and research. It also includes an evaluation of the most important research 
method of modern trials in medicine: the randomised controlled trial (RCT), considering 
its strengths and weaknesses. 
Although 'bias' has many connotations, the Oxford English Dictionary defines it as 'a 
systematic distortion of a statistical result due to a factor not allowed for in its derivation' 
(Pearsall, 2001, p.130). In medical research, the definition most frequently used is 'any 
process at any stage of inference which tends to produce results or conclusions that differ 
systematically from the truth' (Sackett, 1979, p.60). 
The discussion about bias in science (Martin, 1979), and in medical research (Jadad, 
1998a), is not something new. It includes aspects of research from deviations conditioned 
by social and political forces (Martin, 1979) to pure methodological deviations. There is a 
whole range of factors that can lead to research results that differ systematically from the 
truth (Sackett, 1979). 
The possibility of bias in medical research began to receive more attention by researchers 
at the end of the 1970s. The reason for this was a modification in the research 
methodology of papers published in general medical journals. This modification of 
methodology had taken place progressively since the publication of the paper 'The 
Clinical Trial', written by Sir Austin Bradford Hill and published by the New England 
Journal of Medicine in 1952 (Hill, 1952). However, in the 1970s, researchers were 
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increasingly adopting case-control studies methodology, since this allows the researcher 
to obtain rapid results, at a low cost, and using what were then new computer based 
statistical methods (Sackett, 1979). Moreover, the results of such studies were more 
reproducible under different research circumstances, which allowed researchers to 
compare their outcomes. 
Case-control studies have a number of different methodological designs. However, the 
basic structure consists of submitting two or more groups of patients to different 
procedures or treatments and then comparing the outcomes. One of the problems of case-
control studies is that they are very prone to showing biased results. In a pioneer paper in 
1979, David Sackett presented a catalogue of 35 examples of bias that occurred in case-
control studies which could distort the design, execution, analysis and interpretation of 
research (Sackett, 1979). He discussed nine of these, and described the prospects for the 
recognition and prevention of these biases. The most common source of bias was the lack 
of randomisation of participants. 
The fundamental difference between the initial case-control medical trials of the 1950s 
and today's trials is that 50 years ago most of the studies lacked the present requirements 
of scientific standards, particularly with regard to the planning and conduct of the study, 
and the reporting of the results (Salzberg and Muller, 2003). This was the reason for the 
adoption of the Randomised Controlled Trial (RCT) as the gold standard research method 
in medicine. It seemed a natural evolution of the case-control studies, and provided an 
apparently perfect approach to correct the main cause of bias in these studies: the 
randomisation of participants (Jadad, 1998b). It also had more stringent methodological 
rules and quality requirements which, at least theoretically, allowed the researcher to be 
more confident ofthe results ofhis/her trials (Salzberg and Muller, 2003). 
However, the RCT only solves the problem of randomisation of participants. As will be 
explained in the following sections, it does not offer any protection either against the 
other categories of bias that occur in case-control studies (Jadad, 1998a), or intentional 
(or unintentional) methodological deviations in all the phases of a study. Also, one must 
be aware that many trials comparing an intervention with a control group are not really 
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RCTs, if they do not follow rigorously the principles of randomisation (Greenhalgh, 
2001). 
1.2 The randomised controlled trial (ReT) as the main research 
method in medicine 
In order to understand why RCTs (and before them, case-control studies) are recognised 
as the standard method of research in medicine it is necessary to review some historical 
aspects of medical research. Most of the research done before the nineteenth century 
essentially consisted of descriptions of observations about some aspects of a disease in 
one or a few patients in a qualitative way. However, some before/after trials in the 
eighteenth century demonstrated that it was possible to obtain results that were reliable 
and reproducible (Bull, 1959). The structure of before/after trials became progressively 
more sophisticated during the nineteenth century, and became the most common research 
method in medicine in the first decades of the twentieth century. 
According to Doll (1998), these studies suffered from a series of methodological 
weaknesses: 
When I qualified in Medicine in 1937, new treatments were almost always 
introduced on the grounds that in the hands of professor A ... the results in a 
small series of patients ... had been superior to those recorded by professor B ... 
Variability of outcome, chance ... and (the) selection of patients brought about 
apparently important differences in the results obtained... Standard treatments, 
for their part, tended to be passed from one textbook to another without ever 
being adequately evaluated. (Doll, 1998, p.1217) 
The history of controlled trials according to some authors may be traced back to 1747. 
Since this year, there were sporadic attempts to use trials in medical research. At the 
beginning of the 1930's, the British Medical Research Council suggested the alternation 
of treatment among patients with treatment alternating between two different methods. 
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However, according to Doll (1998), the introduction of the controlled trial in its present 
structure only began after 1946. In spite of the obvious improvement for the comparison 
of two or more medical procedures, it only assumed its position as the standard of 
medical research several years after this date. This delay was due to the opposition of 
medical researchers to adopt it, and to accept its results (Everitt and Pickles, 2000). 
In 1952, Daniels and Hill published their results on chemotherapy of pulmonary 
tuberculosis in the British Medical Journal using an improved method of trial (Daniels 
and Hill, 1952). An article by Hill in the New England Journal of Medicine (Hill, 1952) 
explaining the new structure of research used is considered today as the landmark of the 
modern RCT. 
The straightforward design of the clinical trial described by Hill (1952) has subsequently 
been submitted to several changes, increasing its complexity and variety of applications 
in medical research. In addition, the number of categories of RCTs has increased, and a 
RCT is currently classified, according to Jadad, in relation to: 
The aspect of the interventions investigators want to explore. 
The way in which the participants are exposed to the interventions. 
The number of participants included in the study. 
Whether the investigators and participants know which intervention is being 
assessed. 
Whether the preferences of non-randomised individuals and participants are taken 
into account in the design ofthe study. (Jadad, 1998b, pp.l 0-11) 
According to Jadad (1998b), using his classification, there were 16 different types of 
RCTs being employed in research in 1998. This is an indication of the importance and 
widespread use ofRCTs in medical research. 
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As a quantitative and comparative approach to evaluate therapeutic interventions in 
medical practice, the RCT seemed to be a good research option. Additionally, it allows 
researchers to compare their results with the outcomes of other trials using a statistical 
approach. The random allocation of the participants theoretically permits researchers to 
balance unknown prognostic factors, a feature that no other study design ever had in 
medical research (Jadad et al., 1996). 
As the types and complexity of RCTs increased, the possibility of methodological 
deviations and the dependence of researchers on more sophisticated statistical tools also 
increased. Additionally, the difficulties of researchers to understand the ever-growing 
number of different research designs also became more profound (Sackett, 2001). 
1.3 Strengths and weaknesses of RCTs 
Swinscow states that the most powerful studies are the prospective studies (studies where 
the data are collected after the study structure is done), and in medicine the RCT is the 
paradigm of such a study design (Swinscow, 1996). If correctly designed, the RCT 
permits the researcher to do a rigorous evaluation of a single variable in a defmed patient 
group. It also avoids the occurrence of selection bias by comparing two groups that, at 
least theoretically, only differ by the medical intervention under study. As a quantitative 
research method, it generally allows the combination of numerical results of several 
similar trials through meta-analysis (Greenhalgh, 2001). 
This is an important feature of RCTs because most such studies have a limited number of 
participants, and the possibility of enhancing the external validity is undoubtedly a 
positive characteristic. As Egger et at. (2003) point out, one must remember that the 
smaller a study, the larger the effect of a medical procedure required for the results to be 
declared statistically significant. This methodological characteristic could prevent 
researchers from evaluating the real outcome of a procedure that has a small effect, unless 
an isolated RCT had the sufficient number of participants. This is seldom attainable due 
to financial and time constrains. 
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Depending on the research question, a RCT can be as reliable and less expensive than an 
observational prospective cohort study. Although cohort studies are a very powerful 
medical research method employed to evaluate the incidence and potential causes of a 
disease, they are extremely expensive and time consuming (Hulley et al., 2001). As an 
example, the Nurses' Health Study (Fuchs et al., 1999) had as participants 121.700 
American nurses that were observed by the researchers for almost 20 years. Conversely, a 
RCT can be done in a much smaller period of time, especially if the variable under study 
is continuous and changes rapidly with the intervention (Hulley et aI., 2001). 
The above mentioned characteristics of the RCT were undoubtedly fundamental to the 
acceptance of this method as the most important research design for medical research in 
the last 50 years. Actually, the apparent strength of RCTs as a controlled experimental 
design led some authors to recommend them to other areas of science, such as sociology 
(Oakley, 1998). 
However, RCTs also have their limitations and problems, as does any research method, 
although many of them are not obvious to many researchers. Their strength is based on a 
correct interpretation of the problem, and a very stringent respect to a methodological 
schedule. 
The first problem that must be solved before deciding to use a ReT design in a piece of 
research is related to the topic of the intended research project. As stated by Sackett, what 
determines the appropriate research model should be decided by the central research 
question (Sackett, 1997). Some research questions demand the use of a RCT; however, in 
several instances a RCT will not be the correct choice (this point is more thoroughly 
discussed in Section 2.2). 
Furthermore, a RCT is based on a statistical theory that demands the correct 
randomisation of participants. As stated by Altman and Bland: 'We know how random 
samples are expected to behave and so can compare the observations with what we would 
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expect if the treatments were equally effective.' (Altman and Bland, 1999a, p.1209). 
Although the principles of correct randomisation have been extensively published in 
journals and books (Altman, 1990; Altman and Bland, 1999b), ' ... the technical meaning 
of the term randomisation continues to elude some investigators.' (Altman and Bland, 
1999a, p.l209). The researcher must be aware of this methodological aspect, because 
there are situations in medical research where the correct randomisation of participants is 
simply not possible. This may happen for instance when random allocation may not be 
feasible due to ethical constraints, such as in cancer treatment trials. In this case, the use 
of a RCT design could lead to unreliable and invalid results. 
Finally, as the RCT is a quantitative research method, it depends on a very cautious and 
correct statistical analysis. Many systematic deviations may occur in the data analysis, 
either through lack of statistical knowledge, or through intentional manipulation of data 
or results (Mills, 1993). Additionally, the interpretation and dissemination of results of 
RCTs is open to several biases that may distort the conclusions of the studies 
(McCormack and Greenhalgh, 2000; Chan et a!., 2001). 
In summary, a RCT is usually considered the best approach to determine the effectiveness 
and safety of a new treatment. The correct use of its methodology may prevent several 
causes of bias that threaten a study's validity. However, the risk of bias continues to exist 
in a RCT, particularly during data collection, data analysis, and interpretation of the 
results (Hartman et a!., 2002). The occurrence of bias in medical studies became such a 
serious problem in medical research that it is the subject of the next section of this 
chapter. 
1.4 Major categories of bias in medical research and their prevention 
After the seminal paper by Sackett (Sackett, 1979), many examples of bias in medical 
research have been detected and analysed as to their importance and prevalence (Hartman 
et al., 2002), especially in relation to their influence in systematic analysis and meta-
analysis. 
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TABLE 1 - Types of bias that undermine research quality and validity 
Bias Explanation 
Occurs when the randomisation method is less than 
Randomisation bias ideal, e.g. using the day the participant was enrolled 
(even or odd) 
Common when those that are recruiting participants 
Selection bias are aware of the next assignment in the sequence of a 
trial 
When there is a systematic difference in the care 
Performance bias provided to the participants in the comparison group, 
other than the intervention under investigation 
Refers to systematic differences between the 
Attrition bias comparison groups in the loss of participants from the 
study 
Detection bias Occurs when there are systematic differences in 
outcome assessment between the comparison groups 
When the results or conclusions of a study are 
Ascertainment bias systematically distorted by knowledge of which 
intervention each participant is receiving 
Comprises several different biases related to the 
Publication bias publication and dissemination of results of medical 
research 
A common variation of pUblication bias, denoting a 
Language bias tendency of more studies with positive results to be 
published in English 
(Adapted from Jadad, 1998b, and Clarke and Oxman, 2001) 
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In this section I will focus on eight representative categories of bias, which, according to 
the literature (Jadad, 1998b; Song et aI., 2000; Clarke and Oxman, 2001; liini et al., 
2001), jeopardise the quality and validity of RCTs, and systematic analyses. These eight 
categories are summarised in Table 1. These types of bias were chosen due to their 
prevalence in medical research. They share an important characteristic in that they are 
either correctable or avoidable at some stage of the research process (Jadad, 1998b). 
The first category affects the proper randomisation of participants in a trial. As discussed 
in Section 1.3, although randomisation is an established method in Statistics, many papers 
fail at this stage of the research. A simple way to judge if total randomisation was 
performed is by comparing the 'baseline' characteristics of participants at the beginning 
of a trial (Jadad, 1998b). 
There are several reasons for failure to fully randomise participants. Some of them are 
very common as in the example of randomisation bias of Table 1. In this case, the 
researcher is assuming that the possibility of a participant being enrolled in a research 
project is the same every day of the week. This is not true due to the daily variations in 
the availability of medical staff, and to the patients' personal preferences. 
However, the most usual is that the randomisation sequence has not been concealed from 
the investigators (Chalmers et at., 1983). Concealing the sequence ('double blind') is an 
important way to avoid the possibility that personal preferences or beliefs of researchers 
or patients might interfere with the randomisation process and, indirectly, with the 
outcomes of a trial. One must remember that in much research the physician is also the 
researcher. If the randomisation sequence is not concealed, there may be a tendency, 
either voluntary or involuntary, to do 'the best for the patient' and not for the research. 
As stated by Day and Altman: 
Human behaviour is influenced by what we know or believe. In research there is 
the particular risk of expectation influencing findings, most obviously when 
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there is some subjectivity in assessment, leading to biased results ... Blinding 
(sometimes called masking) is used to try to eliminate such bias. (Day and 
Altman, 2000, p.19) 
However, one must remember that despite the best intentions, some treatments or 
procedures have side effects, or a specific methodological structure (such as a surgical 
action), that are so particular that blinding may be impossible. Medical staff, and even 
some patients, will undoubtedly recognise the treatment received by each participant (Day 
and Altman, 2000). 
Errors in randomisation compromise the estimates of treatment effects in controlled trials, 
and can, independently of other causes of bias, overestimate the effects of interventions 
by as much as 40% (Schulz, 1996). However, various methods can be used to assess and 
correct most of the deviations caused by randomisation bias. There are at least two, which 
can identifY the possibility of divergence between different presentations of data (Ohlsson 
and Lacy, 1995). Also, it is currently possible to perform a sensitivity analysis correlating 
the level of subversion of randomisation and the resulting bias in treatment effect 
estimation (Marcus, 2001). 
Selection bias, performance bias, attrition bias, and detection bias are more difficult to 
estimate, and correct. The Cochrane Reviewers' Handbook, discussing the sources of bias 
in trials of healthcare interventions, asserts that: 
Unfortunately, we do not have strong empirical evidence of a relationship among 
trial outcomes and specific criteria or sets of criteria used to assess the risk of 
these biases. There is, however, a logical basis for suspecting such relationships 
and a good reason to consider these four potential biases when assessing studies 
for a review (Clarke and Oxman, 2001, p. 62). 
Several graphical and statistical methods to reveal and correct these biases have been 
tested (Egger et al., 1997a), but the results are still inconclusive (Irwig et at., 1998). 
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Nevertheless, in medicine there is an axiom: 'prevention is the best therapy'. If these 
biases are difficult to detect and correct after a piece of research is completed, it is 
asserted that they can be avoided by correct design and data collection (Jadad, 1998a). 
A researcher can avoid ascertainment bias by preventing participants from knowing the 
nature ofthe interventions of a study, for as long as possible. 'Blinding' of all participants 
is also the centre of the prevention of selection, performance and ascertainment bias 
(Jadad, 1998b). Attrition and detection bias may be corrected by using accurate 
methodological procedures available to RCTs (Begg et al., 1996). 
Important causes of systematic deviations in medical research are publication bias and 
language bias. Publication bias is probably the fOlm of bias most studied in medical 
research, and was the focus of a systematic review (Song et al., 2000). It is important 
because systematic reviews and meta-analyses rely on the fact that all available data 
about a medical subject should be accessible at the time these studies are canied out. If 
not, their results will not reflect current medical knowledge in a specific area. This bias is 
caused by the tendency to publish positive findings more quickly, and in greater number, 
than negative ones (Dickersin, 1990, 1997). 
Its significance to medical practice is undeniable: 
The important consequences of publication bias include the avoidable suffering of 
patients and the waste of limited resources. At the very least, it is arguable that 
under-reporting research is scientific misconduct that may cause inappropriate 
patient care. In addition, it is unethical to abuse the trust of the patients involved 
and to waste invested resources. (Song et al., 2000, p.25). 
The correction of this type of bias depends on a more ethical position of researchers, 
funding sources, and a permanent evaluation of possible conflict of interest by reviewers 
and medical journals. 
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Publication bias may also be linked to the financial relationships between researchers and 
the pharmaceutical industries, or other research sponsors, which may influence the kind 
of results that are published. These relationships may also lead to a subspecies of 
publication bias that is very difficult to evaluate and correct as Brian Martin asserts: 
In spite of rhetoric of openness in research, the practice is often quite different. 
There are numerous examples of suppression (of data), including pressures not 
to undertake research in the first place, institutional controls on dissemination of 
data, and attacks on researchers who produce unwelcome results. (Matiin, 1999, 
p.334). 
Although the idea of suppressing data generally presupposes their existence, the simple 
fact that a certain piece of research is not done by imposition or restriction to its 
implementation can be considered a kind of suppression of data. Blocking dissemination 
or distorting data also has the same effect on the availability of information in a particular 
area of knowledge (Martin, 1999). 
Language bias reflects a tendency to publish more positive results in English than in other 
languages (Egger et al., 1997b). Dissemination of results is important to all researchers, 
and the most important journals are published in English speaking countries. These 
journals also have a tendency to publish more positive results than negative ones. In a 
search at MEDLINE® (15/1112001) looking for bias or biases in the title or abstract, I 
found 32,103 citations. Skimming through the papers, the number of publications in 
languages other than English is extremely low. The reason for this may be a form of 
publication bias, since researchers probably publish in English hoping for wider 
dissemination. Some authors also believe that there is a language bias against European 
journals from non-English speaking countries in medical publication databases (Pentti 
and Isohanni, 1999). 
However, the same author who helped to create the idea of a language bias states in a 
recent systematic review: 
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... systematic reviews that are based on a search of the English language 
literature that is accessible in the major bibliographic databases will often 
produce results that are close to those obtained from reviews based on more 
comprehensive searches that are free of language restrictions ... (However,) in 
some areas of medicine it is essential to broaden the search to include the grey 
literature and material published in languages other than English. (Egger et aZ., 
2003, p.47) 
Finally, an important type of bias, the interpretative bias, is presently receiving more 
attention (Kaptchuk, 2003). It is related to the tendency that researchers and physicians 
have to interpret the data, or the evidence on medical papers, based on their 
preconceptions, traditions of research, disciplinary affiliations or personal experience. It 
is generally considered as an unintended bias, although it can happen also as a deliberate 
attempt to avoid evidence that may contradict one's expectations. Unfortunately, this is a 
type of bias which is ubiquitous in medical practice and research, and that has so far no 
easy solution or prevention. 
The number of types of bias, and their incidence in medical research, became so 
pervasive that Horton stated that: 
A clinical investigator is, to paraphrase Whitney Balliet, a bundle of biases held 
loosely by a sense of method. Bias and medical research are firm and rowdy 
partners. (Horton, 2000, p.959) 
Why did a method of research that was so promising 50 years ago become so prone to 
bias? Is it a structural defect of the RCT methodology, or is it a problem that involves the 
behaviour of the researchers that are employing this method? As will be discussed in 
Chapter 2, it is possible that we are seeing a combination of both these factors in the high 
incidence of methodological deviations in current medical research. Many researchers 
seem to be unaware of a cornerstone of research using the RCT (or other methods): 
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The first step to minimise bias is to have a clear idea of the question, and what 
approach is required and feasible to achieve the answer. The second step is to 
prospectively design the study in detail before, or a priori, the investigation is 
undertaken. (Hartman et a!., 2002, p.27) 
Several methods to avoid the occurrence of bias in RCTs have been discussed in this 
section. However, one of the fundamental strategies to reduce bias in medical 
publications may be that researchers should make a previous publication of their intents 
before the research data collection. In fact, several important journals of medicine now 
require that authors send their research protocols in beforehand, especially in the case of 
systematic reviews and meta-analyses. The rationale is to inhibit researchers from 
manipulating unintentionally (or intentionally) the structure and results of their research. 
To summarise, the problem of bias in medical research is an important issue and is well 
diagnosed. Some authors even believe that it is over-diagnosed, and that bad reporting of 
results does not necessarily mean that defective methods were employed in the RCTs 
(Soares et al., 2004). However, although most of the bias that occurs in medical research 
could be corrected or avoided, this seems not to be happening (Celermajer, 2001). The 
possible reasons for this will be discussed in Chapter 2. 
1.5 The importance of bias in meta-analyses, systematic reviews, and 
evidence-based medicine 
One aspect of RCTs that deserves consideration is that they can be performed with a 
relatively small number of participants and in a shorter interval of time than some 
categories of medical research studies, as discussed in Section 1.3. However, the 
reduction of the number of participants and time of observation in RCTs decrease their 
statistical power and precision (Egger and Smith, 1998). Actually, it is very rare that an 
isolated RCT can provide a definitive response to the solution of a health problem or 
treatment. 
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In fact, it has been known since 1978 that the calculated statistical power of RCTs shows 
that many studies did not have totally reliable conclusions drawn from them due to their 
sample size (Donner, 1984). Although there is a simple method to calculate the necessary 
size of a sample, there are occasions when its use is not feasible, as in the case of a rare 
disease or financial limitations. 
Furthermore, as clinical trials are usually perfornled in different groups of people and in 
different settings, it is improbable that they will provide identical results, even when 
designed to focus on a specific medical subject (Jadad, 1998b). Incidentally, these 
features of RCTs are probably one the most important causes of conflicting publications 
in the lay media, or even in some medical journals. 
The only way that small and isolated RCTs may provide adequate evidence to physicians 
and health policy makers is if their individual results can be combined to provide a more 
precise and trustful conclusion. That is exactly the aim of two important research 
methods: the systematic review and the meta-analysis (Greenhalgh, 2001). If correctly 
performed, these methods can enhance the precision and consistency of data about a 
particular procedure in medicine. 
To be considered as systematic a review must comply with several rules that will be 
discussed in the following paragraphs. However, the first and most important one is: 
A systematic review, in its ideal form, is a review that includes an explicit and 
detailed description of how it was conducted so that any interested reader would 
be able to replicate it. ... (And) should incorporate strategies to minimise bias 
and to maximise precision. (Jadad, 1998b, p.81) 
A review receives the name of meta-analysis if the results of a systematic review are 
combined statistically to generate one single estimate of these results. It must also use 
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statistical tools to verify the homogeneity (compatibility) of the results of the several 
trials, and an evaluation of the possible effects of publication bias in its conclusion 
(Greenhalgh, 2001; Hulley et a!., 2001). 
There are some excellent books about the subject 'systematic reviews'; these include lain 
Chalmers and Douglas G. Altmans' Systematic Reviews (Chalmers and Altman, 1995), 
and the Cochrane Reviewers' Handbook (Clarke and Oxman, 2003). Furthermore, a 
significant number of papers focusing the structure, problems, and evaluation of 
systematic reviews and meta-analyses have been published in the last 10 years in the most 
important medical journals. 
The fundamental reason for so many studies and books about the matter is that systematic 
reviews are becoming one the most important components of the structure of evidence-
based medicine. In contrast, there is a progressive reduction of the importance of 
'journalistic reviews' (Greenhalgh, 2001), or the 'expert reviews' in medical research, 
because both suffer from serious risk of bias. 
One common bias in 'journalistic' and 'expert' reviews is the interpretative bias. As 
discussed in section 1.4, this is related to the tendency that researchers and physicians 
have to interpret the data or the evidence of medical papers in the light of their 
preconceptions, traditions of research, disciplinary affiliations or personal experience. As 
these studies are primarily focused on the 'new scientific breakthrough' in the case of the 
'journalist review', or in obtaining or maintaining the researchers' influence or status in 
the 'expert review', they generally do not obey the first rule aforementioned: to be 
replicable and avoid bias. 
However, even when the first rule of a good systematic review is obeyed, any systematic 
deviations of one or more RCTs can influence future systematic reviews and meta-
analyses (Moher et al., 1999). 
As summarised by Greenhalgh (2001), a researcher who desires to do a systematic review 
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should carefully carry out the following progressive stages: 
• State objectives of the review of randomised controlled trial and outline eligibility 
criteria. 
• Search for trials that seem to meet eligibility criteria. 
• Tabulate characteristics of each trial identified and assess its methodological quality. 
• Apply eligibility criteria and justify any exclusion. 
• Assemble the most complete data set feasible, with the assistance from investigators, 
if possible. 
• Analyse results of eligible randomised controlled trials by using statistical synthesis 
of data (meta-analysis) if appropriate and possible. 
• Compare alternative analyses, if appropriate and possible. 
• Prepare a critical summary of the review, stating aims, describing materials and 
methods, and reporting results. (Greenhalgh, 2001, p.121) 
In each of these stages there is the possibility of introducing one, or more, systematic 
deviations that may compromise the final result of a systematic review or meta-analysis. 
As an example of the complexity of such a method, using only the evaluation of the 
impact of publication bias on meta-analysis, Sutton et al. (2000) estimated that a 
significant number of meta-analyses had missing studies. Most of the time this was due to 
publication bias. 
Actually, the number of unpublished papers on a particular area of medical knowledge 
may vary from 7% to 41 % (Dickersin, 1997). There are several probable reasons for this. 
However, independently of the discussion of the causes, one can imagine the potential 
impact this has in systematic reviews and meta-analyses. 
To exemplify the problem caused by known or unknown bias in the structure of 
systematic reviews and meta-analyses, the introduction of a paper by Mathias Egger and 
George D. Smith can be quoted: 
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That meta-analysis holds potential problems can be illustrated by contrasting the 
conclusions of two meta-analyses comparing low molecular weight heparin and 
standard heparin in the prevention of thrombosis after surgery. One group 
concluded that "low molecular weight heparin seem to have a higher benefit to 
risk ratio than unfractionated heparin in preventing perioperative thrombosis", 
whereas the other considered that "there is at present no convincing evidence 
that in general surgery patients low molecular weight heparin, compared with 
standard heparin, generate a clinically important improvement in the benefit risk 
ratio." ... (Egger and Smith, 1998, p.61) 
Incidentally, both of the reviews evaluated by Egger and Smith (1998) were published in 
1992, one in The Lancet and the other in the British Medical Journal. Although the 
possible causes for such a difference in the reviews' conclusions will be further discussed 
in Chapter 2, it is hardly surprising that many physicians and researchers are somewhat 
perplexed by such contradictory conclusions. 
This is especially true in respect of the idea of 'evidence-based medicine' (EBM). This 
term achieved its place in the history of medicine in the 1990s. Its best initial definition 
was provided by Sackett et al. (1996, p.71): 'the conscientious, explicit and judicious use 
of current best evidence in making decisions about the care of individual patients'. This 
should mean the use of medical research results to help physicians decide what should be 
the best procedure or treatment for individual patients. 
In principle, this is what a physician should indeed do. However, using the 
aforementioned example of meta~analysis it is possibly the moment to ask, as Celermajer 
(2001) did, 'How good is the evidence?'. 
Sniderman (1999) already pointed out one aspect of present medical research that will be 
important for evaluation and discussion in the present study in order to answer 
Celermajer's question, namely the current entanglement between modem medical 
research and the pharmaceutical companies. According to Sniderman: 
23 
Many trials have been completed using similar agents for similar problems, and 
naturally, each company will try to distinguish its products from its competitors, 
even when the overall results are reasonably similar. Similarly, investigators will 
try to distinguish their contribution from those other investigators who take part 
in similar trials. In this enterprise, the interests of the companies and the 
investigators can imperceptibly coalesce. The net result is that important 
scientific debates can become coupled - and sometimes be driven by -
competitive marketing approaches. (Sniderrnan, 1999, p.328) 
Sniderrnan (1999) concludes that both the scientific debate and the marketing competition 
are defensible. However, he suspects that there is also a risk that scientific advocates 
become the companies' advocates. He also asserts that as readers of such pieces of 
research, whether practising physicians or consumers, we should remember that 'our 
interests are not always identical with those who produce them' (Sniderrnan, 1999, 
p.328). 
To summarise, the initial straightforward and comprehensible method of the RCT created 
50 years ago has evolved into a very complex and statistically dependent one. This 
evolution has undoubtedly provided a reliable possible source of medical knowledge. 
However, it may have converted the RCT, and its derivatives, the systematic review and 
the meta-analysis, into a very cryptic matter to many physicians, health researchers, 
medical educators, and health policy makers. Additionally, its current complexity and its 
vulnerability to bias may endanger the possibility of using its conclusions to support 
evidence-based medicine. 
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Chapter 2 
Factors that influence the existence of bias 
in medical research 
2.1 Introduction 
As discussed in Chapter 1, modem medical research relies to a great and increasing extent 
on a quantitative research method, the randomised controlled trial, and its derivatives: the 
systematic review and meta-analysis. Although powerful, these research procedures, like 
any other scientific research approach, are prone to bias. Furthermore, subversion of 
results may occur due to errors either in the structure or in the data analysis of a RCT, 
systematic review, or meta-analysis. These somewhat contradictolY characteristics of 
such a research method are evident in the final paragraph of a major text about the matter: 
The RCT is one of the simplest, most powerful, and revolutionary tools of 
research. Despite their extensive use as research tools over the past 50 years, 
most trials are biased, too small, or too trivial. It is essential that we make more 
efforts to protect ourselves against ourselves during the design, analysis, 
dissemination and use of RCTs. Such efforts will hopefully benefit patients, 
scientists, governments, industry, research institutions, funding and regulatory 
agencies, ethics committees, journalists, and other consumers of information. 
Overcoming the existing barriers will, however, require innovative research 
strategies, and unprecedented levels of commitment, participation, and 
contribution by us all. (Jadad 1998b, p.116) 
The author's intention was undoubtedly to emphasise that, as happens with any research 
method, the results depend on the validity and reliability of the data one can obtain using 
such a method. Furthermore, the quality of such results in medical research has a strong 
relationship with the conduct of the researcher, from the design of a study to the final 
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report of the research. This connection between the researcher and the quality of research 
is in the opinion of Jadad (1998b) the weakest link in medical research studies. 
However, the structural framework of a RCT study may also have its role in the 
occurrence of bias on medical research. One of the aspects that will be discussed in this 
chapter is that the centre of the statistical approach used in controlled trials is hypothesis 
testing. This relies on establishing if there is a certain degree of significance in the 
relationship between the variables under study (Campbell, 2001). As previously 
mentioned in Chapter 1, this process can be undermined at any phase of a study, 
particularly during the acquisition of data, statistical treatment, or discussion of the 
results, by the introduction of systematic deviations (Mills, 1993). 
The rise in the number of published papers based on RCTs has also increased the 
dependence of health programs and policies, medical education, and medical practice, on 
their results. It has seemed reasonable to rely on a method that could give rapid answers 
to important questions in these areas (Evidence-based Medicine Working Group, 1992). 
As the number of papers reporting randomised controlled trials has increased since the 
1970s (Simini, 1998), the number of detected biases and flawed studies also multiplied. In 
1994, an inspired editorial in the British Medical Journal by Douglas G. Altman 
summarised the problem: 
We need less research, better research, and research done for the right reasons ... 
When I tell friends outside medicine that many papers published in medical 
journals are misleading because of methodological weaknesses they are rightly 
shocked ... Why errors are so common? Put simply, much poor research arises 
because researchers feel compelled for career reasons to carry out research that 
they are ill equipped to perform, and nobody stops them. (Altman, 1994, p. 283) 
This strong statement by Altman, combined with the support of some of the most 
important medical journals and researchers, provided the underpinning to the publication 
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ofthe CONSORT statement (Begg et al., 1996). An amendment to the original statement 
was published in 2001 (Moher et aI., 2001). The Consolidation of the Standards of 
Reporting Trials (CONSORT) was a collaborative process between clinical 
epidemiologists, statisticians, joumal editors and reviewers. It aimed to improve the 
practice of medical research by increasing the awareness of researchers on the 
methodological structure of a good trial. 
The most important medical joumals incorporated the original statement as part of their 
requirements for authors in 1997. In 1999, the QUOROM (Quality of Reporting of Meta-
Analyses) report was published which aimed to establish the standards for improving the 
quality of reporting of meta-analyses (Moher et al., 1999). 
The positive response of joumals, medical associations, and researchers to the 
CONSORT and QUOROM statements is an unequivocal demonstration of the importance 
of the problem of bias in medical research. However, both statements had an unforeseen 
side effect: the predominant focus on correcting the research structure rather than the 
researchers' habits. Additionally, the CONSORT statement has been criticised for failing 
to appraise the problem of the inclusion and exclusion criteria of studies, which is an 
important issue with regard to the extemal validity ofRCTs (Gross et ai., 2002). 
Revisiting the topic of his 1994 editorial in the British Medical Journal six years after the 
publication of the CONSORT statement, Altman asserts that: 
I suspect that many basic errors have become less common, but statistics has 
become more complex, and there is evidence of frequent misapplication of 
newer advanced techniques ... Much research is done without the benefit of 
anyone with adequate training in quantitative methods. Many investigators are 
not professional researchers; they are primarily clinicians. (Altman, 2002, 
p.2766). 
As will be discussed in Sections 2.3 and 2.4, the basic mental and scientific behaviour of 
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the modern physician-scientist is essentially shaped inside medical schools. The medical 
'scientist-to-be' will face a long, arduous, and extremely competitive environment in 
which to accomplish successfully the following sequence: graduation - residency 
(specialisation) - post-graduation. These steps are mandatory to enable himlher to have 
some possibility of entering a research group, or being able to seek a grant from a 
research-funding organisation. However, there are perturbing signs that this process is 
being undermined by a tendency to acquire moral deviations due to the intense 
competition existent inside the medical schools (Young, 1997). Moreover, some authors 
assert that much medical research is being carried out only as a career necessity by 
physicians (Altman, 2002). 
The main objective of this chapter is to evaluate to what extent the combination of the 
intrinsic methodological problems of the RCTs, the formation of a physician-scientist, 
and the problems of certain type of research funding, could be contributing to the present 
problems of modern medical research. 
2.2 Intrinsic methodological problems of a ReT 
According to Simes (2002): 
Hence, evidence from trials is most applicable in practice when the design and 
the outcomes chosen are directly relevant to real patients, the trials are 
undertaken against a background of standard medical care, patients in trial are 
broadly representative in the real world, and evidence from trials is integrated 
with individual patient characteristics for meaningful risk-benefit assessment. 
(Simes, 2002, p.407) 
The above quoted statement is extremely sensible. However, as discussed in the following 
paragraphs, it is very rare to achieve all these qualities in a RCT. The reason is that the 
RCTs' basic structure was deeply modified, as they were adapted to the several fields of 
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medicine. Also, to the fact that RCTs are used nowadays to analyse small to moderate 
effects of medical procedures. 
Ironically, the flrst methodological problem of a RCT derives from one of its strengths. 
The statistical approach of hypothesis testing, although powerful and dependable, relies 
on three fundamental assumptions. 
The flrst is that one must have a question that can be answered in a very straightforward 
way: 'Are the results obtained equally in both of the groups that are under investigation?'. 
This is effectively the null hypothesis (Greenhalgh, 2001). The answer to this question is 
fundamental because if there is no difference between the groups, one cannot reject with 
confldence the hypothesis that the two treatments or interventions have the same effects. 
In order to accept or to reject the null hypothesis, the researcher must be certain that both 
groups are identical at the beginning of the trial. The only aspect that should be prone to 
manipulation is the variable under study. This is the foundation, and the requirement of 
randomisation, as discussed in Chapter 1. 
Identical groups in humans are not possible, with the probable exception of groups of 
identical twins. Even when randomisation is used correctly, a researcher must still be 
aware that it is possible that the two groups under study will differ in some potentially 
important aspect. As stated by Jadad: 
You must understand that the risk of imbalance among the groups (under study) 
is not abolished completely, even if the allocation is perfectly randomised. 
(Jadad, 1998b, p.4) 
This might not be a problem if one is exploring a procedure that has an evident effect on 
the outcomes with another that has no effect. However, this is seldom the reality in 
medical research. Generally, RCTs are used for the evaluation of the possibility that two 
or more interventions have a small to moderate difference in their outcomes. 
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In fact, it would be unethical to submit human beings to a randomised clinical trial which 
is comparing two procedures when the researcher already knows that one of the 
interventions is undoubtedly better than the other. Despite the fact that it might seem 
redundant, it must also be stressed that although researchers sometimes fail to remember, 
it is also unethical to submit groups of persons to procedures that are indubitably 
ineffective for their health problems. 
The second assumption that is intrinsic to the statistical model of a ReT is that the 
outcomes will be evaluated in relation to the existence of a significant difference between 
the groups involved in the research. In a sense, a significant result only expresses that the 
difference between the groups was statistically significant. It does not necessarily indicate 
that this outcome is of clinical or scientific importance. For example, a reduction of 2 
mmHg in blood pressure observed when a researcher is evaluating two different drugs 
may be statistically significant, on account of the large sample sizes. However, this 
reduction may have no practical significance in respect of the clinical management of 
people who are under treatment due to high blood pressure (Jekel et al., 1996). 
For such reasons, a medical researcher using a ReT design cannot be sure that herlhis 
results may validly be extended to the whole population in a clinically meaningful 
manner. What he/she has is a statistical indication ofthe possibility that this may be done, 
with a certain degree of uncertainty. In order to evaluate this degree of uncertainty, some 
statistical tools can be used to avoid the problem of assuming that the results of a study 
are 'true in the real world' when they are not. The most reliable one is the confidence 
interval (Altman et al., 2000). 
According to Altman et al. : 
So when should confidence intervals be calculate and presented? Essentially 
confidence intervals become relevant whenever an inference is to be made from 
the study results to the wider world... (because) a single study gives an 
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imprecise sample estimate of the overall population value in which we are 
interested. (Altman et a!., 2000, pA) 
Although the mathematical basis of confidence analysis is beyond the scope of this study, 
the theoretical foundation is not difficult to understand. It is due to the fact that results 
from a single sample of the population are subject to statistical uncertainty, leading to an 
imprecise estimate of the effect of a procedure in the overall population, as already 
discussed. However, the extent ofthe imprecision may also be estimated, and presented in 
the conclusions of a study. In principle, this procedure would allow the reader of a paper 
to estimate how much she/he could depend on the results of one or more RCTs to support 
his/her clinical decisions. 
However, calculating confidence intervals is not as widespread a practice in medical 
studies as perhaps it should: 
The uptake of confidence intervals has not been equal throughout medicine. A 
review of papers published in the American Journal of Physiology in 1996 found 
out that out of370 papers only one reported confidence intervals! (Altman et aI., 
2000, p.7) 
The [mal assumption of the statistical model of the RCT is that the sample used in a study 
is representative of a population. In fact, a correctly randomised RCT, based on a direct 
question about a health problem, and using the necessary number of participants in its 
groups, should provide answers that could be considered as suitable to the whole 
population. However, this is seldom accomplished by an isolated RCT study. 
Actually, the external validity of isolated RCTs has been subjected to severe criticism 
(Gross et a!., 2002). One of the main problem seems to be the inclusion and exclusion 
criteria of participants in a study, which may 'impede generalising from RCTs to real life' 
(Kennedy et al., 2003, p.8). 
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The inclusion or exclusion criteria of participants in RCTs are of extreme importance for 
the possible outcomes of a study, and to the potential use of these outcomes as a guide to 
medical practice. If the inclusion criteria are too restrictive, the RCT result will not 
represent something valid for the population. Conversely, the inclusion within a single 
RCT of participants who have multiple medical problems may conceal the real effect of a 
procedure, and lead to invalid conclusions. 
In fact, there is presently a tendency to classify a RCT as either explanatory or pragmatic. 
The objective of such a classification is to categorise RCTs according to whether their 
methodological frameworks were structured to enhance their internal validity (which 
reflects the efficacy of a certain medical procedure in an ideal situation), or the external 
validity (the generalis ability ofthe results) (Godwin et a!., 2002). 
An explanatory trial tries to maximise the internal validity by assuring rigorous control of 
all variables with the exception of the one under study. One ofthe characteristics of such 
a study is to restrict the inclusion criteria in order to evaluate a possible beneficial effect 
in an ideal situation: the participants have only one known medical problem. As this is 
seldom the reality in medical practice, one may have a result that is, to some extent, 
meaningless (or at least oversimplified) for medical practice. 
Pragmatic trials try to keep a balance between their internal and external validity 
(reliability and generalisability of their results). The exclusion criteria in this kind of trial 
are kept to a minimum. They try to use as participants those who represent the full 
spectrum ofthe population to which the treatment might be applied (Godwin et a!., 2002). 
The central idea of a pragmatic trial is that if a medical intervention exhibits a beneficial 
effect in the trial it will probably be effective in the 'real world'. However, it is extremely 
difficult to establish the limits of what is meant by 'minimum exclusion criteria' in the 
multiple applications ofRCTs in medical research. 
Actually, according to Gross et a!. (2002), many RCTs published in high impact journals 
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do not provide a comprehensive description of the participants' recruitment process. This 
makes it difficult for readers and reviewers to estimate the internal and external validity 
of these studies, and their level of relevance to medical practice. 
For such reasons, even the results of a carefully randomised and controlled study may not 
be directly applicable to an individual patient or a population. In addition, the conversion 
of the evidence obtained in a study sample to a particular patient is problematic due to 
differences related to individual characteristics (age, sex, co-morbidity, cultural and 
genetic variations, etc.) (Mant, 1999). 
According to Greenhalgh (2001), there are also some restrictions to the use of RCTs 
when the study is looking at the prognosis of a disease, the validity of a screening test, or 
when the study focus is the problem of 'quality of medical care'. In the three cases 
aforementioned, specific research methods are available that may be more appropriate 
than a RCT. 
As stated by Greenhalgh: 
For example, an RCT comparing medical versus surgical methods of abortion 
might assess "success" in terms of the number of patients achieving complete 
evacuation, amount of bleeding, and pain level. The patients, however, might 
decide that other aspects of the procedure are important, such as knowing in 
advance how long the procedure will take, not seeing or feeling the abortus (sic) 
come out, and so on. For this analysis, the appropriate route to best evidence is a 
qualitative research method. (Greenhalgh, 2001, p.49) 
These methodological problems of RCTs have a clear influence on systematic reviews. 
Much of the criticism of systematic reviews is based on the argument that reviewers 
construct conclusions based on a feeble structure, the RCT. Furthermore, they are 
allegedly assembling a result as if they were capable of asserting which of the several 
RCTs have a correct structure. As stated by Ioannidis and Lau: 
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The traditional review expert assesses dat~ giving more weight to some and less 
to others, throws some data out, and reaches subjective conclusions in a 
monarchy without laws, sometimes an enlightened one, commonly a tyranny. 
(Ioannidis and Lau, 1998,p.590) 
Furthermore, some authors believe that most systematic reviews are a cause of frustration 
to research users when they recognise that these reviews are often unable to provide 
specific guidance on the efficiency of medical interventions (Petticrew, 2003). 
As will be discussed in Sections 2.3,2.4, and 3.3 of this study, there are several possible 
(and concurrent) reasons for the present situation of endemic occurrence of bias in 
medical research. However, one important source of problems is undoubtedly the various 
intrinsic methodological problems ofRCTs. 
2.3 Contemporary structure of medical courses in Brazil 
Compared with medical education in Europe, the existence of medical schools in Brazil is 
more recent. Historically, the first medical school was established in Bahia State in 1808 
based on the structure of the Portuguese medical schools. However, it only attained the 
status of a true medical school in 1815 (Lima-Gonyalves, 2002). Therefore, medical 
education in Brazil has a history of a little under 200 years. 
In 152 years, from 1808 to 1960, 28 new medical schools were created mainly by the 
federal and state governments. According to Lima-Gonyalves (2002), the regional 
allocation of these schools was appropriate given the existent Brazilian population 
distribution. 
However, from 1961 there was a rapid expansion in the number of schools (Lima-
Gonyalves, 2002). By 1975, there were 73 medical schools in Brazil. In other words, 
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there was an increase of more than 150% in the number of medical schools, in the short 
period of 14 years. Between 1975 and 1999, 19 new schoo Is were created, giving us a 
total of 92 schools. Unofficial data suggests that in 2003 there were 104 medical schools 
in Brazil. 
Unfortunately, according to Lima-Gonyalves (2002), the establishment of medical 
schoo Is between 1961 and 1975 served political and economic interests, which eventually 
did not coincide with the real needs of the Brazilian States as revealed by technical 
surveys. Lima-Gonc;alves also asserts that these schools were created without the 
necessary evaluation of the existence of educational resources for their maintenance and 
development, especially in relation to qualified teachers and adequate teaching hospitals. 
Although there were several isolated attempts by the Ministry of Education and the 
Regional and Federal Councils of Medicine to evaluate and control the Brazilian medical 
schools, these were all somewhat ineffective. Only after 1991, with the creation of 
CINAEM (Comissao Interinstitucional Nacional de Avaliayao do Ensino Medico), could 
a rather methodical diagnosis of the real situation of the Brazilian medical schools be 
achieved. 
CINAEM is a committee composed of members of the National Society of Medical 
Schools, the Brazilian Medical Association, the National Academy of Medicine, the 
Federal Council of Medicine, and several other Councils and Associations related to 
medical practice and education. The fundamental aim of this committee is to evaluate the 
structural and educational profile of Brazilian medical schools. Furthermore, it is meant to 
propose necessary modifications to medical education, and establish permanent 
mechanisms of assessment of medical schools. 
The fmal report of the first two phases of the CINAEM project was published in 1997 
(CINAEM, 1997), and much of the analysis of the contemporary structure of medical 
courses in Brazil summarised in the next paragraphs is based on this report. 
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The first phase of the CINAEM project focused on the evaluation of the structure of the 
medical schools. In order to obtain these data a questionnaire composed of 266 questions 
organised by the Organiza9QO Pan-Americana de Saude (Pan-American Health 
Organisation - OP AS), and modified to some extent by the CINAEM working group was 
employed. These modifications were intended to adapt the OPAS questionnaire to the 
Brazilian situation and the CINAEM objectives. This questionnaire aimed to determine 
which variables were most strongly associated with the quality of the final product of 
these schools: the graduate physicians. The CINAEM committee sent the questionnaire to 
the 80 medical schools that existed in 1991, and 76 schools responded. 
Although this initial survey did not have a quantitative or classificatory characteristic, the 
data obtained were worrisome. Using the OPAS criteria of evaluation of medical schools, 
the human resources (teachers), the physical resources of the schools, the pedagogic 
model, and the final product (physicians), were all assessed as being on average below 
what was expected. However, it must be emphasised here that the results do not apply to 
individual schools, as the CINAEM report does not provide this kind of information. 
The analysis of the questionnaire also showed that, in 1991, 57% of the schools were 
entirely funded by the Brazilian government (the students do not pay any fees during their 
courses), while 43% of them were private. The total number of graduates produced by 
these medical schools was 7554 physicians per year in 1991, according to Lima-
Gonyalves (2002). 
The average number of teachers was 197 per school, and these teachers spent 51 % to 99% 
of their time in activities related to teaching, administration and surgery hours. Full-time 
dedication of teachers to research only existed in 20% of the schools. According to the 
CINAEM report, in 1991 only 56% of the schools had a Teaching Hospital of their own, 
and most of the others declared that were using rented private hospital facilities. In 
addition, 25% of the schools stated that they had no specialisation (residency) 
programmes. 
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The second phase of the CINAEM project focused on the evaluation of the teachers and 
the [mal product of a medical school, the physicians. It is understandable that, after the 
initial results, several schools decided not to continue in the CINAEM project. 
Consequently, the number of medical schools that participated in the second phase of this 
project dropped to 47. Most of the schools that decided not to participate in the second 
phase of this study stated that they were implementing their own internal evaluation 
procedures. One must be aware that the results of the second phase ofthe CINAEM study 
may not adequately characterise medical schools in Brazil, as the schools that remained in 
the project probably had better structures. 
In the second phase of the CINAEM study 4193 teachers and 2214 students were 
evaluated; some of the results are important to the present study. The teachers' opinions 
and personal information were collected using a questionnaire and data provided by the 
medical schools. The students were assessed by two evaluation tests, one at the beginning 
oftheir last year as students, and the other at the end of the same year. These tests focused 
on four main areas of medical knowledge: Internal Medicine, Paediatrics, Obstetrics and 
Gynaecology, and Public Health. In addition, 1637 observations of the behaviour of 769 
students in their daily surgery hours were undertaken. 
According to the CINAEM report, most of the teachers were male (67%), with ages 
between 30 to 49 years, and with on average less than 9 years of experience as medical 
teachers. The majority of them (80%) had a title of specialist due to a residency 
(specialisation) program, 31% had a Masters degree, and 20% a Doctoral degree. 
Furthermore, only 7% of them declared that their specialisation was in Education. These 
proportions are cumulative, and one must be aware that this question had five options 
(graduation, specialisation, Masters degree, Doctoral degree and Post-doctoral studies) 
which should be ticked in a sequence. Consequently, someone who stated that they had a 
Doctoral degree may also possess a Masters degree and a specialist certificate, or just the 
Doctoral degree as will be explained in Section 3.2. 
The majority (70%) of the medical schools stated that they had a mechanism for some 
kind of assessment of their teachers. In 71 % of the 47 schools that gave details of how 
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their teachers were assessed, the number of published papers was an important element. 
Furthermore, in 66% of these 47 schools participation in research projects (even without 
publication ofthe findings) was also taken into account in the teachers' assessment. 
However, as stated by Basile (1998), and presented in the CINAEM report, for the 
majority of the medical teachers in Brazil teaching ~ctivities are only a small part of their 
professional lives. In fact, the CINAEM report showed that, on average, their salary as 
teachers corresponded to just about 25% to 50% of their total income. Most of them were 
satisfied with their total income, although not with their salary as teachers. 
A condition for participating in the second phase of the CINAEM project was that the 
medical school would allow the evaluation of their teachers and students. However, while 
the evaluation of the teachers had a compulsory characteristic, the students' assessment 
was structured as a voluntary participation. It was based on two qualification tests 
undertaken in 42 medical schools and a behaviour analysis of students during their 
surgery hours in 14 medical schools. Only 14 medical schools participated in the 
behaviour analysis study due to the small number of trained personnel available to make 
and analyse these observations. 
The results of the two CINAEM tests showed that in the first one 39% (standard deviation 
+1- 3%) of questions were answered correctly, while in the second, 51% (standard 
deviation +1- 5%). These tests were composed of multiple-choice questions, most of them 
with five alternatives. The behaviour analysis study concluded that 50% of the students 
manifested inadequate humanistic and ethical behaviour in their relationships with their 
patients. According to Lima-Gonyalves (2002), the outcomes of the first two phases of 
the CINAEM project revealed that at the end of their graduation course, a significant 
proportion of the Brazilian physicians had an evident inadequacy in their scientific, 
humanistic, and ethical education. 
In 1998, based on the results of the two initial phases, the CINAEM committee started an 
action research project that aimed to correct the deviations disclosed by the initial studies 
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in the participating medical schools. Unfortunately, there are still no published data about 
the evolution and results ofthis third phase of the CINAEM project. 
2.4 The relationships among pharmaceutical companies, medical 
research, and continuing medical education 
This Section will evaluate the relationships of the pharmaceutical industries and medical 
research from two different points of view. The first will be the influence of 
pharmaceutical companies on the production of research, and on the behaviour of the 
physician as a scientist. The second point of view will appraise the importance of their 
influence in the formation and dissemination of medical knowledge, and their 
significance to the physician as a consumer of medical research and continuing medical 
education (CME). 
There is no trustworthy evaluation of the impact of pharmaceutical companies on medical 
research and medical education in Brazil. However, it will be demonstrated that the 
available data from Europe and the USA show that these companies have an international 
policy, and that this policy displays only superficial differences when applied to different 
countries. 
2.4.1 The influence of pharmaceutical industry on the production and 
dissemination of medical research outcomes 
As stated by Richard Horton: 
Pharmaceutical industry bias is hard to study with any rigour. However, 
Benjamin Djulbegovic and colleagues did find evidence of substantial bias in 
randomised trials of patients with multiple myeloma. (Horton, 2000,p.960) 
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The paper cited by Horton (2000) was published in the same journal, and the authors were 
Djulbegovic et al. (2000). After analysing randomised trials about the subject (treatment 
of multiple myeloma), Djulbegovic et al. (2000) assert that comparing trials funded by 
non-profit agencies, and profit-making companies (mostly pharmaceutical companies), 
there was an evident disparity. Although 74% of trials funded by profit-making agencies 
favoured the new drug treatments, only 53% of non-profit funded studies showed that 
such a difference really exists. The authors even assert that the possibility of violation of 
the principle of 'maximum uncertainty' (equipoise) in the profit-making studies could 
endanger the survival ofthe clinical trial in medical research. 
As stated by Djulbegovic et al: 
The uncertainty principle, or equipoise, states that the patient should be enrolled 
in a randomised controlled trial only if there is substantial uncertainty ("equal 
bet") about which of the trial treatments would benefit the patient most. 
(Djulbegovic et al., 2000, p.635) 
According to these authors, it is possible that industry would only sponsor those research 
projects in a particular area of medicine that are likely to be positive. This selective 
sponsorship would violate the uncertainty principle, which is a fundamental scientific and 
ethical principle ofRCTs. 
Although we must assume that there will always be some differences among researchers 
in a delimited field of knowledge, the aforementioned results, and comments, are 
remarkable. Unfortunately, rather than being an isolated occurrence, the previously 
mentioned example seems to be the rule, rather than the exception (Lexchin et al., 2003). 
Lexchin et al. (2003) carried out an extensive search of papers in MEDLINE® published 
between January 1966 and December 2002, at Embase from January 1980 to December 
2002, and at the Cochrane methodology register. They used a combination ofterms in this 
search based on the key words: 'clinical trials', 'conflict of interest', 'drug industry', 
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'financial support', 'publication bias', 'research design', and 'research support'. They 
also used the QUOROM criteria (Moher et al., 1999) to justify their reasons for the 
inclusion or exclusion of papers in their study. 
The conclusions of this study, published at the British Medical Journal, are summarised 
in a table in their paper: 
What is already known on this topic 
When pharmaceutical company funds research into drugs, studies are likely to 
produce results favourable to the sponsoring company's product. 
What this study adds 
Research funded by drug companies was more likely to have outcomes that 
favour the sponsor's product than research funded by other sources. 
This cannot be explained by the reported quality of the methods in research 
sponsored by industry. 
The result may be due to inappropriate comparators or to publication bias. 
(Lexchin et aI., 2003, p.117S) 
These results are consistent with another systematic review published in the same year in 
the Journal o/the American Medical Association (Bekelman et aI., 2003). These authors 
used as data sources the MEDLINE® database and the Web of Science database, and the 
inclusion and exclusion criteria were different from the Lexchin et al. study. In the 
conclusion of this review, Bekelman et al. assert that: 
Strong and consistent evidence shows that industry-sponsored research tends to 
draw pro-industry conclusions. By combining data from articles examining 1140 
studies, we found that industry-sponsored studies were significantly more likely 
to reach conclusions that were favourable to the sponsor than were non-industry 
studies. (Bekelman et al., 2003, p.463) 
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A still more recent systematic review by Bhandari et af. (2004) was published in the 
Canadian Medical Association Journal. Using data from eight leading surgical journals 
and five medical journals their results also showed that industry funding has a significant 
influence on the results of both surgical and drug trials. The authors also suggest that: 
Future exploration of the complex relation between industry-funded trials and 
authors' conclusions will shed further light on this issue. (Bhandari et al., 2004, 
p.480) 
In fact, such a relation should receive more attention from researchers. However, this may 
prove to be a very arduous task, as few researchers will probably be able to contribute 
with their comments about their associations with the pharmaceutical companies, as 
stated by Garland (2004): 
Pharmaceutical companies seeking regulatory approval are obliged to make the 
results of all clinical trials they sponsor available to regulatory agencies. 
However, there is no requirement for these results to be published or even made 
available to investigators. Those researchers, including myself, who did see 
results of negative paroxetine (an antidepressant drug) industry trials were 
prohibited by non-disclosure contracts from discussing them. (Garland, 2004, 
p.490) 
Quick (2001) summarises well the problems of these relationships between medical 
research and the pharmaceutical industry: 
Clinical trials form the basis of effective research ... but their reliability is 
currently imperilled by three major flaws: conflicts of interest on the part of 
investigators; inappropriate involvement of research sponsors in their design and 
management; and publication bias in disseminating their results ... In a highly 
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competitive world, the pressures may be simply too great for individual 
researchers, universities, medical journals, or public agencies to stem the tide of 
commercial interest. (Quick, 2001, p.1093) 
According to Quick (2001), if clinical trials become a commercial business enterprise, 
due to the relationships between researchers and the pharmaceutical industry, 'the social 
contract which permits medical researchers to use human subjects in return for medical 
advances is broken' (Quick, 2001, p.1093). In fact, this 'social contract' underpins the 
moral entitlement of medical researchers to use human subjects in their research, as far as 
the results of such studies revert free of further cost to the entire population. 
Transforming medical research into a commercial business enterprise would represent a 
further fmancial burden to the whole population, which would be ethically unacceptable. 
One may argue that such a financial burden might be paid back from the eventual fruits of 
such research, making such a commercial business enterprise morally perfectly 
acceptable. However, the evidence that the results of research done under such conditions 
is being in a certain way 'censored' by sponsors (Garland, 2004) invalidates such kind of 
reasoning. 
2.4.2 The influence of pharmaceutical industry on continuing medical education 
Twelve years ago Lexchin (1993) did a systematic analysis of the influence of 
pharmaceutical companies on medical education. He used as data papers published in 
Australia, Canada, New Zealand, Britain, and the USA about the matter, between 1978 to 
1993. His results showed that pharmaceutical companies sponsored continuing medical 
education (CME) courses could have what he called a 'commercial bias', 'even when 
conducted under guidelines designed to ensure the independence of the event' (Lexchin, 
1993, p.1401). 
In the Abstract section of his study he asserts: 
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Physicians are affected by their interactions with pharmaceutical industry. 
Further research needs to be done in most cases to determine whether such 
interactions lead to more or less appropriate prescribing practices. The CMA's 
[Canadian Medical Association] guidelines on this topic should be evaluated to 
see whether they are effective in controlling physician-industry interactions. 
(Lexchin, 1993, p.1401) 
Ten years later Moynihan (2003) declared that doctors and the pharmaceutical industry 
are entangled in a ubiquitous and controversial web of interactions. Furthermore, he 
agrees with Lexchin (1993) that these interactions are widespread, and that evidence 
exists that these relations with industry influence physicians' behaviour. 
Between 1993 and 2003, medical research and CME became too expensive for the 
governments of most countries. Due to this fact, there was an intensive and extensive 
pressure to establish relationships between medical schools and the pharmaceutical 
industry. The industry willingly accepted this task because, as we have discussed in the 
previous section, they already controlled much of medical research. 
However, Baird (2003) asserts that we need to think about the possible consequences of 
the strong academic-industry partnership, because there is a potential imbalance in 
research and educational practices that may endanger public confidence in medical 
practices. 
According to Collier and Iheanacho (2002, p.1405) "the pharmaceutical industry spends 
more time and resources on generation, collation, and dissemination of medical 
information than it does on production of medicines". These authors went on to assert 
that: 
Through their investment on research, transnational companies have an 
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important effect on the direction of medical research generally; via their 
promotional and educational activity, they are probably the biggest individual 
influence on prescribing practice ... However, the huge scale of work involved, 
lack of openness... and distortion of the overall research effort and resulting 
messages make the business of information-generation inefficient and threatens 
patients' interests. (Collier and Iheanacho, 2002, p.1408) 
One of the most important methods of CME are the clinical practice guidelines that 
should be derived from the systematic analyses and meta-analyses of previous studies. 
However, the aforementioned studies suggest that this important medical educational 
mechanism may be biased at two crucial stages: the production of medical knowledge, 
and its dissemination. 
These questionable interactions between the pharmaceutical industry and CME were 
revealed by Choudhry et al. (2002) in a cross-sectional survey of 192 authors of 44 
Clinical Practice Guidelines (CPGs) endorsed by USA and European societies. These 
CPGs were published between 1991 and 1999 and are related to guidelines on common 
adult diseases. 
The results of the survey of Choudhry et al. (2002) demonstrate that 87% of authors had 
some interaction with pharmaceutical industries, and that 59% had relationships with 
companies whose drugs were considered in the guidelines they produced. In the published 
versions of the CPGs, only two authors declared their fmancial interactions with these 
companies. Moreover, 7% of these authors declared that their connection with the 
pharmaceutical industry influenced their recommendations, and 19% of them believed 
that relations with the pharmaceutical companies influenced their co-authors' opinions 
expressed in the CPGs they created. 
Choudhry et aZ. also state that: 
Although the results of this study must be interpreted cautiously in light of the 
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relative low response rate, our results appear to indicate that most CPG authors 
have interactions with pharmaceutical companies and that a significant 
proportion work as employees/consultants for drug manufacturers. (Choudhry et 
aI., 2002, p.615) 
According to Komesaroff and Kerridge (2002), physicians and the pharmaceutical 
industry share a number of interests. The current configuration of the relationships 
between them is the outcome of a long-established culture in which gratuities, gifts, and 
sponsorship of meetings and CME activities are both expected and provided. However, 
funding of conferences and CME programmes has been shown typically to lead to 
information bias in favour of the sponsoring pharmaceutical companies' drugs 
(Komesaroff and Kerridge, 2002). 
An important problem of the domination of CME programmes by the pharmaceutical 
industry is well presented by Choudhry et al. (2002): 
Unlike relationships that individual authors or physicians have with the 
pharmaceutical industry, fmancial conflicts of interest for authors of CPGs are of 
particular importance since they may not only influence the specific practice of 
these authors but also those of the physicians following the recommendations 
contained within the guidelines. (Choudhry et al., 2002, p.616) 
Actually, such influence can be even greater due to the fact that Choudhry et al. (2002) 
reveal that in the majority of the guidelines they have investigated no declarations of a 
potential conflict of interest were made by the authors. 
Several medical associations throughout the world recognise the threat of pharmaceutical 
industries' controlled medical education programmes. As stated by Moynihan (2003b): 
Many individual doctors, and their professional associations, are facing difficult 
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choices about whether they remain part of the industry's extended promotional 
machinery or should seek real distance in their relationships, to give prescribing, 
teaching, and advice that is truly independent. Growing moves towards genuine 
separation may well make previously acceptable conflicts of interest untenable. 
(~oynihan, 2003b,p.1195) 
In fact, the present influence of the pharmaceutical industry over medical education 
programmes endangers two of the main ethical features of medical practice, which are the 
obligation of competence and the prudence of conduct of physicians. As stated by Allman 
(2003): 
One of the stated benefits of the physician-industry entanglement is support for 
educational activities. Patient interest is threatened when that which is presented 
to the physicians as objective, scientifically rigorous, unbiased information is 
commercially slanted to the benefit of a particular manufacturer ... The 
physician who is the mere sum of mind-dulling marketing agendas is less than 
the beneficent and competent agent of the patient's good. (Allman, 2003, p.161) 
An additional ethical issue would be that who in reality is paying for these continuing 
medical education programmes and guidelines 'sponsored' by the pharmaceutical 
industry are the patients, as it will be discussed in Section 7.6.3. 
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Chapter 3 
Research purposes and methods 
3.1 Introduction 
The previous two chapters focused mainly on the subjects that are internationally 
recognised as important to the existence and prevalence of bias in medical research. This 
chapter centres on the research questions and on the discussion of the methodology that 
was employed to answer these questions. However, in order to explain the rationale 
behind the research questions, and even to underpin a posterior assessment of the results 
of this study, a prior discussion of two topics that are seldom examined in studies in this 
area is necessary. 
The fIrst topic is based on the fact that medical research and medical education have 
many common aspects in most countries. Nevertheless, the structure of research 
production and the formation of the physician-scientist may differ among countries. As 
this research focus on fIve Brazilian medical schools, it is necessary to discuss these 
aspects of Brazilian medical research, and this is done in Section 3.2. 
The second topic is related to the existence of some ethical aspects of research that may 
playa role on the occurrence of bias in medical research. With the exception of Section 
2.4, most of the previous discussion about the problem of bias in medical research was 
based on the assumption that: 
Unlike the lay meaning of bias, bias in health research should not be associated 
immediately with a malicious attempt of investigators, funders, or readers to 
bend the results of a trial. Although bias can be introduced into a trial 
voluntarily, it is probably involuntary in most cases. (Jadad, 1998b, p.29) 
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However, there is some disturbing evidence that moral deviations, which may be 
exacerbated by the training of the physician and the physician-scientist, could be related 
to the problem of bias in medical research. This is discussed in Section 3.3 due to its 
eventual role in the discussion of the outcomes of the present study. 
3.2 Medical research in Brazil 
In a recent publication, in a journal funded jointly by the Brazilian Ministry of Science 
and Technology and the Brazilian Academy of Sciences, Zago et al. (2002) state that it is 
a complex matter to try to carry out a survey about the structure of medical research 
production in Brazil. 
This is undoubtedly true, since there is no real control over medical publications in Brazil, 
and most studies are not published in indexed journals. However, the aforementioned 
authors, due to their relationships with the Brazilian Ministry of Science and Technology 
and the Brazilian Academy of Sciences, had access to information that is not readily 
available to most researchers in the area of medical education. Consequently, much of the 
information about medical research production provided in this Section is based on their 
essay. 
In order to envision correctly the real size and importance of Brazilian medical research, 
it is necessary to use some quantitative data. According to the lSI Essential Science 
Indicators (http://www.in-cites.com. last accessed 03/03/2004), from January 1992 to 
October 2002, the Brazilian clinical medicine research production totalled 12586 papers 
(60479 citations). This number of papers represents 0.5% of the global production of 
medical research. In the same period of time, the UK production corresponded to 10.6% 
of global medical research. 
As stated by Zago et al. (2002), in 2002 Brazil had 95 medical schools, and 9349 
physicians graduated from these schools. However, in only 16 of the schools there was 
evidence of an established structure of scientific research. Moreover, 115 of the 128 most 
valued Brazilian medical researchers, according to the evaluation of the Conselho 
Nacional de Pesquisa (National Council of Research - CNPq), were teachers andlor 
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researchers in only eight medical schools and four research centres. Not surprisingly, 
these eight medical schools were responsible for most of the papers mentioned in the 
previous paragraph. Incidentally, the Brazilian government funds all of the eight schools 
and three of these research centres. 
Zago et al. (2002)'s data are consistent with the information presented by Pellegrini Filho 
(2000): 
Universities in Latin America utilise almost 50% of the (total) resources for 
S&T (Science and Technology) and account for 70% to 80% of the scientific 
output. (Pellegrini Filho, 2000, p.347) 
Mari (2002), discussing the problem of the number and distribution of medical 
researchers among the medical schools in Brazil, concludes that a significant portion of 
the Brazilian medical schools' graduates are unprepared to deal with or even correctly 
assess the advances in medical scientific knowledge. He believes that there is an 
important relationship between the quality and quantity of research projects and the 
quality of the available medical education in Brazilian medical schools. 
In relation to Brazilian research, Pellegrini Filho (2000) claims that it is possible that in 
all Latin American countries there is an important disparity between scientific production 
and the dissemination and application of the results. One possible reason for this is the 
isolation of the scientific community from the rest of the society, which makes the 
production and application of scientific research vulnerable to political manipulation of 
fmancial resources. 
Furthermore, Pellegrini Filho (2000) asserts that MEDLINE® indexed in 2000 only 45 
Latin American journals, while LILACS database, which is maintained by the Latin 
American and Caribbean Center on Health Sciences Information (BIREME), had 600 
Latin American indexed journals. This fact would not certainly help in the dissemination 
of Latin American medical research results in Latin America and abroad. 
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Since medical research in Brazil is carried out mostly in medical schools, it is important 
to discuss the structure of medical post-graduation courses in this country because they 
will be responsible for the formation ofthe physician-scientist. 
It is not necessary to have a specialist certificate in order to enrol in a Masters or Doctoral 
programme in Brazil. However, it is extremely rare that a Brazilian physician registered 
in a postgraduate course does not have a previous specialist certificate. This happens 
because almost all students on medical postgraduate courses in Brazil are teachers in 
medical schools. In order to be accepted as a teacher, even as a temporary teacher, 
medical schools require a specialist certificate as a minimum requisite. 
Furthermore, according to Lima-Gonc;alves (2002), the six years of medical education 
required for a physician to graduate in Brazil are not sufficient to guarantee an adequate 
medical knowledge. Consequently, a good residency course (specialisation) became 
progressively compulsory to assure the possibility of success for a physician in a very 
competitive environment. This is especially true if one remembers that, as discussed in 
Section 2.3, teaching is generally only a part of the professional life of a medical teacher 
in Brazil. 
The rapid increase in the number of medical schools discussed on Section 2.3 and the 
escalating demand for a specialisation course, particularly after the 1970s, created a 
vicious circle which resulted in a decline of the quality of medical education in Brazil 
(Lima-Gonyalves, 2002). 
Discussing the last available official data about residency programmes in Brazil, Lima-
Gonyalves (2002) states that in 1998 there were already 1963 specialisation programmes, 
which is a very large number considering that the first programme was created only in 
1945. This number of programmes indicates that a recently graduated Brazilian physician 
had a 70% probability of enrolling in one of them in 1998. As is discussed in the 
following paragraphs, this rapid growth of specialisation programmes was not congruent 
with the Brazilian capacity on the formation of medical teachers and researchers in its 
Masters and Doctoral programmes. 
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The evolution in the number of Masters and Doctoral programmes in Brazil occurred at a 
slower pace than the creation of medical schools and specialisation courses until the 
beginning of the 1970s according to Ramos (1998). From 1970 to 1979, there was a 
remarkable increase in their number due to two factors. The fIrst was the increase in the 
number of medical schools. The second was the new policy of the Brazilian Ministry of 
Education in relation to the requisites that should be fulfIlled by the schools (Ramos, 
1998; Lima-Gonyalves, 2002). 
Unfortunately, the rapid increase in the number of postgraduate courses caused a 
deleterious effect on the quality of these programmes. In 1998 there were already 296 
postgraduate programmes in the medical area in Brazil (Lima-Gonyalves, 2002). 
However, only 44% of the Masters programmes and 56% of the Doctoral courses were 
classifIed as 'good' or 'very good' (Ramos, 1998). 
Furthermore, as stated by Zago et aZ. (2001), the same eight Brazilian medical schools 
and four research centres aforementioned in the discussion about research production in 
Brazil were responsible for 87% of the 'good' or 'very good' programmes. 
Despite the various problems of the graduate and postgraduate courses in Brazil, 
according to Zago et aZ. (2001) over the last 20 years Brazilian medical scientifIc 
production has increased proportionally more than the total scientific production of this 
country. The same authors also assert that, based on the percentage of world citations of 
the Brazilian papers in indexed journals there was also an increase in the quality of the 
medical research production over the same period. 
3.3 Unethical behaviour in medical research: a potential problem 
The discussion about bias in medical research in Chapter 1, and about the potential 
factors that influence its existence in Chapter 2, shows that it is possible that the common 
occurrence of these systematic deviations in medical research may be due to several 
causes. 
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Section 3.2 shows that in Brazil, from the specialisation programmes to postgraduate 
courses, the physician-scientist-teacher has been submitted to a progressive physical and 
psychological strain in order to maintain, or acquire, a position inside a medical school or 
research centre. 
According to some authors, this could be an additional potential reason for the existence 
of bias in medical research. It could favour the existence of unethical behaviours among 
researchers (Smith, 1998; Rennie, 1999). Although these authors show that ethical 
deviations may indeed be a cause of bias, there is no evidence that this could be the main 
factor to explain the existence and persistence of bias in medical research. 
However, there is some evidence that a change of attitudes is occurring during medical 
training, which may be responsible for part ofthe problem. Despite the fact that there is a 
limited literature in this field, the information it yields is frightening. Snodgrass reports 
that 88% of medical students at two Chicago (USA) medical schools, when interviewed, 
admitted that they had cheated at least once in their medical course in order to graduate 
(Snodgrass, 1991). She suggests that: 
Systematic investigation of the attitudes of medical students and practising 
scientists could yield promising information about the relationship between 
ethos and writing in actual situations (Snodgrass, 1991, p. 13). 
Sykes reports that at least 10% of his colleagues, in a medical school in England, claimed 
to have falsified at least some of their research data to satisfy the requirements of their 
courses, even though they considered their projects as important (Sykes, 1994). Perhaps 
more worrying than the fraud itself is the fact that they considered this behaviour as 
normal and necessary. 
These papers reveal something that is more important than the well-known 'publish or 
perish' problem. In the aforementioned papers, medical students are considering their 
unethical behaviour as a morally acceptable conduct, and we must be aware that a 
significant number of them are now researchers. The estimation of how profoundly this 
can affect the future of medical research is very important. 
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Glick (2001), discussing the case of a possible inappropriately lenient reaction by the 
University of London Royal Free and University College Medical School, in a case of 
student cheating in an examination, is helpful for our discussion. The author states that: 
Reviews ofthe literature suggest that we have insufficient reliable data about the 
extent of this phenomenon, its rate of change, its pathogenesis, its prevention, or 
its effective management ... Medical schools should be the major focus of 
attention for imbuing future doctors with integrity and ethical sensitivity. 
Unfortunately there are troubling, if inconclusive, data that suggest that during 
medical school the ethical behaviour of medical students does not necessarily 
improve; indeed, moral development may actually stop or even regress. (Glick, 
2001,pp.250-251) 
According to Glick, this phenomenon can be attributed to, among other causes, 
overemphasis on grades, competition, negative role models, and institutional tolerance to 
cheating. He concludes that it is important to create an environment of peer pressure in 
which certain behaviour is not acceptable. 
Glick's editorial is consistent with the opmlOn of some previous authors. Levy, for 
example, recognised that the most direct and immediate efforts to reduce publication bias 
in the clinical literature should be educational. In his article, he asserts that is necessary to 
" ... discuss all facets of publication bias among us and with our students frequently and 
comprehensively, in its scientific and ethical aspects" (Levy, 1992, p. 118). In addition, 
Pencheon asserts that: 
At school, too many of us have been (and a few still are) exposed to a convenient 
and simplistic view of the world ... Too little emphasis is placed on helping to 
develop our critical faculties, to question assumptions, and to challenge dogma 
. .. Being so poorly prepared to engage uncertainty positively, some of us 
develop our scientific approach despite our training rather than because of it 
(Pencheon, 1999, p. 2). 
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In fact, as is discussed in Chapter 6, one important aspect of current medical education is 
the undeniable influence of the 'hidden curriculum' (Snyder, 1991). According to Lempp 
and Seale (2004): 
Six learning processes of the hidden curriculum of medical education have been 
identified: loss of idealism, adoption of "ritualised" professional identity, 
emotional neutralisation, change of ethical integrity, acceptance of hierarchy, 
and the learning of less formal aspects of "good doctoring." Together they 
achieve the enculturation of students as they develop into both practitioners and 
members ofthe medical profession. (Lempp and Seale, 2004, pp.770-771) 
At this point, we may have to review the traditional defmition of bias because it is based 
on the assumption that most bias in medical papers is an involuntary occurrence. It is 
possible that part of the problems of medical research is a combination of a low level of 
awareness about bias and, possibly, unethical behaviour. Although scarce, the literature 
leads to the conclusion that the educational process on medical schools may be 
responsible, at least in part, for this combination. 
3.4 Research questions: their rationale 
As discussed in the previous two Chapters, bias in medical research and its correction was 
the subject matter of several studies over the last 20 years. The focus of the resulting 
publications was the methodological procedures for detecting and correcting bias. 
Although these studies were important in quantifying the problem and in developing 
research structures less prone to systematic deviations, these efforts have not eliminated 
bias in medical research (Horton, 2000). 
One aspect of this field of study that has received less attention is how much of the 
knowledge about bias is really reaching medical education courses and the medical 
research community. A second aspect that deserves more attention is to identify how 
intensely the information about bias is influencing medical education and research. These 
are important issues because medical schools and postgraduate programmes are partly 
responsible for the conduct of physicians as research consumers, and for the behaviour of 
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future medical researchers (Pencheon, 1999). 
This study has two different but complementary objectives. The fIrst objective is to obtain 
data about the current level of awareness about bias in medical research among teachers 
and students of the last year of the course of medicine, in a sample of medical schools in 
Parana State (Brazil). The second objective is to evaluate how these teachers and students 
perceive the question of bias (whether as a methodological andlor educational problem). 
Additionally, this study has gathered information about the opinion of staff and students 
about the possible educational measures that could help to minimise the occurrence of 
bias in medical research. To achieve these objectives, it was necessary to obtain both 
qualitative and quantitative data (Sackett and Wennberg, 1997), as discussed in Section 
3.5. 
According to these research objectives, the present study focuses on three research 
questions: 
1. What is the level of awareness about bias in medical research among teachers 
of Internal Medicine, Surgery, Gynaecology and Obstetrics, and Paediatrics, 
and students of the last year of the course of medicine, in fIve medical schools 
in the state of Parana (Brazil)? 
2. In the participants' opmlon, are the systematic errors that exist in medical 
research the result of factors related only to the methodology of research, or are 
they also a manifestation of habits acquired during medical education and 
postgraduate courses? 
3. What can be changed in medical education in order to reduce systematic errors 
in research? 
The expression 'level of awareness' in the fIrst research question refers fundamentally to 
the general knowledge of teachers and students about the existence and importance of 
bias in medical research. It is a direct question and can be answered with a quantitative 
approach. However, the second and third questions involve individuals' values and 
experiences, and demand a qualitative methodology (Sackett and Wennberg, 1997). 
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Although assessment of the level of awareness about bias among the participants was 
important to this study, it was also necessary to obtain some complementary information. 
Basically, this comprised two subjects: the sources of information that participants were 
using to obtain their knowledge about bias, and the phase of their medical formation at 
which this was occurring. This information was important because, as discussed in 
Section 1.5, knowledge about bias is not only important to the physician-scientist but also 
to the physician as a consumer of the information contained in medical publications. 
In order to fulfil the objectives of this research, three concurrent methods of data 
collection were employed: questionnaires, interviews and curriculum analysis. The 
proposed methodological structure had the aim of obtaining a complementary perspective 
of the problem, rather then a competing one as is usually attained in a traditional 
'triangulation' method (Barbour, 2001). 
This approach to the study of the possible relationships between medical education and 
bias in medical research is coherent with the opinion of Murphy et al. (1998). Their view 
is that there is a complementarity of qualitative and quantitative methods, which can be 
very useful when studying human resources behaviour in health technology assessment. 
These authors also suggest that the use of a qualitative approach may be useful in 
enlightening the factors that sustain professional practices that are suspect of being 
ineffective or inappropriate in healthcare settings. 
Since the problem of bias is more prominent in clinical trials, I selected as participants the 
teachers from departments that are more involved in clinical and surgical teaching and 
research (i.e., Internal Medicine, Surgery, Gynaecology and Obstetrics, and Paediatrics 
departments). The theoretical basis to this sampling method is the 'purposive sampling' 
(Silverman, 2000). 
This method was chosen because in purposive sampling, we can use groups and settings 
where the processes we want to study are expected to occur more frequently. As a non-
probabilistic procedure, it has the disadvantage that its findings cannot be generalised 
quantitatively to a wider population. However, it is considered to be effective for 
exploring areas of study that are still underdeveloped, and for generating theories or 
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hypothesis (Baker, 1999), which is the case in the research presented here. The theoretical 
basis that underpinned the choice of purposive sampling is more thoroughly discussed in 
Section 3.8. 
Combined with the fact that participation in this study was voluntary, purposive sampling 
was expected to enhance the quantity of data obtained in the qualitative data collection. 
This would be particularly important to the present study, as these data are related to the 
second and third research questions. These questions focus on the relationships between 
medical education and the transmission of knowledge about bias, which is the least 
known aspect about the occurrence and incidence of bias in medical research, as 
discussed in the previous two Chapters. 
Therefore, the possible deficit of generalisability of the data obtained in the answers to 
research question one would be compensated by the improvement of the data acquired for 
the second and third questions responses, which are the main research objectives of this 
study. 
3.5 The assembly and results of the questionnaires and interviews of the 
pilot study 
3.5.1 Structuring the questionnaires 
In order to obtain the data needed to answer the first research question, I decided to use a 
questionnaire for both teachers and students. This approach had a fundamental problem, 
because historically questionnaires have a low response rate when applied to physicians 
in England and in USA, especially if the questions are about sensitive topics (McColl et 
al., 2001). Although I did not have information about similar research in Brazil, it was 
reasonable to assume similar poor response rates. In order to reduce this possibility, 
several measures were taken in order to enhance the response rate, as discussed in the 
next few paragraphs. 
One obstacle to the use of questionnaires was that the problem of bias has received more 
attention in English speaking countries. Conversely, in Portuguese, the number of 
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publications about the matter is scarce. In addition, authors use a range of terms in 
Portuguese, principally 'vies', 'tendencia', 'tendenciosidades', and even 'bias', to 
translate the English word 'bias'. This created a semantic problem for the construction of 
the questions that composed the questionnaires. 
Another problem was that most of the terms used in Portuguese do not have the strong 
negative connotation that the term 'bias' has in English. To reduce the possible effects of 
these problems, the wording, design and sequence of questions was tested with a small 
group of Brazilian physicians who were not based in medical schools. This assessment 
was carried out before the pilot study in order to see if the questions were understood as 
intended by general practitioners. This permitted me to assume that an unanswered 
question, or a non-returned questionnaire, would not be the result of a lack of 
understanding. 
Furthermore, in order to reduce the occurrence of the two aforementioned problems, the 
questionnaires only used Portuguese expressions that could be found in the Descritores 
em Ciencias de Saude (Health Science Descriptors - DeCS). This is an official glossary 
of Epidemiology in English, Portuguese and Spanish from the Pan-American Health 
Organisation. 
A pilot study of the questionnaires was undertaken in July 2002 at a medical school in 
Sao Paulo State (Brazil). This school was selected for the pilot for three reasons. Firstly, 
as I had graduated from this particular school I supposed that it would be easier to contact 
people to participate in the pilot, without having to follow all the normal bureaucratic 
procedures which will be discussed in Section 3.7. Secondly, I anticipated that some of 
the teachers who participated in the pilot would give me some important additional 
information about their opinion of the questionnaire structure, as they would recognise 
me as a former colleague or student. Finally, this particular school does not have much 
contact with the Parana State medical schools where the main data collection of this study 
was performed. 
The questionnaires in the pilot study (Appendix 1) included closed and free-response 
questions, and were structured along the lines recommended by Oppenheim (1992) and 
McColl et al. (2001). The two questionnaires had three fundamental objectives: first, to 
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structure and test the questionnaires that would be used in the main phase of the research; 
secondly, to evaluate any flaws in the questionnaires design that could compromise the 
results of this study; thirdly to estimate the usefulness of the questionnaires in the 
development of the personal interview framework. 
In July 2002, I had my fIrst contact with the Heads of the Departments of Internal 
Medicine and Surgery, and the representatives of the students in these Departments, of 
the medical school selected for the pilot. These two Departments were chosen because 
they contained a signifIcant number of teachers who had a more frequent contact with the 
students during their medical course. Thirty questionnaires for the teachers and the same 
quantity for the students were distributed in stamped addressed envelopes for return. 
The central idea of the aforementioned approach was to permit teachers and students 
freely to decide if they wanted to participate in the pilot study, as a contribution to a 
future research project in another state. My intention was to engage them into the project 
not as participants but as collaborators. I did not want formally to present the piloting of 
the questionnaires as a research project because this would entail, in Brazil, several 
bureaucratic procedures between my university and the school of medicine where I did 
the pilot study. These procedures can be particularly intricate and time-consuming, as will 
be discussed in Section 3.7. 
After the pilot was concluded, discussions with academic staff at the Institute of 
Education, University of London (loE), the Universidade Estadual de Ponta Grossa, and 
participants in the pilot revealed that the wording, layout, and the structure of the 
questionnaires should be changed in order to improve them. These modifIed 
questionnaires, which were used in the main data collection of this study are discussed in 
Chapter 4, and are included in Appendix 3. 
3.5.2 The questionnaires: their role in answering the research questions 
In this section, I will discuss the structure and objectives ofthe questionnaires in the pilot 
study, and their potential role in providing the information discussed in the previous 
paragraphs. Furthermore, I will demonstrate how their results changed some 
methodological concepts that I had at the beginning of this research. The structure and 
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results of the questionnaires used in the main data collection phase will be the subject 
matter of a systematic analysis in Chapter 4. 
The first three questions in the student questionnaire (SQ) and the first four in the teacher 
questionnaire (TQ) aimed to establish whether the respondents were producers or 
consumers of medical information. They were also intended to determine how many 
participants are involved in medical research and, in the case of the TQ, their academic 
background. An example is question 1 ofthe teacher questiolllaire: 
1 Your present occupation (Tick more than one if necessary) 
o Teaching 
o Research 
o Extension 
o Administration 
This information would enable me to compare different responses to the questions that 
followed among the participants (or between different schools of medicine). 
Questions 5-7 (TQ) and 4-6 (SQ) aimed to reveal how the participants acquire 
information about bias in medical research, and whether they use this information to 
evaluate papers, e.g. question 7 of the teacher questionnaire: 
7 How much did your evaluation of papers published in medical journals change with the. 
acquisition of knowledge about bias? Please explain. 
The next six questions were the same on both the TQ and SQ, and focused on the 
participants' views about bias, their level of knowledge of the basic principles concerning 
the subject of bias, and their opinion on how to deal with the problem within medical 
schools. In addition, the answers to these questions would be important for subsequent 
interviews. An example of these questions is reproduced below. The assertion I used in 
this specific question is considered as an important aspect of the effect of bias in the 
results of systematic reviews and meta-analyses. 
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9 In the statements below choose the alternative that is more compatible with your 
personal opinion: 
b- 'Publication bias is a menace to the quality of systematic reviews and meta-
analyses' 
o I totally agree 
o I partially disagree 
o I totally disagree 
o I do not have an opinion about the subject 
The response rate was low: only eleven teachers and one student. The teacher response 
rate is compatible with previous studies, as international surveys demonstrate (McColl et 
ai., 2001). However, the exceptionally low student response rate was attributed to several 
factors. Firstly, distributing the questionnaires via student representatives proved 
inadequate, and in the main data collection the questionnaires were delivered to the 
Graduation Council of the medical schools. Secondly, although the use of personalised 
letters and envelopes is recommended by the literature (e.g. McColl et ai., 2001) I had 
decided, maybe incorrectly, not to personalise them. The fundamental reason was that in 
order to obtain an official list of the students I would have needed to contact the 
Graduation Council of the medical school. This contact would elicit the necessity for 
subsequent bureaucratic measures, as aforementioned. Thirdly, the last year of training is 
extremely time-consuming and stressful to the students, and they may have seen the 
questionnaire as yet another burden. Finally, the low response rate could have been 
related to their feeling that they have a low level of knowledge about bias. 
The answers to the fIrst four questions in the teacher questionnaire (TQ) revealed that all 
of the respondents had completed their doctoral studies and were involved in teaching and 
research. Additionally, ten of them had papers published in the USA and/or United 
Kingdom. These rates are very high for Brazil, as discussed in Section 2.3 and may reflect 
that more academic teachers were more likely to complete and return the questionnaire 
and/or could be caused by the methodology of contacting the possible participants for this 
pilot. 
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The answers to question five of the teacher questionnaire were quite interesting. Only 
three of the respondents reported that they used the Internet to acquire knowledge about 
the problem of bias. However, all ofthem sent me their email addresses. This discrepancy 
may be caused by a language impediment (most of the databases are in English) or a 
difficulty in coping with the technical hitches involved in an Internet search. Anyone who 
has used MEDLINE® for research knows that it is time-consuming and sometimes 
frustrating, because of the huge number of papers one has to evaluate, many ofthem only 
remotely related to the research question. 
The teachers' answers also showed that information about bias might be extensive, 
however, the dissemination of knowledge about bias may be less efficient than it should. 
One can perceive this in their answers to questions 9-b and 9-c, which use two statements 
that are considered accurate according to the literature about bias. The answers to these 
questions showed that the participants have certain knowledge about bias, however it 
does not seem to be very accurate and well based. 
The answers to the last two questions (12 and 13) gave me a pleasant surprise because 
eight of the participants agreed to participate in a tape-recorded interview. Although I 
could not expect such a high proportion in all schools involved in this research, it seemed 
that it would be possible to have a sufficient number of permissions for interviews. 
Even with a small number of participants, the pilot study was important to demonstrate 
some shortcomings in the methodology initially proposed for this research. However, the 
pilot also revealed that the questionnaires could give me responses to the first research 
question, and could contribute to answering the other two questions (see Section 3.4). It 
also exposed the fact that, at least in the case of the teachers who participated in the pilot, 
a certain degree of knowledge about bias and experience as researchers were not 
sufficient to attain a clear image of the problem of bias in medical research. It also 
permitted me to structure the interview schedule as described in the next section of this 
chapter. 
3.5.3 Structuring the interviews 
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The interviews in this research had three main objectives. First, to understand how 
teachers and students of five medical schools of the state of Parana (Brazil) perceive the 
problem of bias in medical research. Secondly, to appraise which were their methods of 
acquisition of their perceptions, and how they were using their knowledge about bias. 
Finally, as described by Tierney and Dilley (2002), I expected that the data collected in 
the interviews could eventually be useful in the improvement of educational practices in 
medical courses. 
Although Fontana and Frey (1998) consider that interviewing is 'the art of science', I 
believe that it is a method to obtain data in a somewhat 'natural' form. It seems to be 
especially useful when one has a problem that can not be solved by a questionnaire, as is 
the case in which the problem under study is too complex to be approached by closed 
questions. There are three basic modalities of interview style: structured, semi-structured, 
and unstructured. Each of them can be used depending on the context and aims of the 
proposed research. 
As the research area I have chosen is underdeveloped, and I needed to collect data about 
people's beliefs and feelings, I have selected a semi-structured interview design for use. 
The fundamental reason for this choice is that it could grant me the possibility of 
modifying or adding particular questions in order to elicit richer information, according to 
the individual characteristics ofthe participants (Robson, 1993; Britten, 1995). This could 
also be useful if the results of the open questions of the questionnaires showed a 
significant difference among the schools in a specific topic. Such differences could be 
better explored with a semi-structured design that would allow me to add some probe 
questions in order to ascertain why these differences occurred in the questionnaires. 
Fundamentally, the interview proposed for the pilot study was intended to allow me to 
obtain data about the participants' opinions about the structure ofthe questionnaires, their 
evaluation of the current level of awareness about bias in medical research inside medical 
schools, and the possible educational solutions to this problem. Therefore, each 
interviewee received a copy of their questionnaire before the interview, because I had to 
assume that several of them would not remember their answers to the questionnaire. 
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The basis of the organisation ofthe interviews was the participants' responses to the open 
questions of the previous questionnaires, and the central objectives of this study as 
discussed in Section 3.4. Since the teachers and students who were interviewed had 
completed the questionnaire, the fIrst two questions in the interview were: 
"Would you like to make any comments about the questions you have answered 
in the questionnaire?" 
"Some/FewlMany of your colleagues did not answer the questionnaire. Could 
you please give me your opinion why that happened?" 
A possible alternative to these questions was: 
"Your answers to the questionnaire are very important to my research. Could you 
please give me more information about question X? 
The main function of these questions was not to collect data, although this did occur. 
Rather, their purpose was to create a 'link' between the interviewer and the respondent. 
The next two questions had a more direct importance in the research: 
"Do you really think that bias in medical research is/is not related to medical 
education? Why?" 
"Which are/could be, in your opinion, the possible educational procedures to 
minimise this problem? Why do you think they can be effective?" 
As a possible respondent could not feel comfortable in disclosing hislher opinion, I 
believed that an alternative question could be: 
"Are you satisfIed with the current measures adopted by the medical community to 
deal with the problem of bias in medical research? Why?" 
3.5.4 The interviews: their role in answering the research questions 
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In this section, the results of the interviews in the pilot study will be discussed. As 
will be demonstrated, these were important for the development of the interview 
schedule used in the main data collection, which will be the subject matter of Chapter 
5. 
The pilot interviews were carried out in the first week of December 2002. I 
interviewed two teachers and two students of the school of medicine that participated 
in the pilot study. One of the students (Student 2) had not answered the 
questionnaire, but agreed to do the interview. 
These interviews lasted for less time than I expected, and I believe this was due to 
two principal reasons. Firstly, these were my first interviews, and I did not make as 
full use of alternative questions as would have been ideal in enhancing the data 
collection. Secondly, as this was a small pilot I did not have enough data available 
from the limited number of returned questionnaires to use as a motivation for the 
discussion. However, this small number of relatively brief interviews provided an 
interesting glimpse into the problem I was proposing to investigate. 
One notable aspect of the pilot interviews was the range of opinions of the teachers in 
respect of what is happening to the students on their medical course. This becomes 
evident in their answers to questions that focused on improving the knowledge of 
students about bias in medical research: 
... We are not giving an opportunity to our students to develop a critical thinking 
about research, results, uses, etc ... To try to correct these problems in the 
postgraduate courses is impossible, as far as I can see ... no chances ... There 
are some schools that are trying to do something about that, but I must confess 
that I do not know the results ... however, something must change ... (Teacher 
1) 
... Our students have a good basis on scientific methodology and ethics ... We 
are doing the best we can do under the circumstances... there is nothing to be 
changed, as far as I can see ... As I have said before, the objective of a good 
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medical school ... and our school is a good one ... is to provide a solid basis in 
medical practice. And that objective is being fulfilled by the present curriculum 
... (Teacher 2) 
The students suggested that the fITst teacher quoted above might be correct: 
You see, our teachers ... physician teachers, I mean ... do not talk: much about 
these topics on research. I do not know why ... other interests maybe ... or lack 
of time ... Some of them really seem to have an excellent knowledge about 
medical research, methodology, etc. However, when they have contact with us 
they only talk about the specific discipline ... diseases, treatments ... do you 
understand? Of course, we have the discipline of scientific methodology, but ... 
who remembers that four or five years later? (Student 1) 
Well ... you see ... that there is much research that have problems ... some that 
is not useful ... well ... this is not really a secret. What I mean is that these 
problems are not really discussed as they should be. There is a kind of ... how 
should I say ... strange feeling ... that this is not to be discussed openly, do you 
understand? It is not a rule ... just that strange feeling ... (Student 2) 
These answers illustrate the possible existence of 'hidden laws' about the subject of bias 
in medical research in this specific medical school. 
Another important point is that the need for a closer contact with the school members in 
order to overcome the natural resistance of the participants to commenting on the subject 
matter of this research became evident. As Student 2 summarised in his interview: 
Researcher: . . . do you think that your colleagues did not answer the 
questionnaire for the same reason? 
Student 2: It is possible ... I do not know ... I am not sure I can tell you ... some 
teachers said to us that the results of that kind of research could be harmful to the 
school ... could be harmful to the research projects, you see ... You know we 
are in a difficult period ... for many of us what teachers say is law ... You should 
have stayed more with us ... explained ... it would probably have helped ... 
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The pilot interviews also showed that it would be difficult to achieve a consensus about 
the possible educational methods that could be employed to overcome ineffective 
transmission of knowledge about bias, at least in this particular school. The teachers who 
were interviewed are highly skilled physicians, and had very strong ideas about the 
matter, as shown by their answers: 
Researcher: I see ... and ... what would be your personal opinion about what 
should change (in medical education)? 
Teacher 1: Well ... my opinion is that we should try to adapt progressively to a 
structure focused on problem-based learning. However, if you ask me if our 
teachers can assume the task, I will have to tell you: no! In addition, we do not 
have fmancial support to do that ... big problem ... Now that you asked, I was 
thinking that we should change the teachers and not the students ... 
Conversely, Teacher 2 had a very different opinion about the matter: 
Researcher: Of course ... So, you do not think that there are other possible 
educational measures to minimise the problem of bias in medical research? 
Teacher 2: Well ... not in the graduation period ... I really believe that this issue 
should receive more attention in the postgraduate courses . . . In the 
undergraduate phase, we do not have much time to use for that ... The time we 
have with the students in a medical school, as you know, is barely sufficient to 
teach them the basis of medicine ... To try to overemphasise this aspect of 
research methodology will not improve our students' chances of becoming good 
physicians. Only a small proportion of them will ever be involved in research ... 
and even these few only after their post-graduate courses ... so ... it is better for 
them as a group to receive a solid formation on the practice of medicine. 
It is obvious that a small number of questionnaires, and four interviews, do not allow 
anyone to jump to defmitive conclusions. However, I believe that these pilot interviews 
demonstrated that my research questions were coherent, and that the structure of the 
interviews of the main data collection could remain the same of the pilot. They also 
established that the interviews would not only be necessary to answer the second and 
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third research questions of this study (see Section 3.4), they would also be essential for 
collecting information about the various possible educational measures required to reduce 
the occurrence of bias in medical research. 
3.6 Medical schools involved in this study 
The grant that allowed me to start the doctoral programme at the Institute of 
Education, University of London, was from the Government of Par ami State (Brazil). 
One of the requirements to receive such a grant was that the proposed research 
should focus (and take place) on the educational structure and problems of this State. 
Therefore, although the organisation and results of the present study are not intended 
to be restricted to a specific Brazilian State, the main data collection occurred in the 
medical schools of Par ami. 
A second but not less important aspect was related to the time and resource 
limitations of this specific doctoral programme. It was intended that it should be 
concluded in three years, and there was no provision of resources to help in carrying 
out the data collection. This meant that the possible contacts with the participants 
was forcefully restricted to the minimum necessary due to the time and resource 
restrictions. 
The possible choice of participants in this research was restricted to the eight medical 
schools that existed in the Parana State at the time of the initial research proposal. 
However, the State Government closed one of the medical schools before the main 
data collection, allegedly due to structural problems of the course and financial 
constraints, which reduced the possible participants to seven schools. 
During the pilot study, it became evident that the opinions of the students of the last 
year of the medical courses were important for the central objectives of this research 
to be met. One of the Parana schools was only recently created and still does not have 
students on the sixth year of its course, which further limited the number of eligible 
schools to six. 
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Finally, one of these six schools did not grant me permission to undertake the 
research on its premises (see Section 3.7), reducing the fmal number of schools that 
participated in this research to five. 
Some details of the structure of the schools that participated in the research, and that 
will be important in the discussion of the outcomes of this study, are presented in the 
following paragraphs. This information was obtained from the official website 
(http://www.educacaosuperior.inep.gov.br last accessed on 25/0312004) of the 
Brazilian National Institute of Educational Studies and Research (INEP), an official 
bureau of the Brazilian Ministry of Education. 
The school of medicine of the Universidade Federal do Parana (Federal University of 
Parana - UFPR), was the first medical school of Parana State and started its activities 
on 09/12/1912. The Brazilian Federal Government funds this university, and its 
medical course follows a traditional curriculum structure with 7150 hours of contact 
teaching over 6 years, including an internship of two semesters. It also offers to its 
students an optional one-semester internship in 24 medical areas in the last year of its 
programme. It does not have a course of Scientific Methodology during the six years. 
Forty-five years later (11/0311957), the Pontificia Universidade Cat6lica (Pontifical 
Catholic University of Parana - PUCPR), a private university that has educational 
units in several Brazilian States, initiated a medical course in its branch in Parana 
State. Until 1999, its curriculum was also traditional with 6319 hours of contact 
teaching over 6 years, including an internship of three semesters. There were no 
optional courses, and the students had a 70 hour module on Experimental Research 
Methodology in the fifth semester. Although this school has changed its curriculum 
to a problem-based one in recent years, the students that participated in this study 
were the products of the traditional structure. 
In 15/0211967, the third medical school in Parana State, and the frrst one funded by 
the Government of the Parana State, was created: the Faculdade de Medicina do 
Norte do Parana. In 1970, this and the other faculties that pre-existed in that area of 
the State were discontinued, and their structure and teachers integrated within a new 
university, the Universidade Estadual de Londrina (State University of Londrina -
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UEL). This school of medicine maintained a traditional medical curriculum until 
1997. In the 1998 it changed its curriculum structure to one based on the problem-
based learning (PBL) model with 8252 hours of contact teaching over 6 years, 
including 2 years of internship. There are no modules that focus specifically on 
Scientific Methodology. 
The Government of the Parana State also funds the last two medical schools that 
participated in this study. Both of them were established in previously existent state 
universities in 1988 (UEM) and 1996 (UNIOESTE), and share the common feature 
of employing a traditional medical curriculum in their courses, including 2 years of 
internship. The course of the Universidade Estadual de Maringa (State University of 
Maringa - UEM) comprises 8657 hours of contact teaching over 6 years and has no 
formal training in Scientific Methodology. Finally, the medical school of the 
Universidade Estadual do Oeste do Parana (State University of the West of Parana -
UNIOESTE) has a programme of 7610 hours of contact teaching over 6 years, which 
includes a 60 hour module of Scientific Methodology and Research in the first year. 
3.7 Obtaining the necessary permissions to do the research 
After the conclusion of the pilot study, it became apparent that one of the main 
obstacles to the success of this study would be obtaining the necessary official 
permissions to do the research in the six universities. 
The central problem was that although medical schools in Brazil are associated with 
universities, all of them maintain their own bureaucratic apparatus because they 
retain a significant administrative autonomy. Additionally, the Departments that 
compose the Brazilian medical schools also have their specific internal rules, which 
can vary considerably from one school to another. 
Consequently, obtaining permission to undertake research within these schools in 
fact entailed obtaining three different consents: the first from the administration of 
the universities, the second from the Graduation Council (or Course Collegiate) of 
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each of the medical schools, and the fmal one from each Department involved in the 
research project. Accomplishing all this is troublesome and time-consuming. 
Since I was a member of a doctoral programme that was considered relevant to my 
university, to the Parana State government, and to the University of London, the first 
phase was unproblematic, because my research was already registered in my university. 
On 15/01/2003, I received via my supervisors the information that I could start the main 
data collection. One week later I had my fIrst contact with the Dean of Research of the 
Universidade Estadual de Ponta Grossa (UEPG). He was aware of the IoE-SETI 
(Secretaria de Ciencia, Tecnologia e Ensino Superior)-Universidade Estadual de Ponta 
Grossa programme, and agreed to make contact with the Deans of Research of the six 
universities that I expected would participate in this study. As this fIrst contact would be 
done by mail, I added to his memorandum a letter explaining the research project and 
providing additional personal information. 
After one month without any response from the Deans of Research I decided to contact 
them bye-mail, and some of them fmally agreed to meet me in order to hear about my 
research project. This stage of interaction between the Deans of Research and the 
researcher only occurred due to the personal efforts of the Dean of Research of UEPG, 
and I was able to contact them personally at their universities at the end of February 2003. 
At the beginning of April 2003, I fmally received the initial approvals that enabled me to 
do the contacts directly with the medical schools. These contacts with the medical schools 
were done face-to-face, as the experience of using e-mails in the previous stage had not 
proved to be very effective. The contacts occurred directly with the Co-ordinator of the 
Graduation Council of each school, and the Heads of the Departments to be involved in 
this research. The result was that fIve schools gave me the permission to do the research 
in their premises, without restrictions. By the end of May 2003, I had received almost all 
of the lists of teachers and students I needed to start the second phase of this study. 
To receive the permissions and the lists of teachers and students by the end of the fIrst 
semester of the year was fundamental to this research, because in Brazil the academic 
year is divided in two semesters separated by one month of vacations in July. Therefore, 
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receiving them at the end of the fITst semester would allow me the five months of the 
second semester to apply the questionnaires and do the interviews before the end of the 
academic year. This was important to ensure that I would be able to contact the students 
for the interviews before they had left the schools after their graduation. 
This first phase of the project was quite time and resources consuming because I had to 
travel to each school twice in three months. Each of these two trips, comprising a visit to 
each of the five medical schools, took at least 10 days and entailed some 1150 km (700 
miles) of travel. 
In fact, I believe that there are three aspects that deserve to be stressed for future 
researchers in this area. Firstly, that research involving several medical schools in Brazil 
has to take into account a rather long period of time to achieve the necessary permissions. 
Secondly, that it is important to have an assistant researcher in each school (if possible), 
as they could deal with the possible problems more rapidly and efficiently than an 
isolated researcher. Finally, that in the case of research in medical schools in Brazil, 
personal contact is much more effective than any other method of communication. 
3.8 Purposive sampling method: why was it used in this research? 
Choosing a sampling method may seem easy at first sight. After all, there are many books 
that can help a researcher to select one that is appropriate to herlhis research objectives. 
However, a researcher will have to take into account not only the objectives of his/her 
research. 
In a perfect world, issues related to time and resource constraints and access to the 
participants would not be a problem. Conversely, in real world research, they are 
fundamental to the defmition of the study design, and to the option of the sampling 
method that will be employed (Robson, 1993). 
In the specific case of this study, I had already envisioned the possible problems that 
could occur in the main data collection as discussed in Sections 3.5 and 3.7. Furthermore, 
the intention of this research was to serve as an exploratory survey about the problem of 
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bias in medical research and its relationships with medical education, rather than an 
explanatory study about this subject. 
To do an exploratory study using a purposive sampling method was not a random option 
of the researcher in this study. In fact, it was the result of the combination of three factors. 
Firstly, the research would involve only five Brazilian medical schools that were not 
randomly chosen (see Section 3.6), and there are more than 100 medical schools in Brazil 
(see Section 2.3). Secondly, the time and resource limitations involved in this study (see 
Section 3.6) also restricted the number of possible participants. Finally, this field of study 
is underdeveloped and it seems important to the future of evidence-based medicine and 
continuing medical education, as was discussed in Chapters 1 and 2. 
Consequently, even at the cost of reducing the external validity or generalis ability of the 
outcomes of this research, the most reasonable approach was to employ a purposive 
sampling or theoretical sampling method (Robson, 1993; Baker, 1999; Silverman, 2000). 
As stated by Baker: 
Non-probability sampling also may be used effectively in the studies that seek to 
explore ideas that are still undeveloped. In such exploratory studies, the object 
may be to generate theories or hypotheses that might then be studied using a 
probability sample (Baker, 1999, p.B8). 
Therefore, a positive aspect of the proposed research method was the opportunity to 
obtain meaningful data that can underpin future research on the area. 
3.9 Tools used in the main data collection 
In this section the structures of the questionnaires for the teachers and students, and the 
structure and objectives of the interviews, which were used in the main data collection of 
this study, will be appraised. These questionnaires and interviews are the result of the 
outcomes of the pilot study, which was discussed in Section 3.5. The final questionnaire 
74 
in Portuguese, and their translation to English, is available in Appendix 3, whereas a 
transcribed and translated interview is presented in Appendix 5. 
The questionnaires had two different but complementary objectives. The first was to 
obtain quantitative data that could permit the first research question of this study (see 
Section 3.4) to be answered. The second was to collect qualitative data that could 
underpin the framework of the interviews, which were used to help answer the other two 
research questions. 
In Section 3.9.1 each question of the teacher and student questionnaires is scrutinised 
with respect to their structure and objectives, while Section 3.9.3 discusses the structure 
and aims of the interviews. 
3.9.1 The teacher and student questionnaires 
The first four questions of the teacher questionnaire were: 
1 Your present occupation (Tick more than one if necessary) 
o Teaching 
o Research 
o Extension 
o Administration 
2 Have you published papers in the last 5 years? (Tick more than one if necessary) 
o Yes, in Brazil 
o Yes, in foreign countries (please cite countries) ...................................... . 
o No, I have not published papers in the last 5 years 
3 Which was (were) the language(s) of publication?(Tick more than one if necessary) 
o Portuguese 
o Spanish 
o English 
o Other .......................................................................................... . 
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4 Your academic background is: 
o Specialist 
o Masters 
o Doctoral 
o Post-doctoral studies 
These four questions were designed to gather some personal information about the 
teachers, their present occupation and their academic background. This information could 
then be compared with that from previous research (see Sections 2.3 and 3.2). In addition, 
it would enable the determination of the extent to which the sample in the present study 
was different from a preceding larger study which involved teachers of Brazilian medical 
schools, the CINAEM project (CINAEM, 1997), discussed in Section 2.3. 
Questions 2 and 3 had the same objectives as in the pilot study: to evaluate whether the 
teachers who responded to the questionnaire were consumers or producers of medical 
research. This evaluation would not be complete without the information about their 
academic background, which was the objective of the fourth question. 
In the informal contacts that occurred in the pilot study, one of the main complaints of the 
teachers was that they were overwhelmed by several different responsibilities in medical 
schools. At the same time, the students in their fmal year complained that it was difficult 
to receive some information about bias, due to the reduced contact they had with their 
teachers (see Section 3.5.4). Question 1 therefore aimed to determine whether the 
participants in the present study were involved with other activities besides teaching. 
Additionally, the sixth question (shown immediately below) was intended to determine 
how often they had discussed the subject of bias with their students in the previous year. 
6 How often did you discuss the problem of methodological deviations (bias) with 
your students in the last year? 
o Frequently 
o Rarely 
o Never 
o I do not remember 
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As discussed in Chapter 1, knowledge about bias entail being aware of several factors that 
affect the methods employed in medical research, and their effects on the results of 
isolated studies, meta-analyses and systematic reviews. 
It was therefore important to establish how the participants were acqumng their 
knowledge about bias, and how this knowledge influenced their evaluation about the 
outcomes of medical research. These were the aims of Questions 5 and 7: 
5 Which was the method that helped you to acquire your present knowledge about 
systematic deviations (bias) in medical research? (Tick one or more boxes) 
o Books about methodology of research 
o Medical congresses or conferences 
o Medical journals. Please cite one ............................................................ . 
o Special courses. Please cite one .............................................................. . 
o The Internet 
o Other (please specifY) ........................................................................... . 
7 How much did your evaluation of papers published in medical journals change 
with the acquisition of knowledge about bias? Please explain. 
Question 5 is a multiple-choice question, and its results will be discussed in Chapter 4, 
while Question 7 is an open question that encompasses a qualitative approach, and its 
outcomes will be considered in Chapter 5. 
In order to evaluate the level of awareness in the teachers who participated in this study 
about bias in medical research, the results of Questions 8 and 9 were used. Actually, these 
questions between them combine seven individual questions. They include four assertions 
that intend to evaluate the personal feelings of the participants about common doubts 
concerning the problem of bias, with three assertions that are considered essentially true 
by authors of the literature discussed in Chapter 1. 
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Questions 8 and 9 were planned as two pooled questions in order to provide solutions to 
two potential problems. The first intention was to reduce the apparent number of 
questions on the questionnaire in an attempt to increase the response rate. The second 
intention was due to the fact that in the pilot study (where they were individual questions) 
it was found that the respondents had a tendency to follow what they believed was a 
logical sequence for the responses. 
To circumvent this problem and attempt to ensure that respondents read and considered 
each statement separately, different kinds of assertions were mixed in the two questions. 
Three assertions (8c, 9b and 9c) are based in the international literature, and are 
considered true by most authors. They were used to evaluate quantitatively the level of 
knowledge about bias in medical research (see Section 4.2.2). Conversely, the remaining 
assertions of questions 8 and 9 focus on areas that are still under discussion. These 
assertions are intended to collect qualitative information about what the participant 
believes about the subject. 
8 In relation to the problem of methodological deviations (bias) in medical 
research you believe that (Please tick): 
Strongly Agree Disagree Strongly Do not have 
agree disagree an opinion 
It is a problem of scientific 
methodology, with no relation to 
undergraduate medical courses 
Courses of scientific methodology are 
responsible for the transmission of 
knowledge about bias 
Methodological deviations (bias) in 
medical research are progressively 
becoming an ethical issue 
Medical journals are responsible for 
the evaluation of methodological 
deviations in papers they publish 
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9 In the statements below choose the alternative that is most compatible with your 
personal opinion (Please tick): 
Strongly Agree Disagree 
Strongly Do not have 
agree disagree an opinion 
Systematic reviews and meta-analyses 
are the best ways to acquire valid 
knowledge in medicine 
Publication bias is a menace to the 
quality of systematic reviews and 
meta-analyses 
Systematic deviations (bias) in 
randomised clinical trials may 
exaggerate the results of future meta-
analyses 
An important feature of this study's methodology was that it included participants from 
five different medical schools (see Section 3.6). Medical schools do share many common 
characteristics as they have the collective objective of, in theory, graduating physicians 
who should be comparable with reference to their medical skills. However, their methods 
to achieve this aim, and their degree of success in accomplishing this task, may differ in 
many aspects as discussed in Sections 2.3 and 3.2. 
Consequently, the use of a rigid interview schedule could result in inconsistent outcomes. 
In order to avoid such a problem, questions 10, 11 and 12 were included in the teachers' 
questionnaire: 
10 In your opinion, how should the knowledge about bias in research be transferred 
to the students of a medical school? 
11 Do you believe that changes in the curriculum of medical schools are necessary 
in order to achieve a better transference of knowledge about bias in medical 
research? 
DYes 
DNo 
12 If your answer to the previous question was Yes, what should be changed? 
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These questions therefore had three objectives. Firstly, to probe the participants' opinions 
about the matter as a single group of medical teachers. Secondly, to try to unveil 
differences among participants from the individual medical schools. Thirdly, to underpin 
the necessary differences in the approaches adopted in the interviews undertaken in each 
individual school. 
Finally, the last two questions, 13 and 14, of the teacher questionnaire were of value for 
my research because written acceptance of an interview would circumvent the need for 
another sequence of permissions, as described in Section 3.7. 
13 Do you agree with a personal interview, if necessary, to enlighten some aspects of 
the present questionnaire? 
DYes 
DNo 
14 If you agree, provided that the anonymity of participants at the presentation of 
the results of this research is assured, would you permit the interview to be 
recorded for subsequent analysis? 
DYes 
DNo 
As discussed in Section 3.5.4, the interviews in the pilot study showed some important 
discrepancies between the opinions of the teachers and students on the matter of the 
transmission of knowledge about bias in research to students. Additionally, the student 
interviews also demonstrated that although most of the teachers had declared in their 
questionnaire that they were transmitting such knowledge to their students, the students' 
opinion was that they were not receiving it. 
Consequently, the first three questions on the student questionnaire, shown below, were 
intended to determine their personal evaluation of their level of knowledge about bias, 
how they obtained such information, and if they were aware of their teachers' efforts to 
transmit to them knowledge about the matter. 
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1 How would you rate your present knowledge about bias in medical research? 
o High 
o Average 
o Low 
o None (if none, please go to question 3) 
2 Which was the method that helped you to acquire your present knowledge about 
systematic deviations (bias) in medical research? (Tick one or more boxes) 
o The curricular courses for graduation 
o Books about methodology of research 
o Medical congresses or conferences 
o Medical journals. Please cite one ............................................................ . 
o Special courses. Please cite one .............................................................. . 
o The Internet 
o Other. (Please specity) ......................................................................... . 
3 How often did your teachers discuss the problem of methodological deviations 
(bias) with you in the last year? 
o Frequently 
o Rarely 
o Never 
o I do not remember 
Question 4 was the same as Question 7 on the teacher questionnaire; however, it had a 
slightly different objective. While the first three questions were closed questions and 
might be answered without much reflection, Question 4 was intended to probe how 
students were using their knowledge about bias in medical research when evaluating 
scientific papers, which is an important issue in continuing medical education. 
4 How much did your evaluation of papers published in medical journals change 
with the acquisition of knowledge about bias? Please explain. 
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The next five questions of the students' questionnaire were the same as Questions 8 to 12 
of the teacher questionnaire discussed previously. It was anticipated that the students' 
answers would allow comparisons to be made between their points of view, as recipients 
of information about bias in medical research, and their teachers' opinions. 
Finally, the last two questions on the student questionnaire, which were the same as those 
on the teacher questionnaire, functioned as a written acceptance for a future interview. 
3.9.2 The interviews 
After the pilot study (Section 3.5), it became clear that the interviews in the main data 
collection phase should fulfil three concurrent objectives. The main objective was 
undoubtedly to answer the second and third research questions of this study (see Section 
3.4). However, the pilot study also showed that in order for this to happen, the interviews 
had to be organised in a way that circumvented two major constraints. The first was the 
amount of time the participants would allow these interviews to last and the second was 
the possibly diametrically opposing opinions of the participants about the importance of 
the matter for medical education. 
In relation to the time needed for the interviews, the pilot study demonstrated that as the 
participants are busy professionals with very tight agendas, the interviews should be 
structured so as to obtain most of the relevant data related to the second and third research 
questions in about 30 minutes. This would entail a difficult compromise between asking 
direct questions whilst trying to avoid slipping into asking leading questions, which could 
result in interviewees agreeing out of politeness or simply stopping talking. A simple 
"yes" or "no" as an answer at the beginning of an interview could jeopardise the 
interview's development in the allowed (restricted) amount of time it would probably 
have. 
To help to overcome these problems, two different strategies were used during the 
interviews. 
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The fIrst strategy was to allow a certain flexibility in the order and wording of the 
questions. However, the basic form of the interviews, as discussed in Section 3.5.3, was 
retained. To help to achieve this objective, the information obtained in the open questions 
of the questionnaires was used. This approach helped to avoid starting the interview with 
questions that could elicit a very strong reaction from the interviewee. 
The second strategy was to try to use something that seemed detrimental to the study on 
fIrst sight: the low response rate of the questionnaires (which will be discussed in Chapter 
4). Accordingly, the interviewees were asked an initial question about their opinion 
concerning the questionnaires' low response rate. This helped create a sort of 
'partnership' between the interviewer and interviewee, and allowed the interviewer 
subsequently to employ direct questions without causing a defensive response from the 
interviewee. 
In fact, with the exception of some minor methodological modifIcations discussed in the 
previous few paragraphs, the structure and aims of the interviews were fundamentally the 
same as the interviews of the pilot study discussed in Sections 3.5.3 and 3.5.4. The result 
of such modifIcations can be better seen in the interview sample available in Appendix 5. 
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Chapter 4 
Quantitative aspects of the questionnaires: 
answering the first research question 
4.1 Introduction 
At the end of May 2003, the necessary permissions from the medical schools that were 
involved in this research (Section 3.7) were received. The schools also provided the lists 
of teachers from the selected departments and students in the last year of their courses, 
which allowed the researcher to defme the possible participants in the study. These lists 
showed that 829 members ofthe five schools (293 students and 536 teachers) fulfilled the 
criteria to be a participant in the study. These criteria were: for the teachers to be a 
member of the Internal Medicine, Paediatrics, Gynaecology and Obstetrics or Surgery 
Departments, and for students to be in the last year of the medical course, as discussed in 
Section 3.4. 
In June 2003, the questionnaires were delivered, in personalised envelopes, to the Co-
ordinator of the Graduation Council of each of the schools. Each of the Co-ordinators was 
responsible for distributing them to the aforementioned Departments, and to the students. 
This approach for the questionnaire distribution was decided in the meetings that occurred 
in the schools that participated in this study, which were required to obtain the 
permissions to do the research (Section 3.7). 
The response rate was low in the case of the teachers (99 questionnaires, 18.5%) and very 
low in the case of the students (21 questionnaires, 7.2%), in spite of two reminders sent 
by email to the Co-ordinatorsinAugust 2003. This low response rate will be more 
thoroughly discussed in Chapter 5, as it became one of the main issues explored in the 
face-to-face interviews. 
However, a low response rate was already expected due to the previous experience in the 
pilot study (Section 3.5.2). In addition, a recently published study carried out in one ofthe 
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medical schools involved in the present research showed that the initial response rate may 
be low in Brazil, even when the subject of the research is important to the respondents 
(Ferreira Filho et ai., 2002). In the case of Ferreira Filho et al. study, the research topic 
was the teachers' opinion about the implementation of a new problem-based learning 
curriculum in the medical course. Although the researchers were members of the same 
medical school, and stimulated the teachers to collaborate by providing their opinions 
about the subject, the initial response rate to a mailed questionnaire was 31.7% (85 
spontaneous participants from a total of268 teachers). 
There are two fmal aspects about the questionnaire responses in the present study that 
must be stressed at this point, which are important for the evaluation of the results. 
Firstly, I did not have any previous personal contact with the participants before the 
present study. Secondly, except in the cases when a participant decided to send me his/her 
name, address, telephone number and/or email address, there was no way of having a 
subsequent contact with them, since the envelopes for the questionnaire return were 
identical. 
Tables ofthe coded results of the questionnaires for teachers and students, as well as the 
coding method in English, are provided in Appendix 4. Although all the data have been 
transformed to numerical figures, in many cases the numbers assigned in the tables do not 
represent an evaluation of the results. They are only codes used to facilitate analysis. 
Most of the numerical data was analysed using Excel 97 SR-2 (© Microsoft Corporation), 
enhanced by statistical features provided by the same company. In some cases the 
software STATS™ (© Decision Analyst Inc.), and STATISTICA (data analysis software 
system) v.6 (© Stat Soft Inc.), were also used. 
4.2 Results and discussion of the teacher questionnaire 
This section will be divided in two sub-sections due to the objectives of the present 
research. In Section 4.2.1, the data relating to the constitution of the teachers' sample in 
this study will be appraised. Section 4.2.2 will contribute to answering the first research 
question of this study (see Section 3.4). 
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4.2.1 What was the constitution of the teachers' sample in this study? 
According to their answers to the questionnaire, the teachers that participated in the 
present study had the following academic backgrounds: 13 (13%) possessed a specialist 
title, 37 (37%) had a Master degree, 42 (42%) a Doctoral degree, and 7 (7%) had 
completed their post-doctoral studies. Additionally, 81 (82%) of them had had one or 
more papers published in the last five years. 
These data strongly contrast with those obtained by the CINAEM project discussed in 
Section 2.3, although the CINAEM data about academic background were cumulative. 
Comparing the percentage of Doctoral degrees (20%), the highest degree considered in 
the CINAEM project, with the data obtained in the present study (42%), the difference is 
statistically significant (z = 5.46, p<0.001). Furthermore, the percentage of teachers who 
published papers in the last five years in this study (82%) is much higher than is typical, 
considering the reality of medical research in Brazil as discussed in Section 3.2. 
The sampling method used in the present research (see Section 3.8) can be partially 
responsible for such differences. It could have entailed a kind of selection of the 
respondents, which had not occurred in the CINAEM project. This selection might have 
been caused, for instance, by the subject matter of the research (bias in medical research). 
Also, there is a possibility that only those teachers that are involved in the research 
process would be interested in such a subject. Both these possibilities were evaluated in 
the interviews (see Chapter 5). 
One of the concerns when structuring the questionnaires (Section 3.5.1) was the 
possibility of a potential language barrier, as most of the papers about bias in medical 
research were published in English. However, the high proportion of participants that 
have published papers in the last five years shows that, at least in this study sample, this 
would not be a great problem. Furthermore, 42 of them asserted that they had published 
their studies in English (42% of the total number of participants, and 52% of those 
teachers that had published papers). Consequently, their answers to the questions that are 
important for resolving the first research question will probably not be substantially 
biased by simple misunderstanding of the terminology employed in the questionnaire. 
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Another important intention of the questionnaire was to determine how these teachers 
acquired their present knowledge about bias. Nearly half of the participants (56 teachers, 
57%) declared that they used more than one method to obtain information about bias in 
medical research. According to the participants' answers, and considering both multiple 
and single responses, the cumulative rank of responses was: 
• 56 (57%): books about methodology of research 
• 53 (54%): information received in medical congress and conferences 
• 27 (27%): special courses (85% of these in their Master or Doctoral degrees) 
• 24 (24%): from papers in medical journals 
• 24 (24%): information obtained fi-om the Internet 
• 14 (14%): other sources of information. 
The above distribution shows some interesting aspects of the teachers' methods used to 
acquire knowledge about bias in medical research. It illustrates that a significant 
proportion of them rely on books, congresses and conferences to attain information about 
the subject. However, these methods do not seem to be the best way to receive reliable 
and updated information about the matter, as will be discussed in the next two paragraphs. 
As discussed in Chapter 1, although the study of bias in medical research is not recent, it 
received greater attention only in the last ten years, when the weaknesses of the 
randomised-controlled trial became evident. Furthermore, as examined in Section 1.4, 
many important categories of bias that occur in medical research are not directly related 
to research methodology. Therefore, it is not a surprise to observe that most of the books 
about medical research methodology of the 1990s, such as Jekel et al. (1996), dedicated 
only a small amount of space to the discussion about bias. Although recent methodology 
books, such as Hulley et al. (2001), show a tendency to enhance the discussion about the 
matter, it becomes evident examining the bibliography related to Chapters 1 and 2 of the 
present study that books of research methodology are not the best way to acquire a 
significant insight into the subject. 
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The second preferred method (medical congresses and conferences) presents even more 
negative aspects than obtaining information about bias from research methodology books. 
As discussed in Section 2.4.2, there is a profound influence of pharmaceutical industries 
on continuing medical education and in the presentations at medical congresses, 
transforming these events into a disguised marketing process. Since these industries are 
considered as one of the most important direct or indirect causes of bias in medical 
research, it becomes difficult to see how trustworthy knowledge about bias in medical 
research can be obtained with such a method. 
It was unexpected to observe that only 23 participants (23% of the total) said they had 
received information about bias in medical research in their Masters or Doctoral courses, 
considering that 86 of them (87% of the total) possess such academic titles. Although it 
must be recalled that these courses were not explicitly cited in Question 5, it was expected 
that more participants would recall having contact with such knowledge in their post-
graduate courses. This expectation was based on the fact that most of these courses 
include a research project. As will be discussed in Chapter 5, one of the reasons might be 
because bias in medical research is not sufficiently emphasised in the postgraduate 
courses in the medical area. 
Finally, the last two important methods of acquiring information about bias in medical 
research, according to the participants, were from papers published in medical journals 
and Internet sources. Incidentally, these were the most important sources of the 
information used to underpin the discussion about bias in Chapters 1 and 2 of the present 
study. 
However, although these methods (medical journals and Internet sources) were present in 
24% of the responses to the questionnaire, only 6 (6%) of the teachers declared that they 
used both methods to acquire knowledge about bias in medical research. This is to some 
extent remarkable for two reasons. Firstly, because 95% of the participants sent me their 
e-mail addresses, which indicates that they have Internet access. Secondly, because public 
university libraries in Brazil suffer from a chronic shortage of printed resources. These 
two factors in combination, theoretically, should have compelled these teachers to use 
both medical journals and the Internet to obtain updated information about bias in 
medical research. 
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As mentioned in Section 3.9.1, one of the major complaints of the teachers in the pilot 
study was that they were overwhelmed by several different responsibilities in medical 
schools. In fact, during informal contacts they asserted that this was the main cause that 
prevented them from being updated in any educational field besides their own speciality. 
If one takes into account only the answers to the first question of the teachers that 
participated in the main data collection of this study, their complaints seem to be quite 
plausible. Considering four main areas (teaching, research, extension programmes and 
administration), the participants declared that they were involved in: 
• 1 (1 %) exclusively on administration 
• 1 (1 %) exclusively on extension programmes 
• 18 (18%) exclusively on teaching 
• 42 (43%) on teaching plus one other area 
• 20 (20%) on teaching plus two other areas 
• 17 (17%) on all the four areas. 
As discussed in Section 2.3, being a teacher in a medical school in Brazil is only part of 
the daily activities for the majority of the teachers. Therefore, the high percentage (79%) 
of participation in other areas besides teaching seems excessive, and will certainly result 
in low levels of opportunities for continuing medical education. 
The fmal subject examined in this section of the questionnaire was related to the teachers' 
personal evaluation about how often they had discussed the problem of bias in medical 
research with their students in the last year. The data obtained in this question will be 
compared with the students' similar evaluation in Section 4.3, and are more thoroughly 
discussed in Chapter 5. According to the teachers that participated in this study, in the 
previous year: 
• 28 (28%) ofthem had discussed the subject frequently with their students 
• 47 (48%) of them had seldom discussed the subject with their students 
• 23 (23%) of them had not discussed the subject with their students 
• 1 (1 %) did not remember. 
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This distribution shows that most of the teachers (71 %) that participated in the present 
study had either seldom or never discussed the problem of bias in medical research with 
their students in the previous year. 
4.2.2 What is the teachers' level of awareness about bias in medical research? 
In order to discuss the level of awareness of the teachers about the problem of bias in 
medical research it will fITst be necessary to discuss in more depth the reasons for and the 
structure of the questions that composed this section of the questionnaires. Section 3.9.1 
provides an outline of the structure of Questions 8 and 9 of the teacher questionnaire, 
which are used in this section to appraise their awareness and personal feelings about the 
subject. 
The third assertion of Question 8 (8c) and the second and third assertions of Question 9 
(9b and 9c) were employed to evaluate the teachers' level of knowledge about bias in 
medical research: 
• Methodological deviations (bias) in medical research are progressively becoming an 
ethical issue. 
• Publication bias is a menace to the quality of systematic reviews and meta-analyses 
• Systematic deviations (bias) in randomised clinical trials may exaggerate the results 
of future meta-analyses. 
These assertions were chosen for three reasons. Firstly, because they are considered as 
true by the majority of the authors in this field of knowledge, as discussed in Chapters 1 
and 2. Secondly, they can also be found easily in the bibliography about the subject of 
bias published in the last 5 years as they are strongly related to publication bias, which is 
probably the best studied topic in this field. Finally, because it could be assumed in the 
present research that any physician that has an adequate level of knowledge about bias in 
medical research would not have problems agreeing with these assertions, due to the 
previous two assumptions of this paragraph. 
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The [mal allegation of the previous paragraph is extremely important to the analysis of 
the responses to Questions 8 and 9 ofthe questionnaire. As discussed in Section 3.4, this 
study is an exploratory piece of research precisely because there is no previous one that 
could show the level of awareness about bias among teachers and students in medical 
schools in Brazil. Consequently, even if it was possible to collect the quantitative data 
needed to answer the fIrst research question, there would be no means of comparing the 
results with some prior study. Therefore, the solution was to possess at least a theoretical 
quantitative expectation of the outcomes, as in the case that the participants were all 
entirely aware of the problem of bias in medical research. 
Employing the assumptions examined in the previous paragraphs, it was presumed that a 
group of medical teachers conscious of the problem under study and that have a 
reasonable academic knowledge about bias in medical research would choose the option 
"strongly agree" as an answer for the three aforementioned assertions. The [mal 
numerical result of such choice would be a mean cumulative response score of 4.0 
(strongly agree), considering the assertions 8c, 9b and 9c, in view of the coding used in 
this research (see Appendix 4). 
In fact, the teachers' responses to the questionnaire showed the following statistical 
outline, considering the mean cumulative response score to the assertions 8c, 9b and 9c: 
• Mean ........................................... 2.84 
• Median ......................................... 3.00 
• Standard errOf. ................................ 0.06 
• Standard deviation ............................ 1.07 
• Sample Variance .............................. 1.14 
• Confidence Level (95%) ..................... 0.12 
• Confidence Intervals of the Mean (95%) 2.72 to 2.96 
These results show that the teachers' sample of this study has a statistically signifIcant 
(and lower) level of knowledge about bias in medical research than what was expected, as 
elicited by the values of the confidence intervals of the mean. However, one must 
consider the limitations and assumptions of the methods employed in this study. 
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Therefore, a sensible approach to such results is that these teachers do have some 
knowledge about bias, but probably not to the required level for a comprehensive 
perception about the subject. 
The remaining four assertions of Questions 8 (8a, 8b and 8d) and 9 (9a) have a different 
connotation when compared with the other three discussed in the previous paragraphs. 
They represent areas of knowledge about bias in medical research and medical education 
that are still undeveloped, or that are under debate. They have been used to probe how the 
teachers that participated in this research react and solve problems related to the practical 
application of their knowledge about bias. Although a numerical coding system has been 
used (see Appendix 4), these numbers do not represent scores about their knowledge on 
the matter, just an instrument to make possible an eventual statistical analysis. 
The fIrst assertion (8a) is related to the pilot study outcomes. Something that was evident 
in the pilot study was that some teachers believed that the problem of bias in medical 
research was strictly a question of violation of scientifIc methodology. For that reason it 
was decided to evaluate the opinion of the participants of the main data collection using 
the assertion: "It is a problem of scientifIc methodology, with no relation to 
undergraduate medical courses". Their opinion about the assertion was: 
• 41 (42%) strongly disagreed 
• 34 (34%) disagreed 
• 16 (16%) agreed 
• 4(4%) strongly agreed 
• 4 (4%) did riot have an opinion about the matter. 
Even without any further statistical analysis, their answer is very clear. The majority 
(76%) disagrees that the problem of bias in medical research can be dissociated from 
medical education. This is a very important fmding of the present study, and will 
subsequently be used in our discussion in Section 4.4. 
The answers to Assertion 8b ("Courses of scientifIc methodology are responsible for the 
transmission of knowledge about bias") showed that: 
92 
• 51 (52%) of the teachers agreed with the assertion 
• 20 (20%) strongly agreed 
• 20 (20%) disagreed 
• 4 (4%) strongly disagreed 
• 4 (4%) did not have an opinion about the matter 
Considering that among the five medical schools involved in this research two did not 
have a scientific methodology course, and in the remaining three the available time for 
such a course is about 1 % of the total available hours of the medical course (see Section 
3.6), these results were noteworthy. In fact, as it was an isolated question about the 
subject, the registered answers do not allow one to decide if these teachers were not 
simply manifesting their desire for the existence (or enhancement) of such a scientific 
methodology course. Consequently, these results were used in the subsequent face-to-face 
interviews, which will be discussed in Chapter 5. 
One important aspect of the problem of bias in medical research is that there is limited 
data about the opinion of teachers in relation to the real purpose and utility of the 
published systematic reviews and meta-analyses as a method for continuing medical 
education (CME). Assertion 9a intended to evaluate their opinion about this doubtful 
aspect of CME. The statement "Systematic reviews and meta-analyses are the best ways 
to acquire valid knowledge in medicine" elicited the following answers from the teachers: 
• 47 (48%) agreed with the statement 
• 17 (17%) strongly agreed 
• 27 (27%) disagreed 
• 3 (3%) strongly disagreed 
• 5 (5%) did not have an opinion about the matter. 
The results indicate that, although there is international concern about the efficacy and 
trustworthiness of the results of systematic reviews and meta-analyses (see Section 1.5), 
most of these teachers (65%) still believe that they are the best ways to acquire valid 
knowledge in medicine. 
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Finally, in order to complete the analysis of the answers to the statements used in 
Questions 8 and 9, the responses to assertion 8d must be considered. It states that: 
"Medical journals are responsible for the evaluation of methodological deviations in 
papers they publish". The answers to this question were: 
• 45 teachers (46%) agreed that medical journals were responsible 
• 24 (24%) strongly agreed 
• 23 (23%) disagreed 
• 4 (4%) strongly disagreed 
• 3 (3%) did not have an opinion about the matter. 
Once more, there is no need for further statistical analysis, as 70% of the teachers agreed 
or strongly agreed with the assertion. In fact, this assertion was introduced in the 
questionnaire in order to try indirectly to determine if the teachers were using their own 
critical appraisal to evaluate the papers methodologically, or if they were relying on the 
peer reviewing of each journal. The answer is clear; they are relying on the journals' 
competence at unveiling possible methodological flaws in the articles accepted for 
publication. 
The [mal subject of this discussion of the quantitative aspects of the teachers' 
questionnaire is related to the answers to Question 11. It was intended to determine 
whether or not the teachers felt a curriculum change was necessary in order to transmit 
knowledge about bias in medical research to their students in an appropriate manner. 
Their answers were: 
• 68 (69%) Yes 
• 31 (31%) No. 
Evidently, the majority of the teachers that participated in this study (69%) believe that 
curriculum changes are needed to achieve the objective of transmitting appropriate 
knowledge about bias in medical research to their students. 
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Attempts were made to undertake more refined statistical analysis of the questionnaire 
data by comparing sub-samples of the data and by undertaking cross-tabulation. 
Unfortunately, the relatively small number of participants in some of the sub-samples 
precluded statistically significant conclusions. However, the combination of such 
information with the interviews data (see Chapter 5) allowed for deeper qualitative 
insights and enabled some conclusions to be drawn at a finer level. 
4.3 Results and discussion of the student questionnaire 
The student questionnaire in this study had some differences in conception and structure 
when compared to the teacher questionnaire discussed in Section 4.2. The main objective 
of both questionnaires was to try to unveil the present level of awareness about bias in 
medical research in five Brazilian medical schools. In addition, they were intended to 
probe the teachers' and students' opinions about the possible methods that could improve 
the transference of such knowledge in the medical course. However, while in the case of 
the teachers it was important to determine several aspects related to their academic life 
(Section 4.2.1), this seemed not to be important in the case of the students. Therefore, the 
examination of the students' responses will be accomplished in one single section of this 
study. 
Before starting the analysis of the data of the student questionnaire, it is necessary to 
comment on one aspect of the students' sample in this study. Either in their answers to the 
questionnaire, or in the subsequent interviews, 15 (71%) of them reported to have 
participated in research projects during their courses. This is a very high percentage of 
participation considering the reality of medical research in Brazil, as discussed in Section 
3.2. As it happened in the case of the teachers (Section 4.2.1), the sampling method and 
the subject matter of the present research may be partially responsible, as those students 
who were involved in research would be more inclined to answer the questionnaire. 
The first question of the student questionnaire intended to appraise their self-evaluation 
about their present level of knowledge about bias in medical research. Their responses 
showed that: 
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• 11 (53%) believed that they had a low degree of knowledge about bias 
• 8 (38%) thought that they had an average degree 
• 1 (5%) declared to have a high degree 
• I (5%) stated that had no knowledge about the matter 
It is evident that the majority of the students (19 out of 21 students) that participated in 
this study believed that they had an average or low comprehension about bias in medical 
research. 
In relation to the approach these students were using to acquire information about the 
matter, their responses were (using a cumulative methodology, as they could choose more 
than one answer in this question): 
• 16 (76%) their curricular courses 
• 9 (43%) medical congresses and conferences 
• 5 (24%) books of scientific methodology 
• 5 (24%) the Internet 
• 4 (19%) other sources 
• 2 (10%) special courses 
• 1 (5%) medical journals. 
As might be expected, 76% of them relied on the information provided in their curricular 
courses. As was the case with their teachers (see Section 4.2.1), the students also used 
medical congresses and books of scientific methodology to acquire knowledge about bias 
in medical research. It was worthy of note that none of them used the combination of the 
Internet and medical journals. 
The students' answers to Question 3 (see Appendix 4) show that the subject of bias in 
research was rarely (62%) or never (33%) a matter of discussion among teachers and 
students in these medical schools. Only one student (5%) reported that such discussions 
occurred frequently. 
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The second part ofthe students' questionnaire, which was intended to establish their level 
of awareness about bias in medical research, began with Question 5. Questions 5 and 6 of 
the students' questionnaire were identical to Questions 8 and 9 of the teachers' 
questionnaire (see Appendix 4). Following the same statistical interpretation used in the 
teachers' questionnaire (Section 4.2.2), the statistical analysis of the students' cumulative 
responses to assertions 5c, 6b and 6c was: 
• Mean ........................................ 2.67 
• Median ................ , .................... 3.00 
• Standard error ............................. 0.14 
• Standard deviation ........................ 1.12 
• Sample Variance .. . . . . . . . . . . . . . . . . . . . . . ... 1.26 
• Confidence level (95%) ................... 0.28 
• Confidence Intervals of the Mean (95%) 2.39 to 2.95 
As happened in the teachers' questionnaire analysis, the confidence intervals of the mean 
(CIM) show that these students do have some knowledge about the subject of bias in 
medical research. However, considering the expected theoretical mean cumulative 
response score of 4.0 as discussed in Section 4.2.2, this knowledge is not to the required 
level for a more meaningful perception about the subject. 
One interesting aspect of the statistical analysis of the results is that it displays that the 
CIM of the teachers (2.72 to 2.96) overlaps the elM of the students (2.39 to 2.95). The 
calculated 95% Confidence intervals for the difference between the means was -0.125 to 
0.462. As these CIMs are related to the same assertions, it is not possible to conclude that 
there is a reasonable statistical possibility that they belong to different populations. This 
hypothetical population (which aggregates teachers and students of the five medical 
schools under study) would possess a common average knowledge about bias, which 
would have a numerical value of 2.81 (CIl' ... 1 (95%): 2.70 to 2.92), according to the 
methodology used in this study. 
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The remaining assertions of Questions 5 and 6 (5a, 5b, 5d and 6a) are also the same that 
were used in the teachers' questionnaire (8a, 8b, 8d and 9a), as can be seen in Appendix 
4. They also share the same theoretical connotation already discussed in Section 4.2.2. 
Consequently, they will be analysed in the next few paragraphs by comparing the 
students' results with the opinions of their teachers. 
In relation to the assertion that bias in medical research would be a problem of scientific 
methodology, with no relation to the medical course (5a), the student opinions were: 
• 15 (71 %) ofthem disagreed 
• 4 (19%) strongly disagreed 
• 2 (10%) did not have an opinion about the matter. 
On this issue, the students' point of view reinforces the opinion of the teachers. 
The same pattern of concordance can be seen in the case of the possible responsibility of 
courses on scientific methodology to transmit the necessary knowledge about bias (5b), as 
the distribution ofthe students' responses was: 
• 15 (72%) of them agreed with the assertion 
• 4 (19%) disagreed 
• 1 (5%) strongly agreed 
• 1 (5%) did not have an opinion about the matter. 
In relation to whether medical journals are responsible for the evaluation of the 
methodological deviations ofthe papers they publish (5d), the proportions of concordance 
and discordance were very similar to the teachers' responses. The results were: 
• 10 (47%) agreed with the assertion 
• 4 (19%) strongly agreed 
• 5 (24%) disagreed 
• 2 (10%) did not have an opinion about the matter. 
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Finally, the last of the assertions of Questions 5 and 6 stated that systematic reviews and 
meta-analyses are the best way to acquire valid knowledge in medicine (6a). This was the 
only assertion that revealed a difference between the teachers and students. The students' 
responses were: 
• 11 (52%) disagreed with the assertion 
• 5 (24%) agreed 
• 3 (14%) strongly agreed 
• 2 (10%) did not have an opinion about the matter. 
While 64% of the teachers agreed or strongly agreed with the assertion, only 38% of the 
students had the same opinion (z=2.34, p=0.03). It would be difficult to evaluate such a 
difference between the students' and teachers' opinions using only the questionnaire data. 
Consequently, the evaluation of the difference will be done in Chapter 5, with the help of 
the qualitative data obtained in the questionnaire and face-to-face interviews. 
The last question on the students' questionnaire that permitted a numerical approach to its 
analysis was Question 8. Similarly to Question lIon the teachers' questionnaire, it 
intended to evaluate the students' opinion about whether it or not a curriculum change 
was necessary in order to attain an appropriate transmission of knowledge about bias in 
medical research. Their answers were: 
• 17(81%)Yes 
• 04 (19%) No. 
Once more, the students' responses revealed the same pattern as their teachers' answers 
previously discussed in Section 4.2.2. 
Hence, the analysis of the second part ofthe students' questionnaire shows that, with only 
one exception (Assertion 6a), the results reproduced the same pattern of responses of the 
teachers' questionnaire. 
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4.4 Conclusions 
Although the results of the quantitative aspects of the questionnaires will be analysed 
further, in conjunction with the qualitative data obtained in this study and considered in 
Chapters 5 and 8, they are already sufficiently clear to pennit two important conclusions 
of the present research to be outlined. 
The fIrst and main conclusion is related to the fIrst research question of this study, as 
discussed in Section 3.4: 
What is the level of awareness about bias in medical research among teachers of 
Internal Medicine, Surgery, Gynaecology and Obstetrics, and Paediatrics, and 
students of the fInal year of the course of medicine, in fIve medical schools in 
the state of Par ami (Brazil)? 
The results of the teachers' and students' responses discussed in this chapter allow 
me to state that, in relation to the participants in this study, the level of awareness of 
bias can be considered insufficient and fragmentary. This conclusion can be 
considered as statistically valid only for the participants of the present research. This 
is due to the sort of sampling method adopted in this research (see Section 3.8) and 
the low response rate to the questionnaires. 
However, one must consider at least two factors that may expand the external 
validity of the present study. Firstly, the teacher profIles in this study (Section 4.2.1) 
show that they have a higher academic background than the average Brazilian 
medical teacher (see Sections 2.3). Secondly, as discussed in Section 4.3, the level of 
knowledge about bias of teachers and students in this research suggests that they 
behaved as members ofthe same statistical population. 
Considering the two aforementioned factors, it does not seem preposterous to assume 
that even an adequate random sample of teachers and students in these medical 
schools would not show a much better result, in relation to the level of awareness 
about bias in medical research. 
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The second important conclusion is related to the genesis of bias in medical research. 
As discussed in Chapter 1, the most frequently considered hypothesis for the endemic 
occurrence of bias in medical research is based in the medical research methodology. 
However, the responses of our participants to Question 9a (teachers) and 6a 
(students) show that they reject the idea that the present occurrence of bias in medical 
research is due mainly to research methodological problems. 
Finally, the third conclusion is that the teachers and students seldom discuss the 
matter of bias in medical research, as can be seen by their answers in Sections 4.2.1 
and 4.3. Such a lack of discussion is likely to be a constraint to the transmission of 
knowledge about bias in medical research and its prevention. 
One interesting aspect of the quantitative analysis of the questionnaires was the 
detection of a similar level of knowledge about bias in medical research among 
teachers and students of the five Brazilian medical schools that participated in this 
study. In addition, it was not possible to detect a difference in the level of awareness 
about bias among these five schools, although they employ different curricular 
structures in their medical courses. Such an outcome may seem peculiar; however, 
there are at least three concurrent causes that may have contributed to the statistical 
similarity of the results. 
The first factor that probably contributed to the final results was that the average 
knowledge of the teachers about the subject was lower than should be expected in 
accordance with the methodology proposed for this study (see Section 4.2.2). 
According to such a methodology, a group of physicians with a reasonable academic 
knowledge about bias in medical research should have an average score in the three 
assertions of 4 (four), with only a very small variation in the confidence intervals of 
the mean. In such a case, the statistical analysis of the means of teachers and students 
would certainly show a statistically significant difference between them. 
A second concurrent cause for the statistical similarity of the level of knowledge 
about the subject between teachers and students in the present study was the 
composition of the student sample. As discussed in Section 4.3, 71% of the students 
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that participated in this study had also participated in research projects during their 
courses. Such a percentage is very high for Brazilian standards and this sample 
composition may well have artificially overestimated the real level of knowledge 
about bias in medical research among medical students. 
Finally, the lack of difference in the level of knowledge about the problem of bias in 
medical research among the medical schools that participated in this research may be 
due to the fact that the discussion about such a problem is not present on their 
curricula. Although they may have different 'intended' curricula, their 'delivered' 
and 'hidden' curricula (see Chapter 6) may be very similar, at least with regard to the 
subject of medical research methodology and the critical appraisal of medical 
research. 
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Chapter 5 
Qualitative outcomes of the questionnaires and interviews: 
answering the second and third research questions 
5.1 Introduction 
While the previous chapter of this study focused on the analysis of the quantitative data 
obtained using the questionnaires, this chapter has a different, although complementary, 
objective. It aims to answer the remaining two research questions (see Section 3.4) 
through a qualitative analysis of the data acquired in the open questions of the 
questionnaires and the subsequent interviews with teachers and students of the five 
Brazilian medical schools involved in this study. However, before the analysis itself, 
some aspects of the participants of the second phase of this research, and of the 
methodology employed in the analysis of the data, need to be presented and discussed. 
5.1.1 Constitution of the teachers' sample in the interview phase of this study 
The first aspect that deserves to be appraised is the composition of the sample of teachers 
and students in this section of the study. As discussed in Section 3.9.1, one of the 
questions on the questionnaires asked the participants whether they would permit a 
subsequent interview or not. Of the 99 teachers who participated in the first phase, 50 
(51%) of them answered "Yes" to this question, while 11 (52%) of the 21 students that 
returned the questionnaires also agreed to be interviewed in the second phase of this 
study. 
At the beginning of the interview stage of this research, the intention was to interview all 
the participants that had agreed to be interviewed, irrespective of the specific number of 
participants in each medical school. This decision was based on the fact that, as discussed 
in Chapter 4, the participants of this study behaved as members of the same statistical 
population, at least in respect to the subject matter of this study. Even though they belong 
to different schools, with different curriculum structures (see Chapter 6), the quantitative 
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analysis of the questionnaires showed that they had a very similar attitude in relation to 
the problem of bias in medical research and its relationships with medical education. 
The interviews occurred between the fIrst week of September 2003 and the last week of 
October 2003. As expected (see Section 3.9.2), most of them (95%) took place during the 
surgery hours of the participants, and had an average duration of 33 minutes. 
Unfortunately, the initial aspiration to undertake 61 interviews was not totally fulfilled. 
From the initial 50 possible interviews with the teachers only 38 actually occurred. This 
reduction was due to three factors: 
• Four of the teachers when contacted by telephone declared that had changed their 
minds and did not want to be interviewed. 
• Three of the teachers did not return any of four or more of the researcher's messages 
asking for a personal contact. 
• Five of the teachers were absent from their medical schools during the period of time 
when the interviews occurred (two were on vacation, and three doing their post-
graduation studies in a different medical school) 
In contrast, all of the 11 students that agreed in the first phase of this study were actually 
interviewed. 
Consequently, 49 participants (38 teachers and 11 students) were interviewed in the 
second phase of this study. From these 49 interviews, 44 were tape-recorded for 
subsequent transcription and fIve were reconstructed from the researchers' notes within 
four hours after they occurred because these participants declared that they would not like 
to have their interviews tape-recorded. After these five were reconstructed, they were 
compared with the taped interviews and, as this comparison did not show major 
inconsistencies concerning their final structure and content, their data were used in the 
subsequent analysis. 
In order to evaluate whether or not these participants significantly differed from the 
original sample of this study, it was necessary to undertake a statistical evaluation of their 
level of knowledge about bias in medical research. It was performed employing the same 
104 
methodology used in Chapter 4 (see Sections 4.2.2 and 4.3), using as data their previous 
answers to the questionnaires. The result of such evaluation was: 
Interviewed teachers 
• Mean ................................................. 2.84 
• Median .............................................. 3.00 
• Standard error ...................................... 0.09 
• Standard deviation ................................. 0.97 
• Sample variance .................................... 0.95 
• Confidence level (95%) ........................... 0.18 
• Confidence intervals of the mean (95%) ........ 2.66 to 3.02 
Interviewed students 
• Mean ................................................ 2.84 
• Median .............................................. 3.00 
• Standard error ...................................... 0.17 
• Standard deviation ................................. 0.97 
• Sample variance... ..................... ........... 0.95 
• Confidence level (95%) .......................... 0.34 
• Confidence intervals of the mean (95%) ........ 2.50 to 3.18 
Comparing these data with the previous results discussed in Section 4.2.2 it becomes 
evident that the average knowledge about bias in medical research of the teachers' sample 
(mean = 2.84) is equal to the average obtained in the analysis ofthe questionnaires (mean 
= 2.84). However, both the confidence intervals of the mean (CIM) and the standard error 
increased due to the reduction of the number of participants (99 to 38). In the case of the 
students, there was an apparent increase in average knowledge, which was raised from 
2.67 to 2.84. However, the calculated 95% confidence intervals for the difference of the 
means was -0.64 to 0.28, which indicates that such a difference has no statistical 
significance. 
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A final aspect of the sample composition ofthe participants in this phase ofthis study was 
their academic background. In relation to this feature, the distribution of the teachers who 
participated in the second phase of this study was: 
• Six (16%) possessed a specialist title 
• Nine (24%) possessed a Masters degree 
• 19 (50%) possessed a Doctoral degree 
• Four (10%) had completed their post-doctoral studies. 
Although there was a certain numeric variation with respect to the distribution of 
academic background discussed in Section 4.2.1, this difference is not statistically 
significant. In the case of the students, the only evident difference was a rise from 71 % 
(see Section 4.3) to 85% in the proportion of those who had participated in research 
projects during their medical courses. However, this difference also lacks statistical 
significance. 
Therefore, considering the data discussed in this section, it is possible to state that the 
participants in the second phase of this study had a similar level of knowledge about bias 
in medical research and a not dissimilar academic background as the participants in the 
first phase (see Chapter 4). However, one must be aware that this statement is based on 
the methodology employed in this study, as discussed in Section 4.2.2. 
5.1.2 Theoretical framework of the interviews' qualitative data analysis 
According to Ryan and Bernard (2000): 
Coding is the heart and soul of whole-text analysis. Coding forces the researcher 
to make judgements about the meanings of contiguous blocks of text. The 
fundamental tasks associated with coding are sampling, identifying themes, 
building codebooks, marking texts, constructing models (relationships among 
codes), and testing these models against empirical data. (Ryan and Bernard, 
2000, p.780) 
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The question of the sampling method employed in this study was discussed in previous 
sections (see Sections 3.8 and 5.1.1). Therefore, according to Ryan and Bernard (2000), it 
remains to be discussed in the present section how themes were identified in this research, 
and how the codebooks of these themes were constructed. It will also be noticed that the 
task of constructing relationships among codes will be achieved during the identification 
ofthe themes, due to the theoretical framework employed for such identification. 
IdentifYing themes (or 'thematic units' as they were named by Krippendorf (1980)) and 
constructing codebooks is, as stated by Ryan and Bernard in a recent review about the 
matter, 'one of the most fundamental tasks in qualitative research' (Ryan and Bernard, 
2003, p.85). These authors also assert that: 
Given the variety for methods available for coding texts, the obvious question is, 
When are the various techniques most appropriate? Clearly, there is no one right 
way to find themes, but some techniques are more effective under some 
conditions than others. (Ryan and Bernard, 2003, p.l 00) 
In most qualitative research, themes are induced from the text itself (interviews, 
documents, etc.). However, although some themes used in the analysis of the interview 
data of the present study did arise from the text of the interview transcripts, this was not 
the case for most of them. In fact, the majority of the themes used in the qualitative 
analysis of this research evolved from the reseatch questions (Section 3.4), the results of 
the pilot study (Section 3.5), arid the quantitative analysis of the questionnaires responses 
(Chapter 4). Although qualitative researchers do not very commonly acknowledge the 
development of themes for qualitative analysis using an a priori approach, it is considered 
valid by accredited researchers, as pointed out by Ryan and Bernard: 
Themes come both from the data (an inductive approach) and from the 
investigator's prior theoretical understanding ofthe phenomenon under study (an 
a priori approach). A priori themes come from the characteristics of the 
phenomenon being studied; from already agreed on professional definitions 
found in literature reviews; from local, common-sense constructs; and from 
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researchers' values, theoretical orientations, and personal experiences ... (Ryan 
and Bernard, 2003, p.88) 
In the case of the present research, the codebook for the qualitative analysis of the 
interviews in this research was based in four major themes: 
1. Case data (which comprises the participants and schools' information) 
2. Questionnaire response rates 
3. Bias in medical research 
4. Possible solutions to the problem. 
The title of these themes was chosen as a reminder oftheir initial origin. For instance, the 
second theme is related to all the data obtained in the participants' answers to the ftrst 
question of the interviews, which was structured based in the low response rate of the 
questionnaires of this research. Conversely, the fourth theme is directly related to the 
third research question of this study (see Section 3.4), and to the participants' answers in 
the questionnaires. The third theme congregates the participants' viewpoints about the 
problem of bias in medical research, in particular their opinion about the possible factors 
that are influencing their existence and prevalence in medical research. 
Several sub-themes where created for each of these four major themes. They were created 
based on the international literature about the subject of bias in medical research, the 
participants' responses to the previous questionnaires, and the researcher notes done 
during the transcription of the interviews. The resulting complete codebook is available in 
Appendix 5, and was the basis for the list of nodes used in NUD*IST 4 (© Qualitative 
Solutions & Research Pty Ltd), which was the software used for the coding and initial 
analysis ofthe qualitative data ofthis study. 
In fact, the defmition of the themes as explained in the previous few paragraphs 
underpinned the choice of the theoretical framework employed in the analysis of the 
qualitative data in this research, which will be discussed in the next sections of this 
chapter. It will become evident during such discussion that the use of 'thematic analysis', 
as described by Aronson (1994) and Boyatzis (1998), was a natural result of the 
combination of the kind of data obtained and the fundamental purposes of this research. 
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5.1.3 Notation system utilised in the presentation of the data 
In the researcher raw data files, as well as in the NUD*IST® files, the identification of 
the participants followed the structure presented in the Interviews' Coding available in 
Appendix 5. However, in order to preserve the anonymity of the participants, the citations 
of excerpts of their interviews in this chapter will be identified only by the words 
'Teacher' or 'Student' followed by a number. This number was randomly assigned to 
each participant, and has no relation to the order of the interviews or the participants' 
medical school. The reason for such a convention is that some teachers and students could 
eventually know the sequence of the interviews in their schools, and that knowledge 
would jeopardise the anonymity of the participants. 
The excerpts of the interviews will be quoted in English. However, the interviews were 
originally undertaken, transcribed and analysed in Portuguese. Although care was taken 
in order to ensure that the English translation could transmit the real meaning of the 
interviewees' opinions, in some cases it was necessary for the researcher to add brief 
comments to enlighten the translated transcript. These comments will always be in 
brackets and in italic (e.g. comments) in order to allow the reader to recognise promptly 
that these are researcher comments. Dots without brackets ( ... ) were used to represent 
small pauses in the interviewees' discourse. In the case that only part of the interviewees' 
response was quoted, these quotations include dots in square brackets ([ ... ]) where 
material has been omitted. 
5.2 Qualitative analysis of the interviews 
The qualitative analysis of the interviews was conducted according to the major themes of 
the Interviews' Coding available in Appendix 5. However, some preliminary explanations 
are required to elucidate some aspects of the structure of this section. 
This section will be divided in three subsections: 
• Questionnaire response rate 
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• Bias in medical research 
• Possible solutions for the problem. 
The fIrst subsection (Questionnaire response rate) is based in the interviewees' responses 
to a very simple question: 'Why, in your opinion, did I have such a low response rate to 
my questionnaires in the fIve medical schools?'. Actually, this question was meant to 
create a kind of partnership between the researcher and the interviewees (see Section 
3.9.2). However, the participants' responses were so rich in information that it became 
essential to answering the remaining two research questions of this study. 
The second subsection (Bias in medical research) contains the participants' viewpoints 
about the causes for the present incidence of bias in medical research. In addition, it 
includes their opinions about the possible influence of present medical education, the 
researchers' behaviour, and other external influences (e.g. the pharmaceutical companies) 
in the high level of methodological deviations that are occurring in medical research. 
Finally, the third subsection (Possible solutions for the problem) analyses the participants' 
suggestions not only for reducing the extent of bias in medical research, but also for 
increasing the level of awareness of medical students about the problem. This dual 
objective of this subsection resulted from the participants' opinions in the second 
subsection, as most of them considered the medical courses (and post-graduation courses) 
as one ofthe most important factors for the present situation of medical research. 
In fact, as it can be evaluated in Section 5.1.2, these three subsections reproduce the 
central themes from which the NUD*IST® nodes where created for the analysis of the 
interviews' transcripts. 
5.2.1 Questionnaire response rates 
The fIrst question in all the interviews of this study was: 
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'Something that really surprised me was the low response rate to my 
questionnaires in all the five medical schools that are involved in this study. In 
your opinion, what could be the causes for such a low response rate?' . 
Interestingly, 78% of the teachers interviewed used the term 'research culture' in the first 
or second phrase oftheir answers. In fact, 95% ofthem used such term in some part ofthe 
interview. As Teacher-41 points out: 
"Teacher-41: We do not have a research culture in our schools ... I believe it is 
very difficult to do this kind of research in Brazil ... I had the same problem in 
my thesis '" I tried to focus my research on a matter that I believed would be 
important to all the Departments that are related to my medical area of research 
... At that time, there were 102 such Departments in all the medical schools in 
Brazil ... I contacted all of them by telephone and by mail ... and received only 
32 answers! And several of them with incomplete data ... I believe that people 
do not value this kind of research ... it is not part of our culture to participate in 
such research. [ ... ]" 
Differently, the students' answers were focused on three basic themes: lack of knowledge, 
lac\ of time, and lack of interest. They were present in combination in 75% of the 
students' interviews, and if considered as isolated themes they were present in 100% of 
the students' interviews. Good examples are provided by the opinions of Student-I 15 and 
Student-1 08: 
"Student-115: Well ... in the case of the students' response rate I believe it was 
lack of interest in the matter ... [ ... ] In fact, the last year of our courses is very 
hard for all of us ... preoccupations with the residency test ... lack of time to do 
everything ... and other problems '" that might also have contributed to the low 
response rate. [ ... ] In fact, the subject matter of your research might also not 
have helped ... Most of my colleagues never had contact with this subject ... 
They may have felt uncomfortable to answer about something that they do not 
know ... or know just a little about ... Our course is essentially technical ... 
medical research is not a preoccupation for many of my colleagues. [ ... ]" 
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"Student-l08: I believe that the students' low response rate was due to the fact 
that research methodology is not part of the curricular structure of our course ... 
The teachers seem not to have an interest in this subject ... [ ... ] If the subject of 
your research was something technical ... practical ... I believe the students' 
response rate would be greater ... [ ... ]" 
The teachers never mentioned the issue of lack of knowledge about bias in medical 
research that was so pervasive in the students' interviews when answering the first 
question. However, when their fIrst answer was followed by the probe question: 'Do you 
believe that the subject matter of my research had some influence in the low number of 
responses?', 80% of them agreed that a lack of knowledge could have been a factor that 
influenced the response rate. This was the case, for example, for Teacher-54: 
"Teacher-54: Oh yes! Of course this (the subject matter of the research) might 
have influenced the response rate ... of course .. . You see ... there is not a 
course about research methodology in our school '" In fact, as you know, 
medical knowledge has grown up a lot in recent decades ... it is becoming 
almost impossible to transmit all that knowledge in the six years we have to do 
it... Unfortunately, we are forced to leave some aspects of medical knowledge 
for the residency course ... or post-graduation courses ... So, many of the 
students that have not answered your questionnaire might still not have had a 
deep contact with the subject ... and some teachers too ... [ ... ]" 
In 35% of the teachers' interviews, the probe question also elicited responses connecting 
the low level of knowledge ofthe students to the medical course itself: 
"Teacher-40: [ ... ] I believe that the medical courses are responsible for that ... 
The student is not receiving enough information about research methods ... In 
fact ... not even enough to understand the methodology and results of a 
published paper ... It is basically an educational flaw in most medical schools I 
know ... [ ... ] And I can say more ... most of the teachers also have a very 
limited knowledge about scientifIc methodology ... [ ... ]" 
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Asked about the possibility that this low level of knowledge could be related to the fact 
that most papers about bias in medical research are been published in English, and by 
American and UK journals, the participants' opinion was almost unanimous; 90% of the 
interviewees (teachers and students) declared that such language barrier do not exist. As 
Teacher-30 pointed out: 
"Teacher-30: I do not believe that this problem oflanguage is important ... As 
you know, most of the best medical books and journals are in English ... Most of 
the medical teachers and students have an adequate level of technical English ... 
This is not a problem ... Of course most of us do not speak fluent English, nor 
would be able to write a paper in English, but they undoubtedly can understand a 
paper ... Also, I know that you can have access to the most important journals in 
all the medical schools of Parana State ... this is also not a problem ... And you 
have Internet connection in all these schools ... [ ... ]" 
The second most common expressions used by the teachers when answering the first 
question, or the second probe question, was 'lack of motivation' or 'not feeling 
motivated' (65% of the teachers' interviews). They were used mainly concerning 
fmancial or career issues, as in the following excerpt from Teacher-20's responses: 
"Teacher-20: Well ... I believe that the main reason (for the low response rate) 
is a general lack of motivation that is presently prevalent in our medical schools 
. .. It is due to low salaries, bad work conditions, etc ... The teachers are 
reducing the time they dedicate to the schools or even to teaching matters .. , Of 
course, this also reflects on the students' behaviour ... they perceive this lack of 
motivation in their teachers. We are having difficulties receiving answers from 
our own teachers and students about important subjects that are affecting our 
medical school ... It is not a problem that happened only with your questionnaire 
... [ ... ]" 
Although Teacher-20 and several other teachers were very categorical in linking the 
possible lack of motivation of the teachers to a similar process occurring among the 
students, the students' interviews do not confirm such an association. In fact, the students 
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showed a remarkable motivation, but focused on one only and specific objective: their 
residency (i.e. specialisation) test. As Student-97 summarised: 
"Student-97: [ ... ] The real problem is that everyone of us (students in the last 
year of the course) is fundamentally focused on our residency test ... Nothing 
else matters '" Who says this is not true, is lying .. . To be sincere, I have only 
answered your questionnaire because I am interested in medical research ... 
However, your envelope remained in my desk for almost a month before I 
opened it ... As there are just a small number of my colleagues that are 
interested in research, you could not have a great response rate ... [ ... ] Even our 
teachers tell us every day that the only thing that matters is to be successful in 
the residency test and get our specialisation certificate ... Otherwise, you will be 
a nobody in medicine ... I heard that every single day in the past two years 
.... [ ... ]" 
In fact, although not with such richness of details, the issue of the 'residency test' was 
present in all but one of the students' interviews. It was generally associated with other 
expressions such as 'lack of time', 'stress', and 'other priorities', and was used especially 
to explain why their colleagues did not respond the questionnaires. This insistence in 
explaining their colleagues' actions is understandable if one remembers that the 
hierarchical system of a medical school is very rigid. The students were possibly just 
reproducing their behaviour in relation to their teachers, as the researcher was introduced 
to them as a 'physician' and 'teacher'. However, it became evident during the interviews 
that the residency test was indeed the centre ofthe life of the interviewed students. 
Finally, when asked if the researcher should use some other method to try to interview 
some non-respondents, once again the respondents (teachers and students) were 
unanimous. They believed that if the person did not answer the questionnaire shelhe 
would not accept to be interviewed. The teachers were especially emphatic in their 
responses. Most of them stated that participation in the present research was discussed in 
their Departments; therefore, it would be useless to try to convince a teacher that had not 
send the questionnaire back to the researcher. 
114 
Although the attempt was made to evaluate if the kind of answers of the respondents had 
differences according to the medical schools to which they belonged, or their academic 
background, these relationships turned out to be statistically non-significant. These 
evaluations were done separately for teachers and students, as the answers analysed in 
this subsection already showed important differences of opinion between teachers and 
students. 
5.2.2 Bias in medical research 
The structured questions discussed in Sections 3.5.3 and 3.9.2 were used in order to 
obtain the participants' opinions about the possible causes of the high level of bias in 
medical papers. However, unlike the initial part of the interview discussed in the previous 
subsection, the order in which they were asked depended on the development of the 
interviews. In addition, some small rephrasing of the questions, as well as different probe 
questions, were used when the researcher felt it was necessary to obtain the maximum 
possible amount of relevant data in the restricted time allowed for the interviews. 
In fact, during the data analysis it was observed that the sequence and structure of the 
questions, as described in the aforementioned Sections, was kept unchanged in 45% of 
the interviews. In the remaining 55% there were some changes due to rephrasing and/or 
individual probe questions. Therefore, in order to keep the reader informed about whether 
the text quoted came from a direct question or from a rephrased/individual probe 
question, we will add the term probe question in brackets before the quoting when 
appropriate. 
The second part of the interview usually began with a question related to the 
interviewee's response to the frrst assertion of Question 8 (teachers' questionnaire) or 5 
(students' questionnaire): 
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In relation to the problem of methodological deviations ( bias) in medical research you believe that : 
( Please tick ) 
Strongly Agree Disagree Strongly Do not have 
agree disagree an opinion 
It is a problem of scientific methodology, 
with no relation to undergraduate medical 
courses 
This assertion was chosen because the majority ofthe participants (teachers and students) 
showed in their responses that they do believe that there is a relationship between the 
present structure of medical courses, and the problem of bias in medical research. The 
researcher usually asked the interviewees to explain in more depth their own answer to 
the assertion. 
The answers to this question were much more direct and focused when the interviewee 
was a teacher than when she/he was a student, as showed in the answers quoted below: 
"Teacher-I 8: Of course they have a strong relationship with the present structure 
of medical courses! ... Fundamentally, because the discussion about this 
problem (bias in medical research) is not considered as a priority ... priorities 
are the technical aspects of medicine ... Eventually a physician will have contact 
with such knowledge in the post-graduation courses . . . eventually ... The 
medical courses are at least partially responsible for what is happening in 
medical research ... undoubtedly ... [ ... ]" 
"Student-l 00: Well ... I believe people are making mistakes because they do not 
know the correct way of doing research ... The medical education I have 
received did not include such kind of information ... The small knowledge I 
have today was acquired participating in the scientific initiation programme ... 
but this is not the basic medical education ... I believe ... If I commit mistakes 
doing research because I was not taught the correct way of doing it then the 
medical course is also responsible for this, isn't it? [ ... ]" 
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Although the opinions quoted above are good examples of a reasonably high proportion 
of the interviewees (60% of the teachers and 55% of the students), they do not truly 
represent the opinion of all participants. The remaining teachers and students divided 
themselves between two main clusters of answers: those who focused on what can or 
should be taught in a medical course, and those who recognised that the problem exists 
but did not believe it is possible to correct it within the present duration of a medical 
course. As exemplified by the answers of Teacher-4 and Student-l 07: 
"Teacher-4: Well ... I must say that when I answered that question of your 
questionnaire I was thinking that in fact the medical course is partially 
responsible for the problem (bias in medical research) ... However, I do not 
believe it is responsible for providing in depth information about the matter ... 
Medical courses are technical courses ... the student is here to learn how to be a 
physician ... It is already almost a miracle we can do that in six years ... The 
problem is that a person graduates ... puts a 'Dr' in front of their name and 
thinks he/she is a teacher and a researcher ... So, what must really be stressed 
during the course ... and it is generally not stressed ... is that they are here to 
become a physician ... they should be aware that they should not engage in 
teaching or research without an adequate post-graduation course ... [ ... ]" 
"Student-I07: Well ... if this problem is happening (bias in medical research) 
the medical education has its share of responsibility ... Some of my colleagues 
spend some days collecting data in the medical records and be1ieve that they are 
researchers ... I think this is wrong ... However, I do not see how something 
could be done with the pte sent structure of the coutse ... I barely had time to 
sleep in this last year ... I think that a solution would be to aggregate the two or 
three years ofthe residency programme to the six years of the normal course ... 
this would eliminate the stress of the residency test and give more time for a 
decent research training programme ... [ ... ]" 
These answers show that, according to the participants, there is undoubtedly a 
relationship between medical education and the incidence of bias in medical research. 
However, to which level of medical education the rectification of the present situation 
should be attributed is still a matter of discussion. In addition, the answers illustrate that 
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the possible solutions to the problem (which will be discussed in the next section) may 
encompass several different and concurrent educational measures. 
The last part of the second phase of the interviews tried to evaluate the participants' 
opinions about other factors that, in their opinion, are also important to the problem of 
bias in medical research. It focused particularly on the researchers' behaviour (e.g. 
misconduct) and external factors (e.g. pharmaceutical companies), and during the data 
analysis was the part that showed the greatest structural variability. 
In some interviews, just the fact of starting to talk about the relationship between medical 
education and bias in medical research was enough to ensure a spontaneous continuation 
of the discourse involving researchers' behaviour and external factors. In these cases, the 
researcher only needed to nod or say some reassuring words (e.g. 'I see ... '). Conversely, 
in other interviews it was necessary to use small probe questions (e.g. 'and the 
pharmaceutics companies?') or even more direct and complex questions (e.g. 'And do 
you believe this is happening principally because of a researcher lack of knowledge or is 
it caused by researchers' misconduct?'). Consequently, the use of the notation (probe 
question) before the identification of the respondent in the next few paragraphs will be 
very frequent. 
The first aspect investigated in the interviews was the participants' opinions about what 
was the main cause for the present extent of bias in medical research. Would it be more 
related to the lack of knowledge of the researchers about the correct methodology or to 
researcher misconduct and external factors (e.g. pharmaceutical companies)? 
The reason for address this aspect was that, as it will be discussed in Section 5.3, there is 
great concern in the international medical research community about the present 
relationships between the pharmaceutical industry and physicians, researchers, and 
medical associations. Several papers where published in the last four years in the main 
American and British medical journals that suggest that these relationships are affecting 
not only medical research, but also medical education and physician attitudes. However, 
the present researcher found no similar concern in Brazilian medical journals. 
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Most of the teachers and students (90%) said that in their opinion was the most important 
factor for the existence and prevalence of bias in medical research was researchers' lack 
of knowledge about the correct research methodology. Interestingly, many of them used a 
Portuguese expression that almost exactly corresponds to 'I would like to believe that ... ', 
or other equivalent expressions. This may imply that what he/she was saying was more a 
hope than a solid opinion. In either the natural flow of their answers or when the 
researcher followed up with a probe question, all admitted that they knew about cases 
involving other causes. However, they stressed that they still believed that lack of 
knowledge was the most important. As stated by Teacher-92: 
"Teacher-92: Well ... I cannot talk about all medical research ... I can talk only 
what I have seen in my daily work ... I believe that the mistakes (in research) 
are occurring by lack of knowledge ... or naivety ... I do not want to believe that 
they are intentional ... At least from the colleagues I know ... However, there 
are many ways that bias may occur in medical research if you are not aware of 
the correct methodology ... And most medical researchers are not (aware) 
[ .... ]" 
When the researcher persisted, asking if Teacher-92 really believed that research 
misconduct was not playing an important role in the number of biased papers, her answer 
was: 
"(probe question) Teacher-92: Well ... we all know that much medical research 
is in fact pointless ... they are done just to enhance the researcher curriculum 
vitae ... Of course, these researches have a rather lax way of sampling and 
presenting the data ... This could be considered scientific misconduct, isn't it? 
... However, I do not know if these researchers are aware about the importance 
of what they are doing ... [ ... ]" 
Conversely, Student-l13 answer is a good example ofthe students' responses: 
"Student-l13: This is a difficult question ... I am not sure if I have enough 
information to answer your questions ... I do not really believe that people 
would make so many mistakes intentionally ... I might have not received a good 
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information about research methodology ... however, I had a very good course 
on Ethics ... all of us (physicians) have, isn't it? ... To manipulate a piece of 
research would be a serious ethical deviation, wouldn't it? ... People talk ... just 
gossip ... that someone has changed the results in order to publish ... but people 
never prove that ... [ ... ]" 
The analysis of the responses showed that there is a possible problem in the way the 
interviewees (teachers and students) understand the idea of scientific misconduct in 
medical research. In several cases researchers who have committed errors in their 
research were, in a certain sense, 'forgiven'. Their conduct was attributed to the fact that 
they "need" to publish, or that "there is not enough governmental support for medical 
research", and that "most researchers are not aware ofthe correct methodology". 
In order to evaluate how the participants perceive the problem of the influence of 
pharmaceutical companies in medical research it was always necessary to use a probe 
question to elicit a response. The question usually used was: 'And the pharmaceutical 
companies, do you believe they have some kind of importance in the problem of bias in 
medical research?'. It was used in the interviews in which the participant said that there 
are other possible causes for the present situation of medical research besides the lack of 
knowledge of the researchers, but did not specify what these causes were. This was the 
case in 43% of the interviews, in which even when the researcher asked about the 
possibility of scientific misconduct the participant did not really made explicit what these 
'other causes' were. 
Surprisingly, despite the importance given to the matter in the international journals, only 
four interviewees (8% of the total) saw the pharmaceutical industry as a possible cause of 
bias in medical research. Some (17% ofthe teachers) even believe that they are important 
partners, as declared Teacher-31: 
"(probe question) Teacher-31: [ ... ] I have no problems with the pharmaceutical 
industry ... Actually, if I did not have the support of the ***(pharmaceutical 
company name omitted by researcher) I would not have been able to do and 
publish more than 10 papers in the last five years ... I see no problem in this 
relationship because they never forced me to do anything that I would not like to 
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do in my research ... And you know how difficult it is to obtain money from the 
Brazilian government ... [ ... J" 
Actually, most teachers (67%) in these medical schools agreed that besides the lack of 
knowledge of research methodology and the lack of motivation, already discussed above, 
there were three other factors that they considered more deleterious to medical research 
than the influence of pharmaceutical companies. These factors are: lack of resources, lack 
of time to do a valid research, and the pressure researchers are under in order to fmish the 
research and publish it in the shortest possible period of time. As Teacher-70 put it: 
"(probe question) Teacher-70: I do not see the relationships with the 
pharmaceutical industry as a problem ... Real problems are that when you start 
to do a piece of research, and need 'X' of resources and time to do it correctly, 
and you receive only half the resources you need ... and begin to suffer all kinds 
of pressure to fmish it quickly ... These are real problems when doing medical 
research in Brazil ... Our medical schools and research fmancing organisations 
think that all research is equal and should be fmished in the same period of time 
... [ ... J" 
the case of the students' opinions about what was discussed in the above few 
paragraphs, it became clear since the beginning of the interview phase of this study that 
they did not have a personal opinion on the matter. They always declared that they did not 
have enough knowledge about the subject to discuss it. When stimulated by the 
researcher, most of them started their discourse with the phrase 'The teachers say that ... ' 
and repeated the same opinions as their teachers. 
However, there were four important teachers' interviews that showed some aspects about 
the problem of the relationships between the pharmac~utics indu~trY and medical 
research. Although they represent less than 10% of the total number of the interviews, 
they may shed light on some aspects of these relationships. The ftrst one to be quoted was 
the answer of Teacher-4 when answering the probe question: 'And the pharmaceutical 
companies, do you believe they have some kind of importance in the problem of bias in 
medical research?': 
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"(probe question) Teacher-4: Well ... I do not believe that it is a problem in 
Brazil ... However, I am aware that this is a problem in the developed countries 
... I was thinking only about medical research here ... As everybody knows, our 
medical research is in its early stages ... probably it is not considered as 
important by pharmaceutical companies ... See ... I am not saying that we are 
less permissive than the researchers in other countries ... it is just a question of 
opportunity ... If they begin to spend in medical research here what they spend, 
for instance, in the USA ... well ... you will see queues of Brazilian researchers 
asking for money ... Only then, I believe that we will begin to have problems 
related to these relationships ... [ ... ]" 
This seems to be a rather sensible opinion. This teacher expresses the view that Brazilian 
medical research is not having problems with relationships between pharmaceutical 
companies and researchers because, in fact, these relationships do not exist in a detectable 
quantity. However, three teachers in three different schools reported that they had had 
problems in these contacts in a very similar way. One ofthem was Teacher-84, who gave 
a rather long statement about her experience, which is summarised bellow: 
"(probe question) Teacher-84: [ ... ] After my Masters, I was interested in (a 
special disease) which treatment is (a specific drug ... [ ... ] As it always happens 
here in Brazil, we were not able to receive a grant to do it ... Then we contacted 
the pharmaceutical company that produced that drug and they were interested .. . 
after all, we had the patients they need to test their drug ... I thought ... [ ... ] 
When we started the research, the company already had the sampling protocol 
ready ... We never even had an opportunity to learn how to do it ... [ ... ] The 
data was collected and sent to the pharmaceutical company statisticians ... and 
to another company in order to do the adequate writing, so it could be published 
in a good journal ... they said at the time ... [ ... ] At the end, we juSt signed a 
paper agreeing with the results ... and it was published ... Much research, which 
is done inside the medical schools, is done exactly like that ... [ ... ] Only after 
my doctoral studies, which were really good, was it that I realised exactly what 
happened ... but it was to late to fix things up, isn't it? ... [ ... ]" 
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The data about this subject collected in the present research are not sufficient to permit 
the researcher to reach any defmitive conclusions. However, it shows that the influence of 
the pharmaceutical industry in medical research done inside the schools that participated 
in this study might be greater than the participants might be aware (or wanted to speak) 
of. Actually, as will be discussed in Section 5.3, this kind of concealed influence from 
these industries in medical research is being reported with an increased frequency in 
international journals in the last few years. 
Finally, as was the case in Section 5.2.1, attempts to evaluate the possibility of connecting 
a specific group of responses to different schools, or to the participants' academic 
backgrounds failed to show statistical significance. 
5.2.3 Possible solutions for the problem 
In this sub-section the participants' proposals meaningful to the possible educational 
measures that could help to minimise the problem of bias in medical research will be 
analysed. No effort will be made in this sub-section to make an in depth comparison with 
the international opinion about the matter, because such a comparison will be a feature of 
Chapter 7. 
In their questionnaires' responses, teachers and students showed an evident preference for 
a curriculum change in order to transmit appropriate knowledge about bias in medical 
research (see Sections 4.2.2 and 4.3). This preference was determined by the number of 
participants that answered 'yes' to a direct question in their questionnaire responses: 
'Do you believe that changes in the curriculum of medical schools are necessary 
in order to achieve a better transference of knowledge about bias in medical 
research?' . 
However, in the interviews' analysis it become clear that such change could mean 
different educational interventions for the interviewees, depending on three factors: 
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• The kind of curriculum their schools were using or implementing at the moment of 
the interviews. 
• Whether the interviewees thought a modification should be done in the normal 
medical course or in the post-graduation courses (residency, Masters, or Doctoral 
courses). 
• The level of knowledge about scientific methodology and the problem of bias in 
medical research a medical student should have at the end of herlhis course according 
to the participants' opinion 
Consequently, those simple 'yes' or 'no' responses in the questionnaires turned out into a 
much more rich, although intricate, mosaic of responses in the qualitative data analysis of 
the interviews in the present research. 
Although some few percentages of the answers are provided simply to illustrate their 
absolute frequency, no attempts were made to evaluate them as a statistical representation 
of the opinions of the teachers and the students who participated in this research. 
Two fundamental reasons underpinned the researchers' decision to present the data in this 
section in such a way. Firstly, because the main objective of this part of the interviews' 
analysis was to collect and analyse as many proposals ofthe participants as possible for a 
future discussion about their potential efficacy and feasibility in Chapter 7. It was not 
proposed as an evaluation about the 'correct', 'incorrect', 'more desirable', or 'more 
frequently chosen' method that should be employed. Secondly, in order to reduce the 
possibility of the occurrence of what Boyatzis (1998) calls "projection", which he 
considers one of the three major threats to the correct use of thematic analysis. As stated 
by this author: 
It is simply "reading into" or "attributing to" another person something that is 
your own characteristic, emotion, value, attitude, or such. With ambiguous 
qualitative information, there is more opportunity for and invitation to projection 
from the researcher than in most types of research. (Boyatzis, 1998, p.13) 
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In most of the interviews it was necessary to use probe questions in order to obtain the 
data, and the present researcher is a physician who also has his own defmed point of view 
about the subject. Consequently, analysing the data using the relative proportions of the 
answers could induce the present researcher, even unconsciously, to disregard important 
information contained in those answers that only a few participants opted for. 
At the beginning of the analysis, it was observed that there was an evident division among 
the teachers that participated in this research. Those teachers that belonged to schools 
with 'traditional' (i.e. sequential) curricula (3 schools) had a greater tendency to propose 
a curricular change in the basic medical course as solution to the lack of knowledge of 
their students about scientific methodology. Conversely, teachers of the schools that 
either already had adopted the problem based learning (PBL) structure (1 school), or were 
in the process of adopting it (l school), where less prone to propose curricular changes in 
their basic medical course. As may be observed in the answers of Teacher-75 and 
Teacher-42: 
"Teacher-75: I do believe that a curriculum modification is necessary ... We 
must introduce our students to the basic concepts of medical research at the 
beginning of their courses . . . and this initial course of scientific methodology 
should be followed by seminars every year throughout their medical courses. 
This is the only way to create and maintain a good level of knowledge in the 
matter ... [ ... ]" 
Conversely, teachers of the schools that either already had adopted the problem based 
learning (PBL) structure (1 school), or were in the process of adopting it (1 school), were 
less prone to propose curricular changes in their basic medical course. As may be 
observed in the answer ofTeacher-42: 
"Teacher-42: [ ... ] It is not necessary a curriculum change . . . It is just a question 
of introducing the discussion of scientific methodology problems in the modules 
we already have ... [ ... ]" 
However, when asked how the eventual modifications could be implemented, both 
teachers recognised that existence of difficulties: 
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"(probe question) Teacher-75: Well ... I must recognise that it is more easy to 
speak about than to do such a change (of curriculum structure) ... It would 
involve the modification, and even a reduction, of other courses ... and this is 
not very easy to do in a structure like ours ... Also, there is a problem of who 
will be responsible for such a course ... We do not have many skilled 
researchers, and those we have are already committed to several other activities 
... It will not be easy ... [ ... ]" 
"(probe question) Teacher-42: [ ... ] The biggest problem 1 can see at the 
moment is our lack of skilled teachers to implement such a modification .. , It 
will have to be a progressive and relatively long process ... [ ... ]" 
A reasonable proportion (55%) of the students that participated in this study showed a 
remarkably similar opinion about the subject when compared with their teachers' 
interviews. In fact, even the proportion of those students that agreed with the opinions 
quoted in the previous few paragraphs was similar to teachers' proportion (60%). The 
only difference was that the students usually started their answers with the phrase: "1 am 
not really sure, but...", or some other equivalent phrase. 
The remaining 40% of the teachers, and 45% of the students either believed that research 
methodology should be a subject for study in the post-graduation courses, or understood 
that there should be a clear distinction between physicians, researchers and medical 
teachers in order to reduce the problem of bias in medical research. Good examples of 
both lines of reasoning are the answers ofTeacher-4 (who had already expressed a similar 
opinion when quoted in Section 5.2.2), and Teacher-7: 
"(probe question) Teacher-4: [ ... ] As I told you before 1 am really convinced 
that physicians, medical researchers, and medical teachers should be considered 
distinct professions, even if they share the same undergraduate courses ... They 
should be prepared to undertake their own separated responsibilities ... The real 
problem I can see is a person who tries to do everything at the same time, which 
is very common nowadays ... The solution (for the problem of bias in medical 
research) is very clear to me ... it is just a question of defming the boundaries 
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that should separate what is to be a physician, a medical researcher, and a 
medical teacher '" [ ... ]" 
"(probe question) Teacher-7: Many of my colleagues may disagree of my 
opinion ... However, I cannot see any possibility of introducing such course 
(about scientific methodology) in the medical undergraduate courses ... In fact, I 
really cannot see a motive to do something like that ... Scientific methodology 
is, and should remain, a part of the post-graduation courses ... If problems are 
occurring because the post-graduation courses are not providing adequate 
information, they are the ones that should be changed .,. [ ... ]" 
Differently from their teachers, the remaining 55% of the students focused their answers 
in only one solution. All of them believe that there is no possible way of introducing a 
new course in the present medical course, and that such knowledge should be provided in 
their residency. As stated by Student-99: 
"(probe question) Student-99: Well ... this is a difficult question ... It is 
possible that our teachers could find a better solution, but, as a student, I do not 
see how a new course (of scientific methodology) could be feasible ... We 
already have more courses than it is possible for a person to handle ... And who 
will be responsible for such a course? ... Anyway, I do believe that it will be 
possible to have something like that in the residency program ... I think that 
such kind of knowledge could be more profitable in the residency because then 
we will be focused in preparing ourselves to be an specialist ... Do you agree? 
... [ ... ]" 
During the analysis of this last part of the interviews, an interesting pattern of responses 
emerged. It was not caused by a specific probe question of the present researcher or 
correlated to any specific answer of the interviewees. Usually, it was an additional 
comment of the interviewee, and occurred in 20% of the teachers' interviews but not in 
the students' interviews. As in the case ofTeacher-31 when talking about the problem of 
bias in medical research: 
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"Teacher-31: [ ... ] And really ... I believe that this problem (of bias in medical 
research) is been overemphasised by the media ... I do not believe that there are 
so many mistakes occurring (in medical research) ... [ ... ]" 
Although it occurred in a relatively low propOltion (20%), and only in the teachers' 
interviews, it is an interesting fmding. These teachers seem to be politely expressing 
something that could be translated as: "Look, this is an important problem to you, because 
it is the base of your research. However, it does not seem such a big problem to us.". 
Therefore, future researchers in this area should be aware of the fact that such kind of 
reasoning, in a more subtle way than an overt opposition, may hinder possible solutions to 
the problem of bias in medical research. 
5.3 Conclusions 
As stated at the beginning of this chapter, the main aim of the interviews was to help to 
answer the second and the third research question of this study. The second research 
question was: 
In the participants' opmlon, are the systematic errors that exist in medical 
research the result of factors related only to the methodology of research, or are 
they also a manifestation of habits acquired during medical education and 
postgraduate courses? 
According to the discussion of the existent evidence in Chapters 1 and 2 and the data 
collected in five Brazilian medical schools (Chapters 4 and 5), it is clear that both these 
two factors are important. Although the methodology currently employed in medical 
research may be partially responsible, the lack of knowledge among physicians and 
researchers about the correct methodological approach to medical problems, which seems 
to have its roots in the undergraduate medical courses, also have its role in the incidence 
of bias in medical research. 
Evidently, such a statement is valid only for the five medical schools that participated in 
this research. However, as it will be discussed in Chapter 7, according to several 
128 
international publications, such a statement may be considered as valid not only in these 
particular medical schools of the Parana State (Brazil), but also in several other countries. 
Furthermore, the data obtained in the present research reveals that the answer to the third 
research question ("What can be changed in medical education in order to reduce 
systematic errors in research?") can be a very difficult one. As it can be perceived by the 
answers of teachers and students of the five Brazilian medical schools, such an answer 
entails a more reflective evaluation of the curriculum structure, teachers' level of training 
in research methods, and aims oftoday's medical teachers and students. 
As was the case in the analysis of the questionnaires (see Section 4.4), the analysis of the 
interviews did not show a substantial difference of opinions among teachers of different 
schools in respect to the problems of the questionnaire response rates (Section 5.2.1) and 
of bias in medical research (Section 5.2.2). Such similarity of opinions is probably due to 
the fact that, although they were teachers in different schools with somewhat different 
curricula, they perceive the subject matter of this research from the same perspective. It is 
interesting to notice that, as discussed in Chapter 6, a curricular change in a medical 
school does not necessarily entail the modification of the beliefs of its' teachers in respect 
to some subjects. 
However, there were noticeable differences in the interviews in relation to the teachers ' 
opinions about the possible educational measures that should be adopted to reduce the 
problem of bias in medical research and the low level of awareness of students and 
teachers about this problem (Section 5.2.3). There was an evident choice for a curricular 
change among the teachers that belong to schools that adopt more traditional curricula, 
while in those schools that have problem-based structured curricula the teachers did not 
perceive that a curricular change would be necessary. 
The difference of points of view of these two groups of teachers is perfectly 
understandable. A traditional medical curriculum is strongly based in the 'specialisation' 
process that occurred in medicine since the end of the 19th century. Such a process in fact 
created a kind of 'compartmentalisation' of medical knowledge that was the basis of the 
present 'Departments' inside medical schools (see Chapter 6). Teachers that are 
accustomed to such a subdivision will naturally see a new area of medical knowledge as 
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detached from their own department or the other existing departments, a situation that 
requires for its solution the reaction of a new physical and bureaucratic structure (i.e., a 
new department). Conversely, the teachers of those schools that have adopted a problem-
based learning model probably do not see the eventual introduction of some new aspects 
of medical knowledge in the modules that compose their curricula as a problem. 
In fact, such a difference of perspective of medical teachers, which seems dependent on 
the curricular structure they are habituated, is more than a curious fmding of this study. It 
is an important aspect to be considered by future researchers in the area, especially if their 
study involves some kind of 'action research' in these medical schools. 
The students that participated in the interviews' phase of this study showed a remarkable 
similarity in their opinions, irrespective of the kind of intended curriculum to which their 
schools submitted them. Their fundamental expectation is to be successful as practising 
physicians, and they can only see an opportunity to be successful if they can do well in 
their attempts to be a specialist in a particular area of medical knowledge. Although there 
is some evidence that this kind of behaviour may be acquired inside the medical schools 
(see Section 5.2.2), the data collected in this study cannot dismiss the possibility that 
these students already had such an opinion at the moment they made their application to a 
medical course. 
Either as a manifestation of pre-existing aspirations or as an acquired trait, these opinions 
of the students show that it will be important to take into account these aspects of the 
students' hidden curriculum (see Chapter 6) before any attempt is made to modify the 
present structure of medical schools curricula. This might be especially true in respect of 
the introduction of concepts about medical research methodology and critical appraisal of 
medical research, topics that these students at the moment do not seem to see as 
fundamentally important to their future professional life. 
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Chapter 6 
Curriculum structure of medical schools: their possible 
influence on the solution for the problem of bias in medical 
research 
6.1 Introduction 
In the discussion of the results of the questionnaires in Chapter 4 it seemed evident that 
the participants believed that curriculum change was necessary in order to attain an 
appropriate transmission of knowledge about bias in medical research. However, the 
analysis of the interviews in Chapter 5 demonstrated that such a change represented 
different educational actions for the participants. Furthermore, it also showed that even 
those participants who believed that such a curricular modification should happen at the 
undergraduate stage of medical education had doubts about its feasibility. 
Consequently, in this chapter I will try to answer three fundamental questions that are 
important to underpin the discussion of the possible solutions for the problem of bias in 
medical research in Chapter 7: 
1. What is the basic structure of the curricula in modem medical schools? 
2. Can we alter the quality ofteaching in a medical school by changing the curriculum? 
3. Why has the present research shown such a degree of resistance to a change, or doubts 
about its feasibility, among the participants? 
As will be seen in the following sections, the answer to these apparently simple questions 
is not straightforward. However, the discussion of these matters will undoubtedly unveil 
interesting and important aspects of present medical education in Brazil, and in other 
countries. 
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6.2 What is the basic structure of the curricula in modern medical 
schools? 
A simplistic but somewhat inaccurate answer could be: there are those curricula based in 
the 'traditional' (i.e. sequential) model, and those based in the 'problem-based learning' 
(PBL) model. 
Although undoubtedly the basic structure of medical courses has many features in 
common all over the world, the above answer leaves aside important differences caused 
by fmancial, political and regional factors. In fact, as Wojtczak and Schwarz assert, 
'medical schools worldwide need to have a set of global standards and requirements to 
guide medical education curricula' (Wojtczak and Schwarz, 2000, p.555). However: 
They (the global standards) represent only a portion of requirements since the 
curriculum of each country and medical school has to address its unique health 
and social needs. (Wojtczak and Schwarz, 2000, p.555) 
These 'unique health and social needs' may sometimes transform similar 'written 
curricula' into a very different 'applied curricula' . As stated by Prideaux (2004): 
In contemporary medical education it is argued that the curriculum should 
achieve a "symbiosis" with the health services and communities in which the 
student will serve. The values that underlie the curriculum should enhance health 
service provision. (Prideaux, 2003, p.268) 
'-,-. 
Such 'symbiosis' would, in fact, really transform our initial question of this section in a 
very difficult one, because it would be difficult to centre our answer only in the written 
proposals of a specific medical school. 
Prideaux (2003) considers that there are three levels of a curriculum: 
• The planned curriculum 
• The delivered curriculum 
132 
• The experienced curriculum. 
The planned curriculum would be what the designers initially intended. This initial 
structure would show the influence of how school administrators organise such ideas, and 
how teachers understand them, and also how they really transfer such ideas to the 
students (which would be the delivered curriculum). Finally, the experienced curriculum 
would be what is in fact learned by the students. Actually, there must also to be ") 
considered the behaviours, knowledge and performances that the learners suppose to be I 
important, which Snyder (1991) named as 'the hidden curriculum' . 
In a medical school these subsequent modifications of the initial idea of a planned 
curriculum may in fact miss any attempt to defme what is the fmal structure that could be 
called a modern medical school curriculum. This is specially true when one remembers 
that medicine is a profession that is based in professional practice, and that this 
professional practice is strongly related to the delivered, experienced, and 'hidden' 
curricula. Consequently, the written proposal of a specific medical school may be 
misleading to the purpose of answering the question that is the basis of this section. 
Additionally, as Burton and McDonald (2001) explain, even the way medical educators 
understand the term 'curriculum' should be investigated: 
Although the concept of 'curriculum' is complex, a common understanding of 
the term by those involved in medical education is essential, given the current 
climate of medical curriculum development and reform. It has not previously 
been established that such a common frame of reference exists. (Burton and 
McDonald, 2001, p.187) 
Covering 85% ofthe medical educators and 35% ofthe third-year medical students at the 
University of Sheffield Medical School (UK), the conclusions of Burton and McDonald 
(2001) are important for the present discussion. Their intention was to gather information 
about what the participants understand by 'curriculum', using an email survey as the 
instrument of their research. 
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Burton and McDonald (2001) make clear that they consider that there is a great difference 
between 'curriculum' and 'syllabus', although the latter may indeed be an element of the 
former. For them, 'syllabus' is simply "a statement or outline ofthe subjects covered by a 
course of teaching ... " (Burton and McDonald, 2001, p.189). Prideaux (2003) makes the 
same point. 
One of the conclusions of Burton and McDonald was: 
If our results represent the kind of understanding of 'curriculum' amongst 
medical educators then they raise the question of whether we are reforming 
curriculum or syllabus. In order to facilitate debate about curriculum reform, we 
believe that it is necessary to step back from the proposed models of change and 
establish a common framework of understanding that will allow us to go beyond 
a superficial tinkering with issues of syllabus. (Burton and McDonald, 2001, 
p.190) 
I believe that their concern is totally justified because it is very difficult to discuss the 
matter of what a modern medical curriculum is if all we have generally presented by 
medical schools are their syllabuses. Furthermore, comparing just the 'statement or 
outline of the subjects covered by a course of teaching' can be misleading to the purpose 
of the present study. 
A possible solution to our problem could be to investigate how governments and 
professional medical associations envisage a modem medical undergraduate curriculum 
as revealed in such publications as: 
• Health Professions Education: a Bridge to Quality, from the Institute of Medicine of 
the National Academies (USA) (Greiner and Knebel, 2004), 
• Tomorrow's Doctors, from the General Medical Council (UK) (General Medical 
Council, 2002), 
• Diretrizes Curriculares Nacionais do Curso de Gradua~iio em Medicina, from the 
Conselho Nacional de Educayao (Brazilian National Education Council) (Brazil) 
(Conselho Nacional de Educayao, 2001). 
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Unfortunately, such an investigation does not provide a definitive answer to our question 
either. These documents from three different countries share a joint problem. All of them 
offer very sensible suggestions about what should be the expected outcome of a medical 
course (i.e. the physician), but only offer general guidelines, and leave to each medical 
school the task of transforming such guidelines into a real curriculum. Interestingly, all 
three documents show an evident intention of creating stronger relationships between 
medical schools and the health services of these three countries. 
Some authors have a harsher opinion concerning this kind of approach to the subject: 
The GMC's vision, laid out in Tomorrow's Doctors ... has both catalysed and 
legitimised the key (curricular) reforms. The core of the revised Tomorrow's 
Doctors is a poorly structured and rather repetitive list of 96 items that are 
supposed to defme a good doctor. This list is dominated by advice on how 
doctors should interact with their patients and colleagues ... Bizarrely, only six 
items describe the unique qualities that distinguish a doctor from other 
healthcare workers. (Williams and Lau, 2004, p.93) 
Actually, such a lack of structured information creates great concern among scholars 
involved with the establishment of standards in medical education. Discussing the 
standards in medical education in European Union, Leinster (2003) asserts that: 
The standards relating to the content of basic medical education are laid down in 
Article 23 of the Directive (*) ... At fIrst sight these appear specific but on closer 
inspection they are so general as to be meaningless as a standard. Without 
further defmition it is impossible to be sure what is meant by 'adequate', 
'sufficient' or 'suitable' and the so-called standards are open to varied 
interpretations by different regulatory authorities and institutions. (Leinster, 
2003, p.508) (* European Council Directive 93/16) 
We can conclude that the task of defming what a curriculum of a modem medical school 
should be is really a difficult one. Probably because of this, most researchers prefer to 
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discuss 'models' of curricula rather than the real structure of a modern curriculum for a 
medical school. 
6.2.1 Curriculum models in modern medical schools 
According to Prideaux (2003) there are two main groups of models: 
• Prescriptive models 
• Descriptive models. 
Prescriptive models focus essentially in defining the objectives, or purposes, of a 
curriculum design in order to structure it. As summarised on Tyler's 'objectives model' 
(1949): 
• What educational purposes should the institution seek to attain? 
• What educational experiences are likely to attain the purposes? 
• How can these educational experiences be organised effectively? 
() How can we determine whether these purposes are being attained? 
(Tyler, 1949, p.1) 
The use of an 'outcomes-based' curriculum is becoming more popular in medical 
education. This shift was due to some serious criticism about the possibility that the 
'objectives model' restricted the curriculum to a narrow range of student skills and 
knowledge. As stated by Prideaux: 
The use of outcomes is becoming more popu1ar in medical education, and this 
has the important effect of focusing curriculum designers on what the students 
do rather on what the staff do .... (However,) An exclusive concern with specific 
competencies or precisely defmed knowledge and skills to be acquired may 
result in the exclusion of higher order content that is important in preparing 
medical professionals. (Prideaux, 2003, p.269) 
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By 'higher order content' is meant the transmission of the capacity of problem solving 
and the processes that should be employed in order to allow the student to acquire values 
that are important in medical practice (Prideaux, 2003). In fact, the 'outcomes-based' 
curriculum is very similar to Tyler's (1949) 'objectives model' curriculum. The 
fundamental difference is that the former entails that the curriculum should be based on 
the expected outcomes to be obtained by students, whereas the latter is based on the 
curriculum designers' belief about the necessary knowledge a physician should obtain in 
a medical school. 
Most of the medical schools worldwide have prescriptive curricula (or syllabuses) that 
they have been adapting progressively since the first half of the 20th century, according 
specially to their internal needs and resources. This has created several 'hybrid' local 
curricula structures that are in fact only variations on the prescriptive curricula theme. 
However, as will be discussed in Sections 6.2.2 and 6.3, they are under heavy pressure to 
evolve into a different curriculum structure. This pressure is due to political and social 
modifications and needs that occurred in the last quarter ofthe 20th century. 
Conversely, descriptive models centre themselves on the importance of situation and 
context (i.e. situational analysis) of a particular school, country or region. As explained 
by Prideaux (2003): 
In this model, curriculum designers thoroughly and systematically analyse the 
situation in which they work for its effect on what they do in the curriculum. The 
impact of both external and internal factors is assessed and implications for the 
curriculum are determined ... What is possible in curriculum design depends 
heavily on the context in which the process takes place. (Prideaux, 2003, pp.269-
270) 
The main criticism of descriptive models is that they are very time and resource 
consuming. In addition, there is no defmite evidence that they provide a better result than 
prescriptive models in medical education. 
6.2.2 The present situation in Brazil 
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As explained in Section 2.3, medical education in Brazil has a history of little less than 
200 years. At the start of this period Brazilian medical education was heavily influenced 
by the European model of medicine, as Brazil was a colony of Portugal. However, a 
radical shift occurred between 1916 and 1925, when the USA government through the 
Rockefeller Foundation started a long period of educational and political influence on 
Brazilian education including, of course, medical education (Lima-Gonyalves, 2002). 
USA medical education was suffering the impact of the 'Flexner Report' (Flexner, 1910). 
The 'Flexner Report', a 364-page report written by Abraham Flexner and officially 
entitled 'Medical Education in the United States and Canada: A Report to the Carnegie 
Foundation for the Advancement of Teaching' had direct consequences for Brazilian 
medical education. Its structure was very well summarised by Hiatt and Stockton (2003): 
(The) ... tome arose from research conducted by Flexner, who claimed to have 
visited and objectively evaluated 156 graduate and twelve postgraduate medical 
schools in the United States and Canada. He sought data on five points for each 
ofthe schools: (1) entrance requirements and adherence to them, (2) the size and 
training of the faculty, (3) the sum and allocation of endowment and fees to 
support the institution, (4) the adequacy and quality of the laboratories as well as 
the training and qualifications of the laboratory instructors, and (5) the 
relationships between the school and its associated hospitals. (Hiatt and 
Stockton, 2003, p.38) 
Although this report has been considered as 'the most influential publication of all' for 
medical education (Johnson, 1983), it really represents the natural evolution of a process 
of medical education evolution: 
It should be noted that Flexner's approach was remarkable, but not entirely 
novel. It was rooted in the British Victorian social reformers' enthusiasm for 
collection and enumeration and likely influenced by an article based on school 
inspections performed by the Council on Medical Education of the American 
Medical Association in 1906. Flexner walked on paths that others had recently 
pioneered. (Hiatt and Stockton, 2003, p.38) 
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The combination of the 'Flexner Report', the new 'prescriptive models' discussed in 
Section 6.2.1 and a strong North American influence in Brazilian medical education 
underpin the present medical curricula in Brazil. 
In fact, this combination had such an intense impact on the Brazilian medical education 
that in a recent editorial in a Brazilian medical journal, Perez (2004) declares that: 
Flexner's proposal was: fl... the definition of admission standards and the 
lengthening of medical education to four years; the introduction of laboratory 
based teaching, the encouragement of full-time teaching; the creation of a basic 
cycle and the expansion of clinical education, specially in hospitals, the linking 
of medical schools to universities, the emphasis on biologic research as a way to 
overcome an empirical approach in medical education, the linking of research to 
teaching and the control of professional exercise through the introduction of 
professional regulation. " These guidelines are still the core of medical education 
and practice but subject to criticism. (Perez, 2004, p.12) 
Although there were (and are) several attempts at modifying Brazilian medical education 
system, we must accept that most of the present curricula (or syllabuses) of medical 
schools in Brazil are still based in concepts from the first half of the 20th century. This 
was caused by the simple fact that in 1950, when the whole process of 'adaptation' to the 
North American 'style' of medical education was completed, there were just 13 medical 
schools in Brazil (Lima-Gon<;alves, 2002), and those which were created after these initial 
13 mirrored their educational structure on these schools. 
Due to the intense relationship with the medical education system in the USA, including a 
large number of Brazilian physicians who had undertaken their post-graduate studies in 
American medical schools, the Brazilian medical schools also started a huge program of 
'residency' (i.e. specialisation). According to Lima-Gonyalves (2002), between 1945 and 
1948 the Brazilian 'residency' programs were structured in two medical schools in the 
States of Sao Paulo and Rio de Janeiro following the basic configuration of similar 
programs in the USA. The remaining Brazilian medical schools soon adopted these 
pIoneer programs. 
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This phase of intense 'specialisation' had its effects in the normal programs of 
undergraduate medical education, as discussed in Chapter 5. Evidently, each school had 
to adapt its curriculum (and syllabus) according to the new internal balance of forces 
caused by the subdivision of the main areas of medicine that occurred. 
At the end of the 1980s this delicate balance of forces inside Brazilian medical schools 
was disrupted. In 1988 the Brazilian Constituent Assembly changed the Brazilian 
Constitution, and, among other changes, created the Sistema Unificado de Saude (Unified 
Health System). Such a system required different physicians from those who had been 
provided by the intense 'specialisation' process inside Brazilian medical schools. Since 
the Brazilian Government funds the most important medical schools, these schools came 
under intense pressure to change their educational processes. The CINAEM project 
discussed in Section 2.3 was a result of such political pressure. 
The fmal result of these internal and external pressures for change in Brazilian medical 
schools has yet to be seen. At the moment it is not possible to foresee which will be the 
curriculum of a modem medical school in Brazil. Some of the reasons for such 
uncertainty will be discussed in Sections 6.3 and 6.4. 
6.3 Can we alter the quality of teaching in a medical school by changing 
the curriculum? 
The question that is the title of this section is part of the title of an elegant speech made 
by Amanda K. Gilbert at 'The Higher Education Research and Development Society of 
Australasia' (HERA) Conference in July, 2002 (Gilbert, 2002), in which she reasons that: 
University teachers are coming under increasing pressure to alter the curricula 
they teach. Often the reasons for this are related to the styles of teaching 
employed by those teachers and their concepts of learning and teaching in 
general. For teachers this can be puzzling and stressful. After all, many are 
highly experienced, well respected by their students and colleagues. Academic 
developers are in a difficult position as they try to encourage teachers to develop 
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critical rationales and beliefs about learning and teaching, often in the context of 
political and organisational agenda. (Gilbert, 2002, p.l) 
In Brazil, Perez (2004) also shows a similar concern about the real motives that are 
involved in the present interest in medical curriculum changes: 
In Brazil in the last two decades medical schools have been accused by civil 
society of not qualifying professionals to meet the needs of population. 
Therefore, it is necessary to recover, however timidly, historical moments of 
medical education, to avoid the generalisation implying that changing curricula, 
reformulating medical courses would be enough to change medical education. 
(Perez, 2004, p.13) 
At this point one may argue that such a discussion about change is only happening due to 
the fact that medical schools are old educational structures, based on beliefs from the fIrst 
half of the 20th century, as discussed in Section 6.2.2. However, evidence from Saudi 
Arabia does not support such a statement. In Saudi Arabia, the frrst medical school started 
in 1969, and the most recent one was inaugurated in 1996. Consequently, we have a 
medical education history in Saudi Arabia of only 35 years. Nevertheless, Alshehri (2001) 
states that: 
A reassessment of the objectives of the curricula is needed. This should be based 
on the country's development plans, social trends, and economical factors. 
Similarly, the contents of the curricula should be reassessed to avoid 
overcrowding of the clinical and basic courses. Vocational skills and attitude 
domains need to be included. (Alshehri, 2001, p.320) 
One interesting aspect of Alshehri's paper is that it has a strong statement about why such 
modifIcations should happen: 
There has to be a reassessment of the objectives of our curricula and what 
changes are required. We have to respond to the social issues, the country 
development plans, as well as available resources. It should be realized that 
unless the educational system responds from within to these issues, it will be 
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forced to respond by external forces in the course of time. (Alshehri, 2001, 
p.321) 
Habituated to a long period of almost exclusive internal control over their curricula, how 
are medical schools responding to the referred 'external forces'? If they are changing, 
how successful are such changes? Which are the possible changes that are really 
meaningful to medical education outcomes, i.e. the graduated physician? 
These are questions that have been the main preoccupation of medical educators and 
academic developers in the last 30 years. In order to answer them one must keep in mind 
that: 
A curriculum is the result of human agency. It is underpinned by a set of values 
and beliefs about what students should know and how they come to know it. The 
curriculum of any institution is often contested and problematic. Some people 
may support a set of underlying values that are no longer relevant. (prideaux, 
2003, p.268) 
As discussed in Section 6.2, most of the medical schools' curricula are a result of a 
combination of beliefs from the fIrst quarter of the 20th century and the political balance 
of forces elicited by the progressive 'specialisation' of medicine. Additionally, in many 
countries the course is divided in two segments. 
In most Brazilian medical schools the first three years ofthe six-year course have a strong 
focus on the 'basic sciences' (anatomy, physiology, etc ... ) while 'professional training' 
of the students occurs in the fmal three years. Most of the teachers involved in the first 
three years are not physicians, whilst most of the teachers of the 'professional training' 
phase are. Such a division creates an extra impediment to curricular changes, because 
these two groups of teachers have different academic backgrounds, and different points of 
view about what a medical student should know. As pointed out by Carraccio e( al. 
(2002), engaging faculty in a major curricular change in a medical school is one of the 
most critical aspects in the success of such a change. 
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This situation does not seem to be an isolated problem of Brazilian medical schools. As 
Whitcomb (2000) states, in a report of the Association of American Medical Colleges 
about ten stories of curriculum change in America: 
Although some schools have been able to introduce a number of structured 
small-group learning exercises into the [mal years of the curriculum, many 
schools, including some that have planned to do so, have not been successful in 
accomplishing even this relatively modest change. The lack of innovation ... is 
almost certainly due to the fact that many members of the clinical faculty do not 
believe that changes are needed. (Whitcomb, 2000, p.5) 
Consequently, just the existence of 'external forces' is not sufficient to entail a successful 
curricular change in medical schools. This 'faculty resistance' to a change may also be a 
factor that may explain the existence of so many 'hybrid' models in the present medical 
schools (Jones et al., 2001). 
The history of medical curricula changes and implementation in the last 30 years is a 
history of some few successes (Davis and Harden, 2003), many partial modifications and 
several unsuccessful attempts (Gilbert, 2002). There seems to be several reasons for these 
different outcomes (Davis and Harden, 2003). However, Spencer and Jordan (2001) 
present an interesting point of view about the possible main obstacle to reforms: 
The ills of healthcare education have long been recognised and it may be argued 
that the slow progress in its reform is due, not only to the lack of institutional 
recognition of the importance of educational innovation and change, but also to 
lack of leadership ... With certain notable exceptions, those who rise to positions 
of authority and influence are appointed because of their expertise and success in 
scientific achievement rather than pedagogical proficiency and vision. (Spencer 
and Jordan, 2001 pp.ii38-ii39) 
Discussing the 'competency model', proposed by the UK Department of Health, Talbot 
(2004) evaluated an important aspect about the 'faculty resistance' to a curriculum 
change. It is the way curriculum designers' beliefs can be very different from the faculty 
beliefs: 
143 
I am not for a moment suggesting that a doctor, at whatever level of training, 
should not be competent in undertaking assigned tasks, but that these 
'monocultural classifications' of competence cause a person to be ' ... only 
understood in terms of sameness and conformity' (*) ... Further, competence is 
not the same as understanding. Understanding brings with it a critical edge and, 
in this era of evidence-based practice, a critical edge is a priceless tool for the 
professional. (* Quoting Garrick, 1998) (Talbot, 2004, p.591) 
It is evident that the 'faculty resistance' to changes is not a position due only to a 
resistance against an external political pressure for a change, but also a genuine concern 
that such a change may have deleterious effects on medical education. Discussing a 
successful curriculum change at the University of Dundee (UK) medical school Davis and 
Harden (2003) report that one of the lessons learned in their successful attempt was that: 
There is a need for the commitment of all staff to the curriculum process. 
Different levels of educational expertise, however, are required. A critical mass 
of staff need to have an understanding of the underpinning educational principles 
and concepts and the educational vocabulary to discuss educational 
developments and to take part in the decision-making processes. Medical staff 
with educational expertise are needed for educational facilities such as the 
clinical skill centre. Professionalism in medical education is needed to support 
the curriculum, the assessment and the staff in their teaching activities. (Davis 
and Harden, 2003, p.607) 
Therefore, one important aspect that is necessary to keep in mind in order to attain a 
successful and enduring curricular change in a medical school is to overcome 'faculty 
resistance'. This can only be accomplished by employing a progressive and time-
consuming process of 'persuasion and enlightenment' about the whole procedure. 
However, such a process of 'persuasion and enlightenment' has to be based in the 
response to a central question: which are the possible changes that are really meaningful 
to medical education outcomes, i.e. the graduated physician? 
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The discussion about the 'possible changes' is as difficult as deciding which is the basic 
structure of the curricula in modem medical schools (see Section 6.2). Actually, what is 
really happening in medical education is a polarisation between 'flexnerian prescriptive' 
models and 'problem-based learning' (PBL) models. The discussion about such a 
polarisation, which has occurred over the last 30 to 40 years (Colliver, 2000), and the 
[mal conclusion about which one of them would be more 'meaningful to medical 
education outcomes', seems far from an end. As Williams and Lau (2004) state: 
Debate has been lively about whether "new" curriculums will actually produce 
better doctors than the old curriculums. Predictably, traditionalists complain that 
medical knowledge is being "dumbed down"; equally predictably, reformers 
claim that liberating students from the drudgery of learning facts will improve 
their problem solving skills. The jury must remain out until the two have been 
adequately compared, although the available evidence indicates that factual 
knowledge is the essential base for developing the problem solving skills of a 
good clinician. (Williams and Lau, 2004, p.93) 
The concern of Williams and Lau is not an isolated manifestation of a specific medical 
school in UK. Colliver (2000), in a systematic review of PBL effectiveness for 
knowledge acquisition and clinical performance, concludes that: 
Despite the claims that the PBL process is based on fundamental educational 
principles and underlying hypothetical mechanisms in a way that should improve 
learning, this review of the research on the effectiveness of PBL curricula 
provides no convincing evidence that PBL improves knowledge base and 
clinical performance, at least not the magnitude that would be expected given the 
extensive resources required for the operation of a PBL curriculum. (Colliver, 
2000, p.266) 
According to Leung (2001), some supporters of the PBL curriculum argue that it would 
be unreasonable to expect that students would do significantly better in a PBL than a 
traditional curriculum when submitted to a clinical performance test. The cause for such 
lack of difference would be that medical students are in a certain way 'selected for 
success in a traditional curriculum' (Leung, 2001, p.306). In fact, according to Lechner 
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(2001) examination results cannot measure deep learning and life-long learning, which 
are important aspects in medical education. 
However, Leung (2001) concludes that although there are several theories to explain how 
the PBL process works as an educational instrument there has been little qualitative 
research about the subject to allow a defInitive conclusion about its effectiveness. 
Furthermore, the 'planned curriculum' of a specifIc medical school can differ from the 
'delivered curriculum' (see Section 6.2), bringing difficulties to the evaluation of which 
was the cause of the 'successful' or 'unsuccessful' outcomes measured at that particular 
school. These differences between the planned and delivered curricula can be very subtle 
or very evident, as exemplifIed in Jones et al. : 
At the University of Washington, for example, "curricular drift" developed 5 
years after a major curricular reform, with both basic scientists and clinicians 
showing regression to the mean in terms of reintroducing teaching topics, and 
expanding teaching time, partly in response to fmancial pressures. At the 
University of Trondheim, Norway, the introduction of a problem-based medical 
curriculum, implemented in 1993, was also compromised by what is described as 
a high degree of autonomy of the individual faculty members and resistance to 
radical change, resulting in a hybrid model of learning methods. (Jones et al., 
2001, p.701) 
Such a behavior of faculty is not an orchestrated phenomenon. It is caused not only 
because they have doubts about the effectiveness of changes, but also because these 
medical educators are foreseeing serious problems to healthcare programs. As William 
and Lau (2004) assert: 
Some medical schools have now largely abandoned formal teaching of basic 
medical sciences, leaving students to explore these crucial areas alone or through 
the poorly suited approach of PBL. No evidence exists that this approach will 
produce better doctors; indeed, new doctors will now risk not knowing enough 
to practise effectively and safely. (Williams and Lau, 2004, p.92) 
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In summary, it seems that 'external forces' by themselves are not sufficient to provoke 
meaningful changes in the present medical curricula. Also, at the moment, it is very 
difficult to evaluate how successful are the changes that are occurring, and if they will 
really mean an advance in medical education. 
Consequently, the answer to the question that is the title of the present section of this 
study (Can we alter the quality of teaching in a medical school by changing the 
curriculum?) is not a straightforward one. Changes in medical curricula are needed due to 
the social and political modifications that are occurring all over the world. However, 
which are the needed changes and how beneficial they will be to medical education is still 
a matter of discussion. 
6.4 Why has the present research shown such a degree of resistance to a 
change, or doubts about its feasibility, among the participants? 
The five medical schools that participated in the present study are from Parana State 
(Brazil). One of them has adopted the problem-based learning (PBL) model in the last 
seven years, while a second one is in a process of adopting a hybrid model using a PBL 
approach in the 'professional training' period of its course. The remaining three are under 
heavy governmental and internal pressure for a change due to the CINAEM report (see 
Section 2.3) and the new Brazilian Unified Health System (see Section 6.2.2). 
The teachers in these schools had suffered or are suffering the traumatic process of 
changing their teaching methods, or have in some cases sincere doubts about the whole 
process of change. The traumatic process of change was well described by Kamien 
(2003), when he narrates the experience of the first nine professors of 'community 
practice' in the Australian medical schools: 
Four of the professors commented on departmental instability due to 
personalities "adept at the art of white-anting" (i.e., undermining). Also, three 
hybrid departments had structural difficulties that led to disagreement about aims 
and resources. One professor described his experience as "cruelly caught 
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between the sociologists on the left and the GPs on the right". (Kamien, 2003, 
p.12) 
Furthermore, several of the teachers in these five Brazilian schools are now facing the 
difficult question of which are the possible changes that are really meaningful to medical 
education (see Section 6.3). For some of them the answer might not be compatible with 
the present intended or performed changes, leading them to an automatic rejection of any 
proposed change, as explained by Bowe et al. : 
However ... sincere intent to change may be short-lived and followed by a 
discouraging return to old behaviors. Failure to sustain the initial resolve to 
change can be misinterpreted as a lack of commitment to one's original goals 
and eventually lead to greater effort expended in rationalizing the status quo 
rather than changing it. (Bowe et al., 2003, p.7l5) 
Considering what was discussed in this section, the findings reported in Chapter 5 
(Section 5.3.3) make sense. Even those teachers that believed that curricular change was 
needed in order to achieve a better transference of knowledge about bias in medical 
research have many plausible reasons to have doubts about the feasibility of such a 
change. 
In the case of the students that participated in the present study, the most reasonable cause 
for their answers about possible curricular changes in their interviews (Section 5.2.3) is 
an effect of the 'hidden curriculum' (see Section 6.2). At the moment, although their 
schools are in a process of changing, the students themselves are focused on one specific 
objective: their specialisation programs. Anything that is not concerned with this specific 
goal will be considered as less important for many of them. This aspect of the 'hidden 
curriculum' will probably survive many years after the 'successful' or 'unsuccessful' 
changes in the 'planned curriculum' oftheir schools. 
The hidden curriculum and the delivered curriculum (Prideaux, 2003) are really important 
in medical schools, and need to be remembered in any attempt to change a specific school 
curriculum. As revealed by Delva et al. (2000) several forces beyond the instructional 
methods of a particular medical school influence medical students learning strategies. 
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According to these authors, the content overload of most medical curricula forces the 
medical students to [md efficient but not necessarily better methods to learn. Delva et al. 
also assert that: 
A second force to be considered is students' perceptions of what is "important". 
Student perceptions of what has value have greater influence on what they do 
than does the instructional context . .. The assessment system is a strong 
indicator of what will be valued and thereby has a powerful effect on student 
learning behavior ... (Delva et at., 2000, p.174) 
Consequently, it seems realistic to admit that proposed changes to medical schools 
curricula may face the overt or veiled opposition of teachers and students. In the case of 
the teachers because they might not be really convinced that change is necessary, and in 
the case of the students because of their beliefs about what will be important for their 
lives as physicians or, more prosaically, what is examined. 
As there is an intense exchange of information between teachers and students inside 
medical schools it is likely that such a combination of interests will be extremely resistant 
to change. Perhaps, the only effective measure to break down such a 'vicious circle' 
would be a long and progressive process of persuasion, rather than a governmental or 'top 
to down' decision about what should be the 'ideal' profile of future physicians. 
6.5 Conclusions 
The question of what should be the basic structure of the curricula in modern medical 
schools is still a matter of discussion. Most of the present medical school curricula are 
adaptations of a basic model developed in the first half of the 20th century. In addition, a 
great debate is occurring at the moment in relation to the possible changes of such 
curricula that can be meaningful for the evolution of medical education. Such debate 
involves political, cultural and internal pressures for a change. The final result (i.e. the 
'modern medical curriculum') is yet to be seen. 
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However, it is clear that any attempt to propose curricular change in order to minimise the 
lack of knowledge about bias in medical research in medical schools will require a very 
careful approach. Any proposal will have to take into account the characteristics of each 
particular medical school. Such characteristics include not only the physical structure and 
resources of each individual school, but also beliefs and aspirations of faculty and 
students. Any attempt to implement curricular change without a careful evaluation of the 
aforementioned individual school characteristics is prone to a less than successful 
outcome. 
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Chapter 7 
The problem of bias in medical research as a reflection of a 
'vicious circle' 
7.1 Introduction 
The problem of the high incidence of bias in medical reseClIch has been considered for a 
long period of time as a methodological problem, as discussed in Chapter 1. From such a 
perspective, besides the evident problem to medical research itself caused by the 
frequency of biased papers, it would also be a potential cause of disruption of modern 
medical education processes such as evidence-based medicine and evidence-based 
learning. Such reasoning about the problem entailed the creation of the most important 
methods of detection and correction of bias, and also provoked the strong reaction of the 
main medical journals against the existence of these alleged 'methodological deviations' 
(see Sections 1.4 and 1.5). Unfortunately, intense efforts over the last 25 years to detect 
eliminate this problem have been less than successful. 
This chapter intends to discuss a different approach to the subject of the present 
prevalence of bias in medical research. Such an approach is fundamentally based on the 
possible existence of a 'vicious circle' which would be responsible for the maintenance of 
high levels of bias despite the present measures adopted for their eradication from 
medical research. The expression 'vicious circle' will be used in this study to represent, 
according to the Oxford Dictionary, 'a sequence of reciprocal cause and effect in which 
two or more elements intensify and aggravate each other, leading inexorably to a 
worsening ofthe situation' (Pearsall, 2001). 
Sections 7.2, 7.3, 7.4 and 7.5 discuss the main elements of such a 'vicious circle' and 
their relationships, and Section 7.6 will focus on possible methods to overcome such a 
situation. 
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7.2 Main components of the proposed 'vicious circle' 
In the first three chapters of the present study several reasons for the existence of bias in 
medical research were discussed. However, as it is common in the existent bibliography, 
most of the time they were discussed as isolated motives for the existence and prevalence 
of bias in medical research. In this section these causes will be examined as elements of 
the 'vicious circle' proposed in Section 7.l.They will be discussed as three interrelated 
subsets of causes for the present prevalence of bias in medical research: 
1- The present structure of modem medical education 
2- The influence of health care related industries in medical education and research 
3- The misuse of medical research methodology. 
This sequence is based on my own perception about the problem, based on a 
bibliographic review (Chapters 1, 2 and 3), the results of my research in five Brazilian 
medical schools (Chapters 4 and 5) and the evaluation of the present curriculum structure 
of medical schools discussed in Chapter 6. It should not be regarded as an immutable and 
predetermined sequence, since the relative importance of each element of the 'vicious 
circle' may differ in different countries and depends on the precise configuration of 
medical research and the kind of sponsorship. However, as will be discussed in the next 
three sections, all three aforementioned subsets of causes are jointly connected to the high 
incidence of bias in medical research, and also to the possible solutions for this problem. 
7.3 The present structure of modern medical education 
The discussion of the results of the present research in Chapters 4 and 5, and the 
evaluation of the curriculum structure of modem medical schools in Chapter 6 showed 
two important aspects of medical education in Brazil and at least some other countries. 
Firstly, it is centred on 'specialisation', despite government efforts aimed to modify such 
a focus. Secondly, that such 'specialisation' has not been associated with a better 
understanding of the issues related to medical research methodological structure and 
problems. 
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Recognising the deficiency of knowledge by physicians of research methodological 
issues, the American Institute of Medicine established in 1991 the Committee on 
Addressing Career Paths for Clinical Research (Whitcomb and Walter, 2000). This 
committee was intended to consider ways of enhancing the quality of training of clinical 
investigators. In its 1994 report (Kelley and Randolph, 1994), the committee recognised 
that few American specialisation programs adequately prepared physicians to undertake 
research involving human subjects. 
In a subsequent evaluation of the problem, Whitcomb and Walter (2000) suggest that 
from the 1400 internal medicine specialisation programs in the USA evaluated in the 
period of 1997-1998 only 170 would be prepared to follow the American Board of 
Internal Medicine recommendations about research training of specialists. It is the 
opinion of these authors that training program directors would face formidable challenges 
to re-structure their programs in order to provide opportunities for students interested in 
careers as medical researchers. 
Although there are no Brazilian data available about the problem discussed in the 
previous two paragraphs, it seems likely that such lack of training about research is also 
happening in the Brazilian specialisation programs. As discussed in Section 6.2.2, the 
educational structure of Brazilian medical schools was adopted as an adaptation of the 
North American model. 
However, it must be remembered that these courses are structured to provide physicians 
with technical clinical training in a specific medical area, and not to prepare them for 
medical research. In fact, these programs may indeed improve the formation of 
technically skilled specialists in several areas of medicine, although they were not 
designed for the formation ofthe 'physician-scientist', or even the 'physician-researcher'. 
This point is well made by Rosenberg (2000): 
Because residency training in internal medicine, either general or subspecialty, is 
designed to train clinicians, it should come as no surprise that it does just that. In 
the past, many programs added training in research to the principal experience of 
preparing expert clinicians, and that, too, was good-as long as the research 
training was rigorous and extensive enough to prepare internists for lengthy 
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careers as physician-scientists. As information in the life sciences relevant to 
health and disease has exploded, however, obtaining the requisite research 
training within a medical subspecialty or even a department has become 
increasingly problematic. (Rosenberg, 2000, pp.831-832) 
The term 'physician-scientist' that I will use in the present discussion was defined by 
Zemlo et al. (2000) as follows: 
... we defme physician-scientists as those individuals holding an M.D. or 
M.D'/Ph.D. degree who perform biomedical research of any type as their 
primary professional activity. We include physician-scientists who are 
conducting basic research (fundamental investigations that do not focus directly 
on patients or their diseases), disease-oriented research (investigations that 
involve the causes and treatments of disease, but do not involve direct contact 
with patients), or patient-oriented research (clinically oriented studies that 
involve physical contact with patients). (Zemlo et al., 2000, p.221) 
Therefore, a 'physician-scientist', according to Zemlo et al. (2000), is a physician whose 
primary professional activity is biomedical research. The term 'physician-researcher' will 
be used here to represent those physicians for whom research is part of their professional 
activity. 
According to the data obtained in five Brazilian schools (Chapters 4 and 5), and the 
conclusions of the CINAEM report (Section 2.3), it is clear that most of the physicians 
involved in research in Brazil can be classified as 'physician-researchers' rather than 
'physician-scientists'. Most of these Brazilian 'physician-researchers' are probably 
involved in medical research despite the fact that they did not receive much formal 
training in medical research methods either in their undergraduate or in their 
specialisation courses. Indeed, the CINAEM report revealed that most of these teachers 
did not possess post-graduation titles (see Section 2.3). 
One of the factors for this involvement by Brazilian 'physician-researchers' in research 
projects despite the lack of formal training to perform them might be pressure from their 
own medical schools. According to the CINAEM report, most Brazilian medical schools 
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reported that the number of published papers and participation in research projects were 
taken into account in the teachers' assessment (see Section 2.3). 
Such a situation may lead, according to Bangdiwala and Munoz (2001), to poorly 
planned, poorly conducted, poorly analysed and poorly presented medical research, which 
situation would be as unethical as recommending an inadequate medication for a patient, 
and does not seem to be an isolated Brazilian problem. 
Discussing the problem of training clinical researchers in biostatistics worldwide in order 
to collaborate as co-investigators in epidemiological studies, Bangdiwala and Munoz 
(2001) offer an interesting overview of the problem. According to these authors, several 
problems happen in these collaborations due to the lack of knowledge about statistical 
methods among physicians and other health professionals: 
Physicians and other health professionals are increasingly aware of their need for 
biostatistical knowledge, not only if directly involved in research activities, but 
also if, as a clinical practitioner, one wishes to keep abreast of advances in the 
field. One alternative for the clinical researcher is to completely rely on a trained 
biostatistician and to blindly accept the answers obtained from such 
collaboration. For the clinicians reading the latest scientific journals in their 
field, this is equivalent to ignoring the methods section of the research articles. 
This is evidently not a healthy approach, for the obvious reason that an 
uneducated researcher is not in a position to critically appraise the literature or to 
effectively collaborate in a research team. (Bangdiwala and Munoz, (2001, 
p.265) 
At the same time that changes in medical education in Brazil and some other countries in 
recent decades seem to be reducing the capacity of 'physician-researchers' to perform 
valid clinical research, or even critically to appraise the medical literature, there is 
evidence of a decline in the number of 'physician-scientists'. In fact, studies about this 
subject in the USA (Rosenberg, 1999; Zernlo et aZ., 2000) and Canada (Honer and 
Linseman, 2004) show a remarkably similar pattern of reduction, indicating that fewer 
young MDs are interested in a career as 'physician-scientist'. 
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Although these authors focus on the fmancial disincentives of a career as 'physician-
scientist', at least Rosenberg (1999, 2000) admits that one of the factors for such a decline 
may be that fewer MDs are being prepared by their training to be capable of becoming 
'physician-scientists' . As Wilkinson and Oddone (2002) state: 
The absence of adequate funding has almost certainly been a major factor, but 
so, too has the virtual absence of programs designed to prepare clinicians for 
clinical research careers. As clinical research has become more complex and 
specialized, formal training is now almost a necessity for those wishing to 
acquire the quantitative and methodological skills necessary to pursue a career in 
clinical research. (Wilkinson and Oddone, 2002, p.99) 
It is interesting to remember at this point one of the conclusions of the qualitative analysis 
of the data of the present study (Section 5.3). It was concluded that the lack of knowledge 
among Brazilian physicians and researchers about the correct methodological approach to 
medical problems apparently had its roots in undergraduate medical courses. The 
discussion in this section of the international situation concerning the issue seems to 
validate that conclusion. 
In summary, the modifications of medical education in recent decades in a number of 
countries have triggered a 'drift ' towards a more 'technically-based' professional 
structure for the production of clinicians, which is transforming the graduate physician 
into a somewhat uncritical consumer of medical research. Further, such modifications 
have entailed a progressive reduction in the number and influence of the 'physician-
scientists' and their replacement by the 'physician-researchers' , a less than ideal 
substitution at a time of progressive sophistication of medical research methodology. 
Such modifications, although possibly enhancing the technical skills of physicians, also 
reduced their capacity for clinical judgement and decision-making (Coulehan and 
Williams, 2003). According to Coulehan and Williams: 
... many physicians are neither aware of the "best evidence", nor how to access 
it, nor how to use it; nor do they utilize basic concepts of probability, utility, 
risk, and benefit in everyday practice. In other words, the popular assumption 
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that modem medical practice must be scientific is questionable, because 
"scientific" implies the use of high-quality data and a logical decision process 
that are often absent. (Coulehan and Williams, 2003, p.8) 
As will be discussed in the next section, such characteristics of today's physicians and 
'physician-researchers' facilitated the present influence of the pharmaceutical industry on 
medical education and research. 
7.4 The influence of the pharmaceutical industry on medical education 
and research 
In Section 2.4 the problem of the relationships of the pharmaceutical industry with 
medical research and continuing medical education was discussed as one of the factors 
that influence the existence of bias in medical research. Although pharmaceutical 
companies are participants in a global set of health care related industries they are 
undoubtedly a most important influence on medical education and research. It will be 
shown in this section how the influence of such industries contributes to the proposed 
'vicious circle' responsible for the unacceptable incidence of bias in medical research. 
It must be stressed that I fully recognise, as most physicians do, the importance of 
pharmaceutical industries in the development of many life-saving and life-enhancing 
therapies, especially in the second half of the 20th century. However, as usually happens 
with the powerful medications these industries produce, such a success was accompanied 
by many deleterious 'side-effects', especially upon medical education and medical 
research. As stated by Antonuccio et aZ. (2003): 
The pharmaceutical industry has contributed to many life-saving innovations in 
medicine and has become one of the most successful industries in the world. As 
a result, pharmaceutical industry financial and marketing influences extend to 
federal regulatory agencies, professional organizations, medical journals, 
continuing medical education, scientific researchers, media experts, and 
consumer advocacy organizations. These extensive influences have created 
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conflicts of interest that have undermined the credibility of medical research and 
education. (Antonuccio et at., 2003, p.1 028) 
The fmancial and political power of the pharmaceutical industry is undeniable. According 
to Abraham (2002) their sales are estimated in US$130 billion in the USA and UK£7 
billion in the UK. Worldwide, these industries generate an annual revenue of more than 
US$400 billion and spent, just in the USA, more than US$19 billion in advertising in 
2001 and US$200 million in lobbying and political campaign contributions over the two 
years 1999 and 2000 (Antonuccio et at., 2003). The effect of such a fmancial and political 
power upon medical research have been so intense that DeAngelis et at. (2001) estimate 
that 70% of all clinical drug trials in the USA are directly or indirectly fmanced by 
pharmaceutical industries. 
Pharmaceutical companies are commercial corporations that depend on their revenues and 
profits to survive and grow. It should not be a surprise that they are using their profits to 
do exactly that. In a perfect world their interests would converge with medical education 
and medical research to meet the needs of public health. Unfortunately, as will be 
discussed further below, the interests of pharmaceutical companies, medical education 
and medical research seem to be progressively diverging from the this ideal objective. 
To explain such a divergence, the influence of the pharmaceutical industry upon the 
individual physician and the present structure of medical education and research must be 
evaluated. 
7.4.1 Physician-industry relations 
The relationships between pharmaceutical companies and practising physicians are 
notorious even for those who are not directly involved in medical practice. As discussed 
in Section 2.4.2, doctors and the pharmaceutical industry are entangled in a ubiquitous 
and controversial web of interactions (Moynihan, 2003). 
As could be expected, this kind of 'partnership' seems to be heavily in favour of the 
stronger 'partner': 
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The medical profession has largely abdicated its responsibility to educate 
medical students and doctors in the use of prescription drugs. Drug companies 
now support most continuing medical education, medical conferences and 
meetings of professional associations. (Angell, 2004, p.1452) 
Angell (2004) also asserts that physicians pretend to believe that drug companies can 
provide objective information about their own products. She believes that it would be a 
self-evident absurdity to consider that medical professionals perceive investor-owned 
companies as producers of impartial and critical evaluations about their products. In fact, 
she states that the answer is that these companies are 'paying' these physicians with 
continuing medical education credits, perks and free lunches. 
However, is such a judgement consistent with the evidence discussed in the present 
study? Would it be really 'a self-evident absurdity' that these physicians are behaving like 
that? My answer to both questions is 'no'. The fundamental reason might be that many of 
these physicians have been transformed into uncritical consumers of the results of 
medical research by the present structure of medical education, as discussed in Section 
7.3. 
Although physicians themselves believe that marketing strategies of the pharmaceutical 
industry do not affect them, there is evidence that such strategies do have an influence on 
physician objectivity and behaviour (Coyle, 2002; Breen, 2004). The importance of the 
combination of such a lack of awareness of physicians about the problem and the present 
influence of the pharmaceutical companies is well summarised by Breen (2004): 
It is a significant ethical failing to aspire to such independence (professional 
independence) and to the respect and trust that underpin an effective doctor-
patient relationship while wilfully or ignorantly denying the evidence that the 
pharmaceutical industry does affect our prescribing behaviour ... Most doctors 
seem to genuinely perceive they are immune to such influences, seeing 
themselves as acting only on the best available evidence in the interests of their 
patients ... These issues are not new, but their significance has increased in 
parallel with the growth of the size, power and influence of the pharmaceutical 
industry. (Breen, 2004, p.4l 0) 
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Obviously, this situation becomes even worse when it involves marketing production 
presented as 'scientific evidence', which these physicians are not equipped to correctly 
appraise (Wazana, 2000) (See also Sections 4.4 and 5.3). 
The issue of the structure of present continuing medical education (CME) seems to be 
even more relevant for our discussion. As discussed in Section 2.4.2 the influence of 
pharmaceutical companies upon CME is evident. Whether such an influence is a positive 
or negative one to practising physicians is still a matter of discussion, although much of 
the evidence supports the idea of a negative influence. An example of such debate can be 
better visualised by the opposing opinions published in an important medical journal (the 
Journal of the American Medical Association): 
The pharmaceutical industry has gone too far. It is assuming a role in continuing 
medical education (CME) that is inappropriate for an industry with a vested 
interest in selling prescription drugs ... As a result, CME is now so closely 
linked with the marketing of pharmaceuticals that its integrity and credibility are 
being questioned. The problem is not new, but it has recently grown to alarming 
proportions. (ReIman, 2001, p.2009) 
Industry-supported conferences, seminars, and symposia are helping physicians 
to provide the best, most appropriate, and most up-to-date health care of their 
patients . .. Patients are the ultimate beneficiaries of industry-supported CME, 
and patients ultimately experience the consequences if physicians are not fully 
informed about the latest medical advances. (Holmer, 2001, p.2012) 
The quoted opinion of Holmer (2001) seems at first sight really sensible. Considering that 
pharmaceutical companies are directly or indirectly involved in most present medical 
research (as will be discussed in Section 7.4.2), these industries seem to be 'the best, most 
appropriate, and must up-to date' source of reliable medical information. However, 
evidence shows that this might not be exactly true. 
In the last two decades pharmaceutical companies have been focusing on the development 
of the so called 'me-too' drugs. 'Me-too' drugs are minor variations of the existing drugs 
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that are highly profitable to pharmaceutical companies (Angel, 2004). These profits are 
due to the fact that small variations in the structure of an existing drug allow these 
companies to continue to have exclusive rights over these medications after their rights on 
the older drug have expired. In order to make profits on such drugs it is required that 
physicians prescribe them. 
The most important problem with the aforementioned drugs is that: 
There is generally no good reason to believe that one me-too drug is better than 
another, since they are seldom compared head-to-head at equivalent doses in 
clinical trials. Instead, they are tested against placebo, and so all we know is that 
they are better than nothing. In fact, it's conceivable that, within me-too families, 
each successive drug is actually worse than the one before. Without suitable 
comparative testing, we'll never know. (Angell, 2004, p.1451) 
According to the U.S. Food and Drug Administration (FDA) Center for Drug Evaluation 
and Research (2004), from 1998 through 2003, 487 drugs were approved by the FDA. Of 
these 487 drugs, only 67 (14%) were considered as being new or improved compounds. 
The remaining 420 (86%) were classified as having therapeutic qualities similar to 
currently marketed drugs, or were new formulations (or combinations) of old ones. 
Consequently, it seems feasible to conclude that the 'latest medical advances' cited by 
Holmer (2001) are not so outstanding. In fact, the pharmaceutical industry is apparently 
using its financial power to dominate CME in order to do a disguised marketing of their 
'me-too' drugs (Angell, 2004). This kind of approach would be extremely profitable to 
pharmaceutical companies, as the cost of the development of a 'me-too' drug is 
considerably less than the development of a really new product. 
Actually, it seems that the described interdependence between physicians and the 
pharmaceutical industry constitutes the first 'loop' of the proposed 'vicious circle' 
(Section 7.1). Physicians believe that they are receiving the 'best evidence' and the 
pharmaceutical industry is providing such 'best evidence' which physicians are not able 
to appraise critically. As these companies are 'rewarded' with greater profits they 
enhance their influence. 
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A sensible question at this point would be: 'Physicians are intelligent professionals, is it 
possible that they are not aware of such a situation?'. Shaughnessy and Slawson (1999) 
have an interesting opinion about this issue: 
Educators faced with adult learners who are overwhelmed with information yet 
underskilled in learning are caught in a paradox. On the one hand, adults are self 
directed and make their own decisions, from what to eat to what to learn. This is 
the psychological characteristic that differentiates them from children. Yet when 
these adults are placed in a learning environment, they immediately revert back 
to the role into which they were conditioned by the pedagogical model - that of 
passive dependency ofthe teacher. (Shaughnessy and Slawson, 1999, p.1280) 
It seems that the pharmaceutical companies are not only aware of such characteristics but 
are efficiently using them for their benefit. 
Of course, the proposed 'loop' would eventually vanish if pharmaceutical companies 
could not control the 'evidence' they use in their contacts with physicians and in their 
CME programs. This will be the subject matter of Section 7.4.2. 
7.4.2 Physician-industry relations associated with the 'physician-researcher' 
In Section 2.4.1 the influence of pharmaceutical industry on the production and 
dissemination of medical research outcomes was briefly discussed. Such a discussion 
focused mainly on one specific problem: the possible influence of the pharmaceutical 
industry in the present incidence of publication bias in medical research. It was also 
suggested in Section 2.4.1 that such a problem might be caused by the direct influence of 
the pharmaceutical industry upon medical researchers, as was illustrated by the quotation 
of Garland (2004) about her problems with a particular pharmaceutical industry 
sponsorship. 
The aim of this section is to deepen such a discussion. It will focus on how (and how 
much) these relationships between the pharmaceutical industry and the 'physician-
researchers' might be related to the growing number of cases of overt and veiled scientific 
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misconduct in medical research. Furthermore, this discussion intends to show the 
importance of the pharmaceutical companies interference on present medical research, 
aimed at the production of 'evidence' used for the marketing processes oftheir products. 
When discussing medical research problems people usually remember cases of outright 
fraud. However, although such cases are important, and have more impact on the media, 
they are probably nearly always, particularly if they pertain to important matters, sooner 
or later unveiled in a 'healthy' and 'peer-reviewed' research structure, not only in 
medicine but also in other fields of knowledge. In fact, in the long run the most important 
and damaging aspects of scientific misconduct are generally those which do not configure 
an overt fraud, but remain unveiled causing long-lasting effects upon scientific 
knowledge, undermining the reliability and credibility of science in a specific area. 
Unfortunately, as will be discussed in this section, medical research seems to have been 
plagued by both overt fraud and such broader instance of scientific misconduct in recent 
decades, probably to an extend never before seen. This situation can be fatal to an area of 
science that is based essentially on trust. Trust is the basis of the physician/patient 
relationship and also ofthe physician/medical research relationship. 
Horton (2001), in discussing a 1998 international medical statisticians' survey, presents 
an appalling glimpse of such a situation: 
A survey of 442 medical statisticians, completed in 1998, obtained a 37% 
response rate. Despite this poor return, half of all respondents knew of at least 
one fraudulent project done in the previous 10 years. Forty-three (26%) 
statisticians reported fabrication and falsification; 32 (20%) described deceptive 
reporting of data; 31 (19%) knew of data suppression; and 16 (10%) were aware 
of instances of deceptive design and analysis. Worse still, 30% of this sample 
had engaged in a fraudulent project. (Horton, 2001, p.594) 
Most medical statisticians are not physicians. They have become indispensable in many 
projects within the present medical research structure essentially due to the progressive 
sophistication of research methods and the (already discussed) lack of knowledge about 
research methodology ofthe 'physician-researcher' (Section 7.3). 
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One could argue that 'physician-researchers' involved in the aforementioned disturbing 
proportion of scientific misconduct may have been driven to produce such studies in 
order to obtain academic or professional prestige. However, this is not the case for the 
statisticians who are often not mentioned as authors in medical studies. What could be the 
forces that are impelling these professionals to collaborate in such projects? 
The answer to such a question may not be as straightforward as most people might 
believe. Such behaviour of medical statisticians and 'physician-researchers' seems to be 
connected with a less discussed aspect of present medical research that Rettig (2000) 
called 'the industrialisation of medical research'. Rettig (2000) used this expression to 
describe the effect in the last 25 years on medical research of companies specialising in 
the design of medical trials, recruitment of physicians and patients, analysis of data and 
reporting of results that are connected to the pharmaceutical industry. In this discussion I 
will show that such 'industrialisation' is becoming more pervasive, and that the 
boundaries between these companies and academic research seems presently rather 
blurred. 
These 'contract research organisations' (CROs) (Rettig, 2000, p.134) were initially 
important to pharmaceutical companies in the USA essentially to provide the 
pharmaceutical industry with the 'evidence' needed for the U.S. Food and Drug 
Administration approval of their drugs. However, they became increasingly more 
influential and internationalised. In 1999 there were at least 550 American and foreign-
based CROs according to Rettig (2000). As stated by Rettig they are now involved in: 
Clinical trial management services for all phases (which) include project 
management, study and protocol design, case report form development, clinical 
database design, data entry and verification, data management, statistical 
analysis and reporting, investigator and site selection, healthy volunteer and 
special population recruitment, investigator meetings, clinical monitoring, 
centralized clinical trial laboratory, bioanalytical and clinical chemistry 
laboratory services, pharmacokinetics and pharmacodynamics, expert report 
writing, and regulatory applications. (Rettig, 2000, p.137) 
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An example of the 'efficiency' of the present work of these 'contract research 
organisations' can be evaluated in the quotation of Teacher-84 in Section 5.2.2 (page 
122). Equally, the influence of such organisations upon medical research is indicated by 
the disclosure that one of them (Quintiles Transnational Corporation) reported a net 
revenue ofUS$I.19 billion in 1998 (Rettig, 2000). 
There are many possible ways to appraise this problem. However, I would like to focus 
on four aspects of the above quotation: 'study and protocol design', 'investigator and site 
selection', 'statistical analysis and reporting' and 'expert report writing'. It will be shown 
that the purposive manipulation of the four mentioned components of medical research 
may entail the production of 'tailored' evidence. Such 'evidence' may be used for a range 
of outcomes, from 'proving' the efficacy of a treatment to providing the 'best evidence' 
to a continuing medical education guideline. 
It is necessary to stress that the proposed manipulation suggested in the preceding 
paragraphs may vary from an overt control over the four mentioned aspects (which is 
probably a rare occurrence) to a more subtle and insidious influence. For instance, one 
can choose an 'investigator and site' that may be more prone to allow some adaptations of 
the 'study and protocol design', and selectively sponsor such research. Subsequently, this 
investigator may accept some help in the 'statistical analysis and reporting' ofherlhis data 
and the help of some 'expert report writing' in order to adequate his/her paper to the 
publication in a prominent medical journal. 
Although such a kind of reasoning may seem a personal opinion, it is underpinned by the 
existing international evidence about the subject and by the data of the present study (see 
Section 5.2.2). 
Some characteristics of the present physician and 'physician-researcher' are important to 
the present discussion. In Section 3.3 some evidence about the possible connection 
between the unethical behaviour of researchers and the existence of bias in medical 
research was discussed. One of the points discussed was that some authors believed that 
medical students were considering unethical behaviour as a morally acceptable conduct. 
In fact, according to Coulehan et al. (2003): 
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We have argued elsewhere ... that the failure of medical education to focus on 
producing good doctors, rather than simply on producing good technicians, is an 
ethical failure ... Medical students, house officers, and practising physicians 
report that they receive little, if any, explicit training in professionalism, and 
many believe that they become less humanistic and more cynical as their 
education progress ... (Coulehan et al. 2003, p.22) 
Coulehan et al. (2003) believe that there is an even more important ethical deficiency. 
According to them, medical students and physicians have an imperfect development of 
the notion of moral responsibility towards the community in which they live caused by 
the non-reflective professionalism engendered by the present medical education. This 
means that these students and physicians would not be able to consider that they have a 
social responsibility that goes beyond good patient care. Considering that the present 
'physician-researcher' is fundamentally a specialist for whom the act of doing research is 
only part of his/her daily activities (see Section 7.3), this lack of social responsibility is 
particularly worrisome. 
Good science is essentially based on the social responsibility of scientists. If some of 
these 'physician-scientists' lack the moral basis that underpins social responsibility, they 
would be prone to accept uncritically 'modifications' in their research, if such 
'modifications' could entail personal or professional advantages. They would become the 
perfect selection for the aforementioned 'contract research organisations'. 
Consequently, such subversion of the 'physician-researcher' moral reasoning towards 
his/her research project and aims is an important and essential step towards the 
production of 'tailored' medical evidence. The successive steps entailing the 
manipulation of the 'statistical analysis and reporting' and the effect of the 'expert report 
writing' ('ghostwriting') will be discussed in the next few paragraphs. 
Most, although not all, of the problems of 'tailored' medical research occur in clinical 
trials. It is important to remember that Section 1.3 showed that most biased data analyses 
in such studies are due to lack of statistical knowledge or to intentional manipulation of 
data or results (Mills, 1993). Considering that current medical education in many medical 
schools is not providing students with the necessary skills to deal with the statistical data 
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analysis required in today's medical research (see Chapters 4 and 5), and that the 
'contract research organisations' all too often exist to 'prove' pre-determined 
assumptions, it is not difficult to understand why so many studies show biased results. 
The problems of research structure and data analysis of present medical research are so 
important to the future of medical science that they will be discussed in more detail in 
Section 7.5. 
Finally, there is the problem of 'ghostwriting', euphemistically described as 'expert report 
writing'. The conclusion of a 1996 survey among 809 authors (69% response rate) of 
papers published in three peer-reviewed large-circulation and three peer-reviewed 
smaller-circulation American journals carried out by Flanagin et al. was: 
In conclusion, our study demonstrates that a substantial proportion of articles in 
peer-reviewed medical journals have honorary authors and ghost authors. The 
fmdings also show that the ICMJE (International Committee of Medical Journal 
Editors) authorship guidelines may not be well understood by all authors 
(Flanagin, et al., 1998, p.224) 
Despite these conclusions, and the effort of medical journals worldwide, this question of 
authorship seems still unsolved. 
A good summary of what has been discussed in the previous few paragraphs is the 
opinion of 13 medical journal editors about the matter: 
As CROs (contract research organisations) and academic medical centres 
compete head to head for the opportunity to enrol patients in clinical trials, 
corporate sponsors have been able to dictate the terms of participation in the 
trial, terms that are not always in the best interest of academic investigators, the 
study participants or the advancement of science generally. Investigators may 
have little or no input into trial design ... and limited participation in data 
interpretation ... These terms are draconian for self-respecting scientists, but 
many have accepted them because they know that if they not, the sponsor will 
find someone else who will ... There have been a number of recent public 
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examples of such problems, and we suspect that many more go unreported. 
(Davidoff et a!., 2001, p.786) 
In fact, medical journals and their editors, according at least to the participants of the 
present study (see Section 4.3), would be the last possible avenue for deterring this 
'flood' of manipulated medical information which is been caused by the so-called 
'conflicts of interests' pervasive in present medical research. However, according to 
Richard Smith, editor for 25 years of the British Medical Journal, this is not happening: 
Journals didn't begin to think about conflict of interest until the 1980s, and even 
the most "advanced" journals didn't actually implement policies until after the 
millennium. Most journals still don't have policies. Yet substantial evidence has 
accumulated on the powerful influence of conflicts of interest, and it is at least 
arguable that medical journals are more an extension of the marketing arm of 
pharmaceutical companies than independent scientific forums. (Smith, 2004, 
p.243) 
At this point I believe that the evidence presented shows the existence ofa second 'loop' 
of the 'vicious circle' proposed in Section 7.1, involving the relationships between 
medical education and bias in medical research. Such a 'loop' was created and is being 
maintained by the deficiencies of medical education and the powerful influence of 
pharmaceutical industries upon medical research and the 'physician-researcher'. 
7.5 The problems of the misuse of medical research methodology 
The strengths and weakness of randomised controlled trials (RCTs), along with some of 
their intrinsic methodological problems, were discussed in the Sections 1.3, 1.4 and 2.2. 
However, such a discussion focused essentially on the technical aspects of their use in 
present medical research. 
This section will present the approaches that are used by some researchers and contract 
research organisations (CROs) to exploit such weaknesses and intrinsic methodological 
problems ofRCTs in order to produce and publish biased 'evidence'. It will also examine 
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how such biased 'evidence' is being used to maintain and reinforce the 'vicious circle' 
proposed in Section 7.1. 
As discussed in Section 1.4, probably the most studied form of bias in medical research is 
publication bias and its various ways of influencing medical knowledge. The real effect of 
such bias has been difficult to evaluate precisely due to the fact that it was problematical 
to unearth the unpublished or duplicated papers about a specific medical procedure or 
treatment. 
However, an elegant and recent paper by Melander et al. (2003) may shed some light not 
only upon the problem of publication bias but also upon the incidence and importance of 
the manipulation of data in medical research and the problem of authorship. These 
authors had the rare opportunity of following up the destiny of 42 short-term placebo 
controlled clinical trials that were submitted by pharmaceutical companies to the Swedish 
drug regulatory authority as a basis for marketing approval for treating depression. 
These 42 clinical trials were related to five selective serotonin reuptake inhibitors 
approved in Sweden between 1989 and 1994. Melander et al. (2003) were not only able 
to track down how they were subsequently published in medical journals, but also to 
compare the results ofthese papers published between 1983 and 1999. 
According to Melander et al. (2003): 
In a cohort of studies ... we found evidence of duplicate publication, selective 
publication, and selective reporting. There was a high frequency of duplication 
due to the inclusion of different subsets of studies in several pooled publications 
... Although both intention to treat analyses and per protocol analyses were 
available in the submission to the regulatory agency, only 24% ofthe stand alone 
publications reported the usually less favourable intention to treat results. In our 
material this selective reporting was the major cause for bias in overall estimates 
based on published data. (Melander et aI., 2003, p.1173) 
This kind of manipulation of data presentation is much more subtle and difficult to 
uncover than the simple statistical manipulation of data discussed in Section 1.3. It would 
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be extremely difficult for a medical journal editor to figure out that the paper submitted 
for his/her approval was based on a 'selected' data analysis. This is especially true when, 
as declared by Smith (2004), the number of paper submissions to the British Medical 
Journal reaches the fantastic number of 8000 a year, a figure that is probably not that 
different to that for other major medical journals. 
There are several reasons for such kinds of behaviour of the 'physician-scientists', as 
discussed in Section 7.4.2. However, Melander et al. (2003) propose one particularly 
interesting and disturbing explanation: 
All the studies in our investigation were initiated by the sponsor, and the 
investigators were usually clinical practitioners for whom academic research was 
not the primary interest. Hence, the decision of how and whether a study should 
be published was probably left entirely to the sponsor. (Melander et al., 2003, 
p.1174) 
These authors consider that to rely only on published data to choose a specific drug for 
depression may be difficult due to the biased evidence that presently exists in the field. 
They also suggest that a choice of a specific selective serotonin reuptake inhibitor based 
on a pooled analysis of publicly available data is not likely to be supported by an analysis 
considering the total body of evidence. 
The process of the manipulation of results and the publishing methods of research 
described above has the clear aim of creating a body of biased evidence strongly 
favouring the use of these drugs in medical practice. According to the data presented by 
Melander et al. (2003), the authors of these papers are behaving as 'ghost-authors' used 
mainly to create an aura of respectability which will permit the use of such papers in overt 
marketing of the drugs to the practising physician, or as part of the pharmaceutical 
industry's CME programs. 
As independent researchers focus on the subject there will possibly be a progressive shift 
of the evidence towards the real effects, including side effects, of the drugs in question. 
However, since these researchers work with more restricted resources and do not have the 
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technical support of the CROs, it may take years (if it ever happens) before the real 
effects of such drugs are unveiled. 
Although lacking the strong connection between the incidence of selective reporting bias 
and the pharmaceutical industry which is evident in Melander et aZ.'s (2003) paper, Chan 
et aZ. (2004a, 2004b) report similar problem in their studies in Canada and Denmark. 
According to Chan et al. (2004b): 
The reporting of trial outcomes is not only frequently incomplete but also biased 
and inconsistent with protocols. Published articles, as well as reviews that 
incorporate them, may therefore be unreliable and overestimate the benefits of 
an intervention. (Chan et aZ., 2004b, p.2457) 
A second, although no less important, problem is caused by the use of the results of 
clinical trials as an expression of the real effects of drugs or procedures in a population. 
As discussed in Section 2.2, the external validity of isolated trials has been severely 
criticised (Gross et aI., 2002), especially due to the fact that the inclusion or exclusion 
criteria of participants in these studies may impede the generalisation of trial results to 
'real life' (Kennedy et aZ., 2003). 
Actually, Dieppe et al. (2004), discussing the problem of the use of non-selective non-
steroidal anti-inflammatory drugs (NSAlDs) based only on the 'evidence' presented by 
published clinical trials, declare in their summary that even high quality scientific 
evidence from drug trials may not be generalised to the whole population. This situation 
would be caused, according to these authors, due to the fact that: 
Minority groups and older people are often excluded from the trials. 
Drugs tend to be used for a wider range of indications than those for which they 
were trialed. 
People at risk of adverse events are often deliberately excluded from the trials. 
Benefits and harms of drugs are not measured on comparable scales. (Dieppe et 
aI., 2004, p.31) 
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In fact, the large-scale adoption of new NSAIDs by Australian general practitioners 
described by Kerr et al. (2003) is a good example of a hasty and uncritical therapeutic 
'shift'. According to these authors, in this particular case such a 'shift' was probably 
based on the 'evidence' provided by the pharmaceutical companies: 
A number of lessons can be gleaned from the Australian experience of large-
scale early adoption of celecoxib and rofecoxib by GPs. Intense drug promotion 
can create perceptions about medications that strongly influence patterns of 
prescribing and use, yet may not be in line with best available evidence. Further, 
such rapid uptake can place patients at risk of adverse drug reactions and serious 
drug interactions through coprescribing. (Kerr et al., 2003, pA07) 
According to Kerr et al. (2003) the increase in the number of prescriptions of these drugs 
in Australia coincided with two marketing campaigns of the pharmaceutical companies. 
One of these campaigns focused on the medical profession, promoting the message that 
these new drugs were 'safer' than the traditional NSAIDs, despite the fact that the studies 
available did not show that the adverse events profile of these drugs was much different 
from the traditional ones. The second marketing campaign focused on the consumers 
through television and newspaper promotion of celecoxib. 
In fact, the studies of Kerr et al. (2003) and Dieppe et al. (2004) are directly related to the 
fmdings of Melander et al. (2003). They ultimately illustrate how the misuse of the 
medical research methodology may be used to create and promote biased 'evidence', and 
to disseminate such biased 'evidence' to physicians and patients. Furthermore, this biased 
information may, intentionally or unintentionally, act as a 'contaminant' of the continuing 
medical education programs, reinforcing the two 'loops' of the proposed 'vicious circle' 
connecting medical education and the present incidence of bias in medical research as 
discussed in Section 7.4. 
The issue of how (and how much) such marketing approaches of pharmaceutical industry 
are affecting medical students is still a matter of discussion. According to Rogers et al. 
(2004): 
172 
There is no published research comparing the attitudes and prescribing habits of 
students exposed to pharmaceutical representatives during medical schools with 
those protected from such influences. However, there is evidence that limiting 
pharmaceutical industry contacts during postgraduate training produces 
specialists who perceive drug company information as less useful ... (Rogers et 
al., 2004, p.412) 
Research on this specific topic would probably be extremely useful to underpin future 
discussions on the possible solutions for the problem of bias in medical research and its 
relationships with medical education. 
7.6 Possible solutions for the problem of bias in medical research 
As illustrated in Sections 7.2, 7.3, 7.4 and 7.5, the acceptance of the hypothesis about the 
existence of a 'vicious circle' (Section 7.1) connecting medical education, medical 
practice, medical research and the pharmaceutical industry makes it easier to perceive 
how these elements are related to the present incidence of bias in medical research. Such 
acceptance also facilitates the discussion of possible solutions to the problem, irrespective 
of the differences that exist among countries and medical educational methodologies. 
However, to accept that such a 'vicious circle' really exists also entails the recognition 
that no isolated action focused on only one subsidiary element of its structure will be 
really successful. 'Vicious circles' have the characteristic of restructuring themselves 
using alternative pathways when submitted to isolated corrective actions that do not focus 
on its core structural element. In fact they may even become stronger and more difficult 
to eliminate, as these alternative pathways may be more sophisticated and intricate than 
the initial ones. 
A possible example of such a problem is the opinion of Douglas Altman (Altman, 2002) 
about the modifications that occurred in medical research since his editorial in the British 
Medical Journal in 1994 (Altman, 1994), which was discussed in Section 2.1. In his 2002 
paper he declared that he suspected that many basic errors of medical research were less 
common in 2002 than in 1994; however, he also stated that he believed that there was 
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evidence of frequent misapplication of the newer advanced statistical techniques ill 
medical research. This is exactly what one should expect from a 'vicious circle' as 
suggested in the previous paragraph. The adoption by the major medical journals of the 
CONSORT statement (see Section 2.1) elicited a sophistication in the structure of 
medical research methodology and reporting but did not eliminate the existence of bias in 
medical research. 
However, ifthe basic cause of the present disarray in medical research is not based on the 
research methodology employed in medical studies, what could be the main element of 
the proposed 'vicious circle' that should be blamed for such a situation? 
Based on the discussion of the three main subsets of causes for the prevalence of bias in 
medical research (Sections 7.3, 7.4 and 7.5) and the results of my research in five 
Brazilian medical schools (Chapters 4 and 5), I believe that it is possible to put much of 
the blame for the current level of bias in medical research on the present medical 
education structure. In the next few paragraphs I will suggest how the present structure of 
medical education, based on a progressive 'specialisation', combined with a low level of 
ethical development of medical students and physicians can be considered as the core 
element of the proposed 'vicious circle' . 
As a physician and teacher I would prefer to blame, as many do, the evident influence of 
the pharmaceutical industry on the behaviour of individual physicians, 'physician-
researchers' and 'physician-scientists' and on the structures of continuing medical 
education programmes and evidence-based medicine. However, although such 
interference is undoubtedly present and important it cannot explain why so many 
physicians, medical researchers, medical educators and medical policy makers accept 
such interference without questioning its ethical basis. 
Pharmaceutical companies are legal producers and sellers of drugs worldwide. 
Consequently, as with other legal industries, they are entitled to promote and sell their 
products, and seek for profit in such endeavour. However, it is not feasible to equate 
commercial ethics and medical ethics. The ethical principles employed by the physician 
are (or should be) based on the suppression of self-interest (Allman, 2003), and such 
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suppression would evidently be suicidal to a profit-based industry. According to Allman 
(2003): 
Suppression of self-interest is an essential activity for the physician ... It is a 
central element of the act of profession described by Pellegrino and Thomasma, 
wherein the physician offers to help the patient, promises to be competent, to act 
in the patient's interest, to restrain his self-interest, and not to violate the 
patient's trust. (Allman, 2003, pp.156-157) 
Consequently, in this discussion no further efforts will be made to compare such different 
ethical principles or to justify such fundamental ethical differences. They are simpiy 
different and will remain like that so long as pharmaceutical companies continue to be 
profit-based organisations and physicians continue to be members of a profession that 
abdicates self-interest. As will be discussed in the next few paragraphs, the complete 
disentanglement of medical practice, research and education from the present influence of 
the pharmaceutical industry is one of the basic steps towards the solution of the problem 
of bias in medical research. 
At first glance, the proposition of such disentanglement may seem preposterous and too 
radical. However, one must remember that medicine has endured with success similar 
educational and ethical challenges in its history, as was the case in respect of antisepsis 
and vaccination in the 19th century. 
In order to discuss the feasibility and ethical basis of the proposed disentanglement, I will 
divide this discussion in three main areas: 
1. The medical student and the practising physician 
2. The present problems of medical research 
3. The challenges to continuing medical education. 
7.6.1 The medical student and the practising physician 
The relationships between pharmaceutical companies and practising physicians were 
discussed in Section 7.4.1. This section will discuss the ethical problems involved in such 
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relationships, which are the real motive that underpin the proposal for a complete 
cessation of these relations between physicians and pharmaceutical representatives. 
Although there has been, according to Rogers et al. (2004), little debate about the ethics 
of the pharmaceutical industry's relationships with medical students, I shall demonstrate 
that the reasoning behind arguing that such contacts inside medical schools need to be 
eliminated is based on the same principles that apply to the pharmaceutical industry's 
relationships with practising physicians. 
The basic problems of relationships between physicians and the pharmaceutical industry 
were discussed in Section 7.4.1 where it was argued that these contacts are not occurring 
f()1" the benefit of the physicians' medical skills, but due to the pharmaceutical industry's 
marketing strategies. Consequently, these contacts are not only unnecessary but also 
deleterious, and should be disapproved of and terminated. 
However, there is an even more important aspect to the relationship between physicians 
and pharmaceutical representatives. This is the question of the common habit of 
physicians to expect pharmaceutical representatives to provide trinkets, perks, free 
lunches, trips, continuing medical education credits, etc. Allman (2003) states that: 
Ostensibly cheap favours are given by friendly representatives, usually with a 
pitch for the product du jour ... Acceptance of these modest gifts seem 
inconsequential; experience suggests otherwise '" How much they really cost is 
unclear; that they are given at such expense to the pharmaceutical manufacturer 
suggest that they alter physician behaviour. (Allman, 2003, p.1S7) 
One may argue that there is no problem here. All legal industries worldwide make some 
direct advertisement to their consumers using such strategies. The real problem behind 
such strategies of pharmaceutical companies is that they are being used not to convince 
the ultimate consumers (the patients) but the physicians. Such a kind of marketing 
transforms the physician into a disguised remunerated promoter of drugs, which is 
ethically unacceptable. In fact, the fmal consumers (the patients) are those who are 
subsidising such expenditures. According to Allman (2003): 
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The receipt of such emoluments serves only the physician's interest and may be 
counter to that of the patient, and thus violates the act of profession. Justification 
for such behaviour rests on an unstated, inescapable, but fragile assumption that 
being a physician confers entitlement ... This occurs at that time when the 
patient most trusts the doctor, during the writing of the prescription, an act that 
promises "Here is how I will help you." If the prescribed product is that which is 
best for the patient, influences brought to bear have been paid for by the patient 
who had no knowledge that he or she would subsidize such expenditures. More 
disturbing, the product marketed by the physician's benefactor may not be that 
which is the best for the patient. (Allman, 2003, p.158) 
Consequently, whether prescribing the best treatment for the patient or, worse than that, 
not the best one, the physician who receives some benefit from pharmaceutical companies 
is at ethical fault. He or she is receiving indirectly (and secretly) from the patient, who is 
the final consumer of the drugs. In this case the physician is receiving more than he/she 
has previously agreed with this patient would be charged for his/her act as a physician. 
This reasoning is also valid in relation to those countries in which the National Health 
Service provides the necessary drugs to the patients (e.g. the UK), as the patients as 
taxpayers are ultimately paying for these medications. Such behaviour conflicts directly 
with the concept of 'suppressing self-interest' which is one of the basic ethical principles 
of medical practice. As Allman (2003) clearly points out: 
The physician is not the drug manufacturer's "customer" and, therefore, has no 
entitlement to privileges rooted in the client-provider relationship ... The 
doctor's obligation is to prescribe the safest, most efficacious, least expensive 
drug, based on scientifically sound, unbiased judgement. Any motive on the part 
of the physician other than the patient's good is indefensible and is the ethical 
descendent ofthe properly discredited practices of kickbacks and fee splitting for 
referrals. (Allman, 2003, p.159) 
It seems pointless to discuss here what should be the precise monetary value of such 
'gifts' from pharmaceutical companies to physicians in order for them to be considered 
ethically 'acceptable'. After all, what is fundamentally unethical is the act of receiving 
such 'gifts', not the amount of money involved. 
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In many medical schools there is a lack of discussion about these ethical problems. 
Furthermore, many of these schools permit their students to have direct and uncontrolled 
contact with pharmaceutical representatives. Consequently, these schools are at least 
partially responsible for the extension of the problem of the present entanglement 
between physicians and the pharmaceutical industry. Although medical students do not 
prescribe, such relationships create in the medical student the incorrect impression that 
they are acceptable and harmless, a notion that she/he will maintain in professional 
practice. 
However, it must be stressed that the simple fact of prohibiting contacts with 
pharmaceutical representatives, and introducing in students' ethics courses the discussion 
of the concepts briefly outlined in the previous few paragraphs, will not be sufficient. As 
discussed in Chapter 6, due to its own characteristics, medical education is strongly based 
in the hidden curriculum and in role models. Consequently, such measures will only be 
efficacious if they are understood, accepted and supported by the majority of faculty 
members of these medical schools. Otherwise, the proposed measures will be at risk of 
becoming just a part of the written curricula of the medical schools and never be 
effectively implemented. 
A simple example may illustrate the fact that physicians for several reasons may 
eventually not adopt a confIrmed method aimed at the improvement of medical practice 
even if such a method is formally required. One of these methods is the simple act of 
handwashing before and after patient contact, which is considered one of the most 
important measures for preventing and controlling hospital transmitted infections 
(Tibballs, 1996). 
The benefits of handwashing have been repeatedly demonstrated over the past 150 years 
(Buchan, 2003), and the requirement for handwashing is based on a fundamental principle 
of medical practice (,First do no harm') (Rea and Upshur, 2001). However, Tibballs' 
study (1996) in an Australian hospital shows that the observed rate of physician's 
handwashing was only 8.6% before and 10.8% after patient contact, although these 
physicians self-estimated their handwashing rates to be much higher. Evidently, there are 
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many possible causes for such a low rate of handwashing among physicians. However, 
the Handwashing Liaison Group (1999) believes that: 
Role models are important in hospital practice. Junior doctors washed their 
hands more often when consultants set an example ... Unfortunately, poor 
practice can also be learnt at the bedside. Junior staff and students taught to wash 
their hands abandoned the habit when others, especially more senior ward staff, 
did not bother. Senior staff should take the lead to achieve lasting behavioural 
change. (Handwashing Liaison Group, 1999, p.686) 
It seems reasonable to suppose that such 'role model' influence will also be extremely 
important for the success of the proposed measures that aim to terminate the present 
relationships between physicians and pharmaceutical representatives. 
Additionally, the medical professional associations should state clearly in their ethical 
guidelines that these associations consider the discussed relationships between physicians 
and the pharmaceutical companies as defmitively unethical, rather than merely 
'undesirable' or 'questionable'. Such a change of perspective about the problem would 
reinforce and legitimise the educational measures proposed above. 
I recognise that the educational measures proposed would not be unproblematic in their 
implementation and may not be easily accepted by the members of some medical schools 
and by some practising physicians. However, the alternative of implementing some other 
more palliative measures will not eliminate one of the loops of the proposed 'vicious 
circle' (see Sections 7.1 and 7.4.1). In fact, palliative measures may entail a kind of 
acceptance, even justification, of the practice, and would only strengthen such a loop. 
7.6.2 The present problem of medical research 
In his editorial at the British Medical Journal in 1994 Douglas G. Altman stated that much 
poor medical research was due to the fact that researchers were carrying out research that 
they were ill equipped to perform (Altman, 1994) (see Section 2.1). More than twenty 
years after his editorial, I must sadly agree with him and comment that many physicians 
179 
nowadays are also ill equipped even to correctly and critically evaluate the results of 
present medical research. 
There are several possible concurrent causes for this lack of knowledge of physicians and 
medical researchers about the methodology of research and the interpretation of research 
results, which were discussed in Chapters 1, 2 and 3. However, considering the data 
collected in five Brazilian medical schools (see Chapters 4 and 5) and the international 
evidence available, it is patent that the present structure of medical education in many 
medical schools should be considered a major cause for this situation. 
Many medical schools seem to have abdicated their responsibility to instruct their 
students about the correct ethical and methodological aspects of medical research while 
favouring the development of a more 'technical' approach to medicine. Such a change 
created a bizarre situation. Their technically well-prepared students will have to acquire 
outside of academia, and mostly after their graduation, the necessary skills to correctly 
appraise the research evidence that will be necessary to keep them abreast with advances 
in their profession. In fact, few will be able to acquire such skills, while most of them will 
become uncritical consumers of 'contaminated' continuing medical education programs 
as will be discussed in Section 7.6.3. 
It should not be a surprise that very few of these physicians become 'physician-scientists' 
as discussed in Section 7.3. Worse than that, some of them will become 'physician-
researchers' without being well equipped for the task, as pointed out by Altman (1994). 
The results ofthe interviews of my research in five Brazilian medical schools (Chapter 5) 
show that it will not be an easy task to convince the medical teachers of the need for a 
curricular change. Such curricular change is absolutely necessary to introduce in these 
schools' curricula the discussion of the ethical and methodological basis of medical 
research in its multiple aspects. Furthermore, this kind of teaching should not be 
considered as supplementary knowledge to the technical skills of their students, but as an 
important tool for the future development of their students as practising physicians or 
medical researchers. 
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More positively, my personal contacts with the teachers that participated in this research 
convinced me that most of them would be likely to accept such curricular modifications if 
they were certain that such modifications would lead to the improvement of medical 
education. 
A fundamental question that remains to be answered about the lack of knowledge among 
many of today's medical researchers concerning research methodology and ethical 
principles is: 'How and why are these physicians being permitted to do medical research 
ifthey do not have the necessary skills?'. 
The answer to this question is quite straightforward. The medical associations and most 
medical schools are very stringent in the matter of not allowing their members to perform 
medical acts that they are not competent to do. Paradoxically, most of these associations 
and schools do not have formal ethical and procedural guidelines that clearly state the 
necessary skills a physician should have in order to engage efficiently in the area of 
medical research. In fact, most of the existing guidelines only focus on ethical aspects of 
the relationships between the researcher and the patients involved in the research. 
This lack of a clear research policy creates a strange situation. The simple fact of being a 
physician seems to be the necessary entitlement to do medical research, despite the well-
knoWn fact that few physicians are being well prepared for such an enterprise. Worse than 
that, many medical schools in some countries use participation in research projects as part 
of the assessment of their teachers (see Section 2.3). Such an assessment policy 
disregards the fact that a well-trained and technically efficient teacher may be ill equipped 
for medical research. 
The situation described in the previous few paragraphs can only be solved by adopting for 
medical research the same stringency employed for the professional acts of physicians. 
More rigorous ethical and procedural guidelines are needed for medical research, and 
these guidelines should be based in the moral principle of the social responsibility of 
science. 
Such improved guidelines will allow local research ethical boards in medical schools to 
evaluate and control much more than the present ethical problems of the relationships 
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between medical researchers and patients. These boards will be able to consider and 
evaluate the methods of a proposed piece of research, the skilfulness of the researcher to 
perform it and the adequacy of the funding that will be employed. Medical schools policy 
makers will also have to accept the fact that undertaking medical research is not 
something that every medical teacher will or should do in his/her professional life. 
These corrective measures will certainly entail a reduction of the medical scientific 
production. However, it is defmitely better to have fewer research projects than biased 
ones, as correctly asserted by Altman (1994). 
The second, although no less important, aspect of the pharmaceutical industry's current 
involvement in medical research is the problem of its funding of such research and the 
consequent conflicts of interest that arise from this. This problem is probably the most 
discussed and controversial issue in medical research at the moment. 
Once the ethical reasoning discussed in Section 7.6.1 is accepted, it does not seem to me 
that the problem of the so-called 'conflicts of interest' is too difficult to solve. It is surely 
obvious that if direct contacts with pharmaceutical representatives are ethically not 
acceptable due to the fundamental ethical differences between academia and the 
pharmaceutical industry, the same reasoning must be applied to the funding of medical 
research by this industry. 
It would be, at the very least, odd to accept that a faculty member who advocates the 
existence of a 'firewall' between his/her students and the pharmaceutical companies 
could accept such funding for herlhis research. In fact, as discussed in Section 7.6.1, it 
would not be a question of discussing how or how much, but a question of why this 
specific teacher accepted such a 'partnership'. Such a kind of rationalisation of the facts 
would transform the difficult task of qualifying and quantifying the so-called 'conflicts of 
interest' into a simple punishable offence of ethical misconduct. 
While the proposed measures can help to revitalise academic medical research, they do 
not prohibit pharmaceutical companies from carrying out and publishing their own 
research about their products. The only difference is that the authors of such research 
would have to clearly state their relationships with a specified company in order to inhibit 
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the present incidence of 'ghost-writing' and 'ghost-authorship' in medical research. Any 
attempt to evade such disclosure should not be considered only as a minor unethical act of 
the authors, as usually happens nowadays, but as a serious and punishable instance of 
misconduct on the grounds of industrial marketing. In fact, I do believe that 
pharmaceutical companies are perfectly capable of contributing to medical advancement 
without the present entanglement with academic medical research. 
Evidently, the proposed measures will not solve all the present problems of medical 
research. However, such a change of perspective will allow medical schools in different 
countries to concentrate their research resources on the investigation of particular aspects 
of medical knowledge and therapeutics that are important to their population's health 
care. These studies would be focused on the topics that are relevant to the well-being of 
these populations and not on the areas of medical knowledge that are particularly 
important to the pharmaceutical industry. 
7.6.3 The challenges to continuing medical education 
The structures of continuing medical education (CME) and life-long learning procedures 
in medicine are worldwide fundamental aspects in the life of physicians. There is no 
doubt about their importance not only in medicine but also in other professions that are 
based on the progressive growing and reshaping of knowledge throughout time. The 
concept that a physician must update herlhis knowledge is a belief that all medical 
students, teachers and practising physicians recognise as true. 
In some countries, such as the USA, attendance on CME programs has a 'mandatory' 
connotation, due to the fact that the 'credits' obtained on CME courses are required for 
maintaining the accreditation of physicians by the professional organisations. In other 
countries, such as Brazil, they are 'recommended' and 'sponsored' by the professional 
organisations, although they do not have a 'mandatory' connotation, as physicians are not 
usually re-evaluated by their professional organisations after their initial certification. 
Such a difference among countries is reflected in the way CME programs are evaluated in 
respect of their quality and academic credibility. For instance, in the USA the 
Accreditation Council for Continuing Medical Education (ACCME) must endorse these 
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programs while in Brazil they are, as previously stated, 'recommended' and 'sponsored' 
by a specific professional organisation related to their educational content. In both cases 
the central idea would be that these courses are receiving a kind of 'certification' that they 
have a good scientific level and are free from commercial bias. 
At frrst glance, the USA model of 'certification' of CME programmes seems much more 
stringent than the Brazilian with respect to the evaluation of the quality and academic 
soundness of such courses. However, according to Elliot (2004) this does not seem to be 
exactly true, as he states that: 
Here's how the business works. The pharmaceutical industry puts up the money, 
usually in the form of an ''unrestricted educational grant". The grant goes for a 
for-profit medical education and/or communications company (MECC) which, 
in consultation with its pharma sponsor, puts together an "educational 
programme". The company and the MECC recruit academic physicians to 
deliver the program in return for a small cut of the grant. If the MECC is 
accredited by the Accreditation Council for Continuing Medical Education, it 
can offer the educational program on its own. (Elliot, 2004, pp.18-19) 
As Elliot (2004) discloses, in those cases when the MECC is not accredited by the 
ACCME, such companies uses the continuing medical education office of a medical 
school which certifies that the program is free from commercial bias. The fmal result is 
that continuing medical education programs in both countries become 'contaminated' by 
commercial bias in either an overt or a veiled way. 
However, one may ask what the problem is, given that practising physicians, academic 
physicians, medical schools, professional organisations, MECC companies and, of course, 
pharmaceutical companies seem all to be profiting from such behaviour? According to 
Allman (2003) the ethical problem is: 
By ceding the financing of continuing medical education to the drug industry, 
the profession and (academic) hospitals endorse a view that education is no 
longer their own responsibility, but instead the responsibility of business ... 
Converting medical education into a hybrid educational and promotional activity 
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is inconsistent with a proper ethic of medicine and the duty of competence. 
Departments are absolved of their didactic responsibilities and then transfer that 
responsibility to those whose intent is something additional to the dissemination 
of scientifically rigorous information. (Allman, 2003, p.162) 
As Elliot (2004) correctly points out, the fmal result is that pharmaceutical companies are 
able to make their advertisements to physicians keeping a false appearance of objectivity. 
One may reason that some advertisement is compensated by the fact that pharmaceutical 
companies are directly financing medical schools, practising physicians and academic 
physicians in doing something that they could not afford to do by themselves. However, 
such reasoning encloses a fundamental ethical imperfection. The imperfection is that this 
kind of reasoning leaves aside the opinion of those who actually fmance these 
programmes: the patients 
There is no possible moral reasoning that may exonerate academic physicians, medical 
schools and professional associations of the ethical misdemeanour of such entanglement 
with pharmaceutical companies. As previously discussed in Section 7.6.1, the moral 
concept of suppressing self-interest is a universal and fundamental basis of medical 
practice. Even if some physicians may sometimes forget this moral concept, there are no 
excuses for academics, medical schools and professional associations doing so too. 
Consequently, the evident solution for the aforementioned problems of continuing 
medical education is the formal and definitive avoidance of relationships with the 
pharmaceutical companies. 
In summary, although both pharmaceutical companies and physicians should undoubtedly 
share a common objective, which would be the improvement of the health conditions of 
the popUlation, there are fundamental and irreconcilable differences concerning the 
ethical principles of the medical profession and the commercial perspectives of 
pharmaceutical companies. Therefore, I propose the total termination of their present 
communal activities in respect of health care, medical education and medical research. In 
my opinion, such disentanglement will be advantageous specifically to those who should 
always be the main beneficiaries of heath care: the patients. 
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In addition, several other educational measures are proposed in this chapter which should 
also be implemented in order to achieve the definitive rupture of the proposed existent 
'vicious circle' connecting medical education and the prevalence of bias in medical 
research. 
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Chapter 8 
Discussion and Conclusions 
8.1 Introduction 
The discussion of the current literature about the problem of bias in medical research in 
Chapters 1 and 2 shows that the present incidence of biased studies is a matter of growing 
concern among medical researchers, educators and medical journal editors. Since 1979 
when Sackett presented one of the first studies about the issue (Sackett, 1979), several 
other researchers have contributed to the objective of detecting and/or avoiding the 
existence of these inaccuracies in medical studies (see Section 1.3). In addition, the most 
important medical journals have adopted several measures over the last decade in order to 
ensure the quality of the studies they are publishing (Begg et al., 1996; Moher et al. 
2001). 
However, such efforts to eliminate the problem of bias in medical research have been 
--
based in 'linear' reasoning about the issue, according to which the known causes of the 
problem would act as concurrent reasons for the present incidence of bias in medical 
research. If such reasoning is correct, each of the possible causes could be regarded as an 
isolated factor, and the possible corrective measures would also be cumulatively effective 
as isolated processes. 
The evaluation of the relevant literature about the problem and the results of the research 
conducted in five Brazilian medical schools lead me to propose that the present incidence 
of bias in medical research is, in fact, principally the result of a vicious circle. Such a 
vicious circle encompasses in its genesis and maintenance the present structure of medical 
research, medical education and the influence ofthe pharmaceutical industry. 
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Although it is not possible to discard the possibility that the various causes for the current 
level of bias in medical research were initially isolated factors, I propose that they are 
nowadays entangled in a self-maintained and well structured arrangement, configuring 
the proposed vicious circle (see Chapter 7). 
In order to expose and explain the most important components of the proposed vicious 
circle it will be necessary to review the main concepts about the origins of bias in medical 
research discussed in Chapters 1 and 2 and also the research results examined in Chapters 
4 and 5. 
It will be shown that, once the known factors for the existence and prevalence of bias in 
medical research are seen as participants in a complex self-maintained structure of a 
vicious circle, it becomes easier not only to see why the present measures against this 
problem are not fully effective, but also how to implement new and more effective 
measures. 
Furthermore, this chapter will discuss how simple, and apparently less harmful, 
components of the vicious circle interconnecting medical research and medical education 
may actually be the possible key to the solution of the problems that afflict modern 
medical research. 
8.2 The industrialisation of current medical research 
In order to clarify what is meant by the term 'medical research' it is necessary to explain 
that research in medicine is presently divided in two main areas: laboratory-oriented 
research and patient-oriented research (clinical research). As Rettig (2000) explains: 
Clinical research is understood today as being the bridge between laboratory 
science and clinical practice. A distinction now is made between laboratory-
oriented research and patient-oriented research, the latter requiring direct 
physician-to-patient interaction. Some patient-oriented research is translational, a 
deliberate effort to apply laboratory research results to a small number of 
patients in a clinical setting. Much of it consists of clinical trials in humans of 
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new diagnostic or therapeutic products (drugs, biologics, medical devices) 
(Rettig, 2000, p.l31) 
In the discussion about the structure and aims of medical research in this section I will use 
the terms 'medical research' and 'clinical research' as synonymous. On the rare occasions 
that I will have to make a comment about laboratory-oriented research I will use the term 
'laboratory research'. 
Another important concept that will be used in the present discussion is that of the 
'industrialisation of clinical research'. Such a concept is well explained by Rettig (2000): 
Industrialization of clinical research fundamentally constitutes the emergence of 
clinical research - and especially clinical trials - as a large, rapid growing "line 
of business". Although this is occurring mainly in drug development, it appears 
also in biotechnology and medical device development. Industrialization also 
reflects an intensified search for efficiency throughout the product development 
cycle, especially in the organization and conduct of drug clinical trials. (Rettig, 
2000, p.140) 
Rettig (2000) also points out that such 'industrialisation' is poorly understood by many 
both in academia and government research agencies. He asserts that it is leading to a 
modification of medical research, which is quite different today in relation to what it has 
been in the recent past. 
In his editorial in the British Medical Journal in 1994, discussed in Section 2.1, Altman 
stated that 'we need less research, better research, and research done for the right reasons' 
(Altman, 1994, p.283). Although his editorial focused mainly on the problems caused by 
the medical researchers' habits, aims and lack of scientific research methodology 
knowledge, I believe that his statement may in fact be extended to many other aspects of 
current medical research. 
However, an initial doubt may arise when one reads such a statement. Is it possible that 
an area of scientific knowledge that seems to be in a continuous and escalating discovery 
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of new treatments for several diseases needs 'less research'? The surpnsmg answer, 
which will be explained in the next few paragraphs, is: yes, it is possible! 
The fIrst aspect that must be discussed to explain this is what the main focus of current 
medical research is, at least considering the number of published papers in medical 
journals. In fact, the majority of papers published would be classified as 'clinical 
research' outcomes according to Rettig's defmition (Rettig, 2000). Laboratory research in 
medicine is rare, extremely time consuming and fmancially very expensive. 
Much such published clinical research, as discussed in Section 7.4.2, is actually the 
product of the action ofthe contract research organisations (CROs). Such companies have 
the central aim of producing as much 'evidence' as possible in order to underpin the 
marketing of pharmaceutical products. In order to achieve this aim, CROs have to 
accomplish two modifications on the studies they produce. The fIrst is to transform these 
studies in something academically acceptable introducing as authors physicians and 
medical teachers that can not be readily connected with the CROs or to the 
pharmaceutical companies. The second modification is to create as many papers as 
possible from the same study in order to enhance artificially the 'evidence' produced. 
Such a behaviour was clearly unveiled by Melander et al. (2003) in their study about the 
fate of 42 placebo-controlled studies submitted to the Swedish drug regulatory authority 
as the basis for marketing approval for a class of drugs: 
. .. 21 studies contributed to at least two publications each, and three studies 
contributed to five publications ... (Melander et al., 2003, p.1171) 
. . . eight studies resulted in three pooled publications based on different 
combinations of studies. The pooled analyses ... appeared simultaneously ... 
with one author in common but without cross reference ... There was no author 
name in common in the pooled and stand alone publications. (Melander et ai, 
2003, p.1172) 
It is necessary to stress that such a number of publications was achieved based on studies 
that compared the drugs and the placebo. From the point of view of drug efficacy such 
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studies, even if correctly implemented and analysed, only show that these drugs are better 
than using absolutely nothing. However, they had undoubtedly fulfilled the central aim of 
producing a great volume of 'evidence' that can be used for marketing purposes. 
One perverse side effect of such publications is to enhance the 'noise' and artificially 
reduce the relative quantity of real 'information' that can be obtained in medical journals. 
Although they may be well written by ghost-writers and well analysed by efficient 
statisticians (see Section 7.4.2), these papers do not entail an enhancement of medical 
knowledge but they certainly do represent a substantial profit for CROs and 
pharmaceutical companies. 
The possibility that this kind of problem can be solved by the current editorial measures 
adopted by the major medical journals is remote. Although the majority of the 
participants of my research in five Brazilian medical schools believe that medical journals 
are responsible for the evaluation of possible bias in the papers they publish (Sections 
4.2.2 and 4.3), even the editors of such journals are sceptical about the efficiency of 
current editorial measures. As Smith (2004) stated: 
Peer review is still in the dark age with most journals, and the BMJ has not 
progressed far. After centuries of being unexamined, the sacred process of peer 
review has been shown through research to be slow, ineffective, a lottery, biased, 
incapable of detecting fraud, and prone to abuse ... Authorship is another issue 
with which we've seen little progress. It long ago became clear that many studies 
included authors who had done little or nothing and excluded people who had 
done a great deal of work. (Smith, 2004, p.243) 
It must also be remembered that most medical journals are also dependent on the 
pharmaceutical companies (and several are in fact an extension of the marketing branch 
of such companies). Those journals that are not an extension of the marketing branch of 
pharmaceutical companies have to ensure the existence of profits in their budgets in order 
to survive economically. To attain such profits many of them rely on the earnings 
obtained from advertisements of pharmaceutical companies and sales of reprints of 
selected papers used by these companies in their marketing programs. 
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Consequently, it seems reasonable to admit that Altman (1994) was correct and that we 
may possibly need 'less research' as he stated. The problem that remains to be solved is 
how such a reduction should happen. 
Actually, the previous few paragraphs show a frightening monolithic and well-structured 
situation. It does not seem to have apparent flaws that could be used to break such a 
powerful loop of economical interests entailed by the current industrialisation of medical 
research. However, as will be discussed in the fmal paragraphs of this section it is 
possible that the solution should involve a less discussed aspect implicated in such a loop. 
This would be, as mentioned by Rettig (2000), the poor understanding of academia and 
government research agencies about the real structure of the industrialisation of medical 
research. 
Altman's statement also includes the need for 'better research'. How could one possibly 
judge what could be considered as 'better research' in medicine? What could be the 
standards that could be used to classify a clinical research as 'better' or 'worse'? 
In fact, such standards not only exist but were discussed in Sections 1.2, 1.3, 1.4 and 2.2 
of the present study and are available in the references that underpinned the discussion in 
these sections. These standards are fundamentally based on the correct and conscious 
choice of the best research method(s) that should be employed to answer the research 
questions and also on an adequate knowledge of the strengths and weaknesses of the 
chosen research method(s). 
According to such standards, as an example, the studies reported by Melander et al. 
(2003) and discussed in the previous paragraphs should not even have been performed 
and certainly did not deserve publication. There is no scientific justification for 
performing and publishing a clinical research comparing a new drug with placebo when 
there is already an available treatment for a specific illness. As Sackett and Oxman (2003) 
correctly pointed out in a rather ironic paper about the problem: 
With our protocol strategies ... as long as your "me too" drug isn't a lot worse 
than a sip of triple distilled water, we can guarantee you a positive trial. (Sackett 
and Oxman, 2003, p.1442) 
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These authors are correct in their ironic evaluation of how easy is to bias such studies. 
The central problem is well known in medical research, and was properly explained by 
James Mills in his paper 'Data torturing' (Mills, 1993): 
There are two major types of data torturing. In the first, which I term 
"opportunistic" data torturing, the perpetrator simply pores over the data until a 
"significant" association is found between variables and then devises a 
biologically plausible hypothesis to fit the association. The second, or 
"Procrustean", type of data torturing is performed by deciding on the hypothesis 
to be proved and making the data fit the hypothesis ... (Mills, 1993, p.1196). 
I suspect that most studies using placebos are very prone to having their data 'tortured' in 
a 'opportunistic' or 'Procrustean' way, transforming their conclusions into something that 
is incompatible with scientific correctness and objectivity. As the researcher in this kind 
of study is fundamentally comparing the effects of a drug against absolutely nothing, 
he/she can easily, consciously or unconsciously, use an 'opportunistic' or 'Procrustean' 
approach to his/her data analysis and research conclusions. In fact, as explained by Mills 
(1993), the fmal result of expert 'data torturing' will not be perceived as biased by most 
skilled readers. 
If this is the case, why such kind of studies are still being performed and published? 
There are several reasons. Some of these are related to the physician-researcher's aims 
and expectations in relation to hislher real motive when doing a piece of research. Others 
are connected to the loop of economic interests described in the previous few paragraphs 
and to the current policy for approval of drugs for marketing of such governmental drug 
control agencies as the American Food and Drug Administration Agency (FDA). 
The governmental drug control agencies in most countries still accept for the initial 
approval of the marketing of a new drug the drug/placebo controlled trials as a 'proof' of 
their 'efficacy' and 'safety'. According to Rettig (2000), since 1997 the FDA has 
markedly reduced its review time for the approval of new drugs. This reduction is 
consistent with a change in the philosophy of drug evaluation. Such a change entailed the 
substitution of a policy of avoiding the premature release of new drugs until safety has 
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been decisively proved by a policy of facilitating rapid access to the possible benefits of 
new therapeutics. As the question of the availability of new drugs for people is a 
worldwide governmental policy matter, many countries are, to a greater or lesser extent, 
adopting the same guidelines. 
Obviously, a policy of faster drug approval does not fit well with the use of a research 
methodology that involves comparing the real effects (and side effects) of a new drug 
with those of one or more drugs that are already used for the same condition or illness. 
These kind of trials are extremely time and resource consuming, and not infrequently lead 
to inconclusive results, requiring new comparisons to be made until the relative efficacy 
and safety ofthe new drug is established with some confidence. 
Although these more in-depth and time consuming studies are not 'shielded' against any 
possibility of bias, the iterative characteristic that is inherent to their methodology is a 
partial guarantee against the 'data torturing' so common in the drug versus placebo 
studies. However, who would care to sponsor such studies once the drug is already 
approved by the governmental drug evaluation agencies? 
The answer may sound cynical and frightening. These drugs will in fact be tested in a 
whole population of users of the therapy. This kind of 'testing' will continue until the real 
effects are fully known or, worse than that, until the volume of harmful side effects will 
eventually force the pharmaceutical companies to stop their production, a feature that is 
becoming common in the drug market (see Section 8.3). 
For the pharmaceutical companies such a kind of 'rapid approval' is welcome as it 
reduces their costs, and the existent CROs are perfectly equipped to produce the 
necessary studies they need for a drug's approval. The studies used nowadays for the 
approval of drugs by governmental agencies (drug versus placebo) also permit CROs to 
create what may seem for someone unskilled in medical research methodology 'solid 
evidence' for the quality and safety of new drugs. 
Such a strategy is clearly seen in the findings of the study by Melander et al. (2003) that 
showed the proliferation of published papers based on a relatively small number of initial 
studies. This 'evidence' can be subsequently used in the pharmaceutical companies' overt 
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or disguised marketing campaigns focussed on the general public or practising physicians. 
The efficacy of such a marketing strategy is evident in the study of Kerr et al. (2003) 
about the early large-scale adoption of new anti-inflammatory drugs by Australian 
general practitioners discussed in Section 7.5. 
For many physician-researchers, using a twisted moral reasoning that 'what is not 
forbidden is permitted', the adoption of the drug/placebo research methodology is also a 
piece of good fortune. With a simple and reproducible research method they can generate 
a great number of studies with 'positive' results which are easier to publish as discussed 
in Section 1.4. Of course, with the support of the CROs, as described in Section 7.5, the 
burden of such a task can also be greatly reduced. 
Consequently, the fmding discussed in Section 5.2.2 that teachers and students in a 
certain way 'forgive' the eventual research errors of physicians-researchers should not be 
a surprise. After all, even the research rules for drug approvals of the governmental drug 
agencies can be considered a little bit lax with respect to medical research methodology. 
As was the case in the discussion of the question of whether 'less research' is needed, 
evaluation of Altman's assertion that 'better research' is needed in medicine (Altman, 
1994) shows that the current industrialisation of medical research constitutes the same 
monolithic and well-structured situation. However, such an evaluation also reinforces the 
feeling that a disturbing kind of ethical lassitude seems to be pervasively present in 
academia and governmental drug regulatory agencies. 
The 'normalisation' of the relationships between academic science and the 
pharmaceutical companies' interests in the industrialisation of medical research might be 
one of the causes of this ethical lassitude. As Sismondo (2004) points out: 
At the beginning of the century (20th century), academic scientists clearly 
perceived that association with pharmaceutical companies was a problem, at 
least for their reputations, if not for substantial ethical reasons. By the 1940s the 
situation had changed considerably, and academic-industrial collaborations had 
become somewhat normalized ... (Sismondo, 2004, p.lS0). 
195 
Such a kind of amalgamation of interests between academics, government and the 
pharmaceutical companies, which can be presumed to have rather different ethical 
perspectives (see Section 7.6), may be one of the key features for understanding the 
present situation of medical research. 
Finally, the last part of Altman's assertion is that medicine needs 'research done for the 
right reasons' (Altman, 1994). Interestingly, this aspect of medical research has been less 
considered in the discussion about the current incidence of bias in medical research. 
Probably this is happening because when one uses a 'linear' approach to the problem it 
becomes difficult to perceive that there are at least three groups of 'right reasons' for a 
particular piece of medical research to be performed. These groups are related to the 
improvement of medical knowledge and medical care, the economic interests of the 
pharmaceutical industry and some physician-researchers, and the policies of the 
government's drug control agencies. 
In a perfect world, these three groups of 'right reasons' would have at least one important 
common point of convergence: the improvement of the well-being of the population as a 
result of the outcomes of medical research. Unfortunately, as will be demonstrated in the 
next few paragraphs, the convergence point has progressively changed in recent decades 
as a result of the industrialisation of medical research. The central 'right reason' of much 
medical research nowadays is essentially personal or industrial profit; and the well being 
ofthe population has gradually become a secondary aim of such research. 
It would be preposterous to believe that before the industrialisation of medical research 
physician-scientists did not expect to receive the merits and profits due to an important 
piece of research. Also, it is understandable that pharmaceutical companies seek for 
profits and that governmental drug agencies have to cope with political and economical 
constraints and the population requirements for better health care. However, what will be 
argued here is that the boundaries among their aims and aspirations became rather blurred 
in recent decades, entailing an unwelcome shift in the objectives of physician-researchers 
and the governmental regulatory agencies towards the interests of the pharmaceutical 
compames. 
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Consequently, the real problem is that the 'right reasons' to do research nowadays seems 
rather dependent on the pharmaceutical companies' needs and objectives. From such a 
perspective the previously discussed study of Melander et aI. (2003) only shows that 
much medical research is frequently being done for one reason: to authenticate the desires 
and aspirations of pharmaceutical companies. 
However, is it possible that such relationships between physician-researchers and 
pharmaceutical companies have in fact changed in recent decades? According to Drews 
(2003), the answer to this question is that these relationships have indeed changed. He 
states that: 
The closeness of the industry to medical biological science and their willingness 
to submit to the rigor and discipline of good science is being replaced by a 
marketing dogma in which R&D (Research and Development) is degraded to a 
tool for generating medicines that qualifY as blockbusters ... Finally, the ethics 
of successful business have replaced those of medicine. The supreme loyalty of 
today's companies is not primarily directed at patients and their physicians but at 
shareholders. Consequently, the most influential figures in today's 
pharmaceutical companies are no longer the heads of R&D but the heads of 
marketing and fmance. (Drews, 2003, p.4ll) 
Drews (2003) identifies as 'blockbusters' those medicines that can each generate annual 
revenues to a pharmaceutical company of or in excess of one billion US dollars. 
Everything necessary to achieve this goal is now considered as the main responsibility of 
its marketing department. 
Also according to Drews (2003), for most of the 20th century the pharmaceutical industry 
was characterized by the following properties: 
• Great individuality. 
• Firm commitment to science and the ways in which science unfolds. 
• Cultural and ethical standards that often seemed to be derived from those of 
medicine itself (Drews, 2003, p.4ll) 
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However, it seems that these qualities are being progressively lost (Abraham, 2002, 
Antonuccio et aI., 2003). According to Drews (2003), one of the reasons is the on-going 
process of mergers between pharmaceutical companies and general consolidation in the 
industry. Today, there are fewer large pharmaceutical companies and also fewer 
differences between the remaining companies in relation to the aforementioned 
'marketing dogma'. 
As the objectives of the most economically powerful 'partner' in the medical research 
enterprise changed there was also a progressive modification not only in the structure but 
also in the aims of much medical research. The rise in the importance of the marketing 
and fmancial departments of pharmaceutical companies and the consequent relative loss 
of importance of the R&D departments entailed a much more aggressive approach of 
these companies towards the 'tailoring' of a new concept of medical research that suited 
their interests. 
Surprisingly, the change in the industry's reasons for doing clinical research did not 
provoke the expected rejection from academia and governmental agencies in relation to 
such an alteration of objectives. In fact, the contamination of these two social structures 
by the new conceptual structure of clinical research of the pharmaceutical companies 
caused a drift oftheir research aims towards the industry model (Abraham, 2002). 
However, why has such a change been occurring inside pharmaceutical companies? And 
why do most of the professional associations, academia and governmental agenCIes 
worldwide seem to be so lenient to the change in the focus of clinical research? 
The answer to the first question is that the productivity of pharmaceutical companies in 
relation to truly new products has been falling short of their own expectations since at 
least 1993, according to the number of submissions made to the European Medicines 
Evaluation Agency (EMEA) and the American Food and Drug Administration agency 
(FDA) (Drews, 2003). In order to maintain their level of profit these companies are 
progressively more dependent not only on the creation of new 'markets' (see Section 8.3) 
but also in the increase of the use of their existing drugs (and 'me-too' drugs, see Section 
7.4.1). 
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Such an increase in the use of existing drugs or ones very similar to them is exactly the 
intention of pharmaceutical companies when using their marketing department and the 
CROs to convince physicians to prescribe and physician-researchers to collaborate in 
dubious research as described in Chapter 7. Consequently, the data presented in Section 
7.4 which showed that the pharmaceutical industry's marketing departments spent in 
2001, just in the USA, more than US$19 billion (Antonuccio et al., 2003) are not 
surprising. It is not a question of creating new drugs; it is a question of selling the existing 
ones. As Drews (2003) points out: 
Most big pharma companies have embarked on strategies that aim primarily at 
profitability. The tool that is most prominently employed to implement this 
strategy is marketing . . . The medical needs of patients and scientific 
opportunities as they emerge from an open process of scientific enquiry have 
become secondary considerations. This attitude not only represents a reversal of 
the process of scientific innovation but also marks a significant deviation from 
the way in which pharma companies operated two or three decades ago. (Drews, 
2003, p.416) 
One may argue, and I would have to agree, that pharmaceutical companies are as entitled 
to seek for profit as any other commercial enterprise. However, the real point is that when 
such companies consider the pursuit of the solutions of medical needs of patients, and the 
support of medical research aimed at really providing such solutions to be secondary they 
cannot be considered as partners of true medical research and medical education. 
In this case, the most important common point of convergence of the 'right reasons' to 
perform a piece of medical research that previously characterized the relationships 
between academia and the pharmaceutical industry clearly disappears. This simple fact 
seems to be easily forgotten by academics, professional associations, physician-
researchers, policy makers and governmental agencies when discussing the problems of 
current medical research and health care. 
Maintaining the image of a 'partner' of medical research while in fact transforming the 
enterprise so that it accepts their methods and aims is a major marketing achievement of 
pharmaceutical companies. Such a success can be seen from several answers of the 
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participants of my study discussed in Section 5.2.2. It seems reasonable to suppose that 
the same is also happening in other medical schools, professional associations and 
governmental agencies. 
In fact, what this discussion about 'research done for the right reasons' (Altman, 1994) 
seems to reveal so far is that the conclusions drawn from the discussions about 'less 
research' and 'better research' are also applicable here. We continue to have a central and 
most powerful force - the pharmaceutical industry - dominating and controlling what 
seems to be the weaker side - academia, medical-researchers and government drug 
control agencies - to such an extent that it might seem that there is little that can be done 
to save medical research and medical education. 
If this was the case, my reasoning about the problem should finish here with the sad 
conclusion that medicine is doomed to become a technical profession dominated by the 
pharmaceutical industry, which would dictate the rules of present and future medical 
education and research. However, I do not think that such a conclusion is correct, and I 
shall explain the reasons for my disbelief in the next few paragraphs. 
For a long period of time academia, practising physicians and the pharmaceutical industry 
had established more or less friendly relationships, although at the beginning of the 20th 
century academic researchers saw the association with pharmaceutical companies as a 
problem (Sismondo, 2004). However, according to Moynihan (2003a), nowadays 'fmding 
senior medical researchers or clinicians without fmancial ties to pharmaceutical 
companies has become exceedingly difficult' at least in the USA (Moynihan, 2003a, 
p.1189). According to Moynihan (2003a): 
Those regarded as 'thought leaders' routinely work as paid members of drug 
companies' advisory boards despite the evidences that the practice is part of 
industry's promotional machinery. (Moynihan, 2003a, p.1189) 
Furthermore, Moynihan (2003a) discloses that pharmaceutical companies are heavily 
sponsoring professional societies and their guidelines writing panels, whilst accredited 
events in continuing medical education seem to be just an occasion for speakers paid by 
these companies to speak about their drugs. 
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Although it is easy to 'demonize' the pharmaceutical industry, it is necessary at this point 
of the present discussion to evaluate clearly which are the possible real causes of the 
present situation of medical research. As discussed in the previous paragraphs it is clear 
that there has been a profound change in the pharmaceutical industry's objectives and 
marketing strategies since the second half of the 20th century. However, it also seems 
obvious that a major change occurred in academia, transforming those previously 
cautious and more or less friendly relationships described by Sismondo (2004) into an 
overt domination. Such domination, in fact, does not seem only to be economical but also 
comprises the modification of the aims and objectives of medical research and medical 
education, as discussed by Moynihan (2003a). 
When discussing the present problems of medical research in Section 7.6.2 it was pointed 
out that many medical schools seemed to have abdicated their responsibility for 
instructing their students about the correct ethical and methodological aspects of medical 
research. Also, as was shown in Section 6.2, governments and professional medical 
associations offer only general guidelines about what should be the expected of the 
outcomes of a medical course. Furthermore, as Moynihan (2003a) states, many of the 
professional medical associations are too connected to the pharmaceutical industry (a 
subject that will be discussed in more detail in Section 8.3). 
These three aspects related to the problem of bias in medical research and its relationships 
with medical education are in my opinion the points that are more prone to be identified 
as the possible targets for modifications that may entail a correction of the problems of 
current medical research. As will be discussed in Sections 8.3 and 8.4 such modifications 
can not only solve the present problems but also prevent the existence of future ones. 
However, at least one conclusion may be drawn from the discussion in this section. The 
current approach of establishing a group of 'norms of conduct' aiming at the maintenance 
and 'improvement' of the current relationships between academic medical research and 
the pharmaceutical industry is inconsistent with reality. As discussed in this section, the 
central objectives of the pharmaceutical industry'S current approach to medical research 
are incompatible with authentic medical science and its ethical foundations. 
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8.3 'Medicalisation' in health-care 
The concept of 'medicalisation' has been proposed in order to identify, analyze and 
criticize the social processes in which human daily life aspects are being transformed into 
medical issues (Verweij, 1999). However, according to Peyser (2004): 
The question of what is pathology and what is normal is not pure science. It has 
profound sociocultural, legal, political, and philosophical implications, all a 
matter of practical human interest. It is too important to be left solely to experts. 
(Peyser, 2004, p.7) 
Peyser (2004) was able to condense in these two small phrases much of the problem 
related to correctly defining the term 'medicalisation'. For the sake of simplicity, I will 
use in this study the opinion of Conrad (1992) that 'medicalisation' is to transform an 
aspect of human life in a medical problem by: 
... using medical language to describe a problem, adopting a medical framework 
to understand a problem, or using a medical intervention to ''treat'' it. This is a 
sociocultural process that mayor may not involve the medical profession, lead to 
medical social control or medical treatment, or be the result of intentional 
expansion by the medical profession. (Conrad, 1992, p.211) 
As pointed out Purdy (2001), such a defmition is value neutral and may in fact permit the 
use of the term in a positive way. Indeed, the term 'medicalisation' will be employed in 
the current discussion precisely because ofthis way of reading the term. To make use of a 
more incisive definition reinforcing the negative aspects of 'medicalisation' as Purdy 
(2001) proposes would be deleterious to the aims of the present discussion, even though I 
agree that the term is usually employed negatively to refer to the phenomenon of reducing 
complex personal and social issues to 'treatable' medical problems. 
As will be demonstrated in this section, the issue of medicalisation involves many of the 
aspects already discussed in Section 8.2. As is the case for the industrialisation of current 
medical research, the problem of medicalisation is highly connected with the economic 
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domination of medical practice, with ethical issues and with the lack of knowledge about 
medical research aims and methods. However, even though medicalisation of health-care 
is tightly connected with the problems that affiict current medical research, it has some 
characteristics that transform it in an especial problem in medicine. 
Some of these characteristics of medicalisation that will be discussed include the 
influence of lay media and the empowerment of specialists and professional medical 
associations. In addition, while in the case of medical research patients are mostly passive 
actors in the process, with respect to medicalisation they and patient associations have an 
important and active role. 
Furthermore, the discussion in Section 8.2 focused on the influence of the pharmaceutical 
industry on current medical research due to the fact that such influence is well studied and 
has an evident connection with the marketing strategies of the pharmaceutical companies. 
However, the producers of medical diagnostic devices and screening tests seem to be 
using the same marketing methods in order to increase their profits. Their influence upon 
current medical research is not as obvious as that of the pharmaceutical industry's but 
their influence on the behaviour of practising physicians and health-care management as a 
whole may be rather important. 
The central problem about evaluating medicalisation is that such a term means, when 
used in a positive way, that there is strong epidemiological evidence that one aspect of 
human life that is not necessarily harmful in itself needs to be avoided or 'treated' to 
prevent future medical problems. However, as Johansson (1996) states: 
If research produces knowledge about health, and knowledge is essential for 
improving health, then health research improves health, particularly through 
policy. Health transition research is exceptionally important to the production of 
useful knowledge ... because it deals with the causes of improved health over 
time. While the logic is sound health research is not. It is a contentious field 
currently producing more confusion than enlightenment, in which continuing 
uncertainty means that it is difficult to identify and apply genuinely useful 
knowledge. (Johansson, 1996, p.3 71 ) 
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There are several examples in which the medicalisation of human habits was in fact a 
positive achievement for health. This was the case of with John Snow's observations 
about the cholera outbreak in London in 1849 (Cartwright and Biddiss, 1972). Although 
Snow did not know what the real cause of cholera was, his evaluation of the water-
drinking habits of 69 people who lived close to a water-pump in Broad Street (London) 
was a masterpiece oflogical thinking. According to Cartwright and Biddiss (1972): 
Snow did not discover the true cause of cholera, the micro-organism, but he 
came very close to the truth. He proved beyond question that cholera is a water-
borne disease and his evidence started a train of events that, in the end, 
controlled the great epidemics of cholera, dysentelY and typhoid. (Cartwright 
and Biddiss, 1972, p.162) 
However, why Snow was successful is seldom discussed. Fundamentally, he was 
successful for three reasons: 
• He was dealing with a one-cause/one-effect problem, 
• Although simple, his research methodology was unbiased and appropriate to 
investigate the problem, 
• According to the historical records, he had no problems in relation to 'conflicts of 
interest'. 
These three reasons for the success of the Snow's approach to the problem of cholera are 
not particular to this situation. They are firmly embedded in the solution to several 
problems that affected human life until the end of the 19th century (Osler, 1921). In fact, 
at the beginning of the 20th century Osler (1921) already connected the idea of 'sanitation' 
to what he called 'the rise of preventive medicine'. 
Another aspect that is seldom discussed about these medical interventions in human life 
and habits is the question of the 'costlbenefit ratio' they entail. In the case of cholera, as 
an example, some people may have had political, religious, personal and economic 
reasons not to accept (and even to deplore) the subsequent results of the application of 
Snow's recommendations for solving the problem. However, for the vast majority of 
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people there was undoubtedly an improvement in the quality of life. Such a costibenefit 
ratio fulfills the necessary social responsibility that is expected from the interference of 
medicine in the population's life and habits. 
More than 70 years after Osler (1921) predicted the rise of preventive medicine 
Johansson (1996) saw health research from a quite different perspective: 
Health research, including health transition research, is distributed over a 
number of fields which in themselves comprise separate academically-based 
disciplines and subdisciplines ... In the present research environment it is 
generally true that most health research is done to advance the welfare of a field 
and the experts in it. The competition between fields means that the overarching 
goal of all social science research - the improvement of human welfare - is 
easily lost in the struggle for disciplinary hegemony. (Johansson, 1996, p.371) 
Johansson (1996) focused his study on the current complexity of the correct defmition of 
health and also looked at the 'competition' among different 'populations of experts' about 
the matter. However, as will be shown, the few lines of his work quoted above are rather 
emblematic in relation to the issue of medicalisation in health-care. 
Such a kind of change in health research is part of the problem that Moynihan et al. 
(2002) called 'disease mongering'~ which is a complete subversion of the initial principles 
of medicalisation discussed in the case ofthe cholera control. As Moynihan et al. (2002) 
argue: 
Within many disease categories informal alliances have emerged, compnsmg 
drug company staff, doctors, and consumer groups. Ostensibly engaged in 
raising public awareness about underdiagnosed and undertreated problems, these 
alliances tend to promote a view of their particular condition as widespread, 
serious and treatable. Because these "disease awareness" campaigns are 
commonly linked to companies' marketing strategies, they operate to expand 
markets for new pharmaceutical products. (Moynihan et al., 2002, p.886) 
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According to these authors, such approach also causes the perverse situation of playing-
down or ignoring the fact that many such conditions are self-limiting, have a relatively 
benign natural history or can be controlled by alternative strategies. 
In order to clarify these negative aspects of medicalisation and explain why this issue is 
important to the present discussion I will use as an example the medicalisation of 
women's health (and, more specifically, of the menopause). I have chosen this aspect of 
human health medicalisation due to the fact that it presents all the negative aspects of 
medicalisation and also because it has been extensively studied and discussed since the 
beginning of the second half of the 20th century. 
There were three phases in the medicalisation of the menopause. The first was to use 
medical language to describe the 'problem' which was followed by the adoption of a 
medical framework to 'understand and explain' it. Finally, based on the existing 
'evidence' medical interventions were introduced to 'treat' such a problem. This fmal 
phase of medicalisation of the menopause comprised not only the drug treatment but also 
diagnostic procedures. 
The transformation of the normal process of the menopause, which occurs in all midlife 
women due to a modification of their hormonal profile, was initiated by calling this 
natural modification a 'hormone deficiency'. As a 'deficiency' it should be treated with a 
'hormone therapy replacement'. This configures a classic case of using medical language 
in order to create the process of medicalisation. However, it would be difficult to 
convince women to initiate a long and expensive treatment, not to mention the side 
effects of such a treatment, just using as a reason the common symptoms of menopause. 
For most midlife women they are mild and transitory as can be depicted by the evaluation 
of the rates of core symptom reporting in Japan, Canada and the USA (Avis et at, 1993). 
However, one way of convincing these women was to link 'hormone deficiency' with 
some real and life-threatening medical condition. As Meyer (2001) states: 
The three major diseases that are being linked with the lower estrogen levels of 
midlife and older women are heart disease, osteoporosis and, most recently, 
Alzheimer's disease. Primary prevention of these diseases is the rationale used 
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for urging healthy midlife and older women to take long term hormone. 
Although there have been many challenges to these links and warnings against 
the widespread use of hormones, these challenges and warnings have either been 
ignored ortrivialized. (Meyer, 2001, pp.769-770) 
These three main diseases that have been connected to menopause share one common 
feature: many factors are involved not only in their onset but also in their development in 
a specific person. Such a characteristic makes their control and treatment rather different 
than in the case of cholera that is a one-cause/one-effect disease. Consequently, common 
sense should be enough to recognise that 'hormone deficiency' could be considered only 
as a possible risk factor, not a direct cause in most cases. 
To transform this possible risk factor into a definitive cause was a major feat of 
'evidence' creation, marketing and distortion of health research. It involved not only all 
the features of the industrialisation of medical research discussed in Section 8.2 but also 
the involvement of the lay media, consumer groups, medical professional associations, 
governmental drug control agencies, practising physicians and academia. 
The involvement of lay media and consumer groups is understandable as it entails the use 
of common marketing procedures. As Moynihan et aZ. (2002) state: 
A key strategy .. , is to target the news media with stories designed to create 
fears about the condition or disease and draw attention to the latest treatment. 
Company sponsored advisory boards supply the "independent experts" for these 
stories, consumer groups provide the "victims", and public relations companies 
provide media outlets with the positive spin about the latest "breakthrough" 
medications. (Moynihan et aZ., 2002, p.886) 
So, it is easy to understand how the lay media, consumer groups and possible 'patients' 
can get involved. However, how and why are medical professional associations, 
governmental drug control agencies, practising physicians and academia engaged in such 
schemes? Whatever the answer the fmal result was impressive. According to Hersh et al. 
(2004) in 1999 there were 90 million hormone therapy replacement prescriptions in the 
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USA alone. Such a level of prescriptions probably also entailed a high (but unknown) 
number of bone mineral density scans and laboratory screening tests for hormonal levels. 
Unfortunately, the answer to the question of the previous paragraph - how and why are 
medical professional associations, governmental drug control agencies, practising 
physicians and academia engaged in such schemes? - is deleterious to the image of these 
groups. As discussed in Chapter 7 and Section 8.2 all these participants in this particular 
case of medicalisation are, willingly or not, profoundly entangled with the pharmaccutical 
industry's interests and aims. 
In July 2002 the Working Group for the Women's Health Initiative Investigators 
(WGWHI) published in the Journal of the American Medical Association the results of a 
randomised controlled primary prevention trial in which 161,809 post-menopausal 
American women were enrolled between 1993 and 1998. The conclusion of this study, 
based on the results obtained from a sample of 16,608 women was: 
Overall health risks exceeded benefits from the use of combined estrogen plus 
progestin for an average 5.2-year follow up among healthy postmenopausal US 
women. All cause mortality was not affected during the trial. The risk-benefit 
profile found in this trial is not consistent with the requirements for a viable 
intervention for primary prevention of chronic diseases ... (Working Group for 
the Women's Health Initiative Investigators, 2002, p.321). 
After the publication of this study, the American Food and Drug Administration Agency 
withdraw its previous certification for the use of such hormonal combination for the 
'treatment' of healthy post-menopausal women. It seemed that this was a good end to a 
bad medical story, except of course for those women who had problems connected to 
their menopause hormonal 'treatment'. 
However, Hersh et al. (2004) show that, although there was a reduction, the number of 
prescriptions of hormone therapy for post-menopausal women in the USA one year after 
the WGWHI publication was still high (53 million/year). Apparently, the central idea that 
menopausal women should be 'treated' is still considered as true by many physicians. 
Bad habits seem really difficult to be eradicated. 
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In fact, the problem ofthe medicalisation ofthe menopause may be related to the last part 
of the defInition used in this discussion. According to this defInition, the persistence in 
the medicalisation of menopausal women could be due to the fact that it leads to 
'intentional expansion by the medical profession' (Conrad, 1992, p.211). 
It is not only pharmaceutical companies, mineral bone density scan device producers and 
screening test producers that are profIting from the medicalisation of menopause. 
Considering that around 12% of the world's population is composed of women who are 
over 45 years old (Kaufert, 1996), one can imagine how many potential 'patients' were 
created simply by the implementation of this kind of medical is at ion. 
It should not therefore be surprising to fmd that women are still being 'treated', and that 
medical professional organisations may be involved in less than ethical attitudes, as Bruhl 
(2003) reveals: 
Several thousand German gynaecologists have been the target of a campaign 
promoting postmenopausal hormone replacement therapy (HRT) which claimed 
that the negative fmdings of a major US study (Conclusion quoted above) were 
of "highly limited relevance" to the German population. The message was, in 
part, disguised as the official statements of a large professional organisation for 
gynaecologists, the Berufsverband der Frauenarzte. (Bruhl, ,K.K., 2003, 1161) 
According to Briihl's account of the problem it is difficult to separate the real 
involvement of the hormone commission of the professional organisation and the 
influence of two German companies that sell hormone treatments. 
Although the end of the 'medicalisation' of women's menopause cannot yet be foreseen, 
its evaluation can show that once more we are facing an ethical dilemma. Considering our 
discussion in the previous paragraphs of this section and in Chapter 7, medical 
professional associations, governmental drug control agencies, practising physicians and 
academia have poorly understood this ethical dilemma. 
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A central issue in the case of the medicalisation of the menopause was what Moynihan et 
al. (2002 called the 'marketing of fear'. This kind of 'marketing' is especially evident in 
the case of the link created between low hormonal levels and osteoporosis. According to 
these authors: 
The construction of the WHO (World Health Organisation) diagnostic criteria is 
such that large numbers of healthy women at menopause will automatically be 
diagnosed as having this "disease" (osteoporosis) because their bones are being 
compared with those of much younger women. Against a background of 
controversy over disease defmition, poor predictive value of bone density 
measurement, and heavily advertised expensive therapies ... corporate backed 
promotional activities are attempting to persuade millions of healthy women 
worldwide that they are sick. (Moynihan et al., 2002, p.889) 
The case of the connection between osteoporosis and bone fracture is illustrative in 
relation to the issue ofthe 'marketing of fear' process, and three aspects ofthe connection 
can be stressed. Firstly, bone densitometry is not a good predictor of future hip fracture 
(Wilkin, 2001) which is the most disabling kind of fracture in elderly people. Secondly, 
hip fracture is rare before the age of 65 and osteoporosis is one of the risk factors 
involved in its occurrence in older women, not a disease that causes hip fracture (Pearce, 
2001). Thirdly, fractures in older women (and also older men) result from falls, most of 
them occurring during normal daily activities (Campbell, 2002). These falls are caused by 
several factors including visual impairment, drugs that act on the central nervous system 
or that lower blood pressure, impaired cognition, etc. (Swift, 2001). 
Consequently, to focus on one risk factor (osteoporosis) and to transform it in a 'disease' 
which midlife women should 'treat' for decades with potentially harmful drugs is 
misleading. Actually, if preventive measures are needed in order to prevent fractures they 
should be implemented by the reduction of all the known risk factors involved in the 
occurrence of fractures in the whole population (not only women) aged over 65 (Day, 
2002). 
The practice of the 'marketing of fear' conflicts directly with one of the fundamentals of 
medical ethics: 'do no harm'. What could be more harmful to a healthy person than 
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deceptively convincing herlhim that she/he is sick and needs 'treatment' for the rest of 
her/his life, and will never be 'cured'? Also, what can be done in order to reverse such an 
expectation of being a 'sick' person when, eventually, it is demonstrated that the 
proposed 'sickness' and 'treatment' are essentially a marketing creation? 
These questions lead to the discussion of a significant matter: the moral problem of 
medicalisation in preventive health-care. Such a moral problem has its roots in a simple 
fact which was described by Verweij (1999): 
For many forms of prevention to be effective, the co-operation or involvement of 
individual persons is necessary. But, as the target groups mostly consist of 
healthy people, it is far from self-evident that these persons will take the 
initiative and request to participation in prevention and health promotion 
programmes. Often prevention programmes have to be brought under the 
attention of members of target groups. (Verweij, 1999, p.89) 
As discussed by Sackett (2002), such characteristics of preventive measures in health care 
entail a different approach and responsibility than those of 'curative' medicine. In 
'curative' medicine someone who needs help with an established disease seeks an 
individual physician. This individual physician can only promise to this particular patient 
to do the best to treat himlher; never to guarantee that his/her medical intervention will 
make the patient better. 
However, the fundamental promise that is implicitly or explicitly made to individuals 
when they are exhorted to accept a preventive intervention is exactly that most of them 
will be better for it, or at least that such interventions will not be harmful to them. If there 
are doubts that such preventive medical procedures or treatments can fulfil this promise it 
should not be implemented, or, in the case that it has already been implemented, it should 
immediately be terminated. As Verweij (1999) correctly points out: 
The main conclusion may be that it is not self-evidently a good thing that 
preventive care is offered wherever possible, even if autonomous choices of 
people are respected and harm is ruled out ... preventive care to healthy people 
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is only accepted if the expected health benefits are large and certain: the burden 
of proof is with the proponent of the intervention. (Verweij, 1999, p.l 07) 
According to Sackett (2002), in the case of the medicalisation of the menopause there was 
a subversion of the basic principle for implementing a medical preventive intervention 
outlined in the previous paragraph. In 1997 a systematic review of 23 trials (Hemminki 
and McPherson, 1997) showed a substantial increase of the risk of cardiovascular disease 
related to post-menopausal hormone therapy. The WGWHI (2002) study only confirmed 
this risk: 
Absolute excess risks per 10000 person-years attributable to estrogen plus 
progestin were 7 more CHD (coronmy heart disease) events, 8 more strokes, 8 
more PEs (pulmonary embolisms), and 8 more invasive breast cancers, while the 
absolute risk reductions per 10000 person-years were 6 fewer colorectal cancers 
and 5 fewer hip fractures. The absolute excess risk of events included in the 
global index was 19 per 10000 person-years. (Working Group for the Women's 
Health Initiative Investigators, 2002, p.321) 
There was therefore enough evidence to stop this medical intervention five years before it 
has actually occurred. One may argue that practising physicians were at that time (1997) 
the subjects of a heavy marketing effort of the pharmaceutical industry, and also were 
being compelled to prescribe by their patients (who were convinced of the need of such 
'replacement' by marketing in the lay media). However, what is the excuse for the lack of 
action of the professional medical associations, governmental drug control agencies and 
academia? 
Professional medical associations do not exist just to defend the interests of physicians. 
The core objective of their existence should be to ensure that their members are strictly 
following the ethical and scientific principles of the medical profession on behalf of 
patient wellbeing. Drug control agencies should be exactly what their name presupposes, 
and act accordingly. Finally, academia should be the moral and scientific reservoir where 
professional medical associations and drug control agencies would [md not only their 
members but also the ethical and scientific support required to fulfil their social 
responsibilities. 
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Conversely, pharmaceutical companies, medical device producers and screening test 
producers are, as discussed in Chapter 7, commercial corporations that depend on their 
revenues and profits to survive and grow. They are undoubtedly important participants in 
the vicious circle that has led to the problems outlined in this section. However, to focus 
only on the control of the objectives and behaviour of these commercial corporations 
would be a misguided interpretation of the problem. This would be to ignore the 
innermost and more modifiable contributors to the vicious circle, namely academia and 
medical education. 
Distinct from the discussion of the industrialisation of current medical research, the 
example of the medicalisation of the menopause shows a much clearer instance of the 
vicious circle in which the pharmaceutical industry, drug control agencies, professional 
medical associations and academia are all entangled. Such an example demonstrates that, 
at least in this particular case, less frequently discussed components of such a vicious 
circle played an important role not only in the creation of the phenomenon of the 
medicalisation of the menopause but also in the maintenance of the erroneous concepts 
that entailed its conception, even when there was enough evidence against this kind of 
medical intervention. 
It is not conceivable that the pharmaceutical industry, medical device manufacturers and 
screening test manufacturers could have created the worldwide conditions needed for 
such a kind of medicalisation without the participation, conscious or otherwise, of the 
other members of the vicious circle. In fact, the same kind of structure seems to be 
involved in several other cases of medicalisation (Moynihan et al. 2002), one of them 
being the 'partial androgen deficiency of the ageing man' (PADAM) (Gladh et al., 2005). 
The case of P ADAM is particularly interesting because it embodies several aspects that 
are similar to the issue of the medicalisation of the menopause. Based on the average 
decline of active testosterone, and symptoms such as 'increased abdominal 
circumference', 'decreased libido', 'less strong erection' and 'lack of energy', Gladh et 
al. (2005) propose the existence of a 'clinically relevant deficit' they called 'partial 
androgen deficiency of the ageing man'. These authors are members of a Swedish 
medical school and their study was partially funded by the pharmaceutical company 
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Organon ®. Based on such group of 'symptoms' and considering that a fall in 
testosterone levels is a physiological fact of ageing in man, one can only imagine how 
many millions of men will be 'diagnosed' as having such a 'clinically relevant deficit'. 
As was demonstrated in this section, the original simple and efficient method used in the 
solution of the cholera problem in London by Snow (Cartwright and Biddiss, 1972) 
evolved into a rather intermingled structure based on economic profit, personal interests 
and the empowerment of professional associations. All such modifications of the ethical 
and structural processes of preventive medicine took place with, at least, the complacent 
acceptance of such deviations by academia. It is therefore necessary for the purposes of 
the present study to discuss the responsibility of academia and medical education. 
8.4 The responsibility of academia and medical education 
It might sound strange to use the term 'responsibility' when discussing the factors related 
to academia and medical education that are important for the present study. According to 
the discussion in Chapter 7 and Sections 8.2 and 8.3, it may seem that these structures are 
victims, or at most helpless collaborators, of a powerful corporate structure that is 
presently dominating medical research, medical education and medical practice. 
However, once they are considered as elements of a vicious circle they in fact become 
'participants' in such a circle. Their influence and responsibility in the maintenance of the 
vicious circle cannot be evaluated by their apparent fragility, but by the role they play in 
the continuation and reinforcement of such a structure. In fact, academia and medical 
education may seem to have different levels of participation and responsibility depending 
on the medical school and country that one is evaluating. However, as will be shown, they 
are always active participants. 
Such a perspective is important not only to describe the known participants of the vicious 
circle in which are entangled the pharmaceutical industry, medical research and medical 
education. It may also give important clues in relation to possible ways of breaking such a 
circle and also about the feasibility of such interventions. 
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In order to correctly evaluate the responsibility of academia and medical education it is 
necessary to delimit which are (or should be) the main duties of both structures. The fIrst 
one should undoubtedly be to produce good doctors. The real problem is to defIne validly 
what a 'good doctor' is. According to Macnaughton (2000): 
.. , doctors need to understand their patients through a scientifIc knowledge ... 
and to appreciate how scientifIc research can help them to make decisions about 
the best treatment for their patients. But this scientillc approach needs to be 
modifIed in the clinical situation when dealing with the individual patient. A 
"humane" doctor is required, with the understanding, assisted by interpretative 
ability and insight, and governed by ethical sensitivity, to apply this scientifIc 
evidence and skills to the individual patient. (Macnaughton, 2000, p.23) 
The above quoted defmition is a rather sensible way of describing how a 'good doctor' 
should be and behave. In fact, a less complex defmition which also encompasses the 
necessary qualities of a 'good doctor' and the responsibility of present medical education 
is the one proposed by Hurwitz and Vass (2002): 
The varieties of good, poor, and bad doctors are diverse and may sometimes 
coexist in the same individual. This does not make becoming a good doctor an 
unattainable ideal. Medical education today should be aiming to marry the skills 
and sensitivities of the applied scientist to the reflective capabilities of the 
medical humanist. (Hurwitz and Vass, 2002, p.668) 
Discussing the reasons why current medical education is successful or not in meeting 
these standards is probably the best way of evaluating the share of responsibility that 
medical education has in relation to the present situation. Macnaughton concedes that 
'this (producing such kind of doctors) is a tall order for medical education to take on' 
(Macnaughton, 2000, p.23). This difficulty is due to the fact that in the 20th century the 
focus of medical education was largely on giving medical students only the scientifIc 
knowledge and skills required of a doctor. 
In fact, the problem in this specifIc matter is to decide whether medical students are being 
'trained' or 'educated' to be doctors. In the present discussion I will use the term 'trained' 
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to represent the view that they should receive in medical schools only the scientific 
knowledge and skills required of a doctor. Conversely, the term 'educated' will represent 
the notion that their medical schools should fulfil all the requisites of the definition of 
Macnaughton (2000) quoted above. 
In Chapter 6 it was argued that medicine is a profession that is based in professional 
practice, and that such practice is clearly related to the delivered and hidden curricula. 
The data obtained in my research, and discussed in Chapters 4 and 5, demonstrate that the 
delivered and hidden curricula of the five medical schools that participated in this study, 
and also the curricula of several other countries, seem to be focused expressly in the 
specialisation of medical practice and learning. Such specialisation usually precludes the 
correct transmission of the ethical and methodological principles of medical research (see 
Chapter 5). However, many Brazilian teachers and students have exposed in their 
answers that they believe that specialisation is not only necessary, but in fact the 
cornerstone of their success as practising physicians (see Chapter 5). 
Therefore, at least in these schools, a medical student would receive only the necessary 
scientific knowledge and skills required of a 'specialised' doctor, and that would not be 
sufficient to fulfil all the requisites of the expected structure of an 'educated' doctor. In 
fact, as discussed in Section 7.6.2, many medical schools seem to have abdicated their 
responsibility to instruct their students about ethical and methodological aspects of 
medical research while favouring the development of a more 'technical' approach to 
medicine. 
Such abdication would constitute an educational flaw, even if one accepted the view that 
these students should only receive 'the necessary scientific knowledge and skills' in order 
to become good doctors. This is true, for example, when one considers that to acquire the 
necessary scientific knowledge entails a critical appraisal of such knowledge, particularly 
in a time of intense industrialisation of medical research (Section 8.2) and medicalisation 
of health-care (Section 8.3). Students who have not received sufficient education about 
the ethical and methodological basis of medical research would be expected to behave, 
whether as practising physicians or as physician-researchers, as uncritical participants in 
the vicious circle that afflicts medical education and medical research. 
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In order to produce good doctors, medical education should not only focus on 
specialisation but also, at least, in giving to medical students the necessary scientific 
knowledge and skills which are required nowadays - and this includes knowledge about 
what is necessary to become a good doctor, in the broader sense. Furthermore, medical 
education must provide the students with the ethical basis that is necessary to underpin 
the development of their social responsibility in respect to science, as discussed in Section 
7.4.2. According to Coulehan et a!. (2003): 
... the failure of medical education to focus on producing good doctors, rather 
than simply on producing good technicians, is an ethical failure. Moreover, the 
introduction and development of biomedical ethics teaching in medical schools 
over the last 30 years has not ameliorated this. (Coulehan et a!., 2003, p.2l) 
It is understandable that such a situation is happening as the teaching of biomedical ethics 
conflicts with the information medical students are receiving in the medical schools due 
to the delivered, experienced and hidden curricula (see Chapter 6). The 'role models' for 
these students, as a result of the failure of academia to provide them with better ones, are 
the 'specialised' and 'successful' physicians, who may not always be the ethical ones as 
discussed in Sections 7.4.2, 7.5 and 7.6.2. 
Additionally, the teaching of medical ethics in many schools is nearly always concerned 
with things like informed consent, beneficence, non-maleficence and justice. However, it 
fails to consider subjects like whether doctors are being drawn to treat certain conditions 
as diseases when they are not and also pays scant attention to the economic and political 
forces that affect medical research and medical education. 
According to such reasoning, a simple course of scientific methodology, which was the 
proposal of several teachers and students that participated in this study (see Section 5.2.3) 
may not accomplish a great deal. As its objectives would be to correct the present low 
level of knowledge about medical research methodology and bias in medical research, the 
students ( and teachers) might see it as a mere accessory to the written curriculum if such 
matters do not become a real preoccupation for academia. 
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This discussion also unveils an interesting aspect that is seldom discussed. When 
academia abdicated from its duty to provide a broader scientific knowledge (which entails 
a critical appraisal of such knowledge) a kind of 'vacant' area in medical education and 
medical research was created. Such vacant area was then occupied by the pharmaceutical 
industry. 
If this is the case, one cannot describe the present situation of medical research and 
medical education as a result of an 'invasion' or the 'domination' of the pharmaceutical 
industry in these areas. At most, it would be a 'consensual appropriation'. For many 
members of academia, also including many in medical schools, this consensual 
appropriation was welcomed since it resulted in a substantial increase in power and 
resources for those who understood and accepted such appropriation. In fact, such a kind 
of acceptance is evident in the answers of some of the participants of my study (see 
Section 5.2.2). 
However, such a partnership had deleterious side effects for medical research and medical 
education (see Section 2.2 and Chapter 7). Actually, it may have contributed to the 
aggravation of an important problem of current undergraduate medical education, 
exposed by Coulehan et al. (2003): 
The socialization process that occurs during medical training conflicts with, and 
tends to diminish, many of the attributes and values usually associated with good 
doctoring ... Although these characteristics are often reinforced by the explicit 
curriculum in medical schools, the tacit learning that trainees receive in the 
hospital and institutional setting promotes other, and often conflicting, personal 
attributes - such as detachment, entitlement, wariness, cynicism, an ethic of 
technique, and a moral myopia about the needs of patients beyond one's 
immediate field of vision. (Coulehan et al., 2003, p.2l) 
Additionally, the pharmaceutical industry's 'appropriation' of a substantial part of 
medical research and continuing medical education (CME) significantly reduced the 
possibility that this educational flaw within undergraduate medical education could be 
corrected in post-graduation courses and CME programs (see Section 7.6.3). 
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Consequently, the opinion manifested in the answers of 40% of the teachers and 45% of 
the students that participated in my research (Section 5.2.3) that medical research 
methodology should be a subject for study in post-graduation courses would not be 
realistic. This is especially true when one remembers that at least part of the current 
problem of the incidence of bias in medical research has its roots in the moral and 
scientific formation of 'physician-researchers' (see Section 7.4.2), and that such 
formation should in fact be structured in their undergraduate courses. 
The appropriation of medical research by the pharmaceutical industry is not happening 
without some traumatic experiences for a number of members of academia, who are 
feeling that their academic freedom and ethical principles are being jeopardised by such 
appropriation. One salient example of such a traumatic experience is the case involving 
Dr. Nancy Olivieri, the Hospital for Sick Children (Toronto), the University of Toronto 
and Apotex, a Canadian pharmaceutical company (Thompson et aI., 2001). 
In this particular case Apotex sued Dr Olivieri due to the disclosure and pUblication of her 
research results about deferiprone (a bivalent ion chelator) which showed a low level of 
efficacy and the occurrence of an increase of hepatic fibrosis in patients with thalassemia 
who used the drug. Dr Olivieri had signed a confidentiality agreement in a previous short-
term, uncontrolled clinical trial with the same drug, which was sponsored by a grant from 
Apotex to the Hospital for Sick Children (Toronto). However, she had not signed a 
similar agreement when she started the second trial. 
Although the complete discussion of this traumatic episode falls outside the scope of the 
present discussion, there are some aspects of it that are emblematic in relation to the 
possible known and unknown problems of the present entanglement between academia 
and pharmaceutical industry. As Nathan and Weatherall (2002) point out, the central issue 
in this case was the failure of academia to defend two essential foundations of science, 
namely academic freedom and the right to publish. 
Analysing the Olivieri case, Nathan and Weatherall (2002) conclude that: 
Although the Olivieri debacle is complicated by personal animosity, poor 
administrative judgment, and bad behaviour among academic colleagues, the 
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case report raises a number of fundamental questions about the research interface 
among teaching hospitals, academic clinical departments of universities, and 
industry. As the authors of the CAU (Canadian Association of University 
Teachers) report state in their summary (Thompson et ai., 2001), these are issues 
that affect the entire biologic-research community. (Nathan and Weatherall, 
2002, p.1369). 
Nathan and Weatherall (2002) also assert that although the Olivieri case was unusual, it 
was not unique, and that there are other examples of serious failure of institutional 
support in similar circumstances. This failure is mostly related to cases in which the 
industry threatens researchers due to conflicts of interests with regard to whether or not to 
publish research results that may be contrary to industry interests. 
The real problem in this particular case, as can be depicted from the discussion of Nathan 
and Weatherall about the position of the University of Toronto, is that it shows that 
academia is sometimes entitling itself to discuss the limits of academic freedom of 
researchers when it affects academia fmancial or power arrangements. What results is 
therefore a rather bizarre situation. Whilst, among other problems, academia is being 
rather lenient in the subject matters of the industrialisation of medical research and 
medicalisation in health-care (Sections 8.3 and 8.4), it can accept the position of judging 
the limits and correctness of two universally established principles of science, namely 
academic freedom and the right to publish. 
Consequently, academia and medical education are failing to accomplish two of their 
central responsibilities: the formation of good doctors and the defence of the central 
ethical principles of good science. Furthermore, these failures are fundamentally due to 
the abdication of academia and medical education of their responsibility to provide a 
broader scientific knowledge and introduce solid ethical principles to medical students. 
Such a failure, combined with an indiscriminate entanglement with the pharmaceutical 
industry is responsible for many of the present problems of medical education and 
medical research. 
At this point it is necessary to conclude that, although it might seem to many a somewhat 
naIve proposition, the absolute disentanglement of the communal activities of academia 
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and the pharmaceutical industry (see Section 7.6.3) is not only desirable but in fact 
necessary in respect to health-care, medical education and medical research. 
8.S Conclusions 
Neither the discussion about bias in research nor its prevention and correction is novel in 
science. The existence of systematic distortions of statistical results, or inaccurate 
processes that may occur at any stage of any piece of research which may interfere with 
its results, are well-studied problems in many fields of science. This is also the case in 
medical research as discussed in Chapter 1. 
However, differently from several other areas of science, the increasing knowledge about 
the problem of bias, its detection and correction (see Chapter 1 and Section 2.2) is not 
resulting in a significant limitation of its level of occurrence in the case of medical 
research. The investigation and discussion of the possible causes for such a puzzling 
situation, and specially the relationship between the problem of bias in medical research 
and the structure of current medical education, which could be one such cause, 
underpinned the formulation of the present study. 
In fact, this study has its roots in an editorial by Douglas G. Altman in which he stated 
that much poor medical research 'arises because researchers feel compelled for career 
reasons to carry out research that they are ill equipped to perform, and nobody stops 
them' (Altman, 1994, p.283). As a physician and a teacher such a statement seemed 
astonishing to me. I could understand that some medical researchers were feeling 
compelled to publish for career reasons. However, it seemed to me hard to believe that 
the high incidence of bias in medical research was due to such a cause. More startling yet 
was his affrrmation that they were 'ill equipped' and that 'nobody stops them'. 
Was it possible that medical researchers are 'ill equipped' to do research when the basis 
of good medical research is readily availab1e, and when the predominant focus of current 
undergraduate medical education and continuing medical education is exactly on 
'evidence-based medicine'? How could it be possible that 'nobody stops them' if 
academia and the professional medical associations have a significant influence upon 
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academic researchers and physicians in respect to counselling and determining the correct 
ethical and methodological aspects of medical research and medical practice? 
In order to at least partially answer these questions I have conducted a research in five 
Brazilian medical schools (see Chapter 3) in order to evaluate three aspects of present 
medical education that could answer the first question in the previous paragraph. The first 
aspect was to appraise the level of awareness of teachers and students about the problem 
of bias in medical research. The second was to gather their opinions about whether these 
systematic errors are being caused only by methodological problems within research or 
whether they are also a manifestation of habits acquired during the process of medical 
education. The [mal aspect was to identifY their points of view about what could be 
changed in medical education in order to reduce the present incidence of bias in medical 
research. 
The results of this research (Chapters 4 and 5) demonstrate that: 
• In relation to the participants of this research the level of awareness about bias in 
medical research can be considered insufficient and fragmentary. Further, there were 
no efficient formal methods of introducing medical students to such a problem in 
medical research in these schools. 
• The participants rejected the hypothesis that the present incidence of bias in medical 
research is due mainly to methodological problems. They were aware that current 
medical education could be one of the causes of the problem. 
• Medical education in the medical schools that participated in my research, irrespective 
of the apparently different curricula, is focused on an intense 'specialisation' of 
medical knowledge and medical practice. 
It also became evident that undergraduate medical students do not have real opportunities 
to evaluate and discuss the structure and problems of medical research. In a 'specialised' 
medical world, it seems that there is neither place nor time for the discussion of such 
problems with undergraduate students. 
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Such a strong focus on 'specialisation' led me to investigate the real structure of a modern 
medical school curriculum (Chapter 6). This investigation revealed that the 
'specialisation' process that is happening in the schools that participated in my study is 
also present in several medical schools of many countries. More than that, it showed that 
there still is a lively debate about what a modern medical curriculum should consist of, 
and especially of how to implement it. 
However, it also became evident that no prescribed model will survive within a medical 
school without the agreement of faculty members and medical students. Unfortunately, it 
seems that the present accepted process of 'specialisation' is neither enhancing the 
present low level of awareness of student and facuIty members about the problem of bias 
in medical research nor contributing to a discussion of alternative models of medical 
education. 
Therefore, I have, sadly, to agree with Altman (1994). The current medical education in 
many medical schools of several countries does not well equip their students to become 
medical researchers. In fact, these schools are not even preparing their students to face the 
challenges of a medical practice based on research evidence. 
However, it may still be argued that this is a minor problem. In any case, the argument 
might continue, these 'researchers-to-be' and practising physicians can always count on 
post-graduation programmes and continuing medical education courses to acquire such 
knowledge. Unfortunately, the evaluation of the current structure of formation of medical 
researchers and the aims oftoday's continuing medical education demonstrates that they 
cannot fulfil such expectations (Section 2.4, Chapter 7). 
At this point of my research it became clear that there is in fact a relationship between the 
problems of current medical research and medical education. However, such a 
relationship does not have a direct 'cause/effect' kind of association. Actually, medical 
research and medical education are participants in a vicious circle in which they are 
entangled together with the pharmaceutical industry, academia, professional medical 
associations and medical journals (Chapter 7). 
223 
It is rather difficult to defme when such a worldwide encompassing vicious circle was 
established; however, there is sufficient evidence about the reasons why and how it is 
being maintained and reinforced in the last decades. These reasons will be given in the 
next few paragraphs, but no attempt will be made to classify them in an order of 
importance, as such an order may well depend on the specific medical school and country 
at issue. However, an attempt will be made to reveal the possible best approaches to break 
out of this vicious circle. 
An important participant of the vicious circle is undoubtedly the pharmaceutical industry. 
From a relatively less important position in respect to medical education and academic 
medical research at the beginning of the 20th century, the pharmaceutical industry is 
presently, directly or indirectly, involved in a significant proportion of academic medical 
research and continuing medical education (CME) (Sections 2.4, 8.2 and 8.3). The central 
problem of such involvement is the subversion of the moral principles that should 
underpin academic medical research and CME. These have been progressively substituted 
by a moral structure that is more compatible with a profit based organisation than with 
real academic science and education (Chapter 7). 
Such a modification of academic medical research and educational objectives, combined 
with an intense and well orchestrated marketing effort, entailed the industrialisation of 
current medical research (Section 8.2), and a substantial part of the phenomenon of 
medicalisation in health care (Section 8.3). Both of these events have been, in recent 
decades, extremely profitable to pharmaceutical industry, but deleterious for medical 
education and academic medical research. 
However, I do not see these problems as being caused solely by the interference from 
pharmaceutical industry in medical education and academic medical research, nor as a 
'domination' of the industry on academia nor as an irremediable effect of any such 
domination (Section 8.4). 
In fact, this apparent domination has only occurred because academia abdicated its duties 
to produce 'good doctors' in order to produce 'good technicians', and also renounced to 
its role in conducting and being responsible for continuing medical education (Sections 
2.4.2 and 8.4). Furthermore, and most importantly, academia abdicated its position as the 
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moral and scientific reservoir of the medical profession in exchange for profit and power 
for some of its members (Chapter 7, Section 8.4). In its misdemeanour academia dragged 
many medical professional associations and medical journals to the same short-sighted 
and self-interested way of behaving, to the detriment of medical education and medical 
research. Consequently, Altman (1994) was possibly right when he stated that 'nobody 
stops them' . 
The [mal conclusion of my thesis is that there is indeed a relationship between the 
problem of bias in medical research and current medical education. However, such 
relationship is dependent, and is being maintained, by a vicious circle. 
Such a vicious circle, in my opinion, will only be disrupted when academia reclaims the 
control and care of academic medical research and continuing medical education, and 
simultaneously decides to produce 'good doctors' (Section 8.4). However, this will only 
happen when academia, which is entitled to do so, votes for a complete disentanglement 
with the pharmaceutical industry (Chapter 7). Less decisive, and apparently more 
palliative, solutions in this matter may only cause further reinforcement of the present 
vicious circle. 
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Nome* ................................................................................................................................ . 
Endereyo* .......................................................................................................................... . 
... ... ... .... .. ... .. . ... . .. ... .... ........... ... ...... ..... CidadelEstado * ........................................................ . 
CEP* ........................... Telefone* ............................... Email* ............................................... . 
Departamento ..................................................................................................................... . 
( *) = Opcional 
1 Sua ocupayao atual (assinalar quantas forem necessarias): 
D Ensino 
D Pesquisa 
D Extensao 
D Administrativa 
2 Possui trabalhos publicados (assinalar quantas forem necessarias): 
D No Brasil 
D No exterior (citar paises) ............................................................................................ . 
D Nao tern trabalhos publicados 
3 Idioma em que os trabalhos foram publicados (assinalar quantas forem necessarias): 
D Portugues 
D Espanhol 
DIngles 
D Outros .......................................................................... . 
4 Formayao academic a: 
D Especializayao 
D Mestrado 
D Doutorado 
D P6s-doutorado 
5 Como voce tern adquirido informayao sobre tendenciosidades (vies) em pesquisa 
medica? (assinale mais de uma OP9ao, se necessario) 
D Atraves de livros sobre metodologia cientifica. 
D Em congressos medicos ou conferencias. 
D Atraves de revistas medicas. Favor citar urn exemplo: ............................................ . 
D Atraves de cursos especiais. Favor citar urn exemplo: ............................................. . 
D Pela Internet 
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6 No ultimo ano quantas vezes discutiu 0 problema de tendenciosidades (vies) em 
pesquisa medica com seus alunos? 
o Freqiientemente 
o Algumas vezes 
o Nenhuma vez 
o Nao me recordo 
7 De que forma a aquisiyao de conhecimento sobre tendenciosidades em pesquisas 
medicas modificou sua mane ira de avaliar trabalhos cientificos publicados em revistas 
medicas? 
8 Em relayao ao problema de tendenciosidades (vies) em pesquisa medica com quais 
afrrmayoes abaixo voce concordaria? (assinale mais de uma se necessario) 
o E exclusivamente urn problema de metodologia cientifica, sem relayao com 0 
ensino medico basico. 
o E responsabilidade do curso de Metodologia Cientifica de cada escola medica 
prover 0 conhecimento sobre estes desvios aos alunos de graduayao. 
o Nao e algo que deva ser abordado no ensino medico basico, devendo ser motivo 
de estudo apenas na p6s-graduayao. 
o As tendenciosidades (vies) em pesquisa medica tern se transformado 
progressivamente em urn problema etico. 
o E responsabilidade das revistas medicas avaliar quais trabalhos apresentam 
tendenciosidades. 
o Nao concordo com nenhuma afirmativa acima. 
9 Nas afrrmativas abaixo escolha uma alternativa que mais se aproxime de sua opiniao 
pessoal: 
a) "Atualmente, revisoes sistematicas e meta-analises sao os melhores meios de adquirir 
novos conhecimentos em Medicina". 
o Concordo plenamente 
o Discordo parcialmente 
o Discordo totalmente 
o Nao tenho opiniao formada sobre 0 assunto 
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b) "Vies de publicas;ao e uma ameas;a a qualidade de revisoes sistetruiticas e meta-
amilises" . 
o Concordo plenamente 
o Discordo parcialmente 
o Discordo totalmente 
o Nao tenho opiniao formada sobre 0 assunto 
c) "Tendenciosidades metodol6gicas em ensaios clinicos randomizados podem exagerar 
de forma significativa os resultados obtidos em meta-analises futuras". 
o Concordo plenamente 
o Discordo parcialmente 
o Discordo totalmente 
o Nao tenho opiniao formada sobre 0 assunto 
10 Em sua opiniao, como 0 conhecimento sobre vies em pesquisa poderia ser transmitido 
aos alunos de urn curso de Medicina? 
11 Voce acredita que sejam necessarias mudan9as curriculares nos cursos de Medicina 
atuais para que a questao de tendenciosidades (vies) em pesquisa medica seja melhor 
transmitida aos alunos? Quais seriam estas mudan9as? 
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12 Concordaria com uma entrevista pessoal, caso seja necessario, para aprofundar 
aspectos do presente questionario? 
OSim 
ONao 
13 Caso concorde, com a garantia de que em nenhum momento sera rompido 0 
compromisso de anonimidade dos participantes durante a apresenta9ao dos resultados 
desta pesquisa, permitiria que ela fosse gravada para analise posterior? 
o Sim 
DNao 
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Name* .............................................................................................................................................. . 
Address* ........................................................................................................................... .. 
.. . ... . . . ... ... ... .. .............. ... ...... ...... City / State* .................................. '" ............................ .. 
ZIP* ............................. Telephone * .............................. Email* ........................................... .. 
Department .................................................................................... , .................................. .. 
( *) = Optional 
1 Your present occupation (tick more than one if necessary): 
o Teaching 
o Research 
o Extension 
o Administration 
2 I have published papers (tick more than one if necessary): 
o In Brazil 
o In foreign countries (cite countries) 
o I have no published papers. 
3 Which was (were) the language(s) of publication? (tick more than one if necessary) 
o Portuguese 
o Spanish 
o English 
o Other. ................................................. . 
4 Your academic background is: 
o Specialist 
o Master 
o Doctor 
o Post-doctoral studies 
5 Which was the method that helped you to acquire your present knowledge about 
systematic deviations (bias) in medical research? (tick one or more boxes) 
o Books about methodology of research 
o Medical congress or conferences 
o Medical journals. Please cite one ............................................................................. . 
o Special courses. Please cite one ............................................................................. . 
o The Internet 
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6 How often did you discuss the problem of methodological deviations (bias) with your 
students in the last year? 
D Frequently 
D Rarely 
DNever 
D I do not remember 
7 How much did your evaluation of papers published in medical journals change with 
the acquisition of knowledge about bias? Please explain. 
8 In relation to the problem of methodological deviations (bias) in medical research, 
with which statements below would you agree? (tick more than one ifnecessary): 
D It is a problem of scientific methodology, with no relation with the medical 
graduation course. 
D The course of Scientific Methodology of each medical school should be 
responsible to provide the knowledge about these deviations to the students. 
D It is a subject that should be discussed at the post-graduation level, and not in the 
graduation course. 
D The methodological deviations (bias) in medical research are progressively 
becoming an ethical issue. 
D Medical journals are responsible for the evaluation of methodological deviations 
in papers they publish. 
D I do no agree with any of the above statements. 
9 In the statements below choose the alternative that is more compatible with your 
personal opinion: 
a) "Systematic reviews and meta-analyses are presently the best way to acquire 
knowledge in Medicine" 
D I totally agree 
D I partially disagree 
D I totally disagree 
D I do not have an opinion about the subject 
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b) "Publication bias is a menace to the quality of systematic reviews and meta-analyses" 
o I totally agree 
o I partially disagree 
o I totally disagree 
o I do not have an opinion about the subject 
c) "Systematic deviations (bias) in randomised clinical trials may significantly 
exaggerate the results of future meta-analyses" 
o I totally agree 
o I partially disagree 
o I totally disagree 
o I do not have an opinion about the subject 
lOIn your opinion, how the knowledge about bias in research should be transferred to 
the students of a medical school? 
11 Do you believe that changes in the curriculum of medical schools are necessary in 
order to achieve a better transference of knowledge about bias in medical research? 
What should be changed? 
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12 Do you agree with a personal interview, if necessary, to enlighten some aspects ofthe 
present questionnaire? 
DYes 
DNo 
13 If you agree, provided that it is assured the anonymity of participants at the 
presentation of the results of this research, would you permit the interview to be 
recorded for posterior analyses? 
DYes 
DNo 
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Nome* ................................................................... ......... ..... .. ...................... .. ..... .... .. ........ . . 
Endere90* .................. ................ ... ... ..... ............ .. ..... ............. . 
............... ....................... ................... .. CidadelEstado* ........................................................ . 
CEP* .............. , ........ .Telefone* ............ ................ . Email* .. . 
( *) = Opcional 
1 Durante seu curso de Medicina, voce colaborou em alguma pesquisa na area medica? 
O Q' ulID 
DNao 
2 Estas pesquisas em que colaborou: 
o Foram publicadas no Brasil 
o Foram publicadas no exterior (citar paises) .......................................... ... . .... .......... . 
o Nao foram publicadas 
o Nao sabe se foram publicadas 
3 Caso tenham sido publicadas, qual foi 0 idioma de publica9ao? 
o Portugues 
o Espanhol 
DIngles 
o Outras ................................................................. . 
4 Como voce tern adquirido informa9ao sobre tendenciosidades (vies) em pesqmsa 
medica? (Assinale mais de uma oP9ao, se necessario) 
o Em meus cursos normais de gradua9ao 
o Atraves de livros sobre metodologia cientifica. 
o Em congressos medicos ou conferencias. 
o Atraves de revistas medicas. Favor citar urn exemplo: .......................................... .. 
o Atraves de cursos especiais. Favor citar urn exemplo: ............................................ . 
o Pela Internet 
o Nao tenho recebido informa90es sobre 0 assunto de nenhuma fonte 
5 No ultimo ana quantas vezes seus professores discutiram 0 problema de 
tendenciosidades (vies) em pesquisa medica com voce? 
o Freqiientemente 
o Algumas vezes 
o Nenhuma vez 
o Nao recordo quantas vezes 
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6 De que forma a aqUlSls:ao de conhecimento sobre tendenciosidades em pesquisa 
medica modificou sua maneira de avaliar trabalhos cientificos publicados em revistas 
medicas? 
7 Em relas:ao ao problema de tendenciosidades (vies) em pesquisa medica com quais 
afrrmas:oes abaixo voce concordaria? (assinale mais de uma se necessario) 
o E exclusivamente urn problema de metodologia cientifica, sem relas:ao com 0 
ensino medico basico. 
o E responsabilidade do curso de Metodologia Cientifica de cada escola medica 
prover 0 conhecimento sobre estes desvios aos alunos de graduas:ao. 
o Nao e algo que deva ser abordado no ensino medico basico, devendo ser motivo 
de estudo apenas na p6s-graduas:ao. 
o As tendenciosidades (vies) em pesquisa medica tern se transformado 
progressivamente em urn problema etico. 
o E responsabilidade das revistas medicas avaliar quais trabalhos apresentam 
tendenciosidades. 
o Nao concordo com nenhuma afirmativa acima. 
8 Nas afrrmativas abaixo escolha uma altemativa que mais se aproxime de sua opiniao 
pessoal 
a) "Atualmente, revisoes sistematicas e meta-analises sao os melhores meios de adquirir 
novos conhecimentos em Medicina". 
o Concordo plenamente 
o Discordo parcialmente 
o Discordo totalmente 
o Nao tenho opiniao formada sobre 0 assunto 
b) "Vies de publicayao e uma ameaya a qualidade de revisoes sistematicas e meta-
anaIises" . 
o Concordo plenamente 
o Discordo parcialmente 
o Discordo totalmente 
o Nao tenho opiniao formada sobre 0 assunto 
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c) "Tendenciosidades metodologicas em ensaios clinicos randomizados podem exagerar 
de forma significativa os resultados obtidos em meta-analises futuras". 
o Concordo plenamente 
o Discordo parcialmente 
o Discordo totalmente 
o Nao tenho opiniao formada sobre 0 assunto 
9 Em sua opiniao, como 0 conhecimento sobre vies em pesquisa poderia ser transmitido 
aos alunos de urn curso de Medicina? 
10 Voce acredita que sejam necessarias mudanc;as curriculares nos cursos de Medicina 
atuais para que a questao de tendenciosidades (vies) em pesquisa medica seja melhor 
transmitida aos alunos? Quais seriam estas mudanc;as? 
................................................................................................................................. 
.................................................................................................................................. 
............................................................................................................................................................................ 
........................................................................................................................................ 
11 Concordaria com uma entrevista pes so aI, caso seja necessario, para aprofundar 
aspectos do presente questionario? 
o Sim 
DNao 
12 Caso concorde, com a garantia de que em nenhum momento sera rompido 0 
compromisso de anonimidade dos participantes durante a apresentac;ao dos resultados 
desta pesquisa, permitiria que ela fosse gravada para analise posterior? 
o Sim 
DNao 
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Name* ............................................................................................................................................. . 
Address* ............................................................................................................................. . 
.. . . .. . .. . . . ... ... ... ... ... ... .. . ....... ....... ... City / State* ................................................................. . 
ZIP* ....................... Telephone* ......................... Email* .................................................. . 
( *) = Optional 
1 Have you collaborated with research projects as a medical student? 
2 
DYes 
DNo 
The research project you participated in: 
D Was published in Brazil 
D Was published in foreign countries (cite countries) 
D Was not published 
D I do not know if it was published 
3 If the research was published, which was the language of publication? 
D Portuguese 
D Spanish 
D English 
D Other. ..................................................................................... . 
4 Which was the method that helped you to acquire your present knowledge about 
systematic deviations (bias) in medical research? (tick one or more boxes) 
D The curricular courses for graduation 
D Books about methodology of research 
D Medical congress or conferences 
D Medical journals. Please cite one ............................................................................. . 
D Special courses. Please cite one .............................................................................. . 
D The Internet 
D I have not received any information about systematic deviations in medical 
research from the sources cited aboves 
5 How often did your teachers discuss the problem of methodological deviations (bias) 
with you in the last year? 
D Frequently 
D Rarely 
D Never 
D I do not remember 
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6 How much did your evaluation of papers published in medical journals change with 
the acquisition of knowledge about bias? Please explain. 
7 In relation to the problem of methodological deviations (bias) in medical research, 
with which statements below would you agree? (tick more than one if necessary) 
D It is a problem of scientific methodology, with no relation with the medical 
graduation course. 
D The course of Scientific Methodology of each medical school should be 
responsible to provide the knowledge about these deviations to the students. 
D It is a subject that should be discussed at the post-graduation level, and not in the 
graduation course. 
D The methodological deviations (bias) in medical research are progressively 
becoming an ethical issue. 
D Medical journals are responsible for the evaluation of methodological deviations 
in papers they publish. 
D I do no agree with any of the above statements. 
8 In the statements below choose the alternative that is more compatible with your 
personal opiriion: 
a) "Systematic reviews and meta-analyses are presently the best way to acquire 
knowledge in Medicine" 
D I totally agree 
D I partially disagree 
D I totally disagree 
D I do not have an opinion about the subject 
b) "Publication bias is a menace to the quality of systematic reviews and meta-analyses" 
D I totally agree 
D I partially disagree 
D I totally disagree 
D I do not have an opinion about the subject 
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c) "Systematic deviations (bias) in randomised clinical trials may significantly 
exaggerate the results of future meta-analyses" 
D I totally agree 
D I partially disagree 
D I totally disagree 
D I do not have an opinion about the subject 
9 In your opinion, how the knowledge about bias in research should be transferred to 
the students of a medical school? 
10 Do you believe that changes in the curriculum of medical schools are necessary in 
order to achieve a better transference of knowledge about bias in medical research? 
What should be changed? 
11 Do you agree with a personal interview, if necessary, to enlighten some aspects of the 
present questionnaire? 
DYes 
DNo 
12 If you agree, provided that it is assured the anonymity of participants at the 
presentation of the results of this research, would you permit the interview to be 
recorded for posterior analyses? 
DYes 
DNo 
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Ponta Grossa, 
Caro 
Meu nome e Marco Antonio Gimenes Basso e sou medico formado pela Faculdade de Medicina de Botucatu 
(UNESP). 
Atualmente sou Professor Adjunto de Fisiologia e Fisiopatologia Medica na Universidade Estadua! de 
Ponta Grossa - PR (UEPG), e desde agosto de 2001 participo do program a de PhD em Educa~ao no 
Instituto de Educa~ao da Universidade de Londres. 
Um dos objetivos da minha tese e avaliar como sao vistos atualmente os desvios metodol6gicos 
(vies, bias) em pesquisa medica, pelos integrantes das escolas de Medicina do Estado do Parana. Ao 
mesmo tempo, gostaria de saber, dos internos e docentes, quais seriam as medidas que poderiam ser 
adotadas para minimizar 0 problema. 
Anexo a esta carta encontra-se um pequeno questionario onde podera externar suas opini5es sobre 0 
assunto. Espero que a devolu~ao do questionario seja facil para voce, e por isso estou incluindo um 
envelope ja selado e endere~ado a mim, para 0 retorno do mesmo. Gostaria que retornasse 0 questionario 
mesmo que nao possa responder a algumas das quest5es ou tenha dificuldades de qualquer natureza. Sua 
opiniao e muito importante para podermos conhecer melhor 0 tema, e suas propostas eventualmente 
poderao trazer avan~os na area da Educa~ao Medica. 
As informa~5es pessoais como nome e endere~o sao opcionais, porem se declaradas facilitariam futuros 
contatos, se forem necessarios. Asseguro que estas informa~5es nao serao usadas na publica~ao da tese, 
nem em futuras publica~5es em revistas cientificas. Considero a anonimidade dos participantes desta 
pesquisa um principio etico que sera rigorosamente cumprido. 
Caso queira qualquer informa~ao adicional, por favor, entre em contato comigo. Estarei a sua disposi~ao 
para esclarecer qualquer aspecto do projeto. 
Desde ja, agrade~o por sua aten~ao e participa~ao na pesquisa. 
Prot. Marco Antonio Gimenes Basso 
Disciplina de Fisiopatologia Medica - UEPG 
Rua Heitor Ditzel 135 
84050-410 Ponta Grossa - PR 
Teletone: (42) 3223-7409 
Email ll1arcoagbasso(ev,uol. conI. Dr 
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Ponta Grossa, 
Dear 
My name is Marco Antonio Gimenes Basso and I am a physician graduated by the 
Faculdade de Medicina de Botucatu (UNESP). 
Currently, I am an Associate Professor of Physiology and Pathophysiology at the 
Universidade Estadual de Ponta Grossa (Parana). Since August of 2001, I am a 
participant of the PhD program at the Institute of Education ofthe University of London. 
The main aim of my thesis project is to evaluate how the members of medical schools, in 
Brazil, perceive the problem of methodological deviations (bias) in medical research. 
Furthermore, I would like to know the opinion of teachers and interns about the possible 
educational measures that could be used to reduce this problem. 
Annexed to this letter you are receiving a small questionnaire. In order to facilitate the 
return of the questionnaire, I am including a pre-stamped and addressed envelope. I 
would ask you to return the questionnaire even if you can not, or would like not, to 
respond to some questions. Your opinion is very important, and your proposals will 
eventually contribute to the improvement of medical education. 
Your personal information, as name and address, are optional. However, this information 
would facilitate future contacts. I can ensure you that your personal information will not 
be used in my thesis or in future publications. In addition, I guarantee that the anonymity 
of the participants is one of the ethical principles of my research. 
If you wish to receive additional information about this project, please contact me by 
mail, telephone, or email. 
Yours truly, 
Prof Marco Antonio Gimenes Basso 
Rua Heitor Ditzel- 135 
84050-410 Ponta Grossa PR 
Telephone: (42) 3223-7409 
Email: marcoagbasso@uol.com.br 
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1. Teacher Questionnaire in Portuguese 
Rela~oes entre a Educa~ao Medica 
e os Desvios Sistematicos (vies, bias) em Pesquisa Medica 
1 Sua ocupa~ao atual lossinolor quonlos olternotivos forem necessorios): 
o Ensino 
o Pesquiso 
o Extensoo 
o Administrativo 
2 Possui trabalhos publicados nos ultimos 5 anos lossinolor quonlos olternotivos forem necessorios): 
o No Brasil 
o No exterior (dlar quais pOises) .. 
o Noo tern trabolhos publicodos 
3 Idioma em que os trabalhos foram publicados lossinolor quonlos olternotivos forem necessorios): 
o Portugues 
o Esponhol 
Dingles 
o QuIros. 
4 Forma~ao academica: 
o Especiolizo~oo 
o Meslrado 
o Doutorado 
o P6s-doulorodo 
5 Como voce tem adquirido informa~ao sobre tendenciosidades (vies, bias) em pesquisa medica? 
( assinale mais de uma apc;iia, se necessaria) 
o Alroves de livros sobre melodologio cienllfieo. 
o Em congressos medicos ou eonferencias. 
o Alraves de revistas medicos. Citar urn exemplo: .. 
o Alroves de cursos especiais. Citar urn exemplo: 
o Pela Internet. 
o QuIros meios. Especificor: 
6 No ultimo ana quantas vezes discutiu 0 problema de tendenciosidades (vies, bias) em pesquisa medica 
com seus alunos? 
o Frequenlemente 
o Algumas vezes 
o Nenhuma vez 
o Noo me recordo 
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7 De que forma a aquish;ao de conhecimento sobre tendenciosidades (vies, bias) em pesquisa medica 
modificou sua maneira de avaliar trabalhos cientificos publicados em revistas medicas? 
8 Em relayao ao problema de tendenciosidades (vies, bias) em pesquisa medica voce acredita que: 
E um problema de metodologia cientifica, 
sem rela~ao com 0 curso de gradua~ao 
o curso de Metodologia Cientifica 
e responsavel pela transmissao 
deste tipo de conhecimento 
------------ -------- -------
As tendenciosidades em pesquisa medica 
estao se tornando progressivamente 
um problema etico 
As publica\ioes medicas sao responsaveis i 
pela avalia\iao das tendenciosidades 
nos artigos que publicam 
Concordo 
plenomente 
I 
Comordo Discordo pordolmente 
9 Nas afirmativas abaixo escolha uma alternativa que rna is se aproxime de sua opiniao pessoal: 
i 
! 
Revisoes sistematicas e mela·analises j 
sao 0 melhor meio de obler conhecimento ! 
atualizado em Medicina 
Vies ( bias) de publica\iao e uma amea\ia a 
qualidade de revisoes sistematicas e 
meta·analises 
As tendenciosidades em ensaios clinicos 
randomizados podem causar altera\ioes nas 
futuras meta·analises 
i 
Concordo 
plenomente 
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Concordo Discordo pordolmente 
T 
Discordo 
totolmente 
Noo tenho 
opiniiio sobre 
o ossunto 
Nootenho 
opinioo sobre 
o ossunto 
1 0 Em sua opiniao, como 0 conhecimento sobre vies em pesquisa poderia ser transmitido aos alunos 
de urn curso de Medicina? 
1 1 Voce acredita que sejam necessarias mudan~as curriculares nos cursos de Medicina atuais para 
que a questao de tendenciosidades ( vies, bias) em pesquisa medica seja transmitida aos alunos? 
o Sim 
o Nao 
1 2 Caso sua res posta a questao anterior seja Sim, quais seriam estas mudan~as? 
1 3 Concordaria com uma entrevista pessoal, casa seja necessaria, para aprofundar aspectos do 
presente questionario? 
o Sim 
o Nfio 
1 4 Caso concorde, com a garantia de que em nenhum momenta sera rompido 0 compromisso de anonimidade 
dos participantes durante a apresentaqao dos resultados desta pesquisa, permitiria que ela fosse gravada 
para analise posterior? 
o Sim 
o Nfio 
Nome * .. 
Endere~o * 
Cidade/Estado * ..... . 
Telefone * 
Departamento. 
( * ) = Opcional 
. .. CEP* . 
E-mail • 
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2. Teacher Questionnaire translated 
Research on the relationship between medical education and bias in medical research 
1 Your present occupation: (tick more than one if necessary ) 
o Teaching 
o Research 
o Extension 
o Administration 
2 Have you published papers in the last 5 years?: (Tick more than one if necessary ) 
o Yes, in Brazil 
o Yes, in foreign countries (please cite countries) . 
o No, I have not published papers in the last 5 years 
3 Which was (were) the language (s) of publication? (Tick more than one if necessary) 
o Portuguese 
o Spanish 
o English 
o Other 
4 Your academic background is: 
o Specialist 
o Masters 
o Doctoral 
o Post-doctoral studies 
5 Which was the method that helped you to acquire your present knowledge about systematic 
deviations ( bias) in medical research? (Tick one or more boxes) 
o Books about methodology of research 
o Medicol congresses or conferences 
o Medicol journals. Please cite one 
o Special courses. Please cite one . . ........... . ......... . 
o The Internet 
o Other (please specify ) 
6 How often did you discuss the problem of methodological deviations ( bias) with your students 
in the last year? 
o Frequently 
o Rarely 
o Never 
o I do not remember 
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7 How much did your evaluation of papers published in medical journals change with the acquisition of 
knowledge about bias? Please explain. 
8 In relation to the problem of methodological deviations ( bias) in medical research you believe that: 
( Please tick) 
Strongly Agree Disagree Strongly I Do not have I disagree on opinion agree I I I 
---------------- ------------ ----- -----i-- ------------+----------+---- ______ .L. 
It is a problem of scientific methodology. I I i 
with no relation to undergraduate medical iii
courses I I l 
------ ----- ------- --~--t------ ------------------- -----
Courses of scientific methodology are I I I 
responsible for the transmission of I . I I 
knowledge about bias t I I I 
---------~------------- - ----t-----l--------~i-----+------
Methodological deviations ( bias ) in ' iii 
medical research are progressively : 
becoming an ethical issue I- I -------------.---. -- ----- ------ ---------- --1-------
Medical journals are responsible for the I 
evaluation of methodological deviations in I I 
papers they publish ! 
9 In the statements below choose the alternative that is most compatible with your personal opinion: 
( Please tick) 
Strongly I 1 Strongly Do not have Agree Disagree I 
agree I disagree on opinion 
Systematic reviews and meta-analyses are 
the best ways to acquire valid knowledge 
in medicine 
-------------------------- - -
-- ------
Publication bias is a menace to the quality 
of systematic reviews and meta-analyses 
--------------------------------
-- ------!------ ,--
Systematic deviations (bias) in 
randomised clinical trials may exaggerate 
the results of future i 
meta-analyses ! : 
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lOIn your opinion, how should the knowledge about bias in research be transferred to the students 
of a medical school? 
1 1 Do you believe that changes in the curricula of medical schools are necessary in order to achieve a 
better transference of knowledge about bias in medical research? 
DYes 
o No 
1 2 If your answer to the previous question was Yes, what should be changed? 
1 3 Do you agree with a personal interview, ifnecessary, to enlighten some aspects of the present 
questionnaire? 
DYes 
o No 
1 4 If you agree, provided Ihal il Ihe anonymity of participanls allhe presenlalian of Ihe results of lhis research is assured, 
would you permit the interview to be recorded for subsequent analysis? 
DYes 
o No 
Name * 
Address * .. 
City/State * ... 
Telephone * ... .............................. Email * . 
Department * ... 
( *) = Optional 
. Code *. 
266 
3. Student Questionnaire in Portuguese 
Rela~oes entre a Educa~ao Medica 
e os Desvios Sistematicos (vies, bias) em Pesquisa Medica 
1 Como voce classificaria seu conhecimento atual sobre tendenciosidades ( vies, bias) em pesquisa 
medica? 
DAlto 
o Medio 
o Baixo 
o Nenhum (Coso sua res posta seia esla, por favor continue no pergunta 3 ) 
2 Como voce tern adquirido informagao sobre tendenciosidades ( vies, bias) em pesquisa medica? 
( Assinale mais de uma op~ao, se necessario ) 
o Em meus cursos normais de gradua~ao 
o Atraves de livros sobre metodologia cientifica. 
o Em congressos medicos ou conferencias. 
o Atraves de revistas medicos. Citar um exemplo: .. 
o Atraves de cursos especiais. Citar um exemplo: . . ......... . 
o Pela Internet 
o Qutros meios. Especificar: . 
3 No ultimo ano, quantas vezes seus professores discutiram 0 problema de tendenciosidades ( vies, bias) 
em pesquisa medica com voce? 
o Frequentemente 
o Algumas veles 
o Nenhuma vel 
o Nao recordo quantas veles 
4 De que forma a aquisigao de conhecimento sobre tendenciosidades em pesquisa medica modificou sua 
maneira de avaliar trabalhos cientificos publicados em revistas medicas? 
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5 Em rela!;ao ao problema de tendenciosidades ( vies, bias) em pesquisa medica, voce acredita que: 
I I 0 0 I Noo tenho Concordo C d Discordo Discordo 0 o. b , oncor 0 0 I opmlOo so re I plenomente I parclalmente totolmente 
I oossunto 
E urn problema de metodalogia cientilico, sem re'o~~l------------ : I r-r~~-
com 0 curso de gmdua~oo I I I -----.-L I 
------------------ ------1----+------r- I ! 
o cursu de Metodologio Cientifico e responsavel pelo I I ! I I 
tmnsmissoo deste tipo de conhecimento ____ L.____ -J-__ ___ 1 __________ 1 ___ --J~~---
i ,I I 
As tendenciosidodes em pesquiso medico estoo se ! I I I ' 
tornondo progressivomente urn problemo etico I _ I I I 
I -+-' , ~ubIiCO~6esm6tiiOOs SOD responsaveis pelo ovOJjo~oo-I--------- 'I' I I t--------
dos tendenciosidodes nos ortigos que publicom I I I' I i 
I t I I 
6 Nas afirmativas abaixo escolha uma alternativa que mais se aproxime de sua opiniao pessoal: 
Comordo I I Discordo I Noo tenho Discordo I 
plenomente I Comordo porciolmente I totolmente opinioo sobre 
o ossunto 
---~--~--------~ I --.-~------ . Revisiies sistematicos e meta-annlises soo 0 melhor meio 
de obter conhecimento atuolizado em Medicina I 
I +-- i 
I 
__________ ___ ____ _______ _______ ____ ____ _--,__________ _ _________ -I--
--
I I 
Vies ( biu» de publi(Q~oo e uma omea~ 0 quolidode de : I i 
I 
revisiies sistematicas e meta-anOlises iii
I 
------- - -- ------- -+------------1 - I· 1 
I 
-----
As tendendosidades em ensaios c1inicos rondomizodos i I I 
podem cousar oltem~iies nos futuros meto-analises I I I i 
7 Em sua opiniao, como 0 conhecimento sobre vies em pesquisa poderia ser transmitido aos alunos de 
um curso de Medicina? 
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8 Voce acredita que sejam necessarias mudanyas curriculares nos cursos de Medicina atuais para que 
a questao das tendenciosidades (vies, bias) em pesquisa medica seja transmitida aos alunos? 
DSim 
o Nao 
9 Caso tenha respondido Sim, quais seriam essas mudanyas? 
1 0 Concordaria com uma entrevista pessoal, caso seja necessario, para aprofundar aspectos do presente 
questionario? 
o Sim 
o Nfio 
1 1 Caso concorde, com a garantia de que em nenhum momento sera rompido 0 compromisso de anonimidade 
dos participantes durante a apresentaqao dos resultados desta pesquisa, permitiria que ela fosse gravada 
para analise posterior? 
o Sim 
o Nfio 
Nome * ................ . 
Endereyo * ...... ..... ..... ............................. . ............. . 
Cidade/Estado * 
Telefone * 
Departamento. 
( • ) = Opcional 
.. E·mail *. 
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. .......... CEP* ........................... . 
4. Student Questionnaire translated 
Research on the relationship between medical education and bias in medical research 
1 How would you rate your present knowledge about bias in medical research? 
o High 
o Average 
o low 
o None (if none, please go to Question 3) 
2 Which was the method that helped you to acquire your present knowledge about systematic deviations 
( bias) in medical research? I Tick one or more boxes) 
o The curricular courses for graduation 
o Books about methodology of research 
o Medicol congresses or conferences 
o Medical journals. Please cite one .. 
o Special courses. Please cite one .. 
o The Internet 
o Other. Please specify 
3 How often did your teachers discuss the problem of methodological deviations ( bias) with you in the 
last year? 
o Frequently 
o Rarely 
o Never 
o I do not remember 
4 How much did your evaluation of papers published in medical journals change with the acquisition of 
knowledge about bias? Please explain. 
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5 In relation to the problem of methodological deviations ( bias) in medical research you believe that: 
( Please tick) 
It is a problem of scientific 
methodology, with no relation to: 
undergraduate medical courses 
Courses of scientific methodology are 
responsible for the transmission of 
knowledge about bias 
Methodological deviations (bias) in i 
medical research are progressively i 
becoming an ethical issue 
Medical journals are responsible for 
the evaluation of methodological 
deviations in papers they publish 
Strongly 
agree Agree 
r----
Disagree 
, 
Strongly 
disagree 
_L ___ _ 
Do not have 
on opinion 
6 In the statements below choose the alternative that is more compatible with your personal opinion: 
( Please lick) 
I Strongly 
t agree 
--------- --1·-
Systematic reviews and meta-analyses 
are the best ways to acquire valid 
knowledge in medicine 
Publication bias is a menace to the i 
quality of systematic reviews and 
meta-analyses ' 
Systematic deviations ( bias ) in I 
randomised clinical trials may I 
exaggerate the results of future 
meta-analvses 
Agree Disagree 
- -1. 
Strongly 
disagree 
Do not have 
on opinion 
~ ---
I 
7 In your opinion, how should the knowledge about bias in research be transferred to the students 
of a medical school? 
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8 Do you believe that changes in the curricula of medical schools are necessary in order to achieve 
a better transference of knowledge about bias in medical research? 
DYes 
D No 
9 If your answer to the previous question was Yes, what should be changed? 
1 0 Do you agree with a personal interview, if necessary, to enlighten some aspects of the present 
questionnaire? 
DYes 
D No 
1 1 If you agree, provided that the anonymity 01 participants atthe presentation of the results of this research is assure4 would 
you permit the interview to be recorded for posterior analysis? 
DYes 
D No 
Name * . 
Address * 
City/State * ...... .. . 
Telephone * . 
! *) = Optionol 
. .......... Code * 
..Email * .. 
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[Teacher questionnaire] 
Research on the relationship between medical education 
and bias in medical research 
1 Your present occupation: (tick more than one if necessary) 
o Teaching 1 
o Research 2 
o Extension 3 
o Administration 4 
2 Have you published papers in the last 5 years? (tick more than one if necessary) 
o Yes, in Brazil 1 
o Yes, in foreign countries (please cite countries) 2 
o No, I have not published papers in the last 5 years 3 
3 Which was (were) the language(s) of publication? (tick more than one ifnecessary) 
o Portuguese 1 
o Spanish 2 
o English 3 
o Other 4 
None 0 
4 Your academic background is: 
o Specialist 1 
o Masters 2 
o Doctoral 3 
o Post-doctoral studies 4 
5 Which was the method that helped you to acquire your present knowledge about 
systematic deviations (bias) in medical research? (tick one or more boxes) 
o Books about methodology of research 
o Medical congresses or conferences 
o Medical journals. Please cite one 
o Special courses. Please cite one 
o The Internet 
o Other (please specify) 
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1 
2 
3 
4 
5 
6 
6 How often did you discuss the problem of methodological deviations (bias) with your 
students in the last year? 
o Frequently 
o Rarely 
o Never 
o I do not remember 
1 
2 
3 
4 
7 How much did your evaluation of papers published in medical journals change with 
the acquisition of knowledge about bias? Please explain. 
8 In relation to the problem of methodological deviations (bias) in medical research you 
believe that: (please tick) 
Strongly Agree Disagree Strongly ! Do not have 
agree desagree an opinion 
It is a problem of scientific methodology, with 1 2 3 4 0 
no relation to undergraduate medical courses 
Courses of scientific methodology are 
responsible for the transmission of knowledge 1 2 4 3 0 
about bias I I 
The methodological deviations (bias) in 
medical research are progressively becoming 4 3 2 1 0 
an ethical issue 
Medical journals are responsible for the I I i 
evaluation of methodological deviations in 4 i 3 2 I 1 i 0 ! 
I papers they publish I I 
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9 In the statements below choose the alternative that is most compatible with your 
personal opinion? (please tick) 
I Strongly Agree I Disagree Strongly Do not have 
agree 
I 
disagree an opinion 
Systematic reviews and meta-analyses are the 
best ways to acquire valid knowledge in 3 4 2 1 0 
medicine 
Publication bias is a menace to the quality of \ 4 I 3 2 1 0 
systematic reviews and meta-analyses I 
I I 
-- I I 
Systematic deviations (bias) in randomised I I 
, 
I I 
clinical trials may exaggerate the results of i 4 
I 
3 
I 
2 1 0 
future meta-analyses I 
I I 
lOIn your opinion, how should the knowledge about bias in research be transferred to 
the students of a medical school? 
11 Do you believe that changes in the curricula of medical schools are necessary in order 
to achieve a better transference of knowledge about bias in medical research? 
DYes 
o No 
12 If your answer to the previous question was Yes, what should be changed? 
2'/6 
13 Do you agree with a personal interview, if necessary, to enlighten some aspects of the 
present questionnaire? 
DYes 
o No 
14 If you agree, provided that it is assured the anonymity of participants at the 
presentation ofthe results ofthis research, would you permit the interview to be 
recorded for posterior analyses? 
DYes 
o No 
Name* 
Address* ................................................................................ . 
... ... ... ... ... ... ...... ... ... ............. ... ... City / State* ..................... , ................................. . 
Z11>* ................... Telephone* ............................. Email* ............................................. . 
( *) = Optional 
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[Student questionnaire] 
Research on the relationship between medical education 
and bias in medical research 
1 How would you rate your present knowledge about bias in medical research? 
o High 
o Average 
o Low 
o None (ifnone, please go to question 3) 
4 
3 
2 
1 
2 Which was the method that helped you to acquire your present knowledge about 
systematic deviations (bias) in medical research? (tick one or more boxes) 
o The curricular courses for graduation 
o Books about methodology of research 
o Medical congresses or conferences 
o Medical journals. Please cite one 
o Special courses. Please cite one 
o The Internet 
o Other. Please specify 
1 
2 
3 
4 
5 
6 
7 
3 How often did your teachers discuss the problem of methodological deviations (bias) 
with you in the last year? 
o Frequently 
o Rarely 
o Never 
o I do not remember 
1 
2 
3 
4 
4 How much did your evaluation of papers published in medical journals change with 
the acquisition of knowledge about bias? Please explain. 
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5 In relation to the problem of methodological deviations (bias) in medical research you 
believe that: (please tick) 
I 
Strongly Agree Disagree i Strongly I Do not habe 
agree 
I 
disagree I an opinion 
--------j 
I It is a problem of scientific methodology, with 1 2 3 \ 4 0 
no relation to undergraduate medical courses I I ! f-------- i i 
Courses of scientific methodology are I 
i 
I 
responsible for the transmission of knowledge 1 2 4 3 0 
about bias 
I I I I 
The methodological deviations (bias) in I 
I 
I 
I medical research are progressively becoming 4 3 2 I 1 0 an ethical issue I I I 
, 
• 
Medical journals are responsible for the 
evaluation of methodological deviations in 4 3 2 1 0 
papers they publish , 
i 1 
6 In the statements below choose the alternative that is more compatible with your 
personal opinion: (please tick) 
Strongly 
agree Agree I 
-.l 
Systematic reviews and meta-analyses are the I 
best way to acquire valid knowledge in i 3 4 
medicine I 
[ 
! 
Publication bias is a menace to the quality of I' 4 
systematic reviews and meta-analyses , 3 
I 
---------------------, 
Systematic deviations (bias) in randomised I 
Disagree 
2 
2 
Strongly 
disagree 
1 
1 
Do not have 
an opinion 
o 
o 
clinical trials may exaggerate the results of I 4 3 2 1 0 
future meta-analyses 
I 
I 
I 
7 In your opinion, how should the knowledge about bias in research be transferred to 
the students of a medical school? 
279 
8 Do you believe that changes in the curricula of medical schools are necessary in order 
to achieve a better transference of knowledge about bias in medical research? 
DYes 
o No 
9 If your answer to the previous question was Yes, what should be changed? 
10 Do you agree with a personal interview, if necessary, to enlighten some aspects of the 
present questionnaire? 
DYes 
o No 
11 If you agree, provided that it is assured the anonymity of participants at the 
presentation of the results of this research, would you permit the interview to be 
recorded for posterior analyses? 
DYes 
o No 
Name * 
Address* ................................................................................................................... . 
... ... ... .. .. .. ... ...... .. ............ ... ... City / State* ............................................................... . 
ZIP* ......................... Telephone* .......................... Email* .......................................... . 
( *) = Optional 
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Teacher Questionnaire Responses 
Q1 Q2 -I -Q; I Q4 I Q5 I Q6 Q8a 1~8~ Q8e R~~r Q9b I Qge I Q11 
1 1 1 I 1 I 2 I 1 and 4 i 2 +-+-1 4 Yes 
1 1 I .1 I 1 I 4 i 3 i. 1 I 1 Yes 
1--1 and4 1 and2 I 1 and3 I 3 I 1,2and5 I 2 ; 2 I 4 i Yes 
·1 and 2 I 1 I 1 ! 3 I 1 and 4 I 1 i 2 i. 2 I Yes 
1 and 2 3 i 0 i 2 6 i 4 4 i 2 Yes 
1 and 4 3! 0 I 1 i 1 and 6 i 2 I ? I 2 i Yes 
1,3 and 4 3 I 0 I 2 1 1 i 2 I 3. i 2 I Yes 
1 1 I ~1. i11 51 3 '21 0 iNo 
1 3 f 0 I 1 I 2and4 i 2 1 3 I 1 L~ 
1 and 3 1 i 1 I 1 I 1 and 3 I 3 I 3 I 2 1 Yes 
1 1 and 2 I 1 and 3 ! 3 I 1 . I 3 4 2 3 I 3 I 4 ! 0 ± 3 lJ'lc> ~~1~ __ r--. 3 I 0 i 1 I 6. I 3 2 3 4 I 1 : 3 'I 0 J2 .. L Yes 
1 and 2 3 0 L. 1 I 1 ... I 3 4 . 2 2 3; 4 : 4 I :3...LY_'C5.. 
1,2,3 and 4 1 3' 2 I 1,2,3,5 and 6 1 4 i 2 4 3 I 3 I 3 4 I Yes 
1 and 2 1 and 2 1,2 and 3 I 3 I 1 and 4 I 2 i 3 I 4 . 3 3 I 4 I 3 3 i Yes 
1 and 2 1 1 and 3 I 2 I 1,3 and 6 I 1 j 4 i 4 4 2.1 ~~_ I 3 3 I No 
I 1 and 4 1 1.....l 3 i 3 and 4 i 2 i 4 .1 1 4 4 r 3 l 2 i~]~ No 
1 and 3 1 1 I 3 I 2 I 2 I 3 1: 3 I 3 ' 2 I 3 I 3 1 No 
1and2 1and2 1and3 i 3! 1and2 I 1 r 4 I 1 I 3 I 3 I.LL.l __ ~-
I 1,2 and 3 1 I 1. i 3 I 1 and 4 I 1 I .4 I 2 I 0 I 3i 4 1 3 4 I Yes 
1 and2 1 I 1 i .2 I 1 and 6 I 1 I 4 L.2 : 2 I 2 i 3 I 3 .j_~ 
1,2,3 and 4 1 I 1 I 2 I 3 I 3 i 2 i 3 3 2 I 4 I 4 2 I Yes 
1 3 I 0 I 1! 1 and 2 I 2 i 3 i 3 3 I 3 I 1 I 3 3 I No 
1,2 and 3 r 3 I 1,2 and 5 I 1 I 4 IT· I 1 i 3 I 4 I 3 I 3 INa 
1 3 0 I 1 I 2 I 3 I 3 I 0 .I 3 1 3 I 0 I 0 0 Yes 
1 1 1 I 2 I 4 I 1 I 2 i 2 I 3 I 4 I 4 2 3 Yes 
I 1,2 and 4 1 and 2 3! 4 I 1 and 4 I. 2 I 3 I 2 L.l..... 2 I 2 3 3 No 
1,2 and 3 1 and 2 1 and 3 I 4 i 6 I 1 i 4 i 2 i 2 0 I 2 3 3 Yes 
1,2,3 and 4 1and2 I 3 I 4 1,2and5 I 1 :-3 J 2 I 3 2 I 2 3 3! Yes 
1,2 and 3 1 i. 1 ! 2 6 I 2 L· 3 2, 3 i 3 I 4. 4 3 I Yes 
1 1 1 ._. I 3 2 I 3 0, _2.i-- 0 ! 0 ,4 0 i . o_~_ 
1 and 2 1 and 2 1 and 3 i 3 , 1,2,3,4and 5 I 1 2 r 1..._ 4 I 4 ; 3 I 3 I 4 I Yes-l 
1 and 2 1 i 1~i. 3 ! 1,2 and 5 I 2 I 3 ! 1 i 4 i 2 I' 2 I 3 3 I No 
1,2,3 and 4 1 I 1 and 3 t 2 i 1,2 and 4 I 2 I 4 I 2 I 3 I 2 3 I 3 I 3 I Yes 
1,2,3 and 4 1 and 2 .' . 1 and 3 T 4 I 1 and 2 I 3L 4 i 4 I 3 1 I 3 I 3 3 i Yes 
1 and 2 1 and 2 1 and 3 ! 2: 4 ! 2 I 4 ! 2 i 3 i 2 i 4 3 3! Yes 
1,2 and 3 1 and 2 I 1 and 3 I 3 i 1 and 3 I 1 I 4 T 2 i 3 ! 3 I 2 i 4 3 I No 
1,2,3 and 4 I I 3 I 1,2 and 5 I 1 I 4 I 2 4 I 2 I 2 I 1 I 3 I Yes 
1 and 2 1 and 2 1 and 3 I 3 I 1 and 5 I 1 I 2 I 1 I 4 I 3 I 4 I 3 I 3 I Yes 
1,2,3 and 4 I 1 and 2 1 and 3 I 3 I 1,2 and 3 I 1 I 4 I 2 I 1 I 4 I 2 I 1 I 3 I Yes 
1,2 and 4 I 1 and 2 1 and 2 I 3 I 5 I 2 I 3 I 1 I 4 I 1 I 4 I 3 I 3 I No 
1,2 and 4 I I 3 I I 1 I 3 I 1 I 3 I 4 I 2 I 3 I 4 I Yes 
1,2 and 4 I I 3 I 2 I 3 I 4 I 1 I 3 I 3 I 4 I 4 I 4. I Yes 
1 and 2 1 and 3 I 2 I I 2 I 4 I 2 I 2 I 3 I 4 I 2 I 3 I Yes 
1,2 and 4 ! 2,3 and 6 1 i 3 J.. 2 3 I 3 4 1 3 .t--,,~o __ 
1,2 and 3 1,2 and 5 2 I 3 I. 4 4 ~ 2 4 3 4 i No. 
1 and 2 1 I 2 4 i 4 3! 4 3 2 2 I Yes 
1,2 and 3 I 1 and 2 1 and 3 I 3 I 1,2,3 and 4 I 2 I 2 I 2 I 2 I 3 I 3 I 2 I 3 I Yes 
1 and 4 1 and 2 1 and 3 I 3 I 1,2 and 5 I 2 I 4 I 2 I 4 I 4 I 3 I 4 I 4 I Yes 
1,2 and 4 I 1 and 2 1 and 3 I 3 I 6 I 2 I 2 I 4 I 3 I 3 I 1 I 3 I 3 I Yes 
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Teacher Questionnaire Responses 
(continued) 
Q1 -I -02-~ I Q4 I Q5 I Q6 ia8~8b I Q8e IQ8d I Q9a I Q9~ I Qge I Q11 
- .... _--
3 0 I 2 I 1 and 2 I 2 I 3 2 I 3 ! 3 I 0 I 0 I 0 Yes 
1 and 2 1 3 0 1 1 1,2 and 5 2 [ 2 I 2 i 3 1 4 I 4 1 3 I 3 1 No 
tfand 2 I 1 and 2 3 I 3 :----- 1 2 4 I 1 ! 4 I 3 ! 4 ! 4 ! 4 ; Y~! 
1 and 2 I 1 1 12 1 2 4! 2 1 3 -I+t 2 I 3 1 3 ' No J 
and 2 I 1 and 2 3 I 3 2,3 and 5 1 2 I 2 1 4 1 ~ 1 I 4 3 I Yes 
1 I 3 I 0 I 2 2 and 6 2 4 I 2 1 n 4 I 4 I 3 I 4 , Yes 
1 and 2 1 and 2 1 and 3 1 2 i I 1 4 1 3 I 4' 4 4 i 4 I 4 i Yes 
1and2 1and2 land3 2 3 11 i f ~~~_ 4 4 No 
1,2,3 and 4 3 0 3 2 and 3 2 I 3 I 2 I 4 I 4 I 0 0 4 Yes 
1 and 3 I 2 0 I 3 1 0 I 2 0 I 3 \ 2 0 I 3 No 
~-,-3and4 1 and2 1 and 3 3 ~I- 2and5 2 3 2 i 3 -I :3 4_1_3--T.~ I Ye~ 
4 1 1 2 1 2 and 3 3 3 4 I 3 1 3 3 I 3 i 4\Yes 
~llnd 4 1 ----J---f-3-- .. 1,2,3,4,5 ancl~~_~_LL_f_4_I, ___ 1 _LLJ 
1 3 0 3 4 3\312 2,4121'-=-_~~ __ + 
1 and2 1 and 2 1 and3 1 4 2,3and5 2 I 1 11 I 2 I 3 j 0 '~-f--~-+-~ 
1 and 4 3 0 I 2 6 3 I 4 1 4 I 3 ! 2 , 4 1 Yes 
1 1 I 1 I 2 i 1 and 3 2 I 4 I 2 3 I 3 I 2 I No 
1,2,3 and 4 I 1 and 3 I 2 I 2 and 5 I 2 I 4 I 4 I 3 ! 2 ' 3 I Yes 
1,3 and 4 2 2 and 3 3!. 3 1. ~L.Li~--+--4-Ll-L-r~~ 
1 1 and 2 1 and 3 4 1 3 1_3 1 _ I 3 I 3 1 4 I 3 I 3 I No 
1 and 4 2 2 I 1 I 2 I 2 I 3 I 2 I 3 3 -[ -2-1 3 1 3 I Yes 
1,3 and 4 I I 2 4 I 3 I 4 I 4 I 3 1 2 2 I 2 1 3 1 Yes 
1 and 2 3 3 4 2 3 No 
1,2and3 3 2 2 3 3 Yes 
1,2 and 3 1 1 I 2 1,2 and 4 2 1 3 I 4 I 3 I 2 I ,.i...l 3 I 3 l Yes 
1,2,3 and 4 1 and 2 1 and 3 1 1,2,3 and 4 1 I 4 I 4 I 3 I ~ 2 I 2 I 3 L~ 
1 and 3 3 0' 2 4 3 I 3 I 2 i 4 ; 3 ; ~~ __ ~I _3_~; No ~~nd2 1 and 2 1,2and3 3 1,2and5 2 I 4 T 2 I 3 _t--_3_1_ ~_~1_4_1- Yes I 
1 1 and 3 1 1 2 I 1 1 1 4 I 2 1 3 I 2 . 4 1 3 I 2 : No 
.------ ~ -+-----n--1--
3 1 and 2 3 3 1 2 i 2 1 3 i 4 J 3 r 3 i 4 ; 2 • 2 , Yes 
o 2 0 4: 0 T 0 I Yes ~=-=-+--~~o;----+--~+-- 4 I 4 TTl -4---~ 
3i21313 No .---=-+-----;--=-;=-----+-.-~-+-;c-+--~--t------r;--t------r;--t---.--t----.--t--4-.----t1 4...L..LJ. 4 Yes 
4 1 2 I 0 1 3 I Yes 
1 and 4 3 0 I 2 [1 and 4 121 3, 2 T-3 13 2~1 3 13 ' No 
1 and 2 1 and 2 1 and 3 I 3 I 2 1 2 I 1 I 1 I 3 1 4 I 3 4 I 4 i Yes 
1,2,3 and 4 I 1 and 2 I 1,2 and 3 I 3 I 2 I 2 I 2 I 2 I 2 I 3 I 4 I 3 I 3 1 Yes 
1 and 2 I 2 I 3 and 4 I 2 I 4 I 2 I 2 I 2 I 2 1 1 I 3 I Yes 
1,2,3 and 4 I 1 and 2 1 and 3 I 2 I 5 I 2 I 3 I 2 I 4 I 4 I 2 I 4 I 3 I Yes 
1,2,3 and 4 I 1 and 2 I 1,2 and 3 I 2 I 3 and 4 I 2 I 3 I 1 I 3 I 4 I 4 I 3 I 4 I No 
1 and 2 1 and 2 3 I 3 1 2 1 3 1 3 1 2 1 3 1 4 I 2 1 3 1 4 1 Yes 
1,2,3 and 4 4 r_~ 3, 4 4! No 
1,2,3 and 4 2 I 2 i 3 3 4 ~ 
1 2 I 3 2 1 2 I Yes 
131211141414131413131No 
1 and 2 I 2 I 1,2 and 6 1 2 I 4 I 2 I 3 1 2 1 4 1 3 1 3 1 Yes 
1 and 2 I 3 I 1,2 and 6 I 1 I 4 I 2 1 3 I 3 ! 4 I 4 I 4 1 Yes 
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Student Questionnaire Responses 
Q1 Q2 Q3 Q5a I ~_ Q5~-- r Q5d -J Q6a -1 Q6b 
2 3 3 4 2 I 3 4·2 I 3 4 
I Q6e Q8 
L.. __ • _ "----yes 
3 3 3 3 2 4 4 4 No 
2 1 2 3 2 3 2 4 4 3~~ 
2 1 2 4 2 2 3 4 2 3_+----6'!:0 
2 3 2 3 2 2 2 4 3 3,~ 
2 2 3 :3 2 4 3 3 0 0 Yes 
2! 112 13 2 I 3 3 41213 I No 
1 i 7 I 3 ; 0 0 0 0 0 I 0 I 01- Yes 
2 I 1and"3--r=:2 --l---O--r-- 4 3 0 2 r 3 I 4 I Yes -1 
3 I 1 and 7 -r 2 ! 3 2 1 4 2 I 3 I 4 ~ 
2 I 1,2 and 3 I 3 f 4 I 2 3 I 2 I 2 I 3 I 3 I Yes 
4 I 2 and 4 3 3 4 2 3 2 3 3 Yes 
3 1 and 3 3 3 2 3 3 2 3 3 Yes 
2 Yes 
-2-- Yes 
-3 -- Yes 
2 1 and 5 I 2 I 3 I 2 T 4 3l 3 I 3 I 3 I Yes 1 
ffi-..1.~nd 6_~--[ 4 4 I 3 3 I 2 I 3 ; 3 I Yes_I 3 _.1...3,6and7 i __ ~ ___ L3 2 I 3 4 I 3 I. 3 I 3 I Yes _ 3 ! 1,3,6andTl 1 I 3 2' 4 I 4 2 I 4 I 3 : Yes 3 I 1 and 6 2 3 2 2 3 2 2 2 Yes 
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N 
00 
~ 
INTERVIEWS' CODING 
(NODES FOR NUD*IST®, USING THEMATIC ANALYSIS) 
1. CASEDATA 
1.1 Participant 
1.2 Title 
1.2.1 Student 
1.2.2 Specialist 
1.2.3 Master 
1.2.4 Doctor 
1.3 School 
1.3.1 PUC 
1.3.2 UEL 
1.3.3 UEM 
1.3.4 UFPR 
1.3.5 UNIOESTE 
1.4 Gender 
1.4.1 female 
1.4.2 male 
1.5 Coded? 
1.5.1 Yes 
1.5.2 No 
1.6 Date of Coding: 
1. 7 Department: 
1.8 Average: 
2. QUESTIONNAIRES' RESPONSE RATE 
2.1 reasons 
2.1.1 language of publications 
2.1.2 lack of interest 
2.1.3 lack of knowledge 
2.1.4 lack oftime 
2.1.5 other priorities 
2.1.5.1 work 
2.1.5.2 residency 
2.2 contact with non-respondents 
2.2.1 possible 
2.2.2 impossible 
3. BIAS IN MEDICAL RESEARCH 
3.1 responsibility for their existence 
3.1.1 medical education 
3.1.1.1 graduation 
3 .1.1.2 post-graduation 
3.1.2 researcher behaviour 
3.1.2.1 misconduct 
3.1.2.2 lack of knowledge 
3.1.2.3 other 
3.1.3 external influences 
3.1.3.1 pharmaceutical companies 
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3.1.3.2 career demands 
3.1.3.3 other 
4. POSSIBLE SOLUTIONS FOR THE PROBLEM 
4.1 methodological 
4.2 educational 
4.2.1 curriculum modification? 
4.2.1.1 Yes 
4.2.1.1.1 participant proposal 
4.2.1.2 No 
4.2.2 scientific methodology course 
4.2.2.1 necessary 
4.2.2.1.1 participant proposal 
4.2.2.2 unnecessary 
4.3 other solutions 
5. QUESTIONAIRE RESPONSES 
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SAMPLE OF THE INTERVIEWS 
(TRANSCRIBED AND TRANSLATED) 
(#) = Omitted in order to maintain anonymity of the participant 
* Teacher (#) 
* School: (#) 
* Title: (#) 
Participant: (#) 
Title: (#) 
School: (#) 
Gender: (#) 
Coded? 
Date of Coding: 
Department: (#) 
Researcher: First of all, I would like to thank you for participating in this research. I 
would also like to reinforce, as already expressed in the questionnaires, that I will keep 
the anonymity ofthe participants in all the phases of the research. 
Teacher: I understand ... 
* Ql Researcher: Well ... despite all my efforts, the number of teachers and students that 
answered the questionnaires was lower than the what can be found in international 
publications. In your opinion, which could be the possible causes of this low response 
rate? 
Teacher: Well ... there is a lack of motivation ... it really reveals a reality ... Most of the 
times that we need an answer, the health professional does not cooperate ... this is not 
related only to your research ... When asked why, they allege lack of time, that it is only 
287 
one more paper to fill in ... they do not understand what they can profit from that ... 
Another possibility is that this kind of matter, of problem, does not affect them ... 
* Q2 Researcher: You said that this kind of problem does not affect them ... Do you 
mean that they do not see this subject as a problem? 
Teacher: Yes ... this is not a priority ... do you understand? Maybe they can not see what 
you are researching as a problem ... Also, many teachers are not very familiar with 
scientific methodology, and probably would not like to disclose such a lack of knowledge 
about the matter ... In the case of the students ... well ... I believe that most of them do 
not have at the moment enough knowledge about medical research to answer your 
questionnaire ... Also, there is something that I call the 'residency paranoia' ... which in 
fact is being a problem in the last years ... You said that you have not been a teacher in a 
medical school in the last 25 years ... Well ... A lot of things changed in the medical 
schools in the last 20 years ... People that dedicate themselves only to teaching and 
researching inside the medical schools are becoming very rare these days ... Most of the 
new teachers are in the schools just because of the status that comes with the title of 
teacher, or for fmancial reasons ... They have a different mentality, which they are, in a 
certain way, transmitting to the students ... You may not believe, but I have received in 
my office students that have just entered the medical school asking what they have to do 
in order to secure a place in our residency program! ... My God! ... This is something 
that should be a problem for them almost six years ahead! ... The normal undergraduate 
program that should entitle them to be a physician is becoming just a kind of 'ritual 
passage' to their specialisation programmes ... 
*Q3 Researcher: Well ... You said that there is a lack of knowledge about the subject of 
bias in medical research among the students ... However, in the questionnaire you 
declared that you do not think that a curricular change would be necessary in order to 
transmit such a knowledge ... Could you please give me your opinion about how and 
when such knowledge should be available to the students? 
Teacher: I must confess that I am not very fond of curricular changes ... Most ofthe time 
such changes cause a lot of problems to be done, and the results are far less effective than 
expected ... You will face several difficulties in order to introduce a new field of 
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knowledge in the present curriculum structure ... I believe that the introduction to the 
basic knowledge about medical research and scientific methodology could be something 
that everyone of the several existent Departments could implement in their normal 
courses ... Of course, this would entail some changes in the way people think and act that 
might not be so simple to achieve ... In fact, I also think that such a subject is so 
important that it should be left to the post-graduation courses ... After all, people need to 
prepare themselves to be a medical researcher, isn't it? ... The undergraduate medical 
courses are not exactly the best place to discuss such kind of information ... the student 
should focus on learning how to be a good physician ... If then, after graduating, he/she 
decides that wants to do medical research ... well ... he/she should do a good post-
graduation training ... Too much research nowadays is being done like baking a cake ... 
you follow a recipe ... put all the ingredients ... shake well ... and then say that you have 
done a research ... This is not correct, I believe ... It is only the best way to perpetrate 
serious mistakes .. . 
*Q4 Researcher: Yes, serious mistakes can occur if you do a research like that ... And in 
your opinion these mistakes are occurring more due to lack of knowledge about the 
correct methodology or due to scientific misconduct of the researchers? 
Teacher: Defmitively due to lack of knowledge! ... Defmitively ... Many post-graduation 
courses are not really preparing people to be good researchers ... They are only machines 
to print Masters and Doctoral diplomas ... and make money ... of course ... There are 
some cases of overt scientific misconduct, but I believe that these are, hopefully, 
occurring in a small number of researches. In fact, if you want to reduce the number of 
bias in medical research, you will have to focus on the post-graduation courses ... It is 
there, not in the undergraduate medical courses, that the problem has its roots ... Also, 
there is the problem that much research is being done inside the medical schools for the 
wrong reasons ... because people need to publish ... just because of their status inside the 
medical schools ... However, these are generally repetitions or adaptations of previous 
researches that will be published in some secondary journal and disappear ... I do not see 
them as necessarily harmful to medical knowledge ... just dispensable ... time and 
resources consuming ... just that ... The real problem is that the medical students may see 
such a behaviour as normal ... This is a real problem ... because they are going to repeat 
and amplify the same mistake ... unfortunately ... 
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*Q5 Researcher: And the influence of the pharmaceutical companies on medical 
research? Do you believe that it may be an important cause of bias? 
Teacher: Well ... I do not believe that it is a problem in Brazil ... However, I am aware 
that this is a problem in the developed countries ... I was thinking only about medical 
research here ... As everybody knows, our medical research is in its early stages ... 
probably it is not considered as important by pharmaceutical companies ... See ... I am 
not saying that we are less permissive than the researchers in other countries ... it is just a 
question of opportunity ... If they begin to spend in medical research what they spend, for 
instance, in the USA ... well ... you will see queues of Brazilian researchers asking for 
money ... Only then, I believe that we will begin to have problems related to these 
relationships ... In fact ... just as an example ... I can say to you that I believe that the 
low level of resources to do a good research project, and the unrealistically small period 
of time that we are allowed to dedicate to do a research, are probably much more 
important causes of bias than the pharmaceutical industries influence ... at the moment ... 
for sure ... This way of seeing medical research is causing much more harm ... You see 
people trying to evaluate a drug or a medical procedure in half the time, and with half of 
the resources needed ... and what can you get as a result? ... Obviously, nothing! ... 
*Q6 Researcher: If you permit me, I would like to return to the problem of lack of 
knowledge about research methodology and the problem of bias in medical research. As 
these subjects are being published essentially in American and UK journals, do you 
believe that people are not reading them due to a language barrier? 
Teacher: Absolutely not! ... People can give you hundreds of excuses for not knowing 
about the subject, ranging from lack of time to lack of interest ... but not that! ... Modem 
medicine is essentially based in books and journals in English in Brazil ... even our best 
journals are publishing now papers in English ... That is certainly not a good excuse for 
the present lack of knowledge about these matters ... Ten or twenty years ago this could 
be a good excuse ... not because of the language, but because of the access to these 
information ... but certainly not now ... 
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*Q7 Researcher: Well ... Although at the beginning of our conversation you have already 
stated some of your beliefs about what should be done, could you please give more details 
about what could be done in medical education in order to reduce the problem of bias in 
medical research? 
Teacher: Well ... when we started this conversation I had a very clear idea about what 
should be done ... However, ... and this is point ... and this is the interesting thing of 
having such conversations ... I believe that something really has to change in the 
undergraduate medical courses ... The problem is that I have been a teacher for a long 
time ... I do not believe in magic changes in a medical school anymore ... In fact, I 
believe that at the end of your research you will probably have collected many opinions, 
an then I would like to read your work ... and think about another possible solution ... 
However, I still insist that the main changes that must be done are in the post-graduation 
courses ... for sure ... Also, we must reinforce the critical evaluation of the researches 
that are done inside the medical schools ... This would reduce the possibility of people 
that are not prepared to do biased research protocols and results, and also reduce what 
could be called an "educational bias" in the minds of our students, who graduate thinking 
that medical research can be done in such a way ... Finally, I strongly defend the position 
that we should have a clear separation between teaching and research ... this would 
reduce a lot the number of researches that are unimportant or even deliberately biased ... 
I am not saying that most of these researches are being intentionally biased ... just that 
most of them are definitively unimportant ... 
*Researcher: Do not worry ... At the end of this research you and all the participants who 
sent me their addresses or email will certainly receive the final conclusions of my work. 
Teacher: That will be very helpful ... It can help us to see the problem from a different 
perspective ... 
*Q9 Researcher: I know that the time you gently allowed me to do this interview is 
almost ending, but I would like to ask you an advice ... Do you believe I could convince 
some of the non-respondents to the questionnaires to be interviewed? 
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Teacher: I am sorry to say that I do not believe you will be able to do that ... I believe 
that those teachers who wanted to collaborate to your research are the ones that sent you 
their questionnaires ... In relation to the students ... well ... in our telephone contact you 
said that you would do (number of interviews omitted by the researcher) students' 
interviews ... I believe that it is more or less the number of students that are involved in 
our scientific initiation programmes at the moment ... Sorry, but I do not believe you will 
be able to convince the others ... they do not have much to tell you about the subject 
matter of your research ... 
* Researcher: Thank you for the advice ... 
END OF RECORDING 
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